Freeze-Dried Chitosan Platelet-Rich Plasma Hybrids for Rotator Cuff Tear Repair by Déprés Tremblay, Gabrielle
 UNIVERSITÉ DE MONTRÉAL 
 
 
 
FREEZE-DRIED CHITOSAN PLATELET-RICH PLASMA HYBRIDS FOR ROTATOR CUFF 
TEAR REPAIR 
 
 
 
 
GABRIELLE DÉPRÉS TREMBLAY 
INSTITUT DE GÉNIE BIOMÉDICAL 
ÉCOLE POLYTECHNIQUE DE MONTRÉAL 
 
 
 
THÈSE PRÉSENTÉE EN VUE DE L’OBTENTION  
DU DIPLÔME DE PHILOSOPHIAE DOCTOR  
(GÉNIE BIOMÉDICAL) 
JUILLET 2017 
 
 
© Gabrielle Déprés Tremblay, 2017.  
  
 
 
UNIVERSITÉ DE MONTRÉAL 
 
ÉCOLE POLYTECHNIQUE DE MONTRÉAL 
 
 
 
Cette thèse intitulée:  
 
FREEZE-DRIED CHITOSAN PLATELET-RICH PLASMA HYBRIDS FOR ROTATOR CUFF 
TEAR REPAIR 
 
 
présentée par : DÉPRÉS TREMBLAY Gabrielle  
en vue de l’obtention du diplôme de : Philosophiae Doctor  
a été dûment acceptée par le jury d’examen constitué de : 
Mme HOEMANN Caroline, Ph. D, présidente 
M. BUSCHMANN Michael, Ph. D, membre et directeur de recherche 
M. NAZHAT Showan, Ph. D, P. Eng, membre 
Mme GALATZ Leesa M, MD, membre externe 
iii 
 
DEDICATION 
TO MY BELOVED FAMILY 
iv 
 
ACKNOWLEDGEMENTS 
This is the end; the end of my Ph. D journey, but the beginning of a new journey. 
Although it seems short, it was the most stimulating and challenging experience yet. This thesis 
embraces time and work from many valuable people. First, I would like to thank my director Dr. 
Buschmann for this wonderful experience. He gave me the chance to work in his laboratory, to 
perform and also to work on the project I really wanted. Moreover, his directions and effective 
discussions helped me built strong analytical and problem-solving skills and also to develop deep 
interest in the research field. Without his illuminating instructions, this thesis could not have 
reached this present form. I need to thank him for his encouragement, guidance, coaching, and 
most of all, his patience with me. Thank you for the trust you had in me.   
I would also like to express my profound gratitude to my amazing supervisor, Anik 
Chevrier. Anik has been wonderful to me; she helped me every time I needed it, she listened to 
me, she guided me, she always took time for me no matter what and she walked me through all of 
the stages of my project. I was lucky to work with her, if it would not been for her I would 
probably not have been here today and passionate about my project. I acknowledge your 
generosity and enthusiasm Anik. Thank you so much for the material, psychological and 
intellectual support you provided me over my Ph. D journey.  Special thank you go to professors 
Caroline Hoemann and, Leesa Galatz, and Showan Nazhar for being members of my thesis 
committee. I’m really thankful for all your assistance.  
During that time, I also had, the opportunity to make incredible and loyal friends and to 
cross paths with so many other colleagues with whom I had the chance to share theories, fears, 
joys, doubts, concerns and achievements; Thank you Karim, Mohamad-Gabriel, Colleen, Daniel, 
Rasheh, Leili, David, Ashkan, Genevieve, Ousama, Etienne, and Chi-Yuan. This laboratory 
taught me much more than I could have learned from any books. I also need to recognize the 
contributions of my colleagues, Julie Tremblay, Jun Sun, Genevieve Picard, Vincent Darras, 
Marc Lavertu, Nicolas Tran-Khanh, Monica Nelea and Chi-Yuan Chang.  
This work would also have been impossible without the support of my beloved family. 
My parents, Monique and Sylvain, have always been the source of my inspiration. They are 
always there for me: to support me, to help me, to push me and of course to love me. They are the 
reason why I succeed. Thank you both for your unconditional faith and love in me. There is also 
v 
 
my little sister, Bianca, whom has been wonderful to me. She always tries to make me feel better 
when something is not right: you are amazing little sis. I would like to also thank, the love of my 
life, Jean-Sebastien. Thank you for always being there for me. Thank you for being so patient 
with me. I love you with all my heart and I want you to know that your love is everything to me. 
Also thank you to my best friends, Nimara, Ines and Roxanne. You were amazing to me and still 
are. A big thank you to those organizations that have provided funding for my studies and 
research: CRSNG and Ortho Regenerative Technologies Inc. 
vi 
 
RÉSUMÉ 
Les déchirures de la coiffe du rotateur sont une des blessures musculo-squelettiques les 
plus répandues de l’épaule. Les techniques de réparation chirurgicales actuellement utilisées 
échouent dans environ 20 à 95% des cas dépendamment de l'âge, la taille, du tabagisme, du 
temps de guérison, de la qualité du tendon, de la qualité musculaire, de la réponse à la guérison et 
des traitements chirurgicaux. La majorité des déchirures chroniques des tendons surviennent 
principalement dans le supraspinatus, ce qui mène à des changements structurels tels que 
l'accumulation de gras, la perte de volume, le remodelage musculaire, la disparition de 
sarcomères et, parfois, une faiblesse musculaire profonde. Trouver un modèle animal similaire à 
l’humain est un défi de taille mais très utile pour améliorer notre compréhension des voies 
cellulaires et moléculaires impliquées dans la pathologie de la coiffe du rotateur. Les pathologies 
du tendon sont aggravées par son potentiel de guérison limité, attribué à la présence de 
changements dégénératifs et à une vascularité relativement faible. Le développement de 
nouvelles technologies pour traiter les déchirures de la coiffe du rotateur nécessite également des 
tests sur des modèles animaux afin d'évaluer l'innocuité et l'efficacité du traitement, avant 
d’effectuer des tests cliniques pour éventuellement améliorer les options de traitement 
thérapeutique. Il est donc important d'évaluer les modèles animaux utilisés pour la  recherche des 
pathologies de la coiffe du rotator; Idéalement, ceux-ci présenteraient une dégénérescence des 
tendons, une atrophie musculaire et une infiltration de gras similaire à celle de l’humain. Notre 
premier but était donc de recenser les traitements cliniques actuels utilisés pour guérir la coiffe du 
rotateur, de décrire les nouvelles stratégies en cours de développement clinique et préclinique. 
Nos résultats ont demontré qu'aucun animal n'a une anatomie comparable à celle des 
humains. Bien que les dernières techniques de sutures semblent augmenter le taux de guérisson 
des tendons, ceci n’a pas été traduit par une amélioration des résultats cliniques. Les patches de 
matrix extracellulaire n’ont pas démontrées de résultats prometteurs dans les essaies cliniques 
randomisés. Il n’existe encore aucune étude sur la réparation de la coiffe du rotateur utilisant des 
facteurs de croissances chez l’humain. L’utilisation de PRP en orthopédie est encore controversée 
et malheureusement aucunes des stratégies actuellement utilisées améliore la réparation des 
déchirures de la coiffe du rotateur. Une solution possible pourrait être l’utilisation d’implants de 
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chitosan-PRP. En résumé, plusieurs stratégies de réparation sont disponibles, mais d'autres essais 
cliniques sont nécessaires pour trouver le traitement optimal pour la réparation de la coiffe du 
rotateur. 
Les implants de chitosane (CS)-PRP ont démontrés qu’ils pouvaient améliorer la 
réparation du ménisque, de la coiffe du rotateur et la réparation du cartilage dans des modèles 
précliniques. Cela nous a conduits à étudier les mécanismes d'action in vitro et in vivo des 
implants CS-PRP. Des formulations lyophilisées contenant 1% (p / v) de chitosane (80% 
désacétylé et masse moléculaire moyenne de 38 kDa), 1% (p / v) de trehalose, un lyoprotectant, 
et 42,2 mM de chlorure de calcium, l’activateur de caillot, ont été solubilisés dans du PRP. 
L'objectif de cette étude était d'étudier les mécanismes possibles par lesquels le chitosan inhibe la 
rétraction des caillots hybrides CS-PRP in vitro, caractériser l'effet du chitosan, du tréhalose et 
une combinaison sur l'activation plaquettaire et la sécrétion granulaire in vitro, caractériser le 
profil de libération de PDGF-AB et EGF à partir de caillots hybrides CS-PRP in vitro, et 
d’évaluer histologiquement la résidence, la bioactivité et la biodégradabilité des implants CS-
PRP in vivo. Nos hypothèses de départ étaient que (1) le chitosane se lierait aux plaquettes d'une 
manière non spécifique inhibant l'agrégation plaquettaire dans les caillots hybrides et la rétraction 
du caillot médiée par les plaquettes; (2) le chitosane activerait les plaquettes et induirait la 
sécrétion des granules; (3) la libération de facteurs de croissances à faible point isoélectrique 
(chargé négativement à pH neutre), comme EGF, serait plus soutenue par les implants de CS-
PRP que la libération de facteurs de croissances avec des points isoélectriques élevés (chargés 
positivement à pH neutre), tel PDGF-AB, en raison d'interactions électrostatiques avec le 
chitosane cationique; (4) Les implants CS-PRP résideraient beaucoup plus longtemps que le PRP 
seul in vivo, où ils induiraient le recrutement cellulaire et l'angiogenèse, mais seraient également 
dégradés à l’intérieur de 6 semaines. 
Nos images confocales, SEM et TEM soutiennent notre première hypothèse selon laquelle 
le chitosan recouvre physiquement les plaquettes et autres composants du caillot sanguin pour 
inhiber l'agrégation plaquettaire, nécessaire pour la rétraction du caillot. Dans les caillots 
hybrides, le chitosane interfère physiquement avec la capacité des plaquettes à adhérer l'une à 
l'autre ainsi qu’au réseau de fibrine, exerçant ainsi des forces mécaniques. Nos deuxième et 
troisième objectifs visaient à déterminer si les plaquettes étaient activées dans les caillots 
viii 
 
hybrides CS-PRP et, dans l'affirmative, comment les facteurs de croissances dérivés des 
plaquettes sont libérés des caillots hybrides CS-PRP. Conformément à notre troisième hypothèse, 
nous avons constaté que le chitosane induisait l'activation des plaquettes et la sécrétion des 
granules dans les suspensions cellulaires, même plus que l'ADP, un agoniste plaquettaire connu. 
Fait intéressant, l'incubation de la suspension cellulaire avec tréhalose et chitosane a légèrement 
diminué l'expression de Pac-1 et de p-sélectine par rapport à l'incubation avec du chitosane seul. 
Même si les conditions d'essai dans le dosage de cytométrie en flux sont différentes du caillot 
hybride, nous avons prévu que les plaquettes dans les caillots hybrides CS-PRP seraient activées 
et libèreraient leur granules, ce qui a été déterminé par des tests ELISA. Notre troisième 
hypothèse de depart, était que le point isoélectrique des facteurs de croissance dérivés des 
plaquettes déterminerait comment les facteurs de croissance seraient libérés des hybrides CS-
PRP. Le point isoélectrique du PDGF est de 9,8 et dans des conditions physiologiques, nous nous 
attendions à une répulsion ionique entre le PDGF-AB chargé positivement et le chitosane 
cationique qui provoquerait une libération rapide et courte. Pendant ce temps, on s'attendait à ce 
qu’EGF, avec un point isoélectrique de 4,6, se lirait au chitosane dans des conditions 
physiologiques et serait libéré de manière plus continue. Contrairement à cela, nous avons 
constaté que les caillots hybrides CS-PRP ont soutenu et augmenté la libération de PDGF-AB et 
d'EGF pendant 1 semaine in vitro, ce qui suggére que d’autres facteurs supplémentaires 
contrôlent leur libération dans ce système in vivo. Nous avons aussi constaté que les niveaux 
cumulatifs de PDGF-AB et EGF libérés dans le milieu de culture étaient plus élevés dans les 
caillots CS-PRP par rapport aux caillots PRP. En ce qui concerne la libération des facteurs de 
croissance, il est important de considérer la contribution de chaque type de cellule présente dans 
la préparation PRP. Les plaquettes sont les principaux contributeurs à la libération de facteurs de 
croissance du PRP et des corrélations positives ont déjà été trouvées entre les doses de plaquettes 
et la quantité de facteurs de croissance libérés, y compris PDGF-AB, TGF-β1, VEGF et EGF. 
Notre quatrième objectif était d'étudier les implants in vivo, et nous avons demontré qu'ils 
présentaient une résidence plus longue et une bioactivité plus élevée que le PRP. 
En résumé, le chitosan enrobe physiquement les plaquettes, les cellules sanguines et les brins 
de fibrine dans les implants CS-PRP, ce qui inhibe l'agrégation plaquettaire, nécessaire pour la 
rétraction du caillot. Les plaquettes sont activées, granules sécrétées et des niveaux plus élevés de 
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PDGF-AB et d'EGF sont libérés à partir de caillots CS-PRP par rapport aux caillots PRP in vitro. 
Enfin, les implants CS-PRP résident pendant au moins 6 semaines après implantation sous-
cutanée et induisent le recrutement cellulaire et la synthèse de tissue de granulation, confirmant 
une résidence plus longue et une bioactivité plus élevée par rapport au PRP in vivo. 
L'objectif de la troisième étude était d'évaluer si les implants CS-PRP étaient capables 
d'améliorer la réparation des dechirures de la coiffe du rotateur dans un modèle de lapin. Des 
déchirures complètes ont été créées bilatéralement dans le tendon supraspinatus (SSP) des lapins 
blancs de Nouvelle Zéalande (n = 4 dans une étude de faisabilité pilote suivie de n = 13 dans une 
étude d'efficacité plus large), qui ont été réparés à l'aide de sutures transosseuses. Du côté traité, 
les implants CS-PRP ont été injectés dans les tunnels transosseux et dans le tendon lui-même, et 
la guérison a été évaluée histologiquement à des points temporels allant de 1 à 2 mois après la 
chirurgie. Nos hypothèses de départ étaient les suivantes: 1) Les implants CS-PRP induiraient le 
recrutement de cellules polymorphonucléaires (PMN) à des moments précoces après la chirurgie, 
2) Les implants CS-PRP seraient dégradés 2 mois après la chirurgie et 3) Les implants CS-PRP 
amélioreraient la réparation des déchirures de la coiffe du rotateur grâce à une augmentation du 
recrutement cellulaire, de l'angiogenèse et du remodelage osseux. 
L'un de nos objectifs était de déterminer la répartition de l'implant et d'évaluer la dégradation 
de l'implant au fil du temps. Un jour après la chirurgie, les implants CS-PRP résidaient à 
l'intérieur du creux osseux, dans les tunnels latéraux et également sur les surfaces du tendon. Les 
implants CS-PRP ont également inhibé l'ossification hétérotopique du tendon SSP à 2 mois tout 
en favorisant la fixation du tendon SSP à la tête humérale grâce à un remodelage osseux accru à 
la tuberosité supérieure. 
Les implants CS-PRP ont induit le recrutement de PMNs à des moments précoces après la 
chirurgie, soutenant notre première hypothèse. Contrairement à la deuxième hypothèse, la 
dégradation des implants et les réactions inflammatoires associées étaient encore en cours dans 3 
sur 9 épaules traitées à 2 mois. Les résultats ont partiellement soutenu notre troisième hypothèse 
selon laquelle CS-PRP améliorerait la réparation de la coiffe du rotateur, en améliorant la fixation 
du tendon SSP grâce à un remodelage osseux amélioré. De manière inattendue, de petites zones 
de tissu de granulation riche en neutrophiles entourant les tissus apoptotiques / nécrotiques 
étaient visibles dans 3 épaules traitées avec CS-PRP à 2 mois. La suppression de l'ossification 
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hétérotopique du tendon SSP (HO) par le traitement CS-PRP a été une découverte inattendue 
dans cette étude. Cette étude semble fournir des preuves que les implants CS-PRP sont sans 
danger et efficaces pour améliorer la réparation des déchirures de la coiffe du rotateur dans un 
petit modèle animal et que cela pourrait être traduit dans un contexte clinique. 
L'objectif de la quatrième étude était d'étudier l'effet de l'utilisation d'implants de CS-PRP 
en conjonction avec des ancres de suture dans des modèles de déchirure de la coiffe du rotateur 
ovins aigus et chroniques et voir si cela pouvait améliorer la réparation de la coiffe du rotateur. 
Dans deux études de faisabilité, des déchirures unilatérales de pleine épaisseur ont été créées dans 
le tendon de l'infraspinatus (ISP) de brebis. Dans le modèle chronique (n = 4 brebis), les tendons 
ont été recouverts d’une membrane de silicone permettant une dégénération chronique pendant 6 
semaines, tandis que les tendons ont été réparés immédiatement dans le modèle aigu (n = 4 
brebis). Les tendons ISP transectés ont été rattachés à des ancres de suture et dans le cas des 
épaules traitées; Les implants composés de CS lyophilisé solubilisés dans du PRP autologue ont 
été appliqués en plus sur l'interface tendon-os et sur le site réparé. 
Le modèle chronique a induit une dégénérescence et une rétraction importante du tendon 
et du muscle, ce qui a rendu la réparation beaucoup plus difficile que dans le modèle aigu. Le 
traitement par implants CS-PRP a induit le recrutement de cellules polymorphonucléaires à 2 
semaines  post-opératoires et a également amélioré l'organisation structurelle du tendon ISP à 3 
mois. Le traitement a également augmenté le remodelage osseux et la croissance interne à 
l'interface tendon-os à 3 mois, ce qui suggère qu'une fixation plus robuste pourrait être obtenue en 
combinant les implants CS-PRP et les ancres de suture. Ces études pilotes fournissent la première 
preuve que les implants CS-PRP peuvent améliorer la réparation des déchirures de la coiffe du 
rotateur dans de grands modèles animaux. 
Notre hypothèse de départ a été partiellement soutenue par le fait que le traitement avec 
des sutures d'ancrage + CS-PRP a conduit à une amélioration de l'apparence structurelle du 
tendon, à un remodelage osseux et une croissance accrue à la jonction tendon-os. Nous avons 
constaté que recouvrir les tendons pendant 6 semaines avec des membranes de silicone de 5 cm 
empêchait probablement une diffusion adéquate d’éléments nutritifs et entraînait une mort 
cellulaire et une dégénérescence sévère du tendon lui-même, ce qui a rendu certains tendons non 
réparables. Bien que la dégénérescence n’ait pas été aussi marquée lorsque les tendons ont été 
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recouverts pendant 2 semaines avec une membrane de silicone de 5 mm, le rattachage à 
l'empreinte initiale aurait été difficile à atteindre puisque l'unité tendineuse avait 
considérablement rétracté. Nous avons constaté que les tissus cicatriciels abondants comblaient 
l'écart entre le tendon et la tuberosité après 2 et 6 semaines. À partir de maintenant, nous 
considérons que le modèle de réparation aiguë est plus cohérent et facilement reproductible que 
le modèle chronique. 
Des cellules polymorphonucléaires (PMN) ont été observées dans le tissue de réparation 
du tendon de l'épaule traité avec des ancres + CS-PRP 2 semaines post-implantation. Le tendon 
traité avec des ancres a seulement montré de la chondrogénèse et l'expression de GAG dans le 
corps du tendon à 6 semaines, alors que ce n’était pas le cas avec le tendon traité avec les ancres 
+ CS-PRP. De manière inattendue, la technique de réparation des ancrages + CS-PRP a entraîné 
un meilleur résultat structurel du tendon que les ancres seules à 3 mois, probablement par une 
modulation du moment de la séquence de guérison ou par un remodelage des tissues de 
réparation accru. Il n'y avait aucun effet délétère spécifique au traitement dans l'articulation de 
l'épaule, ce qui suggère que les implants CS-PRP sont sécuritaires. Les anomalies structurelles 
étaient visibles dans la plupart des glénoïdes, ce qui suggère que des contraintes plus importantes 
sont appliquées sur cette surface par rapport à la tête humérale dans le modèle des brebis. 
L'infiltration de gras dans le muscle ISP a été induite dans les modèles à la fois chronique et 
aiguë, et aucun traitement n’a pu inverser cet effet. Une synovite transitoire légère était présente 
dans l'épaule traitée avec CS-PRP à 2 semaines, ce qui a été résolu à 6 semaines et 3 mois, une 
fois que le biomatériau a été dégradé. 
En résumé, les techniques de développement pour augmenter la réparation de la coiffe du 
rotateur restent cliniquement pertinentes. Les défis techniques associés au modèle de réparation 
chronique chez les brebis rendent le modèle aïgu plus préférable pour les études futures. Ces 
deux études pilotes fournissent la première preuve que les implants CS-PRP améliorent la 
réponse de guérison chez les grands modèles animaux de réparation de la coiffe du rotateur, en 
partie grâce à un remodelage osseux accru au tissu de réparation du tendon et à l'interface osseuse 
sous-jacente. 
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ABSTRACT 
Rotator cuff tears are the most common musculoskeletal injury occurring in the shoulder. 
Current surgical repair fails to heal in 20 to 95% of cases depending on age, size, smoking, time 
of repair, tendon quality, muscle quality, healing response, and surgical treatments. The majority 
of chronic tendon tears occurs mostly in the supraspinatus and ultimately leads to structural 
changes such as fatty accumulation, loss of volume, muscle remodeling, subtraction of 
sarcomeres, and sometimes, profound muscle weakness. Finding the right animal model is 
challenging but critically important to improve our understanding of the cellular and molecular 
pathways involved in rotator cuff pathology. These problems are worsened by the limited healing 
potential of injured tendons, attributed to the presence of degenerative changes and relatively 
poor vascularity of the cuff tendons. Development of new techniques to treat rotator cuff tears 
also requires testing in animal models to assess safety and efficacy prior to clinical testing to 
improve therapeutic treatment options. Hence it is important to evaluate appropriate animal 
models for rotator cuff research with degeneration of tendons, muscular atrophy and fatty 
infiltration similar to humans. Our first purpose was to review current clinical treatments and new 
repair strategies under development both clinically and pre-clinically. 
Our findings showed that none of the animals have anatomy comparable to humans. 
Although the latest suture techniques seem to somewhat increase the rate of tendon healing, this 
has not been translated into improved clinical and functional outcomes. Extracellulaire matrix 
(ECM) patches have not shown promising results in randomized clinical trials and scaffolds still 
need clinical studies. Still no study exists on rotator cuff repair using growth factors in humans. 
Platelet-rich plasma (PRP) use in orthopedics is still controversial and none of these strategies 
enhance rotator cuff tear repair. One possible effective technique could be using chitosan-PRP 
implants. In summary, several repair strategies are available but further clinical trials are needed 
to find the optimal treatment for rotator cuff repair.  
Chitosan (CS)-PRP implants have been shown to improve meniscus and cartilage repair 
in pre-clinical models. This has led us to investigate in vitro and in vivo mechanisms of action of 
CS-PRP implants. Our second purpose was to investigate possible mechanisms by which 
chitosan inhibits retraction of CS-PRP hybrid clots in vitro, characterize the effect of chitosan, 
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trehalose and a combination of both on platelet activation and granule secretion in vitro, 
characterize the release profile of PDGF-AB and EGF from CS-PRP hybrid clots in vitro, and 
histologically assess the residency, bioactivity and biodegradability of CS-PRP implants in vivo. 
Our starting hypotheses were that (1) chitosan would bind to platelets in a non-specific way 
inhibiting platelet aggregation in hybrid clots and platelet-mediated clot retraction; (2) chitosan 
would activate platelets and induce granule secretion; (3) the release of growth factors with low 
isoelectric point (negatively charged at neutral pH), such as EGF, would be more sustained from 
CS-PRP hybrids than the release of growth factors with high isoelectric points (positively 
charged at neutral pH), such as PDGF-AB, due to electrostatic interactions with cationic chitosan; 
(4) CS-PRP implants would reside longer than PRP in vivo, where they would induce cell 
recruitment and angiogenesis, but would be degraded within 6 weeks. 
Confocal, SEM and TEM images supported our first hypothesis that chitosan physically coats 
platelets and other components of the blood clot to inhibit platelet aggregation, needed for clot 
retraction. In the hybrid clots, chitosan physically interferes with the ability of the platelets to 
adhere to each other and the fibrin network, hence exerting mechanical forces. Our second and 
third aims were to investigate whether platelets are activated in CS-PRP hybrid clots and, if so, 
how platelet-derived growth factors are released from CS-PRP hybrid clots. Consistent with our 
third hypothesis, we found that chitosan induces platelet activation and granule secretion in cell 
suspensions, even more so than ADP, a known platelet agonist. Interestingly, incubation of cell 
suspension with trehalose along with chitosan slightly decreased expression of Pac-1 and p-
selectin compared to incubation with chitosan alone.  
Even though test conditions in the flow cytometry assay are different than in the hybrid clot 
system, we expected platelets within the CS-PRP hybrid clots to be activated and release their 
granule content, and this was ascertained by ELISA assays. Our third starting hypothesis was that 
the isoelectric point of platelet-derived growth factors would determine how growth factors 
would be released from our CS-PRP hybrids. The isoelectric point of PDGF is 9.8 and, under 
physiological conditions, we expected ionic repulsion between positively charged PDGF-AB and 
cationic chitosan to result in burst release. Meanwhile, EGF, which has an isoelectric point of 4.6, 
would be expected to bind to chitosan under physiological conditions and be released in a more 
sustained manner. In contrast to this, we found that CS-PRP hybrid clots sustained and increased 
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release of both PDGF-AB and EGF for 1 week in vitro, which suggested that additional factors 
are controlling their release in this system. We found that cumulative levels of PDGF-AB and 
EGF released in the culture medium were higher in the case of CS-PRP clots compared to PRP 
clots. With regard to growth factor release, it is important to consider the contribution of each cell 
type present in the PRP preparation. Platelets are the main contributors to growth factor release 
from PRP and positive correlations were previously found between platelet doses and the amount 
of released growth factors including PDGF-AB, TGF-1, VEGF and EGF. Our fourth aim was to 
investigate the implants in vivo, and they were shown to exhibit longer residency and higher 
bioactivity than PRP.  
In summary, chitosan physically coats platelets, blood cells and fibrin strands in CS-PRP 
hybrid clots, thus inhibiting platelet aggregation, which is required for clot retraction. Platelets 
are activated; granules secreted and higher levels of PDGF-AB and EGF are released from CS-
PRP hydrid clots compared to PRP clots in vitro. Finally, CS-PRP implants reside for at least 6 
weeks post-implantation subcutaneously and induce cell recruitment and granulation tissue 
synthesis, confirming a longer residency and higher bioactivity compared to PRP in vivo.  
Our third purpose was to assess whether CS-PRP implants were capable of improving 
rotator cuff tear repair in a rabbit model. Complete tears were created bilaterally in supraspinatus 
(SSP) tendons of New Zealand White rabbits (n=4 in a pilot feasibility study followed by n=13 in 
a larger efficacy study), which were repaired using transosseous suturing. On the treated side, 
CS-PRP implants were additionally injected into the transosseous tunnels and the tendon itself, 
and healing was assessed histologically at time points ranging from 1 day to 2 months post-
surgery. Our starting hypotheses were that: 1) CS-PRP implants would induce recruitment of 
polymorphonuclear cells (PMN) at early time points post-surgery, 2) CS-PRP implants would be 
degraded by 2 months post-surgery, and 3) CS-PRP implants would improve transosseous rotator 
cuff repair through an increase in cell recruitment, angiogenesis and bone remodeling.  
One of our objectives was to determine implant distribution and assess implant 
degradation over time. At 1 day post-surgery, CS-PRP implants were resident inside the bony 
trough, in the lateral tunnels and also adhered to tendon surfaces. CS-PRP implants inhibited 
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heterotopic ossification of the SSP tendon at 2 months while also favoring attachment of the SSP 
tendon to the humeral head through increased bone remodelling at the greater tuberosity.  
CS-PRP implants induced PMN recruitment at early time points post-surgery, supporting 
our first hypothesis. In contrast to the second hypothesis, implant degradation and associated 
inflammatory reactions were still ongoing in 3 out of 9 treated shoulders at 2 months. Results 
partially supported our third hypothesis that CS-PRP would improve rotator cuff tear repair, since 
treatment improved SSP tendon attachment through increased bone remodeling. Unexpectedly, 
small areas of neutrophil-rich granulation tissue surrounding apoptotic/necrotic tissues were 
visible in 3 CS-PRP treated shoulders at 2 months. The suppression of SSP tendon heterotopic 
ossification (HO) by CS-PRP treatment was an unexpected finding in this study. The bony trough 
was incompletely healed in some rabbits at 2 months. This study seems to provide evidence that 
CS-PRP implants are safe and effective in improving rotator cuff tear repair in a small animal 
model, and that this could potentially be translated into clinical setting.  
Our fourth purpose was to investigate the effect of using CS- PRP implants in conjunction 
with suture anchors in chronic and acute ovine rotator cuff tear models and see if it can improve 
rotator cuff repair. In two subsequent pilot feasibility studies, unilateral full-thickness tears were 
created in the infraspinatus (ISP) tendons of mature female Texel-Cross sheep. In the chronic 
model (n=4 sheep), the tendons were capped with silicone and allowed to degenerate to chronic 
stage for 6 weeks, while the tendons were immediately repaired in the acute model (n=4 sheep). 
Transected ISP tendons were reattached with suture anchors and, in the case of treated shoulders; 
implants composed of freeze-dried CS solubilized in autologous PRP were additionally applied to 
the tendon-bone interface and on top of the repaired site.  
The chronic defect model induced significant tendon degeneration and retraction, which 
made repair more challenging than in the acute defect model. Treatment with CS-PRP implants 
induced recruitment of polymorphonuclear cells at 2 weeks post-operatively and improved ISP 
tendon structural organization at 3 months. Treatment also increased bone remodeling and 
ingrowth at the tendon-bone interface at 3 months, suggesting that a more robust attachment 
could be achieved by combining CS-PRP implants with suture anchors.  
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Our starting hypothesis was supported in that treatment with anchors + CS-PRP implants 
led to improved tendon structural appearance and increased bone remodeling and ingrowth at the 
tendon-bone junction. We found that capping the ISP tendons for 6 weeks with 5-cm silicone 
tubes likely prevented proper nutrient diffusion and led to cell death and severe tendon 
degeneration, which rendered some tendons unrepairable. Although degeneration was not as 
marked when the tendons were capped for 2 weeks with 5-mm silicone length, reattachment at 
the footprint would have been difficult to achieve since the tendon-muscle unit had significantly 
retracted. We found that abundant scar tissues were bridging the gap between the capped tendon 
and the tuberosity after 2 weeks and 6 weeks. As of now, we consider the acute repair model to 
be more consistent and easily reproducible. 
Polymorphonuclear (PMN) cells were observed in the tendon repair tissue of the shoulder 
treated with anchors + CS-PRP for 2 weeks. The tendon treated with anchors only showed 
chondrogenesis and GAG expression within the tendon body at 6 weeks, while the tendon treated 
with anchors + CS-PRP did not. Unexpectedly, the anchors + CS-PRP repair technique resulted 
in better tendon structural outcome than anchors only at 3 months, possibly through a modulation 
of timing of the healing sequence or through increased repair tissue remodeling. There were no 
treatment-specific deleterious effects in the shoulder joints, suggesting that CS-PRP implants 
have high safety. Structural abnormalities were visible in most glenoids, suggesting that greater 
stresses are applied on that surface compared to the humeral head in sheep. Fatty infiltration of 
the ISP muscle was induced in both chronic and acute models, and no treatment was able to 
reverse that effect. Mild transient synovitis was present in the shoulder treated with CS-PRP at 2 
weeks, and this was resolved at the later 6 weeks and 3 months time points, once the biomaterial 
was degraded. 
In summary, developing techniques to augment of rotator cuff repair remains clinically 
relevant. The technical challenges associated with the chronic repair model in the sheep make the 
acute model more preferable for future studies. These pilot studies provide the first evidence that 
CS-PRP implants improve the healing response in large animal models of rotator cuff repair, 
partly through increased bone remodeling at the tendon repair tissue and underlying bone 
interface.  
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CHAPTER 1 INTRODUCTION  
More than 28 million Americans are affected by musculoskeletal injuries, estimated to 
cost more than $254 billion each year (Praemer, Furner et al. 1999). Rotator cuff tears are among 
the most common injuries occurring in the shoulder and are often seen in older athletes of 
overhead sports, like tennis or basketball (Yamamoto, Takagishi et al. 2010). It is a widespread 
crisis, causing high rate of morbidity and inability in workplaces and sports (Lehman, Cuomo et 
al. 1995, Yanke and Chubinskaya 2015). Rotator cuff tears are associated with structural and 
architectural alterations of the musculotendinous unit, such as tendon retraction, fatty infiltration 
and muscular atrophy (Antoniades, Scher et al. 1979, Borges, Borchard et al. 2007, Periayah, 
Halim et al. 2014). 
Cuff tears result in shoulder pain, stiffness, weakness and loss of motion (Trent, Bailey et 
al. 2013). It usually starts as an acute tendinopathy with progressive degeneration leading to a 
partial thickness tear and eventually full rupture (Neer, Craig et al. 1983). The shoulder joint can 
still function with minimal pain in spite of a rotator cuff tear by using the deltoid and the 
scapular stabilizing muscles (Feeley, Gallo et al. 2009), however limited function of upper 
extremities will impair the ability to carry out basic activities (Nho, Brown et al. 2009, 
Yamamoto, Takagishi et al. 2010). Rotator cuff injury is the second most common 
musculoskeletal pathology after lower back pain (Picavet and Schouten 2003) and is the most 
common shoulder condition that patients seek therapy for (Gomoll, Katz et al. 2004, Riley 2004).  
Cuff tears may cause irreversible changes in the structural and physiological properties of 
the shoulder, causing intolerable chronic pain (Funakoshi, Majima et al. 2006) and severe 
functional disability, as well as compromise joint mechanics leading to degenerative changes 
(Aurora, McCarron et al. 2007). Degenerative changes in the structure and composition of the 
tendons make healing very difficult. After surgical repair, failure rate ranges between 20 to 95% 
(Galatz, Ball et al. 2004) due to tendon degeneration, hypo vascularization (Cohen 1985, Jackson 
2007, Gulotta, Kovacevic et al. 2009, Longo, Franceschi et al. 2009, Lui, Zhang et al. 2010, 
Longo, Forriol et al. 2011, Ahmad, Howard et al. 2012), muscle atrophy, fatty infiltration of 
tendon and muscle and a lack of tendon-to-bone integration (Gartsman 1997, Totani, Cumashi et 
al. 1998, 2005). Tendon vascularization is mostly compromised at the junction zones and sites of 
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torsion, friction or compression (Sharma and Maffulli 2006), which reduces the chances of 
adequate self-repair (Chahla, Dean et al. 2016). 
Patients with re-tears usually experience some pain relief but continue to have lower 
functional outcomes (Heldin and Westermark 1999, Galatz, Ball et al. 2004). Rotator cuff 
insertion site, also known as the enthesis, is never completely reformed after surgical 
reattachment (Gulotta and Rodeo 2009, Chung, Kim et al. 2014). The overall structure, 
composition, and organization of a normal insertion site do not regenerate, especially, the 
calcified cartilage zone (Gerber, Schneeberger et al. 1999). Instead, healing occurs through fibro 
vascular disorganized scar tissue formation (Pencev and Grotendorst 1988, Robertson, Maley et 
al. 1993), lacking strength, load-to-failure, and biomechanical tendon properties leading to 
increased risk of further damage and high re-tear rates (Galatz, Ball et al. 2004, Angeline and 
Rodeo 2012, Del Buono, Oliva et al. 2012) (Galatz, Ball et al. 2004, Boileau, Brassart et al. 
2005, Galatz, Sandell et al. 2006, Angeline and Rodeo 2012, Del Buono, Oliva et al. 2012).  
Current standard surgical treatment involves open or arthroscopic repair of torn tendons 
frequently using suture anchors in a variety of configurations (McElvany, McGoldrick et al. 
2015). The goal of suturing repair is to increase initial fixation strength, mechanical stability and 
increase biological tendon-to-bone healing (Cole, ElAttrache et al. 2007), which most often fails. 
The current suturing techniques are thought to increase footprint contact area, which could 
improve the rate of healing but re-tear rates are still relatively high (Denard and Burkhart 2013). 
Considerable variation in surgical procedures exists, confirming the lack of a single reliable 
technique (McElvany, McGoldrick et al. 2015). It is recognized that current surgical treatments 
need improvement (Gerber, Fuchs et al. 2000, Galatz, Ball et al. 2004). Improving repair 
techniques could be achieved through biological or synthetic tendon grafts or through 
augmentation devices (Dwivedi, Chevrier et al. 2017, Ghazi zadeh, Chevrier et al. 2017), 
however success is limited. The current goal is to completely regenerate the fibrocartilaginous 
insertion zones through biological augmentation.  A good cuff repair technique should decrease 
pain, increase strength as well as range of motion (Cole, ElAttrache et al. 2007). New techniques 
in tissue engineering have been postulated to increase rotator cuff tear repair, such as scaffolds, 
growth factors and cell seeding (Derwin, Badylak et al. 2010), but their uses are still preliminary. 
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Despite the advances in tissue engineering, rotator cuff tear repair still represents an enormous 
challenge. 
Platelet-rich plasma (PRP) is a plasma fraction with a high platelet concentration 
(Deprés-Tremblay, Chevrier et al. 2017) that is obtained through whole blood centrifugation 
divided by weight particle. Activation of platelets in PRP releases several growth factors, such as 
PDGF, TGF-β, IGF, VEGF, and EGF (Sheth, Simunovic et al. 2012). PRP has been suggested to 
stimulate revascularization and enhance growth factors that could potentially increase tendon 
healing (Barber, Hrnack et al. 2011). Growth factor release at the injury site could eventually 
lead to cell proliferation, cell differentiation and angiogenesis (Sheth, Simunovic et al. 2012). 
PRP has been used to treat several soft tissue pathologies, however the results have been 
inconsistent, possibly due to its short half-life and high diffusibility (Li, Xu et al. 2014). Routine 
use of PRP to treat rotator cuff tears is not supported by current clinical evidence (Castricini, 
Longo et al. 2011).  
Chitosan (CS), a biodegradable and biocompatible natural polymer, is obtained through 
chitin deacetylation (Muzzarelli 2009, Krueger, Wenke et al. 2012). Once injected, chitosan is 
slowly hydrolyzes by lysozymes and produces chito-oligomers, which favours correct 
deposition, assembly and orientation of collagen fibrils in ECM reformation in tissues 
(Muzzarelli, Mattioli-Belmonte et al. 1999). In the context of cartilage repair, implants of CS-
glycerol phosphate (GP)/blood have previously been shown by our research group to increase 
cell recruitment, vascularization and bone remodeling (Chevrier, Hoemann et al. 2007, 
Hoemann, Sun et al. 2007), activate a beneficial phenotype of pre-wound healing macrophages 
(Hoemann, Chen et al. 2010) and enhance tissue repair integration through osteoclast activity 
(Chen, Sun et al. 2011), all of which are expected to also be beneficial for rotator cuff repair. 
More recently, we have developed freeze-dried formulations of CS that can be solubilized in 
PRP to form injectable CS-PRP implants that coagulate in situ. We have shown that residency 
time and bioactivity of CS-PRP implants are superior to that of PRP alone in vivo (Chevrier, 
Hoemann et al. 2007). CS-PRP implants were tested in meniscus repair models and were shown 
to induce cell migration and repair tissue synthesis, while PRP alone or wrapping the meniscus 
with a collagen membrane did not (Chevrier, Deprés-Tremblay et al. 2016, Ghazi zadeh, 
Chevrier et al. 2017). CS-PRP were also tested in a chronic cartilage repair model and were 
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shown to improve repair tissue quality and induced bone remodeling, while treatment with PRP 
alone did not (Dwivedi, Chevrier et al. 2017). Hence, the starting hypothesis for this project was 
that the biological effects of CS-PRP hybrid implants would also be beneficial for rotator cuff 
tear repair.  
 
1.1 General objective 
The aim of the current thesis was to make significant contributions to enhance current surgical 
rotator cuff tear repair strategies. The research presented here was carried out with an objective 
to improve current surgical procedures in rotator cuff tear repair by applying chitosan-PRP 
implants. In the first study, the mechanisms of action of chitosan-PRP implants were investigated 
in vitro and in vivo, focusing on the effect of chitosan on platelet-mediated clot retraction, on 
platelet activation and granule secretion, on the release of growth factors (PDGF-AB and EGF) 
from PRP and CS-PRP, on the induction of cellular recruitment by the implants, bioactivity and 
on their biodegradability. In the second study, pilot and pivotal studies in a small rabbit model 
investigated how chitosan-PRP implants improved transosseous rotator cuff tear repair. Finally, 
in the third study, the effect of using chitosan-PRP implants in conjunction with suture anchors 
was investigated in larger chronic and acute sheep models.  
1.2 Study 1: Chitosan inhibits platelet-mediated clot retraction, 
increases platelet-derived growth factor release, and 
increases residence time and bioactivity of platelet-rich 
plasma in vivo 
1.2.1 Hypotheses for Study 1 
Our starting hypotheses were that: 
 Chitosan would bind to platelets in a non-specific fashion to inhibit platelet aggregation in 
hybrid clots and platelet-mediated clot retraction;  
 Chitosan would activate platelets and induce granule secretion;  
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 The release of growth factors with low isoelectric point (negatively charged at neutral 
pH), such as EGF, would be more sustained from CS-PRP hybrids than the release of 
growth factors with high isoelectric points (positively charged at neutral pH), such as 
PDGF-AB, due to electrostatic interactions with cationic chitosan;  
 CS-PRP implants would reside longer than PRP in vivo, where they would induce cell 
recruitment and angiogenesis, but be degraded within 6 weeks. 
1.2.2 Methods and objectives for Study 1 
Gravimetric measurements, confocal and electronic microscopy were used to investigate possible 
mechanims by which chitosan inhibits clot rectraction in hybrid clots. Flow cytometry and 
ELISAs were used to characterize the effect of chitosan and lyoprotectant on platelet activation, 
granule secretion and growth factor release. Finally, subcutaneous implantation in rabbits was 
used to assess implant residency and biodegradability in vivo. 
1.3 Study 2: Freeze-dried chitosan-PRP implants improve 
transosseous rotator cuff repair in a rabbit model 
The aim of this study was to assess whether chitosan-PRP implants are capable of improving 
transosseous rotator cuff repair in a rabbit model, focusing on implant distribution at early time 
points and the histological properties of the repaired site at later time points.  
1.3.1 Hypotheses for Study 2 
Our starting hypotheses were that:  
 CS-PRP implants would induce recruitment of polymorphonuclear cells (PMN) at early 
time points post-surgery;  
 CS-PRP implants would be degraded by 2 months post-surgery;  
 CS-PRP implants would improve transosseous rotator cuff repair trough an increase in 
cell recruitment, angiogenesis and bone remodeling. 
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1.3.2 Methods and objectives for Study 2 
Complete bilateral surgical tears were created in the supraspinatus tendon of the rotator cuff of 
skeletally mature rabbits. The tears were immediately repaired with sutures via a transosseous 
repair technique. On the treated side, a hybrid mixture of freeze-dried chitosan reconstituted with 
autologous PRP was injected into the transosseous tunnels and the tendon itself. The objective of 
the pilot study was to determine feasibility of using CS-PRP implants to improve rotator cuff 
repair in a small number of rabbits. The objective of the larger efficacy study was to determine 
the histological properties of the repaired site at 8 weeks post-surgery. 
1.4 Study 3: Freeze-dried chitosan-platelet-rich plasma implants for 
rotator cuff tear repair: Pilot ovine studies 
The aim of this study was to investigate the feasibility of using chitosan-PRP hybrids in large 
chronic and acute animal models of rotator cuff repair. 
1.4.1 Hypotheses for Study 3 
Our starting hypothesis was that: 
 CS-PRP implants would have positive effects on chronic and acute rotator cuff repair 
through increased cell recruitment, vascularization and bone remodeling. 
1.4.2 Methods and objectives for Study 3 
A complete surgical tear in the infraspinatus tendon of the rotator cuff was induced unilaterally 
in the shoulder of sheep. In the chronic model, the end of the tendon was covered with a 5-cm-
long silicon tube to prevent spontaneous healing. The tear was repaired with suture anchors six 
weeks after release. In the acute repair model, a complete surgical tear was also created in the 
infraspinatus, but the tear was immediately repaired with suture anchors. In both models, a 
hybrid mixture of freeze-dried chitosan reconstituted with autologous PRP was injected at the 
repaired site at the time of repair, and healing was assessed histologically.   
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CHAPTER 2 LITERATURE REVIEW 
2.1 Basic biology of tendons 
Healthy tendons are white brilliant soft connective tissue structures (Sharma and Maffulli 
2005), made up of tenoblasts and tenocytes that constitute about 90-95% of the cellular elements 
of tendons (Kannus and Jozsa 1991), with the remaining 5-10% consisting of chondrocytes at the 
tendon attachment site, synovial and vascular cells (Sharma and Maffulli 2005). Tenoblasts are 
immature spindle-shaped tendon cells with high metabolic activity. Once mature, they transform 
into tenocytes, which are characterized by a lower metabolic activity (Kannus and Jozsa 1991). 
Tenocytes are responsible for the production of extracellular matrix (ECM) including collagens, 
proteoglycans and other ECM proteins (Birk and Mayne 1997). Tendons are viscoelastic tissues 
that display stress relaxation and creep (Viidik 1973, Oxlund 1986) with high mechanical 
strength and good flexibility (O'Brien 1992, Kirkendall and Garrett 1997). Tendon tensile 
strength is proportional to the thickness of the tendon and collagen content. Approximately 20% 
to 30% of the dry weight of tendon is made up of proteoglycans, glycosaminoglycans, minor 
collagen (type-III, & type-XII), elastin and cell materials (Koob and Vogel 1987, Vogel, Sandy 
et al. 1994), while collagen type-I accounts for 65-80%. 
 
Figure 2-1: Schematic drawing of a basic tendon structure (Docheva, Muller et al. 2015). 
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Tendons not only transmit muscle forces to bones, but also act as buffers by absorbing 
external forces, limiting eventual muscle damage (Best and Garrett 1994). Thus they distribute 
loads applied to them in order to excute movements (Benjamin, Toumi et al. 2006).  
 
Figure 2-2: Anatomy of a normal tendon (Sharma and Maffulli 2005). 
Tendon cellularity, vascularity and natural healing ability are extremely low (Benjamin 
and Ralphs 1997). Tendon vascularity is mostly compromised at junctional zones and point of 
torsion, friction or compression (Sharma 2006). Tendons receive their blood supply mainly via 
the epitendinous blood vessels, myotendinous and osteotendinous junctions and through the 
paratenon or the synovial sheath (Carr and Norris 1989, Kvist, Hurme et al. 1995). Few vessels 
perforate through the tendon body as they are obstructed by the calcified barrier (Doschak and 
Zernicke 2005). The circulus articuli vasculosus, a meshwork of vasculature around the joint, 
provides nutrient to the glenohumeral joint (Bray, Smith et al. 2001), which necessitates 
reapposition of these surrounding soft tissue and meshwork structures, once injured (Bunker, Ilie 
et al. 2014). Adhesion formation after intrasynovial tendon injury results in major clinical 
problems (Manske 2005). Disruption of the synovial sheath allows granulation tissue and 
exogenous tenocytes to invade the repair site. Surrounding cells predominate over endogenous 
tenocytes, allowing the surrounding tissue to attach to the repair site forming adhesions (Sharma 
and Maffulli 2005).  
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Tendons consume on average 7.5 times less oxygen than skeletal muscles using 
anaerobic energy production, leading to low metabolic energy requirements. Low metabolic 
energy demand is required to carry heavy loads and maintain tension over long periods of time 
(Williams 1993), thus reducing the risk of ischemia and necrosis, especially during tensional 
stresses. However, this results in slow healing and recovery once damaged (Williams 1993, 
Docheva, Muller et al. 2015). At low strain rates, tendons are able to absorb more mechanical 
energy but are a lot less efficient at carrying mechanical loads. At higher strain rates, tendons are 
stiffer but more efficient in transmitting larger loads from muscles to bones (Wang 2006). 
Excessive loading during physical exercises can also lead to tendon degeneration (Selvanetti, 
Cipolla et al.). Tendons respond to excessive loadings by inflammation or degeneration 
(Benazzo, Zanon et al. 2000), usually manifested by pain, formation of lipids, proteoglycans and 
eventual calcification in tendon lesions (Kannus and Jozsa 1991). This can lead to the release of 
various cytokines and changes in cellular activities (Leadbetter 1992). Ischemia of tendons will 
occur when tendons are under maximum load for a prolonged period of time and once 
reperfusion has occurred, free radicals will be released, causing damage to tendons (Goodship, 
Birch et al. 1994, Bestwick and Maffulli 2000), degeneration and even tenocytes death (Birch, 
Rutter et al. 1997). Excessive mechanical loading also induces prostaglandin E2, an 
inflammatory mediator capable of decreasing collagen production and proliferation (Langberg, 
Skovgaard et al. 1999, Cilli, Khan et al. 2004).  Disproportionate loading also induces stretching 
in tenocytes activating protein kinases and biological responses (Arnoczky, Tian et al. 2002). 
Moreover, injured tendons cannot restore the native extracellular matrix, but instead change the 
biological and mechanical environments (Montgomery, Petrigliano et al. 2012), forming scar 
tissue and disorganized extracellular matrix (Katzel, Wolenski et al. 2011).  
However, repetitive healthy loading can increase remodeling and functional 
improvements in tendons (Magnusson, Langberg et al. 2010). Remodeling is a healthy balance 
between synthesis and degradation of collagen, required during healing (Bishop, Klepps et al. 
2006). Healthy mechanical loading might also improve healing of injured tendons (Groth 2004). 
Nevertheless immobilization or disuse can lead to stress deprivation, hence changing tendon cell 
shape, number, and collagen fiber alignment leading to degeneration (Hannafin, Arnoczky et al. 
1995), however short-term immobilization can help recovery and healing of tendons in certain 
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scenarios (Ma, Shen et al. 2007, De Aguiar, Chait et al. 2009). Without significant amount of 
mechanical loading, atrophy, decreased in tensile strength and stiffness will eventually occur 
(Amiel, Woo et al. 1982), changing its organization and mechanical properties of the unloaded 
tendon (Uchida, Tohyama et al. 2005, Thomopoulos, Zampiakis et al. 2008, Galatz, Charlton et 
al. 2009).  
Tendons are attached to bone through a specialized interface referred to as the insertion 
site, also known as the enthesis (Lu and Thomopoulos 2013), or osteotendinous junction 
(Benjamin, Toumi et al. 2006). The distinct organization of this tendon-to-bone insertion site is 
essential for proper function of the glenohumeral joint and accounts for the surgical challenges 
associated with reconstruction of damaged entheses (Apostolakos, Durant et al. 2014). The 
enthesis is defined as a specialized area where tendon meets bone (Benjamin and Ralphs 2001) 
and is critical as it allows for the transimission of forces, while dissipating forces away from the 
enthesis itself (Benjamin, Kumai et al. 2002, Angeline and Rodeo 2012, Lu and Thomopoulos 
2013). Mineral content and collagen fiber orientation give the enthesis a unique transition with 
grading mechanical properties (Thomopoulos, Genin et al. 2010). Tendon-bone attachments are 
biomechanically, compositionally, and structurally complex. Their compositions vary 
dramatically along their length in collagen structure, ECM, mineral content, geometry, and 
viscoelasticity properties. This gradation in the composition and structure (Stouffer, Butler et al. 
1985, Moffat, Sun et al. 2008, Genin, Kent et al. 2009, Liu, Birman et al. 2011) distributes forces 
from a flexible to a rigid material (Thomopoulos, Genin et al. 2010), by a shallow attachment 
angle (Liu, Birman et al. 2011, Picker 2011).  
Two types of tendon attachment sites exist, according to the types of tissue present at the 
attachment, either dense fibrous connective tissue or fibrocartilage. They equate in indirect or 
direct attachments, respectively (Woo S 1988). Fibrous entheses attach directly to bone via 
fibrous tissue, similar in structure to the tendon body and are found in the deltoid attachment to 
humerus, adductor magnus to linea aspera of the femur, and pronator teres (Benjamin, Kumai et 
al. 2002, Lu and Thomopoulos 2013). Fibrocartilaginous entheses attach to bone through a layer 
of fibrocartilage at tendon-bone interface (Benjamin and Ralphs 2001, Benjamin, Kumai et al. 
2002, Lu and Thomopoulos 2013) and are more prone to overuse injuries (Benjamin, Kumai et 
al. 2002, Lu and Thomopoulos 2013). Fibrocartilaginous entheses are found at the rotator cuff 
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and Achilles tendons (Lu and Thomopoulos 2013, Padulo, Oliva et al. 2013). A typical 
fibrocartilaginous enthesis has 4 distinc zones; pure dense fibrous connective tissue (tendon), 
uncalcified fibrocartilage, calcified fibrocartilage, and bone. Pure dense fibrous connective tissue 
is composed of pure tendon, populated by fibroblasts (Lu and Thomopoulos 2013), consisting 
mainly of linearly arranged collagen type-I and -III, elastin and proteoglycans (Laiho, Weis et al. 
1990, Wrana, Attisano et al. 1994, Angeline and Rodeo 2012, Lu and Thomopoulos 2013). 
Uncalcified fibrocartilage is an asvascular zone of uncalcified or unmineralized fibrocartilage 
populated by fibrochondrocytes and consists of the proteoglycan aggrecan and type-I, type-II and 
type-III collagens (Kim, Galatz et al. 2009, Angeline and Rodeo 2012, Lu and Thomopoulos 
2013). The uncalcified fibrocartilage zone functions as a force damper to dissipate stress 
generated by collagen fibers bending (Benjamin and Ralphs 2001). Then the tidemark, a 
basophilic line separating the uncalcified and calcifed fibrocartilage zones, is defined as a 
mechanical boundary between soft and hard tissue (Angeline and Rodeo 2012), decreasing the 
risk of damage during movement (Angeline and Rodeo 2012). Calcifed fibrocartilage is an 
asvascular zone of calcified or mineralized fibrocartilage populated by fibrochondrocytes, which 
consists predominantly of type-II collagen as well as aggrecan and type-I and -X collagens 
(Laiho, Weis et al. 1990, Wrana, Attisano et al. 1994, Benjamin and Ralphs 2001, Scott, Cook et 
al. 2007, Angeline and Rodeo 2012, Lu and Thomopoulos 2013, Padulo, Oliva et al. 2016). This 
zone represents the “true” junction of the tendon insertion, creating a boundary with the 
subchondral bone (Benjamin and Ralphs 2001). This junction is highly irregular and provides 
mechanical integrity to the enthesis (Benjamin and Ralphs 2001). Lastly, bone, which consists of 
osteoclasts, osteocytes, and osteoblasts residing in a matrix type-I collagen and carbonated 
apatite mineral (Angeline and Rodeo 2012, Lu and Thomopoulos 2013). 
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Table 2-1: Zones of fibrocartilaginous entheses 
Zones Composition 
Zone 1 
Pure dense fibrous connective tissue; Tendon 
Type-I collagen, tendon cells aligned. Ordered 
arrays oriented in direction of tensile force 
(Smith, Xia et al. 2012). 
Zone 2 
Uncalcified fibrocartilage 
Type-II collagen with high levels of 
pericellular Type-III collagen, small amount of 
type-I collagen, decoring, and aggrecan 
(Kumagai, Sarkar et al. 1994, Spiller, Wrona et 
al. 2016). 
Zone 3 
Calcified fibrocartilage 
Type-II, -I and –X collagen and aggrecan 
(Galatz, Rothermich et al. 2007). Fibril less 
aligned (Spiller, Wrona et al. 2016). 
Zone 4 
Bone 
Stiff carbonated hydroxyl apatite mineral 
within a scaffold of type-I collagen (Spiller, 
Wrona et al. 2016). 
 
2.2 Tendon and enthesis development 
Several critical factors influence the formation of the enthesis. Scleraxis (Scx) is a transcription 
factor associated with tendons and tenogenesis and is expressed in progenitors cells of all tendon 
tissues (Cserjesi, Brown et al. 1995, Schweitzer, Chyung et al. 2001, Brent, Schweitzer et al. 
2003, Murchison, Price et al. 2007). SOX-9 is associated with chondrogenesis, expressed in 
proliferative chondrocytes, and responsible for chondrocyte differentiation (Huang, Chung et al. 
2001, Asou, Nifuji et al. 2002, Akiyama 2008). Indian Hedgehog (Ihh) and parathyroid hormone 
related protein (PTHrP) drive chondrocyte proliferation and differentiation which form a 
feedback loop maintaining proliferative cells available for development at the growth plate 
(Thomopoulos, Genin et al. 2010). These factors, identified as having important roles in growth 
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plate development, may also play a role in the development of the enthesis. Fibrocartilaginous 
entheses are formed by endochondral ossification (Bunker, Ilie et al. 2014). Initially, 
mesenchymal stem cells (MSCs) differentiate into chondrocytes (Saha 1971) that deposit 
cartilaginous material, which becomes calcified (Benjamin and Ralphs 1998), then chondrocytes 
form the mineralized cartilage matrix (Blitz, Viukov et al. 2009). Finally chondrocytes align in 
rows and collagen fibers line up parallel to the long axis of the tendon (Clark and Harryman 
1992, Rickert, Jung et al. 2001). During enthesis development, tendon first attached to the 
hyaline cartilage of the humeral head, which is not yet mineralized. Next the ossification occurs 
where the hyaline cartilage becomes eroded by osteoclasts and lamellar bone is deposited by 
osteoblasts remaining in matrix (Gao, Messner et al. 1996, Benjamin and McGonagle 2009). 
Finally, the hyaline cartilage rudimentary bone is resorbed and the fibrocartilage continues to 
form as a result of fibroblast metaplasia resulting in the formation of a graded enthesis (Gao, 
Messner et al. 1996, Benjamin and McGonagle 2009). In a mature enthesis, chondrocytes are 
well aligned in rows in the calcified and non-calcified fibrocartilages, which increase tensile 
strength and fibrocartilaginous matrix integrity (Rickert, Jung et al. 2001). Moreover, mature 
fibrocartilaginous enthesis shares many similarities to the growth plate structure development 
also formed through endochondral ossification of bone, which has characteristics of an arrested 
growth front (Watkins, Auer et al. 1985, Blitz, Viukov et al. 2009). The growth plate is divided 
into different zones according to the morphology of the cells as well as the state of calcification 
(Provot and Schipani 2005). These zones include the reserve zone, the proliferative zone, and the 
hypertrophic zone. It is likely that the transcription factors that modulate growth plate maturation 
play a role in enthesis maturation. Similar chondrocyte-like cells appear at the enthesis 
development and eventually mineralize to create the interface between the tendon and bone 
(Thomopoulos, Genin et al. 2010). Increasing tissue mineralization could increase tendon-bone 
healing (Rotini, Marinelli et al. 2011), since enthesis mineralization probably coincides with 
mineralization of the proximal epiphysis in the layer organization (Schwartz, Pasteris et al. 
2012). Hence reinforcement of fibrocartilage could be achieved by increasing the number of 
collagen fibers and spatial organization (Coleman, Fealy et al. 2003, Snyder, Arnoczky et al. 
2009, Longo, Lamberti et al. 2012, Tutwiler, Litvinov et al. 2016).  It has been suggested that 
entheses can act as growth plates for apophyses at tendon attachment sites (Knese and Biermann 
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1958). The cartilage at the enthesis is initially derived from that of the embryonic bone rudiment. 
However, this hyaline cartilage is eroded during endochondral ossification and replaced by 
enthesis fibrocartilage that develops within the adjacent tendon by fibroblast metaplasia (Gao, 
Messner et al. 1996). 
 
2.3 Tendon and enthesis healing  
Tendon healing depends on multiple cell sources, which include fibroblasts 
(Abrahamsson, Lundborg et al. 1989), inflammatory cells (Gelberman, Chu et al. 1992, Boyer, 
Watson et al. 2001), synovial cells (Ark, Gelberman et al. 1994, Abrahamsson, Gelberman et al. 
1995, Amiel, Harwood et al. 1995) and mesenchymal stem cells (MSCs) (Yamamoto, Tokura et 
al. 2003). An injured or compromised tendon passes through 3 different main healing phases. 
The inflammatory phase begins with inflammatory cells migrating to the repair site guided by 
chemotactic factors, characterized by an influx of blood vessels and fibroblasts (Gulotta and 
Rodeo 2009) eventually forming a hematoma. Inflammatory cells such as neutrophils, 
monocytes and macrophages are attracted to the site by pro-inflammatory cytokines (Lin, 
Cardenas et al. 2004). Macrophages play essential roles in promoting and resolving inflammation 
and in facilitating tissue repair (Thomopoulos, Parks et al. 2015). Macrophages are classified into 
two groups, classically activated (M1) or alternatively activated (M2), both driven by specific 
conditions (Murray, Allen et al. 2014). In tendon injury, it is hypothesized that M1 macrophages 
promote repair by stimulating ECM production and that later on M2 macrophages resolve 
inflammation and clear excess ECM (Sugg, Lubardic et al. 2014). Disturbing this homeostasis 
between M1 and M2 macrophages may result in defective repair and impaired tissue function.  
After few days the proliferation stage starts by synthesizing the ECM component, mostly 
collagen type-III and proteoglycans, in a random manner by the recruited fibroblasts, inducing 
cell proliferation and matrix deposition. An increased in cellularity and water absorption is 
observed. 6-8 weeks after injury, the remodeling stage takes place consisting of 2 sub-stages 
lasting around 1 or 2 years. The first sub-stage, the consolidation stage, involves a decreased in 
cellularity, matrix production, fibrous tissue, and collagen type-III is replaced by collagen type-I, 
through tissue remodeling due to ECM turnover mediated my matrix metalloproteinases (MMPs) 
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(Gulotta and Rodeo 2009). The collagen fibers start to organize, resulting in stiffness and 
strength. 10 weeks after injury, the maturation stage starts increasing collagen fibril crosslinking 
and tendinous tissue formation (Docheva, Muller et al. 2015). 
 While fibrocartilaginous transition zone forms during fetal development, scar tissue rich 
in type-III collagen (Hynes 1999, Awad, Boivin et al. 2003) and weaker mechanical strength 
(Patel, Gualtieri et al. 2016) forms between the interfaces in adult tendon-to-bone healing (St 
Pierre, Olson et al. 1995, Thomopoulos, Hattersley et al. 2002, Spiller, Nassiri et al. 2015, 
Spiller, Wrona et al. 2016). Healing following cuff repair depends on robust mechanical 
properties at the junction between bone and tendon (Lee, Lee et al. 2016), which could be 
influence through modulation of cell signaling pathways. Tendon to bone healing represents an 
enormous clinical challenge due to the lack of regeneration of this specialized structure (St 
Pierre, Olson et al. 1995, Liu, Panossian et al. 1997, Fujioka, Thakur et al. 1998, Aoki, Oguma et 
al. 2001, Wong, Qin et al. 2009, Spiller, Wrona et al. 2016). All fibrocartilages associated with 
normal entheses are avascular and this also contributes to a poor healing response at and near 
attachment sites. The avascularity reflects the mechanical conditions to which the tissues are 
subject, notably compression (Benjamin, Toumi et al. 2006). Attachment of tendon to bone 
presents a great challenge during surgical repair because a soft compliant material attaches itself 
to a stiff material. Mineralized interface region exhibited significantly greater compressive 
mechanical properties than the non-mineralized region (Moffat, Sun et al. 2008). It is thus 
important to note that the restoration of a normal enthesis can be significantly enhanced by a 
variety of biological modulators (Benjamin, Toumi et al. 2006).  
Whether entheses can reform after surgical reattachment are questions of considerable 
clinical importance. Surgical reattachment of rotator cuff tear with current repair techniques 
leads to a more abrupt interface and a disorganized scar tissue that is mechanically a lot weaker 
than a native interface (Thomopoulos, Hattersley et al. 2002, Tutwiler, Litvinov et al. 2016). This 
exposes the insertion to high stresses and an increased risk for failure (Smith, Xia et al. 2012). 
Enthesis healing appears to depend upon bone ingrowth into fibrovascular interface tissue. 
Therefore secure healing between tendon-bone, involves bone ingrowth into fibrocartilage and 
outer tendon (Gulotta and Rodeo 2009).  Moreover, healing is often delayed in both animal 
models (Shea, Hallows et al. 2002) and in the clinical situation (Liu, Hang et al. 1996), how to 
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accelerate the healing process also becomes a focus of interest. A method that speeds tendon 
healing without causing muscle fiber atrophy and pennation angle change could be beneficial 
(Melamed, Beutel et al. 2015). Restoration of this footprint might increase the likehood of a 
regenerated native-like enthesis with normal function.  
 
2.4 Rotator Cuff Anatomy and Pathology 
The rotator cuff muscles are a group of muscles consisting of the subscapularis, 
supraspinatus, infraspinatus, and the teres minor (Di Giacomo 2008). The last three are 
inseparable, while the subscapularis is joined to the rest of the cuff via the rotator interval 
(Parsons, Apreleva et al. 2002). All of these muscles are attached to the head of the humerus via 
their specific tendons, which control rotation and position of the arm (Di Giacomo 2008). The 
rotator cuff muscles assist shoulder motion but primarily provide stability (Di Giacomo 2008) by 
keeping the head of the humerus in place, centred into the glenoid, through exertion of forces in 
the coronal and transverse planes (Parsons, Apreleva et al. 2002), allowing abduction or forward 
elevation of the arm (Basmajian and Bazant 1959, Saha 1971). This centering is achieved by 
matching forces around the glenohumeral joint (Pandey and Jaap Willems 2015). The 
supraspinatus and the infraspinatus have long sarcomere lengths, which contribute to 
glenohumeral stability in resting position while the subscapularis stabilizes the glenohumeral 
joint in the position of apprehension (Di Giacomo 2008). The subscapularis is the largest and 
most powerful tendon that arises from the anterior surface of the scapula. It intertwines with the 
supraspinatus tendon at the greater tuberosity of the humerus and acts as the main internal rotator 
(Parsons, Apreleva et al. 2002). It initiates abduction and acts throughout the range of abduction 
of the shoulder (Parsons, Apreleva et al. 2002). The infraspinatus is a thick triangular muscle, 
arising as fleshy fibers with tendinous fibers at the edges of its surface. The ISP tendon glides 
over the lateral border of the spine of the scapula, passes across the posterior part of the capsule 
and inserts into the greater tuberosity (Di Giacomo 2008). The teres minor is a fine, elongated 
muscle that starts from the dorsal face of the scapula. It inserts itself in the posterior part of the 
capsule (Di Giacomo 2008). The infraspinatus and the teres minor both lie below the scapular 
spine and act as external rotators. The infraspinatus primarily acts with the arm in neutral 
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position and the teres minor is active with external rotation in 90° of abduction (Parsons, 
Apreleva et al. 2002).  The supraspinatus is a long, thin muscle with fibers arising from the 
medial portion and the base of the fossa of the scapula. The supraspinatus has the shortest fibers 
of the four rotator cuff muscles and operates over the greater sarcomere length range 
(Mathewson, Kwan et al. 2014). The SSP tendon portion converges with those of the 
subscapularis and the infraspinatus and acts as the superior stabilizer of the humeral head (Di 
Giacomo 2008). It inserts into the major tuberosity and a small portion inserts into the lesser 
tuberosity, which may serve more as an accessory attachment. The supraspinatus tendon is 
constrained on either side by other soft tissues and passes underneath the coracoacromial arch, 
making it prone to compression (Lake, Miller et al. 2010). Areas of tendons that are subjected to 
compression, like under the acromion, produced significant amounts of proteoglycans to resist 
deformation in the direction of compression (Klinger, Buchhorn et al. 2008, Seeherman, 
Archambault et al. 2008). The majority of tendon tears occur in the supraspinatus, more 
specifically in the “so-called” critical zone, about 1-cm proximal to the insertion of the central 
portion (Rudzki, Adler et al. 2008). The anterior portion transmits the majority of the contractile 
load, and since more stress is applied to the anterior section of the shoulder on a daily basis, 
leading to high risk for a tear.  
Major conditions affecting tendons are tendinitis, characterized by inflammation and 
pain, and tendinosis, a tendinous degeneration (Maffulli, Khan et al. 1998). Many factors, either 
intrinsic or extrinsic, are involved in the onset and progression of tendinopathies, such as age, 
gender, anatomical variants, body weight, smoking, systemic disease, sporting activities, 
physical loading, occupation, and environmental conditions (Riley 2004, Rees, Wilson et al. 
2006). Rotator cuff injuries are common and often require surgical repair to restore the tendon to 
its bone. Chronic rotator cuff tears are associated with structural changes such as fatty 
accumulation, loss of muscle volume, retraction, which all result in muscle remodeling, 
retraction of sarcomeres and profound muscle weakness (Williams and Rockwood 1996). The 
deltoid becomes the only shoulder elevator if the supraspinatus tendon is torn and dysfunctional 
(Parsons, Apreleva et al. 2002). However, if the sarcomeres of the muscles become overstretched 
so that the myofilaments overlap, the contractile function becomes compromised (Di Giacomo 
2008). Progression of a tear will also lead to superior subluxation of the humeral head and 
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eventually, dysfunction of the shoulder. Pathology in rotator cuff tear is also influenced by the 
micro vascular supply of rotator cuff tendons (Parsons, Apreleva et al. 2002). A cuff tear is 
condidered irreparable when closing results in poor footprint coverage or when the closure 
results in post-operative retear (Pandey and Jaap Willems 2015), hence reparability is dependent 
on size and shape of the tear. Cuff tears can be traumatic, due to significant trauma or 
degeneration, which are multifactorial in aetiology (Pandey and Jaap Willems 2015), and often 
involve one or more tendons (Smith, Xia et al. 2012).  
 
2.5 Surgical Treatments of Rotator Cuff Tears 
The most common surgical interventions available to repair rotator cuff tears involve 
different suturing techniques. Open repair techniques were the first to be performed but mini-
open or fully arthroscopic procedures are now the gold standard. The superiority of arthroscopy 
versus open or mini-open repair is still unproven and controversial at this point (Galatz, Ball et 
al. 2004) (Appendix A).  
Ji et al. (Ji, Bi et al. 2015), Liem et al. (Liem, Bartl et al. 2007) and Kasten et al. (Kasten, 
Keil et al. 2011) found no significant difference between arthroscopy versus mini-open repair 
patients. Nho et al. (Nho, Shindle et al. 2007) and Van der Zwaal et al. (van der Zwaal, 
Thomassen et al. 2013) also observed no difference in functional outcomes, range of motion and 
complication rates between mini-open and arthroscopy. However, in another study, a greater re-
tear rate was observed in patients who had undergone arthroscopy versus the ones whom had had 
mini-open surgery (Zhang, Gu et al. 2014). Mall et al. (Mall, Chahal et al. 2012) found no 
difference in arthroscopy versus open repair. However, although Bishop et al. (Bishop, Klepps et 
al. 2006) showed comparable results in arthroscopy versus open repair for tears smaller than 3 
cm, the re-tear rate was doubled after arthroscopy with tears larger than 3 cm. Feeley et al. 
(Feeley, Gallo et al. 2009) showed that arthroscopy resulted in less soft-tissue trauma in elderly 
patients with low functional demands since it is a slightly invasive surgical intervention. 
However, arthroscopy requires high dexterity to be performed correctly (Baleani, Ohman et al. 
2006) and can also lead to the resection of the corticoacromial ligament, which worsens rotator 
cuff tears. Moreover arthroscopic treatment can lead to greater failures compare to open surgical 
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suture repair (Koh, Kang et al. 2011). Some studies have shown that arthroscopic procedures can 
decrease postoperative pain, facilitate faster recovery and give better aesthetic results (Verma, 
Dunn et al. 2006, Kang, Henn et al. 2007). However, others (Shinoda, Shibata et al. 2009, Kim, 
Lee et al. 2013) have found no significant difference between open and arthroscopic procedures 
both of which significantly improve clinical outcomes and shoulder function. Lorbach et al. 
(Lorbach and Tompkins 2012) hypothesized that since arthroscopy results in less pain after 
surgery, patients may tend to exercises sooner.  
Initially, transosseous tunnels were used to perform open rotator cuff repair. This 
technique uses sutures placed directly into transosseous tunnels inside the greater tuberosity for 
tendon fixation (Cole, ElAttrache et al. 2007), but is limited by bone quality (Denard and 
Burkhart 2013). Now, cuff repair is usually performed with suture anchors using different 
configurations: the single-row, the double-row, and the suture bridge repair technique, also 
called the transosseous-equivalent repair technique. The goal of using suture anchors is to restore 
the initial footprint and tendon alignment by suturing the tendon directly into the humeral head 
(Cole, ElAttrache et al. 2007). This technique increases footprint contact area, which is thought 
to improve the rate of healing but this requires a non-degenerated tendon with a good healing 
potential (Docheva, Muller et al. 2015) and re-tear rates are still fairly high (Denard and 
Burkhart 2013). The suture bridge, or the transosseous-equivalent technique (TOE), is an 
improvement of the double-row repair technique. This approach seems to provide a more 
uniform compression and a greater surface contact, which is expected to enhance the attachment 
and the pull-out strength (Cole, ElAttrache et al. 2007). This procedure is also assumed to restore 
normal anatomy and function of the shoulder (Di Giacomo 2008). Furthermore it may create 
excessive tension on the tendon leaving an avascular area at the repair site (Denard and Burkhart 
2013). A common problem of early failure with suture anchors is the pull out of the suture 
through the tendon (Baleani, Ohman et al. 2006). 
In controlled laboratory studies using cadaveric shoulders Kim et al. (Kim, Elattrache et 
al. 2006) compared double-row versus single-row repairs; DR had 42% less gap formation, 46% 
more stiffness and 48% more load at failure than SR repair. Mazzocca et al. (Mazzocca, Millett 
et al. 2005) found similar outcomes for both techniques, but DR had greater success at restoring 
the initial footprint of the tear. Apreleva et al. (Apreleva, Ozbaydar et al. 2002) compared 
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transosseous with single-row anchors; and the transosseous technique seemed to be best at 
restoring the anatomy of the supraspinatus tendon. (Park, Cadet et al. 2005) had comparable 
results, where transosseous repair resulted in greater ultimate load of failure and lower pressure 
on the repair site. Transosseous repair was also compared to double-row technique by Waltrip et 
al (Waltrip, Zheng et al. 2003) using cadaveric shoulders. Transosseous repair increased the 
number of cycles to failure. It was also shown that transosseous repair concentrated the stress at 
the attachment site; while DR and SR repair concentrated the stress on the bursal side of the 
tendon, which may explain the greater rate of re-tear in these techniques (Sano, Wakabayashi et 
al. 2006). Siskosky et al. (Siskosky MJ 2007) showed that transosseous-equivalent (TOE) had 
higher ultimate load of failure but no change in initial stiffness or gap formation compared to DR 
repair. TOE was also shown to be more resistant to rotational and shear stress and to reduce gap 
formation (Costic RS 2006, Cole, ElAttrache et al. 2007). Therefore, it seems like TOE is better 
in cadaveric studies, but that has not translated into superior clinical outcomes.  
In clinical studies comparing different suturing techniques (Appendix B), Aydin et al. 
(Aydin, Kocaoglu et al. 2010), Grasso et al. (Grasso, Milano et al. 2009), Nho et al. (Nho, 
Slabaugh et al. 2009), Wall et al. (Wall, Keener et al. 2009), and Koh et al (Koh, Kang et al. 
2011) found no significant difference in clinical outcomes between arthroscopic single-row (SR) 
repairs versus arthroscopic double-row (DR) repairs. Ying et al. (Ying, Lin et al. 2014) also 
found that both techniques improved clinical outcomes. The UCLA shoulder scoring test, 
incidence of recurrent defects, shoulder muscle strength, range of motion and patient satisfaction 
were similar in the two groups with tears smaller than 3 cm. However, double-row showed a 
greater rate of tendon healing, smaller rate of re-tear and greater muscle strength in patients with 
tears greater than 3cm (Ying, Lin et al. 2014). On the other hand, Ma et a.l (Ma, Chow et al. 
2011), Mascarenhas et al. (Mascarenhas, Chalmers et al. 2014) and Trappey et al. (Trappey and 
Gartsman 2011) showed that DR repair provides better tendon strength compared to SR. 
Carbonel et al. (Carbonel, Antonio Martinez et al. 2012), Chen et al. (Chen, Xu et al. 2013), and 
Prasathaporn et al. (Prasathaporn, Kuptniratsaikul et al. 2011) demonstrated that DR repair group 
had higher rate of tendon healing compared to SR repair group. In addition, Millet et al. (Millett, 
Warth et al. 2014) found a higher re-tear rate with SR repair patients compared to DR. Gartsman 
et al. (Gartsman, Drake et al. 2013) compared TOE to SR and found a higher tendon healing rate 
21 
 
in TOE repair. Even if there is no consensus on which surgical technique to use, the suture 
bridge technique may seem to be more appropriate at repairing massive rotator cuff tear, since it 
provides a more uniform compression hence favoring healing rate.  
A common surgical procedure performed on symptomatic patients with massive tear, 
muscle atrophy and fatty accumulation is arthroscopic debridement (Clement, Nie et al. 2012). 
This procedure involves irrigation and debridement of joint surfaces, thus removing enzymes and 
crystals to provide short-term pain relief, but long-term success is limited. Furthermore, more 
than a third of surgeries result in unsuccessful outcomes such as persistent pain and disabilities 
(Seitz, McClure et al. 2011). However, cuff repairs are prone to failure regardless of repair 
technique used (Heldin and Westermark 1999, Galatz, Ball et al. 2004). The best rotator cuff tear 
surgical treatment is currently a topic of debate, since current repair strategies do not regenerate 
the functionally graded transiotional tissue interface (Smith, Xia et al. 2012). A biological 
strategy improving patient’s intrinsic healing potential is needed (Melamed, Beutel et al. 2015). 
When rotator cuff pathology is a result of mechanical impingement, reshaping the acromion by 
acromioplasty may be the favored surgical procedure. The acromioplasty is believed to relieve 
the pressure on the cuff, caused by impingement (Neer, Craig et al. 1983). However, reviews 
found no statistically significant difference in subjective outcome after arthroscopic rotator cuff 
repair with or without acromioplasty at intermediate follow-up with failure rates ranging from 15 
to 20% (Chahal, Mall et al. 2012, Shi and Edwards 2012). In addition, acromioplasty with 
coracoacromial (CA) ligament release increases superior glenohumeral instability (Su, Budoff et 
al. 2009). 
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2.6 Animal Models of Rotator Cuff Repairs 
Animal models are practical means to understand molecular pathways and pathologies of 
rotator cuff tears and to develop new technologies to improve existing treatments (Liu, Manzano 
et al. 2011). Rotator cuff repair animal models should lack spontaneous tendon healing or scar 
tissue formation after tendon injury. Although no animal model is identical to human, the tendon 
size should also allow for suture repair techniques as used in humans. Ideally, irreversible 
muscular atrophy, stiffness and fatty accumulation should be present post-injury (Derwin, Baker 
et al. 2007). Quadrupeds use their supraspinatus to accelerate, while humans use it in arm raising. 
The supraspinatus muscle acts against gravity and under greater strain in humans compared to 
animals. Shoulder movement in quadrupeds is restricted to the sagittal plane, while bipeds rotate 
and move in the coronal plane, providing more mobility (Sonnabend and Young 2009). 
Quadrupeds use their forelimbs for weight bearing during locomotion and not for overhead 
activities, which differs greatly from humans (Grumet, Hadley et al. 2009) and makes it 
challenging to find a good animal model for shoulder injuries. Moreover a true rotator cuff is 
defined as the blending of individual flat tendons to form a single insertion. Rabbits, rats, dogs 
and sheep all have tendons that do not blend before inserting into humeral head; hence they all 
lack this aspect of the human rotator cuff anatomy (Sonnabend and Young 2009). An acute 
rotator cuff tear model is also inappropriate to study tendon degeneration, but useful to evaluate 
atrophy and fatty accumulation in rotator cuff muscles (Liu, Manzano et al. 2011). Chronic 
rotator cuff models have also been developed, mostly in the sheep (Coleman, Fealy et al. 2003, 
Gerber, Meyer et al. 2004). 
 
2.6.1 Rat 
Rats have the greatest anatomic similarity to humans because of the presence of an 
acromial arch and the overhead reaching activities (Derwin, Baker et al. 2007). Only in rats is the 
acromion immediately adjacent and positioned over the supraspinatus tendon, similar to humans 
(Soslowsky, Carpenter et al. 1996). The rat’s forward arm elevation is similar to human arm 
abduction (Perry, Getz et al. 2009) and the range of motion decreases after rotator cuff tears in 
rats, which is consistent with alterations in shoulder function observed in humans (Perry, Getz et 
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al. 2009). Rotator cuff tears in rats will also result in cartilage degeneration in the humeral head 
and the glenoid (Kramer, Bodendorfer et al. 2013). However, the acromial arch structure is 
somewhat different in quadrupeds: the portion of the rat supraspinatus muscle that passes under 
acromial arch is muscular and not tendinous like in humans (Grumet, Hadley et al. 2009).  
Although the rat is a reasonable model, it has a few major differences with respect to 
human. First, rotator cuff tears heal better in rats than in humans, due to the higher regenerative 
potential of their musculoskeletal system (Liu, Manzano et al. 2011). Rotator cuff tears undergo 
spontaneous healing in rats, which does not happen in human (Derwin, Baker et al. 2010). The 
supraspinatus provides less coverage in rat and most of the coverage is from the subscapularis 
instead (Liu, Manzano et al. 2011). In addition, the rat supraspinatus lacks the irreversible 
accumulation of muscular fat and postoperative re-tears making it less suitable to evaluate repair 
techniques (Derwin, Baker et al. 2010). In rats, the infraspinatus tendon may be a better model to 
represent the human supraspinatus, since it undergoes more fatty accumulation, muscular atrophy 
and more muscular retraction (Liu, Manzano et al. 2011). Re-tear has not been documented post-
operatively in rat model, making it less suitable for translational studies (Galatz, Charlton et al. 
2009). Even with these limitations, the rat is seen as an appropriate and cost-effective model to 
investigate initial safety, repair mechanisms and efficacy of treatments although its small size 
makes it challenging to perform surgical repairs (Derwin, Baker et al. 2007). 
Rats are mostly used to investigate extrinsic and intrinsic factors that contribute to rotator 
cuff tears. In rats, most studies have been done using the transosseous tunnels repair technique 
with the SSP tendon (Galatz, Rothermich et al. 2005, Galatz, Sandell et al. 2006, Galatz, Charlton 
et al. 2009, Ide, Kikukawa et al. 2009, Bedi, Kovacevic et al. 2010, Liu, Manzano et al. 2011, 
Manning, Kim et al. 2011, Hettrich, Beamer et al. 2012, Buchmann, Sandmann et al. 2013, Oak, 
Gumucio et al. 2014, Zhao, Peng et al. 2014, Zhao, Zhao et al. 2014, Ross, Maerz et al. 2015, 
Zhao, Xie et al. 2015, Huegel, Kim et al. 2016, Peach, Ramos et al. 2017, Tucker, Gordon et al. 
2017). Briefly, the supraspinatus is exposed by supination of the forearm, transected from its 
tendon insertion site. A drill hole is created transversely in a cranialecaudal orientation through 
the proximal humerus. Fibrocartilage is removed from the insertion site. The tendon is grasped 
using a double-armed 5-0 Prolene suture in a Mason-Allen method. The suture is then passed 
through the drill hole and tied the distal supraspinatus to its original footprint on the humeral 
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head (Galatz, Charlton et al. 2009). Only one study used  the transosseous repair technique with 
the ISP tendon (Harada, Mifune et al. 2016). Two more recent studies used polyamide 
nonabsorbable sutures repair technique in a Mason-Allen configuration with the SSP tendon 
(Melamed, Beutel et al. 2015, Fabis, Danilewicz et al. 2016). 
 
2.6.2 Rabbit 
In rabbit rotator cuff tears, atrophy occurs at early time points and fatty accumulation 
occurs at later time points similar to humans (Liu, Manzano et al. 2011). The rotator cuff in 
rabbits also heals in a fashion that is similar to humans (Gupta and Lee 2007). The supraspinatus 
and infraspinatus tendons have both been used as repair models, but recent studies have shown 
that the subscapularis could be a better approximation of human conditions since it passes under 
an enclosed arch and that fatty accumulation is prominent (Edelstein, Thomas et al. 2011). The 
subscapularis tendon and the scapular channel are similar in human; both travel beneath the 
acromion and insert into the greater tuberosity of the humerus (Grumet, Hadley et al. 2009). In 
that respect, the rabbit’s subscapularis may be more comparable to the human supraspinatus. The 
rabbit is also bigger than the rat therefore facilitating surgical models and many standard-of-care 
surgical techniques (Thomopoulos, Parks et al. 2015), as larger animals provide greater accuracy 
and reproducibility (Derwin, Baker et al. 2007). 
The rabbit model is mostly used to study muscular changes associated with rotator cuff 
tears like muscle atrophy, twitch tension which is a single contraction in response to a brief 
threshold stimulation and fatigue index which determines energy depletion during exercise 
(Edelstein, Thomas et al. 2011). Most of the preclinical studies in rabbits have used the 
transosseous repair technique with the SSP tendon (Appendix C) (Uhthoff, Sano et al. 2000, 
Matsumoto, Uhthoff et al. 2002, Sano, Kumagai et al. 2002, Uhthoff, Seki et al. 2002, Uhthoff, 
Trudel et al. 2003, Uhthoff, Matsumoto et al. 2003a, Koike, Trudel et al. 2005, Kobayashi, Itoi et 
al. 2006, Koike, Trudel et al. 2006, Chang, Chen et al. 2009, Trudel, Ramachandran et al. 2010a, 
Trudel, Ryan et al. 2010b, Trudel, Ramachandran et al. 2012a, Trudel, Ryan et al. 2012b, Friel, 
Wang et al. 2013, Uhthoff, Coletta et al. 2014, Uhthoff, Coletta et al. 2014, Friel, McNickle et al. 
2015, Gilotra, Nguyen et al. 2015, Kim, Kim et al. 2016, Cheon, Kim et al. 2017, Trudel, Melkus 
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et al. 2017). Briefly, a 3-cm longitudinal anterolateral skin incision is made, exposing the SSP 
tendon. A complete surgical tear is created, as close as possible to the insertion site. The 
remaining fibrocartilaginous stump is removed. A bony trough (2 mm diameter and 5-7 mm 
deep) is drilled in the cancellous bone of the greater tuberosity. Three small drill holes (1.4 mm 
diameter) are drilled from the lateral aspect of the humerus to connect to the bony trough. Two 
3.0 prolene sutures are passed through the lateral holes, the bony trough and the tendon itself in a 
modified Mason-Allen configuration and tightened over the lateral aspect of the cortex, thus 
pulling the tendon over the bony trough.  
Some studies used the transosseous repair technique with the ISP tendon (Funakoshi, 
Majima et al. 2006, Yokoya, Mochizuki et al. 2008, Itoigawa, Suzuki et al. 2015) Few studies 
used either the single-row (Nho, Cole et al. 2006, Quigley, Gupta et al. 2013, Oh, Kim et al. 
2015, Kim, Kim et al. 2016) or the double-row (Quigley, Gupta et al. 2013, Oh, Chung et al. 
2014) or the transosseous-euqivalent repair technique (suture bridge) (Quigley, Gupta et al. 2013, 
Fei and Guo 2015, Kim, Kim et al. 2016). Only one study used polyamide non-absorbable 
sutures with the SSP tendon (Fabis, Danilewicz et al. 2016) and one used the transosseous 
matress sutures repair technique with the ISP tendon (Inui, Kokubu et al. 2012). 
 
2.6.3 Sheep 
Tendons in sheep heal spontaneously even without surgical intervention, unless healing is 
actively stopped (Gerber, Meyer et al. 2004). Since it is fairly easy to wrap the end of its tendons 
to prevent spontaneous healing, the sheep becomes an interesting choice for a chronic model 
(Coleman, Fealy et al. 2003). The sheep infraspinatus is similar in size to the human 
supraspinatus (Edelstein, Thomas et al. 2011). Although the sheep infraspinatus is not 
intraarticular, there is still a bursa under the tendon and repair has some contact with the synovial 
fluid that lubricates the bursa (Turner 2007). Availability, ease of handling and housing, low cost 
and acceptance to society as a research animal, makes ovine model useful to study rotator cuff 
tear repair (Turner 2007). Large animal models, like rabbit, sheep and canine have a high re-tear 
rates post-operative, making them suitable to test various repair techniques for human conditions 
(Derwin, Baker et al. 2007, Schlegel, Hawkins et al. 2007).  
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Most of the studies involving sheep models have either used the double suture anchors repair 
technique with the ISP tendon (Appendix D) (Lewis, Schlegel et al. 1999, Meyer, Hoppeler et al. 
2004, Meyer, Lajtai et al. 2006, Kovacevic and Rodeo 2008, Zumstein, Rumian et al. 2014, Luan, 
Liu et al. 2015) or the transosseous bony trough technique with the ISP tendon (Gerber, 
Schneeberger et al. 1999, Lewis, Schlegel et al. 1999, Schlegel, Hawkins et al. 2006, Rodeo, 
Potter et al. 2007, Klinger, Buchhorn et al. 2008, Kovacevic and Rodeo 2008). Briefly, the 
double suture anchors involve two suture anchors that are deployed into the dense bone of the 
medial footprint of the proximal humerus, 1 cm apart and 2 mm to 4 mm deep to the cortex. 
Sutures are passed from inferior to superior through the infraspinatus tendon and tied in simple 
mattress fashion on the superior surface of the tendon (Luan, Liu et al. 2015). The transseous 
repair technique briefly involves two or three modified Mason-Allen stiches that are placed into 
the tendon end and passed through a bony trough created at the site of the original insertion and 
tied over the greater tuberosity (Gerber, Schneeberger et al. 1999). Some studies used the Mason-
Allen bone screws repair technique (Gerber, Meyer et al. 2004, Gerber, Meyer et al. 2009, 
Gerber, Meyer et al. 2015, Peterson, Ohashi et al. 2015, Wieser, Farshad et al. 2015), in which 
the rotator cuff is repaired by re-attaching the bone chip to its original site or as near to this site as 
possible with attachment of the remaining sutures to a 3.5-mm cortical bone screw with a washer 
(Wieser, Farshad et al. 2015). Few other studies used the TOE suture bridge repair technique 
(Lovric, Ledger et al. 2013), single row repair technique (Uggen, Dines et al. 2010), allograft 
bone-suture anchors in Mason-Allen pattern (Coleman, Fealy et al. 2003), and bioabsorbable 
suture anchors technique in Mason-Allen pattern (Klinger, Buchhorn et al. 2008, Baums, Spahn 
et al. 2012, Baums, Schminke et al. 2015). 
 
2.6.4 Dogs and non-human primates 
Although the above three mentioned species are the most commonly used, dogs are 
sometimes used as an animal model for rotator cuff repair since they tolerate casting, slinging, 
treadmill running, post-operative rehabilitation protocols, and are good chronic models (Derwin, 
Baker et al. 2007). Canine models also produce loads to the rotator cuff that are similar in 
magnitude to those experienced on a daily basis by humans (Edelstein, Thomas et al. 2011). 
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However, they are less accepted by the society as research animal. Non-human primates have 
very similar function and anatomy to humans, but are rarely used due to high cost and complexity 
of their housing and treatment (Edelstein, Thomas et al. 2011). 
Table 2-2: Advantages and disadvantages of different animal models for rotator cuff repair. 
Animal models Advantages: Disadvantages: 
Rat  Acromial arch & overhead activities 
 SSP below arch 
 Cost-effective 
 Similar forward arm elevation 
 
 Scar tissue formation & healing RC 
without treatment 
 No postoperative re-tears 
 Small size 
 SSP shorter 
 Fat infiltration in ISP only 
 RCT heals better 
 Less coverage from SSP  
 SSP that passes under arch is musculous 
and not tendinous 
 Weight-bearing joint 
Rabbit  Larger & more accurate 
 Scapular bony tunnel 
 Similar muscle atrophy & fatty 
infiltration 
 Similar healing properties 
 Good to study RCT & nerve injury 
 Subscapularis similar to human SSP 
 Used for auto grafts & dermal grafts 
 Weight-bearing joint 
 Minimal or no overhead activities 
 ISP is muscular and not tendinous 
 Less effective at retaining sutures 
 More bony prominence 
 
Sheep  Larger & more accurate 
 Ease of handling & housing 
 Accurate to repeat surgeries 
 ISP similar size to human SSP 
 Availability 
 Good chronic model & to test various 
suturing techniques 
 Weight-bearing joint 
 Anatomy not comparable to human 
 Spontaneous healing  
 No overhead activities 
 
Dog  Produce loads to the rotator cuff that are 
similar to humans 
 Tolerate casting, slinging, treadmill 
running, and post-operative 
rehabilitation protocols. 
 Good chronic models 
 Ethical challenges 
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Non-human Primate  Most similar function and anatomy to 
humans 
 High cost and complexity of their 
housing and treatment 
 Ethical challenges 
 
2.7 Technologies under Development for Rotator Cuff Repair 
2.7.1 Platelet-rich plasma  
Platelet-rich plasma (PRP) has gained popularity in sports medicine and orthopaedics but its 
efficacy in rotator cuff tear repair is still unclear. To obtain PRP, small amount of the patient’s 
own blood is spun through a centrifugation process to concentrate platelets. Several types of PRP 
have been used for clinical cuff repair augmentation (Appendix E). PRP can be applied as a 
liquid (with or without calcium-based activation prior to application) or can be implanted as a 
solid matrix, in which case it is called platelet-rich fibrin (PRF). In addition, the isolation process 
will determine whether the PRP or the PRF contains leukocytes or not. There are four distinct 
PRP formulations. First the leukocyte-reduced platelet-rich fibrin matrices (P-PRF), which are 
made from activating autogenous thrombin within the plasma to create fibrin clots and this 
formulation of sequestered platelets can be sutured between tendon-bone interface (Otarodifard, 
Bruce Canham et al.). Second, leukocyte-enriched platelet-rich fibrin matrices (L-PRF), which is 
obtained as a result of slow polymerization, in order to keep leukocytes. Leukocytes are white 
blood cells that release cytokines and growth factors and are hypothesized to aid in healing 
(Otarodifard, Bruce Canham et al. , Dohan Ehrenfest, Rasmusson et al. 2009). This L-PRF 
matrix is believed to hold many growth factors and cytokines, and can release them in the 
wound site for prolonged times (Kumar and Shubhashini 2013). The third formulation 
leukocyte-platelet-rich plasma (L-PRP) is prepared by retaining the leukocytes during the PRP 
process formulation. The fourth formulation, platelet rich in growth factors (P-PRP), a 
preparation of plasma with high concentrations of platelets and growth factors, in which 
leukocytes have been eliminated during the process (Patel, Gualtieri et al. 2016). There is also 
BMAC (bone marrow aspirate concentrate) that is obtained through centrifugation of iliac crest 
punctuation. 
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Platelets release growth factors from the α-granules and the dense granules, which contain 
many different cytokines and bioactive factors, such as growth factors (Rodeo, Delos et al. 2012) 
that have chemotactic paracrine roles, which regulate inflammation, angiogenesis, synthesis and 
remodeling of tissues (Andia, Sanchez et al. 2010, Zhou, Estrera et al. 2013). The growth factors 
within these platelets, such as insulin-like growth factor-1 (IGF-1), platelet-derived growth factor 
(PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor-B (TGF-B), 
have all been implicated in tendon healing (Otarodifard, Bruce Canham et al. , Lu, Vo et al. 
2008).  
Pre-clinical studies investigating PRP for rotator cuff repair are few. Most use the rat model 
(Beck, Evans et al. 2012, Hapa, Cakici et al. 2012, Cabitza, Banfi et al. 2014, Dolkart, Chechik et 
al. 2014, Ersen, Demirhan et al. 2014), with a few studies published in rabbits (Chung, Song et al. 
2013, Wu, Dong et al. 2014). Some studies showed repair improvement with application PRP, 
while others did not. BMAC (bone marrow aspirate concentrate)-PRP has been shown to increase 
proliferation and migration of tendon-derived stem cells (TDSCs) and prevent the aberrant 
chondrogenic and osteogenic differentiation of TDSC (Kim, Song et al. 2017). 
Clinical data of PRP for rotator cuff repair is more abundant (Appendix E). Leukocyte-
rich PRF has been used as solid implants to attempt cuff repair augmentation by a few groups 
(Sanchez Marquez, Martínez Díez et al. 2011, Antuna, Barco et al. 2013, Zumstein, Rumian et al. 
2014), but no improvement was reported. Pure-PRF devoid of leukocytes was used more often 
(Barber, Hrnack et al. 2011, Castricini, Longo et al. 2011, Bergeson, Tashjian et al. 2012, Rodeo, 
Delos et al. 2012, Weber, Kauffman et al. 2013), with two studies showing lower re-tear rates 
with P-PRF (Barber, Hrnack et al. 2011, Castricini, Longo et al. 2011), two studies showing more 
failures with P-PRF (Bergeson, Tashjian et al. 2012, Rodeo, Delos et al. 2012) and one study 
showing no difference between both groups (Weber, Kauffman et al. 2013). Leukocyte-rich PRP 
was used in a four Level I trials, where showed no clinical improvement but a lower re-tear rate 
compared to the control group (Randelli, Arrigoni et al. 2011), better repair integrity (Gumina, 
Campagna et al. 2012) and less post-operative pain (Holtby, Christakis et al. 2016). Charousset et 
al. (Charousset, Zaoui et al. 2014) compared massive rotator cuff tear repaired arthroscopically 
with or without L-PRP (Level III study) and found no difference in outcomes, either functionally 
or radiographically, however, retears tended to be lower in the L-PRP group (Charousset, Zaoui 
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et al. 2014). Studies using P-PRP devoid of leukocytes employed plateletpheresis systems (Jo, 
Kim et al. 2011, Jo, Shin et al. 2013, Malavolta, Conforto Gracitelli et al. 2014, Jo, Shin et al. 
2015) or centrifugation methods (Ruiz-Moneo, Molano-Munoz et al. 2013, Flury, Rickenbacher 
et al. 2016, Gwinner, Gerhardt et al. 2016, Pandey, Bandi et al. 2016) to isolate the PRP. Five 
studies showed less re-tear or partial re-tears in the P-PRP-treated group (Jo, Kim et al. 2011, Jo, 
Shin et al. 2013, Malavolta, Conforto Gracitelli et al. 2014, Jo, Shin et al. 2015, Pandey, Bandi et 
al. 2016), while five studies showed no effect of P-PRP (Ruiz-Moneo, Molano-Munoz et al. 
2013, Flury, Rickenbacher et al. 2016, Gwinner, Gerhardt et al. 2016). 
The most effective platelet and leukocyte counts, as well as the ratio of plasma proteins, 
timing of delivery (Salamanna, Veronesi et al. 2015), remains unknown (Murray, LaPrade et al. 
2016). The majority of PRP-augmented rotator cuff studies have used PRP at the time of surgery 
(Castricini, Longo et al. 2011, Rodeo, Delos et al. 2012). Once activated, platelets release growth 
factors almost immediately with total elution within one hour, and a half-life of few minutes 
(Mooren, Hendriks et al. 2010). A tendon healing study showed that the spike in cell 
proliferation, growth factors production, ECM production occurs within 7-14 days post-injury 
(Galatz, Sandell et al. 2006). Furthermore, each cytokine will contribute at different time points 
after repair (Murray, LaPrade et al. 2016). Thus, timing of delivery remains an important clinical 
question for optimizing tendon healing (Murray, LaPrade et al. 2016). It has been postulated that 
PRP will improve tendon healing by increasing the concentration of growth factors and by 
promoting revascularization of surrounding tissues (Barber, Hrnack et al. 2011), however, results 
have been inconsistent so far.  
Taken together, these studies seem to reflect a lack of significant evidence or any strong 
benefit for the use of PRP-augmentation RC repair (Castricini, Longo et al. 2011, Randelli, 
Arrigoni et al. 2011, Theodoropoulos 2011, Jo, Shin et al. 2013). Different studies used different 
PRP preparations with different platelet concentration and different surgical approaches, which 
may explain the different outcomes. Lower re-tear rates may translate into improved clinical 
scores at longer time points, and in that respect, treatment with PRP might eventually improve 
cuff repair. The efficacy of PRP remains an open question in orthopedic rotator cuff repair. 
Moreover there is no evidence that delivery of GF alone induces tendon regeneration or scarless 
healing (Galatz, Gerstenfeld et al. 2015). Future research should use high or higher 
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concentrations, a more sustained delivery method (Lu, Vo et al. 2008), and maybe several 
administration dosages intraoperatively (Patel, Gualtieri et al. 2016). 
 
2.7.2 Tendon Patches & Grafts  
Grafts are used as scaffolds for tissue ingrowth and as collagen substitutes; a perfect 
scaffold should increase load to failure and decrease stress, thus shielding injured tissue (Barber, 
Herbert et al. 2008). They require good strength and tissue compatibility and some are made up 
of polycarbonate polyurethane, polytetrafluoroethylene, and polyester. Concerns include 
persistent inflammation and loss of integrity over time, with fragmentations leading to 
mechanical failure (Murray, LaPrade et al. 2016). Biological patches are used as a vehicle and 
structural support in tissue engineering and cellular delivery (Denard, Jiwani et al. 2012). Natural 
biomaterials include, collagen, silk, fibrin, hyaluronic acid, elastin, alginate, chitosan, porcine 
small intestine submucosa (SIS), human, porcine, bovine dermis and decellularized tendon 
xenografts (Clark and Harryman 1992, Longo, Lamberti et al. 2010, Longo, Lamberti et al. 
2012). Some patches are nondegradable and aim to provide permanent mechanical support to 
promote self-healing 
The concept of ECM patches is to reinforce the strength of a repair by offloading the 
tendon repair. The patch could provide a scaffold for new growth and differentiation. They may 
also be used a delivery vehicle for cells and GFs (Galatz, Gerstenfeld et al. 2015). ECMs are 
derived from dermis, small intestine submucosa (SIS), fascia lata, and pericardium, obtained 
through decellularization treatment, chemical cross-linking, lamination of multiple layers, or 
lyophilisation (Aurora, McCarron et al. 2007). A porcine collagen dermal patch (Badhe, 
Lawrence et al. 2008) was used as a RC augmentation repair in a study of 10 patients, which 
showed significant functional improvement with 80% graft potency on MRI at 4.5 years. 
However, Soler et al (Soler, Gidwani et al. 2007) used a porcine dermal collagen as an 
augmentation material for massive RC tear repair, and all patients demonstrated signs and 
symptoms of a recurrent tear. Dopirak et al. (Bond, Dopirak et al. 2008) tested Graftjacket, an 
extracellular matrix (ECM) human cadaveric dermis scaffold, during arthroscopic total rotator 
cuff replacement in 16 patients. The overhead strength was improved but failure was reported in 
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3 patients (Bond, Dopirak et al. 2008). Positive outcomes after applying human dermis as an 
augmentation in large RC defects were documented in other studies (Snyder, Arnoczky et al. 
2009, Rotini, Marinelli et al. 2011). Other studies showed improvement in maximum load but not 
in linear stiffness at the repair site (Omae, Steinmann et al. 2012). Burkhead et al. (Burkhead WZ 
2007) showed an increase tissue ingrowth into the Graftjacket graft itself after two years. Patients 
with arthroscopic SR repair augmented with Graftjacket had higher ASES (American Shoulder 
and Elbow Surgeons) and constant shoulder scores after 24 months (Barber, Burns et al. 2012). 
The extracellular matrix grafts are still available and sometimes used in surgery as augmentation 
devices for soft tissue. ECM grafts showed benefits in some animal studies but not in recent 
randomized controlled clinical trials (Ahmad, Henson et al. 2013). Hence further investigations 
are needed to prove their efficacy. Futures controlled comparison studies are necessary to clearly 
define the advantages and limitation of each biomaterial. When using any ECM devices, it is 
important to note that a loss of mechanical and suture retention properties is expected (Aurora, 
McCarron et al. 2007). However, all of the processed ECM devices have similar hydroxyproline 
content as tendon, except GraftJacket (Aurora, McCarron et al. 2007). 
Extracellular devices such as small intestine submucosa (SIS) have been used as scaffolds 
for the repair of full-thickness infraspinatus tear in a canine model. Six months after the surgery, 
the injured tendon was similar to native tendon (Adams, Zobitz et al. 2006). However, it was 
impossible to determine if the observed site was remodeled tissue or new tissue. SIS scaffold was 
also tested in supraspinatus tendon of rabbits. After only 8 weeks, 4 of 5 implants were replaced 
by dense collagen, but load to failure was inferior to control tendon (Aurora, McCarron et al. 
2007). Metcalf et al. (Metcalf MH 2002) used Restore, a small intestine submucosa (SIS) 
scaffold deriving from a porcine source, in 12 patients during arthroscopic procedures. Two years 
post-surgery, MRI showed thickening and incorporation of cells but no improvement in shoulder 
function (Metcalf MH 2002). Moreover, Sclamberg et al. (Sclamberg, Tibone et al. 2004) used 
MRI to evaluate 11 patients 6 months post-implantation of Restore and revealed that 10 of 11 
repairs had failed. Iannotti et al. (Iannotti, Codsi et al. 2006) also tested Restore in human cuff 
repair and found an increase in pain and inferior tendon healing. Barber et al. (Barber, Burns et 
al. 2012) tested Restore and 15 patients had poor quality tendon, 4 patients had postoperative 
inflammatory reactions and all had decreased tendon strength and adduction strength. SIS and 
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dermis devices may not be able to provide good mechanical reinforcement in rotator cuff tear 
repairs (Aurora, McCarron et al. 2007). 
Hirooka et al. (Hirooka, Yoneda et al. 2002) tested a synthetic scaffold, made up of 
polytetrafluoroethylene for reconstructing rotator cuff tears in 27 patients. They obtained fairly 
good results; the JOA score (Shoulder surgery classification system issued by Japanese 
Orthopedic Association) was improved and so was the abduction strength. Unfortunately, there is 
still limited data on its effectiveness.  
There is also the possibility of tendon transfer, when the rotator cuff tear is considered 
irreparable with tendon retraction and fatty infiltration (Thes, Hardy et al. 2015). They can be 
derived from autografts, allografts, or xenografts. However, musculotendinous transfer results in 
donor site morbidity (Funakoshi, Majima et al. 2005). The latissimus dorsi with or without the 
teres major transfer has been shown to increase mobility and function, as well as decrease pain 
(Namdari, Voleti et al. 2012, Grimberg and Kany 2014). However, it does not prevent humeral 
head migration or progression of osteoarthritis (Grimberg and Kany 2014). Only one animal 
study has used fresh autograft fascia lata scaffold in supraspinatus using a rabbit model (Sano, 
Kumagai et al. 2002). Two weeks post-implantation, collagen type-II and -III were increased as 
well as chondrocytes and cell density, similar to the natural healing process (Sano, Kumagai et al. 
2002).  In addition, rarely does the transferred tendon material match the tensile properties of the 
repaired tissue (Docheva, Muller et al. 2015). Moreover, patch grafts become mechanically 
weaker over time (Funakoshi, Majima et al. 2005). The ideal scaffold should be biocompatible, 
support cell attachment growth with high surface area, promote tenogenic differentiation 
pathway, and not inflammatory responses, and, when not biodegradable, be able to mimic native 
tenodon architecture and mechanical properties (Docheva, Muller et al. 2015). 
 
2.7.3  Cells 
Mesenchymal stem cells (MSCs) have been studied over the last two decades for the 
treatment of bone defects, cartilage and meniscal regeneration, tendinopathies and muscle lesions 
(Lendeckel, Jodicke et al. 2004), for their ability to differentiate into different mesodermal tissues 
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(Mora, Iban et al. 2015). MSCs may facilitate RC tear healing directly, by differentiating into 
tenocytes or osteoblasts, or by recruiting progenitor cells, and by reducing inflammation (Murray, 
LaPrade et al. 2016).  
Kida et al. (Kida, Morihara et al. 2013) created a bone marrow chimeric (BMC) rat by 
bone transplantation. Four weeks after the transplantation, they transected the supraspinatus from 
its insertion site bilaterally. On the right shoulder an extra drilling procedure was made in the 
greater tuberosity of the humerus. A total of six holes were drilled to perform the transosseous 
repair technique, while no drilling was performed on the contra lateral shoulder (control group). 
At four weeks post-surgery, BM-MSCs infiltrated the repaired tendon and mechanical resistance 
was increased in the drilling group (Kida, Morihara et al. 2013). Gulotta et al (Gulotta, Kovacevic 
et al. 2009) have applied bone marrow-derived mesenchymal stem cells (BMSC) in a rotator cuff 
repair model in 80 rats. They observed no improvement in histological or biomechanical 
properties; hence they hypothesized that BMSC alone, may not be sufficient for rotator cuff tear 
repair improvement. Oh et al. (Oh, Chung et al. 2014) tested adipose tissue mesenchymal stem 
cells (AMCSs) in rotator cuff rabbit repair. The AMSC group showed better tendon healing and 
more regeneration compared to the non-AMSC group (Oh, Chung et al. 2014).   
Only two clinical studies have studied the application of MSCs in rotator cuff surgery. 
One study harvested bone marrow mononuclear cells (BMMCs) from iliac crest of 14 patients 
during transosseous stitches repair. These patients had higher UCLA shoulder-scoring test 
compared to pre-operative and the MRIs showed better tendon integrity (Ellera Gomes, da Silva 
et al. 2012). However this study had no control group, rendering conclusions difficult. Hernigou 
et al. (Hernigou, Flouzat Lachaniette et al. 2014) observed significant improvement in healing 
outcomes in patients receiving MSCs with standard-of-care RC repair at 10 years follow up. 
MSCs as an enhancement therapy improved healing rate and quality of the repaired surface 
(Hernigou, Flouzat Lachaniette et al. 2014). Although two clinical studies have evaluated MSCs 
in the context of RC repair, no level I studies have yet been performed (Ellera Gomes, da Silva et 
al. 2012, Hernigou, Flouzat Lachaniette et al. 2014). A recent review (Beitzel, McCarthy et al. 
2013) concluded that the use of MSCs augmentation in cuff repair should be considered an 
experimental technique demonstrating the need for further research (Apostolakos, Durant et al. 
2014).  
35 
 
Yokoya et al. (Yokoya, Mochizuki et al. 2012) showed an improved mechanical strength 
and an increase in collagen type-I with a polylactic acid scaffold seeded with BMSCs in a rat 
model at 4 months. Kim et al. (Kim, Lee et al. 2013) compared the use of a tridimentional open-
cell polylactic acid scaffold with and without BMSCs in RC repair. At 6 weeks, BMSCs 
augmentation showed greater amount of collagen type-I to controls. Allogeneic tendon stem/ 
progenitor cells (TSPCs) were seeded on a silk-collagen scaffold that was implanted in a rabbit 
rotator cuff injury model. Results showed that TSPC-seeded silk-collagen scaffold increased 
collagen content and biological environment without any sign of inflammation (Shen, Chen et al. 
2012). 
Then in 2011, Gulotta et al. (Gulotta, Kovacevic et al. 2010) used allogeneic BM-MSCs 
transduced with membrane type-1 matrix metalloproteinase in supraspinatus acute repair. At four 
weeks, they observed an increase in fibrocartilage and biomechanical strength. A rat model was 
used to test allogeneic BM-MSCs transduced with human bone morphogenetic protein-13 (BMP-
13) in acute supraspinatus tendon repair. No change in structure, composition or strength was 
observed at the repair site compared to untransduced MSCs-treated group (Gulotta, Kovacevic et 
al. 2011). Allogeneic BM-MSCs were then transduced with adenoviral-mediated scleraxis (Ad-
Scx) in rat supraspinatus acute repair. An increased in fibrocartilage, mechanical resistance and 
stiffness was seen compared to the group treated with MSCs only (Gulotta, Kovacevic et al. 
2011). When cells are to be used, it might be more appropriate to introduce them at the later stage 
when they can enhance endogenous healing process (Docheva, Muller et al. 2015). However, it is 
still unclear whether the phenotype remains stable when the cells are implanted into a tendon 
lesion (Docheva, Muller et al. 2015). 
 
2.7.4  Scaffolds, Cells and Combinations 
Scaffolds provide a temporary template during tissue regeneration, some even mimic the 
native ECM properties (Funakoshi, Majima et al. 2005). Ideally, they would promote cellular 
attachment, migration, proliferation, differentiation to the proper phenotype, allow 
vascularization and nutrient delivery, have good biodegredation rate and mechanical properties 
adequate to support new tissue formation (Chang, Kuo et al. 2009). 
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Funakoshi et al. (Funakoshi, Majima et al. 2006) used a nonwoven chitin fabric in the 
repair of infraspinatus tears in 21 rabbits; they observed an increase in cell number and collagen 
fiber alignment. Structural and biomechanical properties were also enhanced, however a few 
specimens had detached at the tendon-bone junction (Funakoshi, Majima et al. 2006). Poly (D, L-
lactide-co-glycolide) (PLGA) scaffolds created by electro spinning were introduced in the 
infraspinatus of rabbits. An increase in bone formation at the scaffold-bone interface and an 
increase in type-II collagen and proteoglycan content were observed. However no significant 
difference was seen in ultimate failure load and stiffness, although the tendons were weaker than 
normal (Inui, Kokubu et al. 2012). Elderly rat models were used to study the efficacy of MSCs 
with a collagen membrane. A chronic defect was created, detaching the supraspinatus from its 
insertion site. One month post-injury, the tears were repaired with sutures only, Collagen-1 
membrane (OrthoADAPT bioimplant, Penta Biomedical) or Collagen-1 membrane with MSCs 
implanted. The group with OrthoADAPT seeded with MSCs had significantly higher maximum 
load at 3 months (Tornero-Esteban, Hoyas et al. 2015). However the stiffness was not increased. 
The authors suggested that MSCs could potentially increase rotator cuff healing (Tornero-
Esteban, Hoyas et al. 2015).  
BMSCs harvested from iliac crest of two rabbits during arthroscopy were cultured and 
seeded on polylactic acid scaffold and the same scaffold without stem cells was used in contra 
lateral shoulders. The scaffold seeded with stem cells showed an increase in collagen type-I 
(Kim, Lee et al. 2013). Yokoya et al. (Yokoya, Mochizuki et al. 2012) used polyglycolic acid 
sheet seeded with cultured autologous BMSCs in the repair of infraspinatus lesions in rabbits. 
After 16 weeks, collagen type-I and the mechanical strength were significantly increased. 
Moreover a knitted silk-collagen scaffold seeded with allogenous stem cells harvested from 
Achilles tendons were used to augment rotator cuff repair in rabbits. Fibroblasts ingrowth in the 
scaffolds and a decrease in lymphocyte infiltration were observed (Shen, Chen et al. 2012).  
Lu et al. (Lu and Thomopoulos 2013) developed a triphasic scaffold to mimic the graded 
transitional zones of the entheses. The 3-layered scaffold was produced using PLGA knitted 
sheets, PLGA micro spheres and PLGA/bioactive glass micro spheres to mimic the tendon, 
fibricartilage, and bone regions, respectively. Fibroblasts were seeded onto the PLGA sheets, 
osteoblasts were seeded onto the bioactive glass, and although some migration was observed into 
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the central core no fibrocartilage-like region formation was observed in the central core of the 
scaffold. Moreover neither the tensile properties nor the attachment potential of the triphasic 
scaffold have been reported in this study (Paxton, Baar et al. 2012). Moffat et al. (Moffat KL 
2011) used a biphasic-nanofiber scaffold containing mineralized and nonmineralized regions for 
RCT repair in rats. They showed viable chondrocytes with collagen-proteoglycan matrix in both 
regions of the scaffold with fibrocartilage-like transition zone. 
Then a single pluripotent cell type design (Zuk, Zhu et al. 2002, Guilak, Awad et al. 2004, 
Kern, Eichler et al. 2006) was stimulated by gradations of different local stimuli to eventually be 
used in tendon-to-bone construct (Phillips, Burns et al. 2008, Wang, Wenk et al. 2009, Shi, Wang 
et al. 2010). The hypothesis was that stimuli would induce local cell differentiation, resulting in 
graded cells and tissue type (Zuk, Zhu et al. 2002, Guilak, Awad et al. 2004, Kern, Eichler et al. 
2006). Ma et al. (Ma, Goble et al. 2009) proposed to culture tissue phases with MSCs separately 
and then allow them to self assemble (Ma, Goble et al. 2009). However, osteoblast-like and 
fibroblast-like cells interactions did not generate a fibrocartilage transition zone. Phillips et al. 
(Phillips, Burns et al. 2008) cultured fibroblasts on a construct that had been conjugated with a 
linearly graded increase in Runx2, an osteoblastic transcription factor. The osteoblastic 
transdifferentiation of the cells positively correlated to Runx2 concentration, indicating that a 
graded interface could be obtained (Phillips, Burns et al. 2008). MSCs were seeded on the surface 
of a silk construct adsorbed with BMP-2 and IGF-1 in osteochondral medium (Wang, Wenk et al. 
2009). This construct resulted in graded increases in calcium, GAG deposition and collagen type-
I, -II and -X gene transcriptions. The gradient achieved resembled the native transition from 
unmineralized to mineralized fibrocartilage to bone (Wang, Wenk et al. 2009). The stratified 
tissue construct poses practical challenges for use. Isolating fibroblasts, chondrocytes, and 
osteoblasts from three different sites would involve costs and high levels of pain (Smith, Xia et 
al. 2012).  
Hence cells, scaffols and combination can aid rotator cuff tendon regeneration, but further 
studies are still required. This preclinical evidence can be used as a step forward in clinical 
translation. However acceptable strategies for tendon pathology will require proper combination 
of cells and scaffolds to obtain successful outcomes (Montgomery, Petrigliano et al. 2011). 
Unfortunately no biological augmentations are perfectly suited for rotator cuff repairs yet. 
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2.7.5  Growth Factors & Cytokines 
Growth factors can be applied by local injection or subcutaneoulsy (Rickert, Jung et al. 
2001, Hamada, Katoh et al. 2006, Uggen, Dines et al. 2010). GFs are rapidly cleared following 
injection, but this could be resolved by using scaffolds or coated suture material seeded with GFs. 
Growth factors are produced mostly by platelets and fibroblasts and are able to control growth 
and differentiation of different cells (Ahmad, Henson et al. 2013). Platelet-derived growth factor 
(PDGF) is known to increase collagen type-I and induce TGF-βI (Wurgler-Hauri, Dourte et al. 
2007). FGF-2 applied to repaired SSP tears in rat resulted in accelerated bone ingrowth thus 
improving biomechanical properties and histological scores at 2 weeks. However, no differences 
were seen at 4 and 6 weeks, suggesting that FGF-2 accelerated ingrowth but not the final 
outcome (Ide, Kikukawa et al. 2009). Human recombinant PDGF-BB implanted in collagen type-
I graft for RC repair improved biomechanical strength and anatomic appearance of healing 
tendons in a sheep model (Hee, Dines et al. 2011). It was also tested in rat rotator cuff repair 
where the group treated with PDGF-BB had collagen-bundle alignment similar to controls 
(Wurgler-Hauri, Dourte et al. 2007). PDGF-BB was shown to increase DNA and collagen 
synthesis from tenocytes in vitro (Uggen, Dines et al. 2005).  Uggen et al. (Uggen, Dines et al. 
2010) tested PDGF-BB in the infraspinatus tendon repair in sheep. They used PDGF-BB-coated 
sutures to repair the tendon, which resulted in better histological properties after 6 weeks at the 
bone-to-tendon junction but did not change tendon strength. Subsequently rhPDGF-BB-coated 
sutures (human recombinant) were used in sheep and improved histological scores, but no change 
was observed in load-to-failure (Ide, Kikukawa et al. 2009). Another study in sheep used a type-1 
collagen scaffold with rhPDGF-BB (human recombinant Platelet-derived growth factor) to 
augment infraspinatus repair (Hee, Dines et al. 2011). The anatomic appearance was significantly 
enhanced as well as the biomechanical strength.  
Regenerative fetal wound healing is characterized by low expression of TGF-B1 and 
TGF-ß2, with high levels of TGF-ß3 and in contrast, adult scar-mediated wound healing was 
characterized by opposite expression.  TGF-β3 is a cytokine that plays a role in cell proliferation, 
differentiation and matrix synthesis. Its expression is relatively high during fetal wound healing 
but decreases in post-natal stages. Hence it was hypothesized that exogenous injection of TGF-β3 
could promote scarless healing (Huang, Wang et al. 2002). This hypothesis led to a study 
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assessing TGF-β in a rat supraspinatus tear repair model. TGF-β1 group had an increase in type-
III collagen and a scar-mediated repair with poorer mechanical properties. TGF-β1 group showed 
no difference histologically and biomechanically compared to controls (Kim and Lee 2011). A 
recent study by the same research group observed healing enhancement and an increase in 
strength of tendon-bone healing following sustained TGF-B3 injections (Manning, Kim et al. 
2011). Kovacevic et al. (Kovacevic, Fox et al. 2011) tested the delivery of TGF-B3 in an 
injectable calcium-phosphate scaffold in repaired RC of rats. TGF-B3 improved the strength of 
the repair sites at 4 weeks significantly. 
Healing of the insertion site is dependent on bone ingrowth into the repaired tendon 
(Rodeo, Potter et al. 2007). It was hypothesized that osteoinductive GFs would improve tendon-
bone healing. BMPs belong to the TGF-B superfamily and stimulate bone formation, regulate 
fibrocartilage, neotendon, and ligament formation (Hoemann and Fong 2017). For these reasons, 
the ability of BMPs to improve RC healing is currently under investigation in preclinical studies. 
Local application of BMP-2 for enthesis formation in a rotator cuff rabbit model resulted in 
increased ultimate failure loads for BMP-2 (Hashimoto, Yoshida et al. 2007). Dines et al. (Dines, 
Weber et al. 2007) used recombinant BMP-14 coated sutures, which accelerated tendon healing 
and enhanced strength. However, no biomechanical or histologic difference was observed. 
Addition of BMP-13 on a collagen scaffold improved the loads to failure at 6 weeks (Murray, 
Kubiak et al. 2007). Rodeo et al. (Rodeo, Potter et al. 2007) used BMP-2, -3, -4, -5, -6 and  BMP-
7, TGF-B1, TGF-B3, and FGF within an osteoinductive bone protein extract placed on the 
tendon-bone interface and that resulted in no improvement. Addition of osteoinductive GFs and 
BMP-12 on tendon-to-bone healing in a sheep model showed increased formation of new bone, 
fibrocartilage and improved load-to-failure (Kovacevic and Rodeo 2008). RhBMP-2-coated 
human cadaveric dermal patch was inserted in a chronic rotator cuff rabbit injury, where it 
increased new bone formation and improved biomechanical properties such as ultimate tensile 
strength (Lee, Lee et al. 2016). All of these new technologies involving growth factors face 
important challenges. The amount of growth factor needed, the right combination of GFs or 
genetic modification, and if so, which GFs or genes to target, the incorporation of carriers for the 
GFs, and the timing of delivery still need to be clarified (Docheva, Muller et al. 2015). 
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Ultimately, this topic of orthopaedic medicine will need to be further studied, howeverthe future 
of this field is promising (Apostolakos, Durant et al. 2014) 
Metalloproteinase (MMP) inhibitors can also be used since MMPs synthesis is increased in 
the case of rotator cuff tears, which degrades the extracellular matrix (Del Buono, Oliva et al. 
2012). A healthy balance between MMPs and MMP inhibitors is important in maintaining 
integrity of ECM tissue (Brew and Nagase 2010). Dysregulation, with elevated levels of MMPs 
is associated with tendon degeneration and rupture (Riley 2004). Inhibitors of MMP-13 were 
shown to enhance fibrocartilage formation, collagen organization plus the load to ultimate failure 
(Bedi, Fox et al. 2010, Del Buono, Oliva et al. 2012).  
However there is still no study on rotator cuff repair using growth factors in humans 
(Randelli, Randelli et al. 2014). Growth factors can enhance repair and enable tissue 
regeneration, nevertheless clinical investigations are required to establish the proper timing, 
dosage and the delivery method (Ahmad, Henson et al. 2013) (Angeline and Rodeo 2012).  
 
2.8 Chitosan 
Chitin (β (14) N-acetyl-D-glucosamine) is a natural polysaccharide synthesized by 
many living organisms and made up of ordered crystalline microfibrils (Younes and Rinaudo 
2015). Chitin occurs as two allomorphs, α and β. α-chitin isomorph is the most abundant one and 
is mostly found in fungal and yeast cell walls, krills, lobsters, crab tendons, shrimp shells, and 
insect cuticles (Younes and Rinaudo 2015). α-chitin is formed by recrystallization (Persson, 
Domard et al. 1992, HELBERT and SUGIYAMA 1998), in vitro biosynthesis (Bartnicki-Garcia, 
Persson et al. 1994), or enzymatic polymerization (Sakamoto, Sugiyama et al. 2000). β-chitin 
isomorph is a lot less abundant and is only found in association with other proteins in squid pens 
(Rudall 1969, Rudall and Kenchington 1973) and tubes synthesized by pogonophoran and 
vestimetiferan worms (Blackwell 1965). The chains in these two allomorphs are organized in 
sheets and held by intra-sheet hydrogen-bonds, which control solubility, swelling and reactivity 
(Younes and Rinaudo 2015). 
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Figure 2-3: Chemical structure of chitin.  
Chitin isolation from shellfish requires the removal of two main components, proteins by 
deproteination (DP) and inorganic calcium carbonate by demineralization (DM) processes. 
Several different procedures can be used to carry out deproteination and demineralization, like 
chemical or enzymatic treatments (Younes and Rinaudo 2015). Chemical deproteination is 
performed using chemicals that simultaneously depolymerize the biopolymer. Complete removal 
of proteins is extremely important, since a high proportion of the population is allergic to 
shellfish (Younes and Rinaudo 2015). Enzymatic DP can either be performed after or before DM 
using both purified and crude extracted proteases, but is, however, a lot less efficient than 
chemical methods (Younes and Rinaudo 2015). Chemical demineralization is useful in removal 
of minerals, primarily calcium carbonate and is performed by acid treatment with HCL, HNO3, 
H₂SO4, CH₂COOH, or HCOOH (Percot, Viton et al. 2003). Dimineralization treatments mostly 
change with the mineralization degree, extraction time, temperature, particle size, acid 
concentration and solute-solvent ratio (Younes and Rinaudo 2015). However, chemical 
treatments have some drawbacks; it harms the physico-chemical properties, affects waste H2O 
with contaminants, and increases the cost of chitin purification process. On the other hand, 
biological DM using microorganisms, increases reproductibility, decreases process time, is 
easier, involves less solvent consumption and decreases energy consumption. Deproteination and 
demineralization can be processed simultaneously by adding different strains of microorganisms 
(Younes and Rinaudo 2015). Moreover in some cases, an extra step is also added, decolorization, 
which removes residual chitin pigments.  
Unfortunately, chitin is not readily used due to its high level of acetylated groups, rigid 
structure, and its poor solubility in aqueous solution (Ahmadi, Oveisi et al. 2015). Hence is 
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frequently modified to chitosan for biomedical applications, which involves 4 steps, 
demineralization (DM), deproteination (DP), decolorization (DC), and deacetylation (DA) of 
chitin. Chitosan is a linear semi-synthetically derived aminopolysaccharide copolymer of β 
(14) linked D-glucosamine (GlcN) and N-acetyl-glucosamine (GlcNAc): a polymer of N-
acetyl-2-amino-2-deoxy-D-glucopyranose and 2-amine-2-deoxy-D-glucopyranose in the 
repeating glucosidic residue (Agrawal, Strijkers et al. 2010). Its backbone is similar to cellulose, 
in which the repeating units are linked through (14) β-glycosidic bonds with a modified degree 
of N-deacetylation, except that the acetylamino group replaces the hydroxyl group on C2 position 
(Holland, Tessmar et al. 2004, Dash, Chiellini et al. 2011).  
First the rigid crystalline structure of chitosan is obtained from arthropod exoskeleton by 
alkaline N-deacetylation of chitin (Roberts 1992) (Sun, Wang et al. 2009). Chitin deacetylation 
removes acetyl groups from the GlcNA monomeric units to generate D-glucosamine (Glc) 
(Baskar and Sampath Kumar 2009). The percentage of acetyl groups removed by the chemical 
deacetylation is termed the degree of deacetylation (DDA), which is equivalent to the ratio of 
glucosamine to the sum of glucosamine and N-acetly-glucosamine units. Either acid or alkali can 
be used to chemically deacetylate chitin to obtain chitosan polymer. However, glycosidic bonds 
are more susceptible to acid, hence alkali deacetylation is used more often (No and Meyers 1995, 
Hajji, Younes et al. 2014). Chitin deacetylation can be done either heterogenously (Chang, Tsai 
et al. 1997) or homogenously (Sannan, Kurita et al. 1976). Heterogenous deacetylation involves 
treating chitin with hot concentrated solution of NAOH during few hours, and chitosan is 
produced as an insoluble residue with 85-99% DDA (Younes and Rinaudo 2015). Homogenous 
deacetylation involves dispersion of chitin in concentrated NAOH, followed by dissolution is 
crushed ice, and produces soluble chitosan with a DDA around 45 to 55% (Kurita, Sannan et al. 
1977). The deacetylation conditions used will determine the polymer molar mass and DDA. 
Alternatively, naturally occurring chitin deacetylases found mostly in fungi and insects (Sundara 
1982) can also catalyze the hydrolysis of the N-acetamino bonds in chitin (Araki and Ito 1974, 
Alfonso, Nuero et al. 1995, Gao, Katsumoto et al. 1995, Tsigos and Bouriotis 1995, Tokuyasu, 
Ohnishi-Kameyama et al. 1996). Then depolymerisation can be performed as a last step to break 
down the polymer into monomers or a mixture of monomers. Usually polymers are 
depolymerized at high temperatures, driven by an increase in entropy. Several techniques exist 
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for depolymerisation, such as ultrasound (Tang, Huang et al. 2003), heat (Jarry, Chaput et al. 
2001), enzymatic hydrolysis (Howard, Ekborg et al. 2003), and chemical hydrolysis (Mao, Shuai 
et al. 2004). The favored technique is using nitrous acid since it is economical, rapid and can be 
controlled easily to produce desired sizes of chitosan monomers (Tommeraas, Varum et al. 
2001).  
 
 
Figure 2-4: Chitin extracted from shellfish from which chitosan is made by N-deacetylation 
(Ahmadi, Oveisi et al. 2015). 
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Figure 2-5: Chitosan flow production (Ibrahim and Zairy 2015). 
 
Chitosan is used in various fields, such as drug delivery, gene therapy, vaccines and tissue 
engineering (Hoemann and Fong 2017), because of its polycationic, biocompatible, antibacterial, 
wound healing, mucoadhesive and biodegradable properties. N-acetyl moieties in chitosan are 
structurally realated to various GAGs and HAs, thus making it suitable for tissue engineering 
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uses (Suh and Matthew 2000, Hoemann, Hurtig et al. 2005). It can also be processed into 
hydrogels (Roughley, Hoemann et al. 2006, Hastings, Kelly et al. 2012), nanofibers (Jayakumar, 
Prabaharan et al. 2010), beads (Jayakumar, Reis et al. 2007), microparticles (Prabaharan and 
Mano 2004), nanoparticles (MacLaughlin, Mumper et al. 1998, Koping-Hoggard, Varum et al. 
2004), and porous scaffolds (Ma, Gao et al. 2003, Yan, Wang et al. 2010, Barroso, Viveiros et al. 
2014). 
 
 
Figure 2-6: Schematic representation of chitosan structure (Dash, Chiellini et al. 2011). 
 
Chitosan is insoluble at high pH, although this can be reversed by sulphating the amines, 
making the molecule anionic and H2O soluble (Suh and Matthew 2000). Chitosan is a very 
interesting molecule since it is fairly easy to modify its physicochemical properties. The relative 
ratio of N-acetyl-G-glucosamine and D-glucosamine residues determine the polymer’s structure 
(Dash, Chiellini et al. 2011). At pH higher than 6.0, due to quaternisation of the amine group that 
have a pka of 6.3, the amines become deprotonated and the biopolymer loses its charge, thus 
becoming insoluble (Dash, Chiellini et al. 2011). At lower pH, the amine groups get protonated 
and become positively charged. As pka value depends on chitosan DDA, the solubility depends 
on DDA and the methods of deacetylation used (Cho, Jang et al. 2000). Both the molar mass and 
DDA affect its solubility, mechanical strength, and its degradation rate. Increasing DDA 
decreases the number of relative positions for hydrolysis degradation, which results in decreased 
degradation rate and greater crystallinity (Kurita, Sannan et al. 1977, Hirano, Tsuchida et al. 
1989, SASHIWA, #160 et al. 1991).  
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Figure 2-7: Schematic illustration of chitosan’s versatility: At low pH, chitosan’s amine groups 
are protonated conferring polycationic behaviour to chitosan. At high pH, chitosan’s amines are 
deprotonated and reactive (Dash, Chiellini et al. 2011). 
 
Chitosan biocompatibility refers to the ability to interact with living cells, tissues or 
organs without being toxic or triggering immunological reaction or rejections, hence tolerated 
and accepted by biological sytems after being brought into direct contact with them (Halim, 
Keong et al. 2012). Once inside the body, chitosan can be degraded by chitinases, which are 
lysosomal enzymes that provide a first-line innate immune defense by damaging any chitin-
containing pathogen cell walls or by lysozymes found in various cell types (Lee, Da Silva et al. 
2011). Chitinases hydrolyze the 0-linkage between consecutive GlcNA residues in chitin-like 
molecules (Eide, Norberg et al. 2012). Therefore chitosan biodegradability refers to the 
breakdown of the polymer into smaller fractions of D-glucosamine and N-acetyl-glucosamine 
oligomers and monomers, catalyzed by either enzymes or chemicals (Halim, Keong et al. 2012).  
Chitosan is also known to influence the migration behaviour of immunomodulatory cells, 
such as neutrophils and macrophages (Okamoto, Minami et al. 1993, Kosaka, Kaneko et al. 
1996), and is considered a neutro-chemoattractive (Usami, Okamoto et al. 1994, Usami, 
Okamoto et al. 1994, Usami, Okamoto et al. 1998), which does not provoke chronic 
47 
 
inflammation (Hoemann and Fong 2017). Chitosan stimulatory effect on macrophages and 
neutrophils is due to its acetyl residues on its chain. Chitosan only transiently increases the 
immune system reaction, due to body reaction when impregnated with tissue fluids, which 
eventually becomes biotolerated and metabolized by degradation (Nishimura, Nishimura et al. 
1986, Muzzarelli 1997, Ueno, Mori et al. 2001). Innate immune responses and clearance rates 
correlates with both physical form and chitosan chemical structure (Hoemann and Fong 2017). 
Modifications, such as changes in DDA, cross-linking, polyethylene glycol (PEG) 
treatment, wheat germ agglutination treatment, rigorous heat treatment, and oxygen plasma 
treatment influence its biocompatibility and biodegradability (Halim, Keong et al. 2012). Higher 
DDA induces chitosan-cell interactions because of its free amino group (Dash, Chiellini et al. 
2011), and induces inflammatory response due to a decrease in degradation rate (Kean and 
Thanou 2011). However, lower DDA chitosan degrades faster leading to the accumulation of 
many amino saccharides, resulting in acute inflammatory reaction (Dash, Chiellini et al. 2011). 
This can lead to negligible fibrous tissue encapsulation (Kim, Seo et al. 2008), by stimulating 
macrophages activity, increasing nitric oxide, reactive oxygen species, TNF-a, interferon, IL-1, 
TGF- and PDGF. Nevertheless, since proteins and lipids are lacking in its structure, it is 
impossible to develop specific antibodies against chitosan or its oligomers, unless coupled in 
subsystems with other substances, such as albumin (Rodriguez-Vazquez, Vega-Ruiz et al. 2015). 
Chitosan has positive effects on wound healing such as hemostasis, tissue regeneration 
and fibroblast synthesis of collagen (Sun, Wang et al. 2009). It is used as a scaffold material for 
tissue regeneration, since it increases granulation tissue formation, cell adhesion, angiogenesis, 
proliferation, function and integration of repair tissue with host tissue (Hoemann, Hurtig et al. 
2005) (Yao, Yang et al. 2012). Chitosan cationic scaffold has also a suitable microstructure, 
desired mechanical strength, ability to support cell residence and an appropriate degradation rate 
for tissue engineering. It also prevents scar tissue from re-modeling and supports tissue 
regeneration (Yao, Yang et al. 2012). CS increases wound healing, cellular organization 
(Okamoto Y 1992), inflammatory cells and fibroblasts recruitment via N-acetyl-B-D-
glucosamine, which is released during its gradual degradation (Ueno, Yamada et al. 1999, 
Kojima, Okamoto et al. 2004, Dai, Tanaka et al. 2011, Jayakumar, Prabaharan et al. 2011c). CS 
produces less scarring (Ueno, Yamada et al. 1999, Ueno, Mori et al. 2001, Azad, Sermsintham et 
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al. 2004), induces vascularity and supplies chito-oligomers at the lesion site, resulting in better 
collagen fibril incorporation into ECM (Shigemasa and Minami 1996, Rao and Sharma 1997). 
High DDA CS increases fibroblast proliferation while low DDA decreases firboblastic activity 
(Howling, Dettmar et al. 2001). Stimulation of fibroblastic proliferation requires the presence of 
serum, in which CS interacts with GFs present in the serum, hence potentiating their effects 
(Howling, Dettmar et al. 2001). Chitosan is also linked to scarless healing in soft tissue and 
adhesion formation during tendon healing after surgery (Wang, Mo et al. 2010). The lack of 
precipitation, coupled with the in situ gelling of chitosan permits it to adhere to the repair site 
long enough to modulate the healing sequence, thus increasing tissue regeneration (Cho, Kim et 
al. 2008, Melamed, Beutel et al. 2015). Functional and performance properties are associated 
with chitosan DDA and molar mass. Furthermore, biological properties, such as wound healing 
and osteogenesis enhancement as well as degradation by lysosymes in subsystems (Gerentes, 
Vachoud et al. 2002) are affected by viscocity. Viscocity is proportionally correlated with 
chitosan concentration and molar mass and is inversely correlated with temperature and chain 
length. Deacetylation conditions also change viscocity by changing inter- and intra-molecular 
repulsion forces within the copolymer (Dash, Chiellini et al. 2011). It also decreases with 
increased acetic acid concentration, due to increased protonation and solubilisation. Acetic acid 
can increase solubility and decrease the pH of the solution (Agnihotri, Kulkarni et al. 2006). 
Moreover, because of its cationic hemostatic properties, chitosan activates platelets (Chou, 
Fu et al. 2003), while inhibiting clot retraction mechanisms. With its high positive charge density, 
chitosan adheres to negatively charged biological tissues and displays good cell adhesive 
properties. Chitosan is capable of promoting wound healing through modulation of inflammatory 
and other cell functions, such as PMNs, macrophages and fibroblasts (Ueno, Mori et al. 2001). It 
also increases granulation tissue formation and thickness of wound tissues (Ueno, Yamada et al. 
1999, Ueno, Mori et al. 2001). However if CS resists degradation, a fibrous encapsulation will be 
formed around the implant and the tissue adjacent will be scarce of macrophages and populated 
with fibroblasts (Azab, Doviner et al. 2007).  
To our knowledge, there have been only a small number of publications using chitosan in 
rotator cuff repair. Melamed et al. (Melamed, Beutel et al. 2015) found that rotator cuff tear 
repair augmented with chitosan gel matrix enhanced healing of soft tissues, as well as fibrous 
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tissue, fibroblastic reponse and cell migration (Melamed, Beutel et al. 2015). However, the 
regenerated tendon-bone insertion site was not similar to native with neither a tidemark present 
nor an increase in collagen type-II. Chitosan was also shown to increase rotator cuff repair in rats 
by decreasing muscle fiber fibrosis and by preventing muscle atrophy (Robinson, Pachornik et al. 
2010). Moreover, a nonwoven chitin fabric used as a matrix in cuff repair increased biological as 
well as mechanical regeneration of rotator cuff in rabbits (Funakoshi, Majima et al. 2006). 
 
2.8.1 Chitosan/whole blood hybrids for cartilage repair 
Cartilage repair by current surgical methods is challenging, due to its avascular structure, 
its lack of significant progenitor cells, and its poor regenerative ability (Martins, Michelacci et al. 
2014). Strategies for cell implantation within joints poses huge challenges, since joint is a fluid 
environment, that bears strong shear forces, mechanical loads, and is stiff (Martins, Michelacci et 
al. 2014). Cartilage scaffolds require a structure that induces growth of new tissue, mechanical 
characteristics similar to native, thus increasing chances that the reparative strategy will be 
compatible with host’s tissue cells (Athanasiou, Shah et al. 2001, Sittinger, Hutmacher et al. 
2004). Chitosan structure ressembles GAGs closely, which seems to be appropriate for cartilage 
regeneration, since GAGs are a major component of the cartilage ECM (Majima, Irie et al. 2007), 
and chitosan is also known to have very good wound healing properties (Sivashankari and 
Prabaharan 2016). 
Marrow-stimulation alone for cartilage repair does not produce hyaline-like repair 
cartilage, partly because the blood clot in the lesion retracts to a smaller percentage of its original 
volume via platelet-mediated clot retraction mechanisms (Morgenstern, Ruf et al. 1990, White 
2000). Our laboratory had the idea several years ago that stabilizing the blood clot formed in the 
cartilage lesion could potentially improve cartilage repair by providing a suitable environment for 
migration of progenitor cells and formation of new repair tissue. This gave rise to the concept of 
mixing solubilized CS, which is thrombogenic and has wound healing properties, with 
autologous blood to produce injectable implants. Incorporation of chitosan stabilizes blood clots 
by creating an adherent clot capable of resisting clot retraction mechanisms (Chevrier, Hoemann 
et al. 2007, Hoemann, Sun et al. 2007, Marchand, Rivard et al. 2009). Near-neutral solutions of 
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chitosan-GP (Chenite, Chaput et al. 2000) can be mixed with whole blood and injected over 
surgically prepared cartilage defects where they solidify in situ (Hoemann, Hurtig et al. 2005, 
Hoemann, Sun et al. 2007). Blood clots release various chemotactic factors, clots contain fibrin 
which permits integrin-based cell attachment and migration, and erythrocytes hemolyze after 3 
days (Chevrier, Hoemann et al. 2007), leaving porous channels that allow cellular migration 
(Hoemann and Fong 2017). CS-GP/blood implants induced several significant modifications in 
the healing sequence at early time points in microdrilled cartilage defects of skeletally mature 
NZW rabbits. Mingling of CS particles with blood clot in CS-GP/blood implants promoted 
neutrophil and mesenchymal stem cell recruitment and transient vascularity, and increased 
remodeling of the subchondral bone, leading to better repair tissue integration (Chevrier, 
Hoemann et al. 2007, Hoemann, Sun et al. 2007, Chen, Sun et al. 2011). The hyaline quality of 
the repair tissue, as well as the integration of repair cartilage was improved within the lesion 
(Chevrier, Hoemann et al. 2007, Hoemann, Sun et al. 2007). CS-GP/blood implants also 
promoted macrophage polarization towards a pro-wound healing alternatively activated 
phenotype, labeled M2 (Hoemann, Chen et al. 2010, Chen, Sun et al. 2011). Macrophages have a 
phenotypic plasticity, which is also called macrophage polarization; in which they adopt different 
phenotypes either M1 or M2 (Mosser and Edwards 2008). M1 macrophages produce reactive 
oxygen species and secrete pro-inflammatory factors. M2 macrophages secrete high levels of 
anti-inflammatory factors and express low levels of pro-inflammatory mediators. Chitosan-
GP/blood implants were also tested in sheep with microfractured condylar and trochlear defects, 
where the implants were shown to increase volume of repair tissues and increase hyaline 
character, GAG and collagen content, while decreasing the incidence of cyst formation 
(Hoemann, Hurtig et al. 2005).  
In follow-up studies, thrombin was added to CS-GP/blood implants to accelerate 
solidification in situ (Marchand, Rivard et al. 2009, Marchand, Chen et al. 2011). Treatment with 
the implants improved structural integrity and integration of the repair tissue at 6 months and led 
to a higher hyaline quality of the repair tissue (Marchand, Chen et al. 2011). CS-GP/blood 
implants used in conjunction with coagulation factors also promoted large blood vessel formation 
in healing microdrill holes, particularly after residual CS particles were cleared (Mathieu, 
Chevrier et al. 2013).  
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Finally, in the latest studies, isotonic solutions of chitosan were mixed with whole blood 
and allowed to solidify prior to implantation into microdrill holes (Lafantaisie-Favreau, Guzman-
Morales et al. 2013, Guzman-Morales, Lafantaisie-Favreau et al. 2014). Pre-solidified implants 
attracted neutrophils, osteoclasts and abundant bone marrow-derived stromal cells, which 
stimulated bone resorption followed by new woven bone repair and remodeling and promoted 
repair tissue-bone integration. Chitosan molar mass was found to affect healing. Implants 
containing CS of 150kDa degraded less quickly and induced more apoptotic neutrophils and bone 
resoprtion than other CS implants with lower molar mass (40 kDa or 10 kDa).  
Chitosan-GP/blood implants were also tested in a randomized controlled trial of 80 
patients with focal lesions on femoral condyles. Treatment was either microfracture augmented 
with chitosan-GP/blood implants (BST-CarGel, now from Smith and Nephew) or microfracture 
alone (Stanish, McCormack et al. 2013). At twelve months, tissue repair quantity and quality was 
superior for patients treated with BST-CarGel. The group showed significantly greater lesion 
filling and a more hyaline-like cartilage (Stanish, McCormack et al. 2013). At an average of 13 
months, 21 out of 41 BST-CarGel treated patients and 17 of the 39 microfracture patients 
underwent elective second look arthroscopies during which osteochondral biopsies were 
collected. BST-CarGel group had better international cartilage repair society macroscopic score, 
the light microscopy showed better filling, integration, and tissue appearance. BST-CarGel group 
had significantly better structural parameters, surface architecture and better organization of the 
repair tissue, with collagen stratification similar to hyaline cartilage (Méthot, Changoor et al. 
2015). The same randomized controlled trial was extended to 5 years. Patients were clinically 
assessed with MRI to quantify the degree of lesion filling, T2 relaxation time and with the 
Western Ontario and McMaster Universities Osteoarthritis index subscale. Patients treated with 
BST-CarGel showed greater lesion filling, greater repair tissue T2 relaxation time and superior 
tissue quantity and quality over 5 years compared to microfracture alone. Using chitosan-GP with 
uncoagulated whole blood reinforces blood clot, inhibits retraction, increases cell adhesion and 
prolongs residency of tissue repair factors found in the blood (Shive, Stanish et al. 2015 ). BST-
CarGel is currently commercialized in several countries. 
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2.8.2  Rationale for using chitosan-PRP hybrids in rotator cuff repair 
Our laboratory has recently implemented the use of PRP combined with freeze-dried 
chitosan formulations to form injectable implants for tissue repair applications (Chevrier, Darras 
et al. 2017). One drawback of the original BST-CarGel technology is that chitosan hydrolyzes 
over time, which leads to a loss of product viscosity (Varum, Ottoy et al. 2001). In addition, the 
chitosan and glycerolphosphate solutions must be stored in separate containers to prevent a 
solution to gel transition that occurs over time (Lavertu, Filion et al. 2008). One way to overcome 
these limitations is to lyophilize or freeze-dry the chitosan formulation. The use of platelet-rich 
plasma (PRP) instead of whole blood would be expected to enhance the implants’ bioactivity due 
to the presence of high levels of platelet-derived growth factors. PRP releases growth factors that 
are important for tissue repair, regeneneration and play vital roles as essential signalling 
molecules to initiate specific cell response in biological environment (Lee, Silva et al. 2011). 
PRP increases endothelial, epithelial, epidermal regeneration, collagen, soft tissue healing, 
hemostatic reponse to injury, and decreases dermal scarring (Mohammadi, Mehrtash et al. 2016). 
However, PRP diffuses very rapidly while quickly releasing its GFs (Busilacchi, Gigante et al. 
2013), mitigating its effects and efficacy. Chitosan can be used as a stimulant for platelet 
activation with PRP treatment, since platelets are activated by physical or chemical stimuli, like 
CS (Zucker and Nachmias 1985, Kroll, Hellums et al. 1996, Li, Delaney et al. 2010, Brown, 
Narayanan et al. 2013) (Hattori and Ishihara 2016). Therefore CS could increase PRP treatment 
efficacy (Oktay, Demiralp et al. 2010, Busilacchi, Gigante et al. 2013, Kutlu, Aydin et al. 2013). 
Initially, we systematically modified the chitosan molar mass and concentration, as well 
as lyoprotectant concentration in order to identify compositions that would rapidly (<1 minute) 
and completely solubilize in PRP, have paste-like handling properties upon solubilization and 
coagulate rapidly (<5 minutes) to form solid chitosan-PRP hybrid implants that are stable and 
homogenous (Chevrier, Darras et al. 2017). Chitosan-PRP implants were also shown to reside for 
at least 14 days in vivo and enhance cell recruitment to surrounding tissues compared to PRP 
alone (Chevrier, Darras et al. 2017). These chitosan-PRP implants were tested in a meniscus 
repair model where they were found to increase cell recruitment, vascularisation, remodeling and 
repair tissue integration compared to injection of PRP alone or wrapping with a collagen 
membrane (Chevrier, Deprés-Tremblay et al. 2015, Ghazi zadeh, Chevrier et al. 2017). Chitosan-
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PRP implants wre also used in a chronic cartilage repair model in the rabbit where they were 
shown to improve the quality of the repair tissue and induce bone remodeling (Dwivedi, Chevrier 
et al. 2017). All of the above would also be expected to have positive effects on rotator cuff tear 
repair, which triggered the initiation of the current project.  
 
CHAPTER 3 ORGANIZATION OF ARTICLES 
The scientific contribution made by this thesis is presented here. The first scientific 
contribution was a literature review on rotator cuff repair. The purpose of the first paper was to 
review current clinical treatments and pre-clinical approaches for rotator cuff tear repair. The 
review focused on current clinical surgical treatments, new repair strategies under development 
both clinically and pre-clinically, and also described different animal models available for rotator 
cuff research. These findings were then further discussed as well as future directions for rotator 
cuff tear repair. The paper is entitled “Rotator cuff repair: A review of surgical techniques, 
animal models and new technologies under development”. Although previous manuscripts have 
reviewed accepted clinical treatments and pre-clinical models, to our knowledge, this is the first 
existing manuscript that combines both as well as technologies under development. The paper 
has been published in “Journal of Shoulder and Elbow Surgery”.  
The purpose of the second study was to investigate possible mechanisms by which 
chitosan inhibits retraction of CS-PRP hybrid clots in vitro, characterize the effect of chitosan, 
trehalose and a combination of both on platelet activation and granule secretion in vitro, 
characterize the release profile of PDGF-AB and EGF from CS-PRP hybrid clots in vitro, and 
histologically assess the residency, bioactivity and biodegradability of CS-PRP implants in vivo. 
The results are presented in the article titled “Chitosan inhibits platelet-mediated clot retraction, 
increases platelet-derived growth factor release, and increases residence time and bioactivity of 
platelet-rich plasma in vivo”. This study explored the cellular and molecular mechanisms of 
chitosan-PRP implants both in vitro and in vivo; focusing on clot retraction, platelet activation 
and growth factor secretion, the induction of cellular recruitment, vascularization and 
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biodegradability of the implants. This paper has been submitted to the journal “Biomedical 
Materials”. 
In the third study, chitosan-PRP hybrids were used in conjunction with surgical repair by 
suturing in a rabbit rotator cuff repair model. The objective was to assess implant retention at 
early time points post-operative and the histological properties of the repaired cuff at 2 months 
post-operative. The results are presented in the article titled “Freeze-dried chitosan-PRP implants 
improve supraspinatus tendon attachment in a transosseous rotator cuff repair in the rabbit”. This 
paper has been submitted to the “Journal of Orthopaedic Research”. 
The purpose of the fourth study was to test whether chitosan-PRP hybrid are capable of 
improving rotator cuff healing after surgical repair in large animal models. The histological 
properties and repair responses at the attachment site of the infraspinatus tendon were 
investigated in delayed and acute repair sheep models. The results are presented in the article 
titled “Freeze-dried chitosan platelet-rich plasma implants for rotator cuff tear repair: Pilot ovine 
studies”. This paper has been submitted to the journal “ACS Biomaterials Science and 
Engineering”, for publication in a special issue entitled “Biomaterials in Canada”. 
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Abstract 
Rotator cuff tears are the most common musculoskeletal injury occurring in the shoulder. 
Current surgical repair fails to heal in 20 to 95% of cases depending on age, size, smoking, time 
of repair, tendon quality, muscle quality, healing response, and surgical treatments. These 
problems are worsened by the limited healing potential of injured tendons, attributed to the 
presence of degenerative changes and relatively poor vascularity of the cuff tendons. 
Development of new techniques to treat rotator cuff tears also requires testing in animal models 
to assess safety and efficacy prior to clinical testing. Hence it is important to evaluate appropriate 
animal models for rotator cuff research with degeneration of tendons, muscular atrophy and fatty 
infiltration similar to humans. The purpose of this paper is to review current clinical treatments 
and pre-clinical approaches for rotator cuff tear repair. The review will focus on current clinical 
surgical treatments, new repair strategies under development both clinically and pre-clinically, 
and will also describe different animal models available for rotator cuff research. These findings 
will then be discussed as well as future directions for rotator cuff tear repair.  
 
Keywords: Rotator cuff repair, Animal models, Technologies under development 
 
Level of evidence: Review article 
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4.1 Introduction 
More than 28 million Americans are affected by musculoskeletal injuries, costing more 
than $254 billion each year 94. Rotator cuff injury is the second most common musculoskeletal 
pathology after lower back pain 93 and the most common shoulder condition for which patients 
seek therapy 33. In the United Kingdom, the prevalence of shoulder problems based on 
consultations in primary care is estimated to be 2.4% 71. Between 30% and 70% of such shoulder 
pain is due to disorders of the rotator cuff 84.  More than 17 million Americans may be susceptible 
for shoulder impairment due to rotator cuff tendon deterioration and eventual tearing 68.  
Cuff tears usually result in shoulder pain, stiffness, weakness and loss of motion. The 
shoulder joint can still function with minimal pain despite a rotator cuff tear; however, limited 
function of the upper extremities often impairs the ability to carry out basic activities. Rotator 
cuff disease may start as an acute tendinopathy with progressive degeneration leading to a partial 
thickness tear and eventually a complete tear 85. Large tears result in disuse muscle atrophy with 
fatty accumulation within muscles, which may irreversibly decrease muscle function 67. 
Following rotator cuff repair, failure to heal occurs in 20-95% of cases and has been shown to 
correlate with tear size, time from injury, tendon quality, fatty atrophy, and surgical repair 
technique. Degenerative changes in the structure and composition of the tendons make healing 
very difficult.  
The aim of the current review is to describe the current clinical surgical treatments for 
rotator cuff tears, review the different animal models available for rotator cuff research and 
summarize new repair approaches that are under development both clinically and in pre-clinical 
studies. Although previous manuscripts have reviewed accepted clinical treatments and pre-
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clinical models, to our knowledge, there is no existing manuscript that combines both as well as 
technologies under development. 
 
4.2 Rotator Cuff Anatomy and Pathology 
The rotator cuff muscles are a group of muscles consisting of the subscapularis, 
supraspinatus, infraspinatus, and the teres minor 32. All of these muscles are attached to the head 
of the humerus via their specific tendons, and control the rotation and position of the arm 32. The 
rotator cuff muscles assist shoulder motion but primarily provide stability by centering and 
pressing the humeral head on the glenoid 32, through exertion of forces in the coronal and 
transverse planes 89. The supraspinatus and the infraspinatus contribute to glenohumeral stability 
in the resting position while the subscapularis stabilizes the glenohumeral joint in the position of 
apprehension 32. Rotator cuff tendons respond to excessive loading by inflammation or 
degeneration 5. This is usually manifested by pain, formation of lipids, proteoglycans and 
sometimes calcified tissues in the tendon lesions, which can lead to the release of various 
cytokines and adverse changes in cellular activities 69. Rotator cuff tendon pathology is also 
influenced by the microvascular supply of rotator cuff tendons 90. 
Traditionally, degenerative rotator cuff tears were thought to begin at the anterior part of 
the supraspinatus tendon, adjacent to the biceps tendon. The anterior portion was believed to 
transmit the majority of the contractile load, and since more stress would be applied on a daily 
basis, this tendon would be at high risk for a tear 83. However, recent studies suggest that 
degenerative tears occur about 15 mm posterior to the biceps within the crescent at the junction 
of supraspinatus and infraspinatus, hence a more posterior location 56. These tears then propagate 
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in both anterior and posterior directions 53. Chronic rotator cuff tears are associated with 
structural changes such as loss of muscle volume, fatty accumulation, retraction, which all result 
in muscle remodeling, subtraction of sarcomeres and profound muscle weakness 115. Progression 
of a tear may also lead to superior subluxation of the humeral head and eventually, dysfunction of 
the shoulder. Pathology in rotator cuff tear is also influenced by the microvascular supply of 
rotator cuff tendons 90. Rotator cuff tears can also result from an acute trauma, most frequently a 
fall onto an outstretched arm. Supraspinatus is again the most commonly involved tendon; 
however, there is a high association with subscapularis tears 76. 
 
4.3 Surgical Treatments of Rotator Cuff Tears 
Non-operative treatments can be used to manage the majority of rotator cuff tears, 
especially in patients with lower demands. However, rotator cuff tendons do not heal 
spontaneously and surgical treatments is often required in patients who have persistent symptoms 
and functional impairment post conservative treatment. Operative treatment of both traumatic and 
non-traumatic tears can be successful, with some authors reporting better results in younger 
patients with traumatic tears compared to degenerative tears 9. Successful results were initially 
reported with both open repair techniques using deltoid detachment and then subsequently 
through a “mini-open” deltoid split. Currently, fully arthroscopic procedures are generally 
considered to be standard of care for the majority of tears. The superiority of arthroscopy versus 
open or mini-open repair is still unproven and controversial at this point (Table 1). Overall, 
functional outcomes, clinical scores and re-tear rates are similar between arthroscopy versus 
mini-open repair patients. However, mini-open repair seems to be associated with more post-
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operative complications whereas decreased short-term pain is seen with arthroscopic repair. 
Faster recovery, a quicker return to exercise and better aesthetic results are other potential 
advantages of arthroscopic repair. 
Initially, transosseous tunnels were used to perform open rotator cuff repair. This 
technique uses sutures placed directly into bone tunnels extending from the rotator cuff footprint, 
exiting laterally on the tuberosity where they are tied. A limitation of this technique can be bone 
quality and now, cuff repair is usually performed with suture anchors using different 
configurations: the single-row, the double-row, and the suture bridge repair, sometimes called the 
transosseous-equivalent (TOE) repair technique. The goal of using sutures anchors is to restore 
the tendon footprint by suturing the tendon directly onto the tuberosity of the humerus. In 
controlled laboratory studies using cadaveric shoulders, the superior biomechanical performance 
of the transosseous-equivalent technique (TOE) over the double row technique and of the double 
row technique over the single row technique seems clear 21, 55, 77, 105, but this has not been 
translated into better clinical or functional outcomes (Table 2). The double row repair technique 
does seem to improve the rate of tendon healing and to decrease re-tear rates over single row, and 
this could prove to be beneficial in the long-term. 
 
4.4 Animal Models of Rotator Cuff Repair 
Animal models are practical means to understand cellular and molecular pathways and 
pathology of rotator cuff tears and to develop new technologies to improve existing treatments. 
Rotator cuff repair animal models should lack spontaneous tendon healing after tendon injury. 
The tendon size should also allow for suture repair techniques similar to those used in humans. 
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Ideally, irreversible muscular atrophy, stiffness, and fatty accumulation should be present post-
injury 23. No animal model is identical to human, and each model has its advantages and 
disadvantages (Table 3). A true rotator cuff is defined as the blending of individual flat tendons 
to form a single insertion. Rabbits, rats, dogs and sheep all have tendons that do not blend before 
inserting into humeral head; hence they all lack this aspect of the human rotator cuff anatomy 106.  
Rats have the greatest anatomic similarity to humans because of the presence of an 
acromial arch 23. However, the acromial arch structure is somewhat different in quadrupeds: the 
portion of the rat supraspinatus muscle that passes under acromial arch is muscular and not 
tendinous like in humans 35. The rat’s forward arm elevation is similar to human arm abduction 
and the range of motion decreases after rotator cuff tears both in rats and in humans 91. Rotator 
cuff tears in rats will also result in cartilage degeneration on the humeral head and the glenoid 64. 
Although the rat is a reasonable model, it has a few major differences with respect to human. 
First, rotator cuff tendon heals better in rats than in humans 24, 72. The supraspinatus provides less 
coverage in rat versus human and most of the coverage is from the subscapularis instead 72. In 
addition, the rat supraspinatus lacks the irreversible accumulation of muscular fat and rates of 
failure of healing  (“re-tears”) seen in humans, making it less suitable to evaluate repair 
techniques 24. In rats, the infraspinatus tendon may be a better model to represent the human 
supraspinatus, since it undergoes more fat accumulation, muscular atrophy and more muscular 
retraction 72. Even with these limitations, the rat is seen as an appropriate and cost-effective 
model to investigate initial safety, repair mechanisms and efficacy of treatments although its 
small size makes it challenging to perform surgical repairs 23. 
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The rabbit model is mostly used to study muscular changes associated with rotator cuff 
tears such as muscle atrophy, twitch tension (which is a single contraction in response to a brief 
threshold stimulation), and fatigue index (which determines energy depletion during exercise) 26. 
In rabbit rotator cuff tears, atrophy occurs at early time points and fatty accumulation occurs at 
later time points as in human 72. The rotator cuff in rabbits heals in a fashion that is similar to that 
of humans 41. The supraspinatus and infraspinatus tendons have both been used as repair models 
in the rabbit, but recent studies have shown the subscapularis may be a better approximation of 
human pathology since it passes under an enclosed arch and fatty accumulation is prominent 26. 
The subscapularis tendon and the scapular channel are similar in human; both travel beneath the 
acromion and insert into the greater tuberosity of the humerus 35. In that aspect, the rabbit’s 
subscapularis may be more comparable to the human supraspinatus. The rabbit is also bigger than 
the rat, therefore facilitating surgical models and techniques, as larger animals provide greater 
accuracy and reproducibility 23.  
The sheep infraspinatus is similar in size to the human supraspinatus 26. Although the 
sheep infraspinatus is not intra-articular, there is still a bursa under the tendon and repair has 
some contact with the synovial fluid that lubricates the bursa 108. Availability, ease of handling 
and housing, low cost and acceptance to society as a research animal, makes ovine models useful 
to study rotator cuff repair 108. Transecting the infraspinatus tendon in sheep and performing an 
immediate repair does not mimic the human condition; However, acute studies are suitable to 
assess different repair techniques or biological augmentations 92, 108. Animals are different than 
human due to their ability to heal through tissue ingrowth and neovascularisation 108. In the 
sheep, once the infraspinatus tendon is cut from its insertion site, scar tissue can bridge the space 
between the tendon stump and the footprint 108, although gaps at the tendon-bone interface are 
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often seen 63, 92, and the resulting enthesis is usually reported as inferior to normal both 
histologically and biochemically 73. In 2003, Coleman et al 20 developed a chronic model by 
covering the transected tendon end with Gore-Tex, which allowed for nutrient diffusion, to 
actively stop scar tissue formation around the stump while improving discrimination between 
tendon and scar tissue 20. However, in chronic delayed repair, massive tendon retraction can 
prevent direct reattachment 20. Turner et al 108 recommended to not exceed a timeframe of 4 
weeks for a delayed repair. A different ovine chronic model involves releasing the infraspinatus 
by osteotomy and covering the bone fragment with a silicon tube 31. This technique has been used 
to study muscle atrophy, fatty infiltration and retraction of the musculotendinous unit 80, but does 
not approximate the human condition. 
 
4.5 Technologies Under Development for Rotator Cuff Repair 
Augmentation 
4.5.1 Extracellular Tendon Patches  
Tendon patches are used as scaffolds for tissue ingrowth and as collagen substitutes, 
which should increase load to failure and decrease stress shielding compared to injured tissue 
(Table 4). Metcalf et al 79 used Restore, a small intestine submucosa (SIS) scaffold deriving from 
a porcine source, in 12 patients during arthroscopic procedures. Two years post-surgery, MRI 
showed thickening and incorporation of the material but shoulder function did not improve 79. 
Sclamberg et al 101 used MRI to evaluate 11 patients 6 months post-implantation of Restore and 
revealed that 10 of 11 repairs had failed. Iannotti et al 45 also tested Restore in human cuff repair 
and found an increase in pain and inferior tendon healing. Bond et al 8 tested Graftjacket, an 
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extracellular matrix (ECM) human cadaveric dermis scaffold, during arthroscopic rotator cuff 
repair in 16 patients. The overhead strength was improved but failure was reported in 3 patients 8. 
Burkhead et al 10 showed an increase tissue ingrowth into the Graftjacket patch after two years. 
Patients with arthroscopic SR repair augmented with Graftjacket had higher ASES (American 
Shoulder and Elbow Surgeons) and Constant shoulder scores after 24 months 3. The extracellular 
matrix patches are used in surgery as augmentation devices but have not shown any benefit in 
recent randomized controlled clinical trials. Hence, further investigations are needed to prove 
their efficacy.  
 
4.5.2 Scaffolds 
Poly (D,L-lactide-co-glycolide) (PLGA) scaffolds created by electrospinning were 
introduced in the infraspinatus of rabbits, after surgically inducing a rotator cuff tear. An increase 
in bone formation at the scaffold-bone interface and an increase in type II collagen and 
proteoglycan content were observed. However, no significant difference was seen in ultimate 
failure load and stiffness between treated and untreated repairs 48. BMSCs harvested from iliac 
crest of two rabbits during arthroscopic infraspinatus tear repair were cultured and seeded on 
poly-L-lactic acid scaffold and the same scaffold without stem cells was used in contralateral 
shoulders. The scaffold seeded with stem cells showed an increase in collagen type-1 60. Yokoya 
et al 118 used a polyglycolic acid sheet seeded with cultured autologous BMSCs in the repair of 
infraspinatus lesions in rabbits. After 16 weeks, collagen type-I and the mechanical strength were 
significantly increased. Silk-collagen scaffolds seeded with tendon stem/progenitor cells (TSPCs) 
increased collagen content without inducing inflammation in a rabbit rotator cuff injury model 
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103. This preclinical evidence can be used as a step forward in clinical translation. However, 
acceptable strategies for tendon pathology will require “the ideal” combination of cells and 
scaffolds to obtain successful outcomes. Currently the best cell/scaffold combination is unknown 
and concerns exist over future availability due to regulatory constraint and cost considerations. 
 
4.5.3 Stem Cells 
Bone marrow-derived mesenchymal stem cells (BMSC) failed to improve healing in a rat 
rotator cuff repair model 36; however, adenoviral-mediated transduction of syngeneic BM-MSCs 
with the gene for membrane type-1 matrix metalloproteinase 37 or scleraxis (Ad-Scx) 38 was 
shown to increase fibrocartilage repair and tendon biomechanical strength. Conversely, 
transduction with human bone morphogenetic protein-13 (BMP-13) had no effect 39. Drilling in 
the greater tuberosity while performing transosseous repair for the supraspinatus led to 
infiltration of the repaired tendon by BM-MSCs and increased mechanical resistance in a bone 
marrow chimeric (BMC) rat 54. Adipose tissue mesenchymal stem cells (AMSC) improved 
tendon healing in a rotator cuff rabbit repair model 86. One clinical study harvested bone marrow 
mononuclear cells (BMMCs) from the iliac crest of 14 patients during transosseous suture repair. 
These patients had higher UCLA shoulder scores compared to pre-operative and the MRIs 
showed better tendon integrity 27, but this study had no control group, rendering conclusions 
difficult.  
Few studies have used bone marrow aspirate concentrate (BMAC), which is usually taken 
from the iliac crest to augment rotator cuff repair. BMAC is prepared by centrifuging bone 
marrow aspirate to concentrate the mesenchymal stem cells. Hernigou et al 43 injected iliac crest 
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bone marrow-derived stem cells aspirated during arthroscopic single-row rotator cuff repair in 45 
patients, while another 45 patients underwent arthroscopic SR repair without augmentation. At 6 
months, 100% of the augmented-group had healed compared to 67% of the patients without 
BMAC. MRIs confirmed an increased healing rate and quality of the repaired surface with 
BMAC injection 43. Centeno et al reported improved function and pain scores in a multi-site 
registry study of 102 patients, a subset of which had isolated rotator cuff tears that were treated 
with injections of bone marrow concentrate also containing platelet-rich plasma and platelet 
lysate 14. 
Another surgical approach to draw stem cells to the repair tissue is the “crimson duvet” 
technique. The crimson duvet is a clot issued from bone marrow vents, which are punctured in 
the greater tuberosity during rotator cuff repair. The perforation has to reach the cancellous bone, 
letting the bone marrow flow out. Microfracture of the greater tuberosity was used in two clinical 
trials 82, 87, with one reporting greater healing in a subset of patients with larger tears 82. Uhthoff 
et al 110 argued that releasing BMSC from the greater tuberosity might enhance healing due to the 
influx of fibroblasts and vessels increasing the healing response.  
 
4.5.4 Growth Factors & Cytokines 
Growth factors can enhance repair and enable tissue regeneration; nevertheless, further 
clinical investigations are required to establish the proper timing, dosage and the delivery 
method. PDGF-BB was tested in rat rotator repair cuff model, where the treatment group was 
found to have collagen-bundle alignment similar to controls 117. Uggen et al 109 used PDGF-BB-
coated sutures to repair sheep infraspinatus tendon, which resulted in improved histological 
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properties after 6 weeks at the bone-to-tendon repair, but did not change tendon strength. An 
infraspinatus sheep repair model showed enhanced anatomical appearance and biomechanical 
strength with a type-1 collagen scaffold loaded with rhPDGF-BB 42. TGF-β1and TGF-β3 were 
used in rat supraspinatus tear repair. The TGF-β1 group had an increase in type III collagen and a 
scar-mediated repair with poorer mechanical properties. However, the TGF-β3 group showed no 
difference histologically and biomechanically compared to controls 57. As of now, there is still no 
study on rotator cuff repair using growth factors in human. 
 
4.5.5 Platelet-rich plasma  
Platelet-rich plasma (PRP) has gained popularity in sports medicine and orthopaedics but 
its efficacy in rotator cuff tear repair is still unclear. To obtain PRP, a small amount of the 
patient’s own blood is spun through a centrifugation process to concentrate the platelets. Several 
different types of PRP have been used in an attempt to augment repair. PRP can be applied as a 
liquid (with or without calcium-based activation prior to application) or can be implanted as a 
solid matrix, in which case it is called platelet-rich fibrin (PRF). PRF differs from PRP, where 
blood is collected without the use of any anticoagulant and is immediately centrifuged. In 
addition, the method of isolation will determine whether the PRP or the PRF contains leukocytes 
or not (leukocyte-PRP/PRF or pure-PRP/PRF), the benefits of which are currently unknown. 
Platelets release growth factors from the α-granules and the dense granules, which contain many 
different cytokines and bioactive factors that have a chemotactic paracrine role, which regulates 
inflammation, angiogenesis, matrix synthesis, and remodeling of tissues. It has been postulated 
that PRP will improve tendon healing by increasing the concentration of growth factors and by 
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promoting revascularization of surrounding tissues; however, results have been inconsistent in 
clinical trials so far. 
Pre-clinical studies investigating PRP for rotator cuff repair are few. Most use the rat 
model 25, 65, with a few studies published in rabbits 18, 116. Some studies showed repair 
improvement with application of PRP, while others did not. 
Clinical data on PRP for rotator cuff repair is more abundant (Table 5). Leukocyte-rich 
PRF has been used as solid implants to attempt cuff repair augmentation by a few groups 1, 121, 
but no improvement was reported. Pure-PRF devoid of leukocytes has been used more 
commonly, with two studies showing lower re-tear rates with P-PRF 4, 13, one study showing no 
difference between both groups 114 and conversely, two studies showing more failures with P-
PRF 6, 97. Leukocyte-rich PRP was used in two Level I trials, where it showed no clinical 
improvement but a lower re-tear rate 95 and better repair integrity 40 compared to the control 
group. Studies using pure-PRP devoid of leukocytes employed plateletpheresis systems 49-51, 75 or 
centrifugation methods 98 to isolate the PRP. Four studies showed lower re-tear or partial re-tears 
in the pure PRP-treated group 49-51, 75, while one study showed no effect of pure-PRP 98. Lower 
re-tear rates may translate into improved clinical scores at longer time points, and in that respect, 
treatment with PRP might eventually improve cuff repair. It is particularly difficult to assess the 
efficacy of PRP from the different published studies, since they all vary in platelet count, single- 
versus double-spin cycles, methods of application, growth factor concentration, leukocyte 
concentration, platelet activation, surgical repair, and postoperative rehabilitation. The efficacy of 
PRP remains an open question in orthopedic rotator cuff repair.  
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4.5.6 Chitin and chitosan 
Chitosan is a linear copolymer of β (14) linked D-glucosamine (GlcN) and N-acetyl-
glucosamine (GlcNAc) obtained from crustaceous exoskeleton by alkaline N-deacetylation of 
chitin. To our knowledge, there have been only a small number of publications using chitin and 
chitosan in rotator cuff repair. Funakoshi et al used a nonwoven chitin fabric in the infraspinatus 
of 21 rabbits where they observed an increase in cell number and collagen fiber alignment and 
enhanced structural and biomechanical properties 29. Melamed et al 78 found that rotator cuff tear 
repair augmented with chitosan gel enhanced healing of soft tissues. Chitosan was also shown to 
improve rotator cuff repair in rats by decreasing muscle fiber fibrosis and by preventing muscle 
atrophy 96.  
Our laboratory has worked extensively with chitosan-glycerol phosphate (GP)/blood 
implants for cartilage repair applications. Near neutral solutions of chitosan-GP can be mixed 
with whole blood and injected over surgically prepared cartilage defects where they solidify in 
situ and improve marrow-stimulated cartilage repair 44. We have recently implemented the use of 
PRP combined with freeze-dried chitosan to form injectable implants for tissue repair 
applications. Chitosan-PRP implants were shown to reside for at least 14 days in vivo and 
enhance cell recruitment to surrounding tissues compared to PRP alone. These chitosan-PRP 
implants were tested in a meniscus repair model where they were found to increase cell 
recruitment, vascularisation, remodeling and repair tissue integration compared to injection of 
PRP alone 16. We are currently assessing whether these mechanisms will have similar beneficial 
effects in the context of rotator cuff repair.  
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4.6 Conclusions 
The majority of chronic tendon tears occurs in the supraspinatus and ultimately leads to 
structural change such as fatty accumulation, loss of volume, muscle remodeling, subtraction of 
sarcomeres, and sometimes profound muscle weakness. Finding the right animal model is 
challenging but critically important to improve our understanding of the cellular and molecular 
pathways involved in rotator cuff pathology. Ultimately, such information is required to improve 
therapeutic treatment options. However, none of the animals have anatomy comparable to 
humans. Open versus mini-open or arthroscopy does not seem to have a significant impact on 
clinical outcomes. Latest generation techniques involve the use of different configuration of 
sutures. Double-row configuration seems to increase the rate of tendon healing but this has 
generally not translated into improved clinical and functional outcomes. ECM patches have 
shown some promising findings in some animal studies, but not in randomized clinical trials. 
Scaffolds and cells are becoming more popular in tissue engineering as a structural support and a 
cellular delivery aid but further clinical studies are still needed. Growth factors have been shown 
to improve healing but there is still no study on rotator cuff repair using growth factors in 
humans. One strategy would require using the ideal combination of growth factors and scaffold 
together to complement each other. PRP use in orthopedics is still controversial and under 
investigation for now, and there is still limited data on its effectiveness. None of these strategies 
are perfectly suited for rotator cuff tear repair. One possible effective technique could be using 
chitosan-PRP implants. In summary, several repair strategies are available but further clinical 
trials are needed to find the optimal treatment for rotator cuff repair.  
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Abstract 
Platelet-rich plasma (PRP) has been used to treat different orthopaedic conditions, 
however, the clinical benefits of using PRP remain uncertain. Chitosan (CS)-PRP implants have 
been shown to improve meniscus, rotator cuff and cartilage repair in pre-clinical models. The 
purpose of this current study was to investigate in vitro and in vivo mechanisms of action of CS-
PRP implants. Freeze-dried formulations containing 1% (w/v) chitosan (80% degree of 
deacetylation and number average molar mass 38 kDa), 1% (w/v) trehalose as lyoprotectant and 
42.2 mM calcium chloride as clot activator were solubilized in PRP. Gravimetric measurements 
and molecular/cellular imaging studies revealed that clot retraction is inhibited in CS-PRP hybrid 
clots through physical coating of platelets, blood cells and fibrin strands by chitosan, which 
interferes with platelet aggregation and platelet-mediated clot retraction. Flow cytometry and 
ELISA assays revealed that platelets are activated and granules secreted in CS-PRP hybrid clots 
and that cumulative release of PDGF-AB and EGF is higher from CS-PRP hybrid clots compared 
to PRP clots in vitro. Finally, CS-PRP implants resided for up to 6 weeks in a subcutaneous 
implantation model and induced cell recruitment and granulation tissue synthesis, confirming 
greater residency and bioactivity compared to PRP in vivo. 
 
Keywords  
Chitosan, platelet-rich plasma, clot retraction, platelet activation, implant residency 
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5.1 Introduction 
Platelets are blood cell components that have recently been implicated in regulation of immune 
responses, cancer metastasis, vascular development, and angiogenesis, but are primarily responsible 
for haemostasis in the wound response, while simultaneously playing an essential role in healing by 
initiating specific cell responses through the release of several growth factors (1). Platelet-derived 
growth factors have received attention for tissue engineering and regeneration purposes in orthopedics 
and in other regenerative medicine fields. Unfortunately, growth factors are costly to produce and 
often inefficient in delivery to specific tissues (2). A more direct approach  to produce and deliver 
growth factors is through injection of platelet-rich plasma (PRP). PRP is an autologous blood-derived 
product that has an  increased concentration of platelets compared to physiological levels. Once the 
platelets in PRP are activated they release their alpha-granules containing multiple  growth factors, 
among them PDGF, TGF-, VEGF, EGF and IGF-1. PRP has been used clinically to treat different 
orthopaedic conditions (3), since it is believed to enhance not only cell proliferation, but also 
extracellular matrix deposition, remodeling, angiogenesis, and collagen synthesis. However, delivery 
of PRP to specific sites is  problematic  since its physical stability is low resulting in rapid dispersion 
and low residence time (4). In addition, growth factors have a very short half-life and are released 
rapidly from PRP. Currently, the clinical benefits of using PRP to improve tissue repair and 
regeneration remain uncertain (3). 
Chitosan, a polysaccharide obtained by chitin deacetylation, has been used in several tissue 
engineering and regenerative medicine applications (5). Chitosan is known to promote wound healing 
by enhancing migration of inflammatory cells, cell proliferation and matrix formation. This 
polysaccharide is non toxic, biocompatible and biodegradable, making it suitable for pre-clinical and 
clinical use. We have worked extensively with chitosan for several years, beginning with the initial 
discovery that chitosan can be mixed with glycerol phosphate (GP) and still remain soluble in near-
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neutral conditions of pH and osmolality (6). Chitosan-GP solutions were mixed with whole blood to 
form voluminous stable clots that are applied to cartilage defects in order to improve repair induced by 
marrow stimulation procedures such as microfracture (7-10). We subsequently developed a method to 
produce lyophilized formulations of chitosan (CS), trehalose (as lyoprotectant) and calcium chloride 
(as clot activator) that are soluble in PRP and form injectable CS-PRP implants that coagulate rapidly 
in situ (4). We identified some formulation properties that control implant performance and showed 
that CS-PRP implants have the potential to improve meniscus, rotator cuff and cartilage repair (11-
13). Combinations of chitosan and PRP have been used in other pre-clinical injury models as well, 
however, studies are scarce and report varying levels of success. Chitosan films (DDA 85% and 400 
kDa) were used in conjunction with PRP in a rat excision model, and found to improve wound healing 
when compared to sham control, PRP or chitosan film alone (14). In a rabbit cranial defect model, an 
86% DDA chitosan sponge used alone or in combination with PRP failed to improve repair compared 
to recalcified PRP alone (15). A composite of chitosan (DDA 94% and 680 kDa) and tricalcium 
phosphate (TP) was mixed with PRP and injected into osseous defects in the goat, where it improved 
repair compared to chitosan-TP by itself or untreated controls (16). 
The purpose of the current study was to (1) investigate possible mechanisms by which chitosan 
inhibits retraction of CS-PRP hybrid clots in vitro, (2) characterize the effect of chitosan, trehalose 
and a combination of both on platelet activation and granule secretion in vitro, (3) characterize the 
release profile of PDGF-AB and EGF from CS-PRP hybrid clots in vitro, and (4) histologically assess 
the residency, bioactivity and biodegradability of CS-PRP implants in vivo. Our starting hypotheses 
were that (1) chitosan would bind to platelets in a non-specific fashion to inhibit platelet aggregation 
in hybrid clots and platelet-mediated clot retraction; (2) chitosan would activate platelets and induce 
granule secretion; (3) the release of growth factors with low isoelectric point (negatively charged at 
neutral pH), such as EGF, would be more sustained from CS-PRP hybrids than the release of growth 
factors with high isoelectric points (positively charged at neutral pH), such as PDGF-AB, due to 
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electrostatic interactions with cationic chitosan; (4) CS-PRP implants would reside longer than PRP in 
vivo, where they would induce cell recruitment and angiogenesis, but be degraded within 6 weeks.  
 
5.2 Materials and methods 
5.2.1 Preparation of freeze-dried chitosan formulations 
Raw chitosans were purchased from Marinard, processed in-house and characterized by NMR 
spectroscopy (17) for degree of deacetylation (DDA) and size-exclusion chromatography/multi-
angle laser light scattering (18) for number average molar mass (Mn). Chitosan (80% DDA; Mn 
38 kDa) was dissolved in deionized water and 28 mM hydrochloric acid (Sigma-Aldrich) for 16 
hours on a rotator at room temperature. Filter-sterilized CaCl₂  (270 mM) and trehalose (15% 
w/v) solutions (both from Sigma-Aldrich) were then added to reach final concentrations of 1% 
(w/v) chitosan, 42.2 mM CaCl2 and 1% (w/v) trehalose prior to filtration through 0.2 µm filters 
(Millipore). The solution was dispensed in 1-mL aliquots in 3-mL glass vials for freeze-drying 
with the following cycle: 1) Ramped freezing to -40oC in 1 hour then isothermal 2 hours at -40oC, 
2) -40oC for 48 hours at 100 millitorrs and 3) Ramped heating to 30oC in 12 hours then 
isothermal 6 hours at 30oC, at 100 millitorrs. 10µL Rhodamine-chitosan tracer (19) of 
corresponding DDA and Mn was added to the vials that were subsequently used for fluorescent 
microscopy.  
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5.2.2 Preparation of platelet-rich plasma (PRP) 
The Polytechnique Montreal institutional ethics committee approved the project and all 
subjects enrolled in this research (n=3 males and n=3 females, with some donors sampled more 
than once) responded positively to an Informed Consent Form. For each donor, blood was 
extracted and anti-coagulated with 12.9 mM sodium citrate. The blood was then centrifuged 
using an ACE E-Z PRPTM centrifuge at 160 g for 10 minutes at room temperature. The 
supernatant and first 1-2 mm of erythrocyte sediment was removed and then centrifuged again at 
400 g for 10 minutes at room temperature. Only the bottom ~1.5 mL of each tube was retained 
and resuspended to make PRP. This isolation method yields a leukocyte-rich PRP (L-PRP) which 
typically contains ~3X more platelets than blood along with a leukocyte fraction (~0.8X that of 
blood) and a small erythrocyte fraction (~0.2X that of blood). Alexa-647 fibrinogen (Invitrogen) 
was prepared as a stock solution at 1.5 mg/mL in 0.1 M sodium bicarbonate (pH 8.3), and added 
to the PRP that was subsequently used for fluorescent microscopy (0.5mL of Alexa-647 
fibrinogen added to 4.5mL of PRP). 
 
5.2.3 Solubilization of freeze-dried chitosan formulations in platelet-rich 
plasma (PRP) 
Each freeze-dried cake (1mL freeze-dried formulation in each vial) was solubilized with 1mL 
of PRP and mixed vigorously for 10 seconds. The solubilized formulations were dispensed either 
into glass tubes to assess clot retraction and for imaging or into 48-well culture plates for 
characterization of release profiles. 
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5.2.4 Assessment of clot retraction 
Chitosan-PRP formulations (~250 µL) were dispensed in glass tubes placed on a heat block at 
37°C and allowed to clot for 1 hour. Serum was removed and % clot mass lost was quantified by 
gravimetric measurements. Clots were fixed with 0.5% (v/v) glutaraldehyde (EMS)/0.3% (w/v) 
paraformaldehyde (Sigma-Aldrich)/0.3% (v/v) Triton X-100 (Sigma-Aldrich). Controls were 
PRP recalcified with 42.2 mM CaCl2. Duplicate clots were prepared for each donor, except for 
one donor, where one clot was prepared. 
 
5.2.5 Confocal fluorescent and spinning disk microscopy imaging 
Fixed clots were sectioned with a razor blade at ~ 1mm thickness and mounted with Mowiol 4-88 
(Fluka)/glycerol (Sigma-Aldrich)/n-propyl gallate (Sigma-Aldrich) mounting medium (prepared in-house) 
on MatTek glass bottom dishes (Cedarlane). High resolution 2D and 3D images were captured with an 
Olympus FV1000 spectral confocal laser scanning microscope (Olympus Canada), using a PLAPON 
Apochromat oil objective (60X, NA 1.42). The excitation/emission wavelengths were 635/644-755 nm for 
the fibrin network (Alexa-647 fibrinogen tracer), and 543/555-625 nm for the chitosan (rhodamine tracer). 
Erythrocytes were also imaged for some samples (autofluorescence using 488/500-540 nm). The 
acquisition parameters were adjusted to avoid signal saturation. 3D images were reconstructed with Imaris 
software (Bitplane). The confocal microscope is also adapted for a Yokogawa spinning disk module 
(Quorum), controlled with the MetaMorph software (Molecular Devices). Given the high dynamic range 
of the EM-CCD digital camera (Hamamatsu), the spinning disk module was used to capture images with 
fixed acquisition settings for all the samples without reaching any signal saturation. Only the fibrin 
network was imaged with this module, using a UPLSAPO Super Apochromat objective (40X, NA 0.95) 
and excitation/emission wavelengths of 642/662-738 nm. 
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5.2.6 Scanning electron microscopy (SEM) imaging 
Fixed clots were embedded in paraffin (Fisher), sectioned at 3 µm thickness with a Leica 
RM2155 microtome and collected on SuperFrost Plus glass slides (Fisher). The sections were 
then deparaffinized, post-fixed in 2% (v/v) glutaraldehyde (EMS)/0.1 M sodium cacodylate 
(Sigma) pH 7.2 and washed in water. The post-fixed sections were removed from slides using a 
super fine point tweezers and placed onto a conductive carbon adhesive tape (EMS). The sections 
were immobilized by blowing compressed air and then gold sputter coated for 25 seconds using 
an Agar manual gold sputter-coater (Marivac Inc).  
SEM images were acquired with a Quanta FEG 200 ESEM (FEI Company) in high vacuum 
mode with working distance 5.6 to 5.7 mm and accelerating voltage 20kV. 
 
5.2.7 Transmission electron microscopy (TEM) imaging 
Fixed clots were post-fixed in 1% (v/v) osmium tetroxide (Sigma-Aldrich), washed in 
deionized water, incubated with 2% (v/v) uranyl acetate (EMS) for 1 hour, washed, dehydrated in 
a graded ethanol series, cleared in xylene and embedded in Embed-812 (EMS) medium at 60oC. 
100 nm sections were collected using a diamond blade and an RMC MT-7 ultramicrotome and 
mounted on copper grids. The images were acquired with a JEM 2000FXII transmission electron 
microscope (JEOL; Tokyo, Japan) operated at 80 kV. 
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5.2.8 Preparation of cell suspension and flow cytometry 
Whole blood was anticoagulated with 10.9 mM sodium citrate, centrifuged at 190 g for 15 
minutes and the supernatant collected. Supernatant was centrifuged at 2,500 g for 5 minutes to 
pellet the cells. Cell pellet was resuspended in HEPES/Tyrode’s buffer (10 mM HEPES, 137 mM 
NaCl, 2.8 mM KCl, 1 mM MgCl2, 12 mM NaHCO3, 0.4 mM Na2HPO4, 5.5 mM glucose) with 
1.35% (w/v) BSA (all from Sigma-Aldrich) and left to incubate for 1 hour. The cell suspension 
was then mixed with, either ADP (Sigma, final concentration 20 µM), solubilized chitosan 80% 
DDA Mn 38 kDa (final concentration 1% w/v), trehalose (final concentration 1% w/v) or 1% 
(w/v) chitosan and (1% w/v) trehalose simultaneously. Fluorescein isothiocyanate (FITCs) 
labeled anti-Pac-1 and anti-CD62P antibodies (Biolegend), which recognize activated platelet 
GPIIb/IIIa complex and granule membrane protein P-selectin, respectively, were added to the 
tubes as per manufacturer’s instructions and the tubes were incubated at room temperature for 20 
minutes. The cells were fixed with 1% (w/v) paraformaldehyde/10 mM HEPES/0.15 mM NaCl 
pH 7.4 for 15 minutes at room temperature. The samples were then kept on ice until analysis. The 
fluorescence intensity of 10, 000 events per sample were analyzed using a flow Moflo cytometer 
(Beckman Coulter Life Sciences). 
 
5.2.9 Quantification of growth factors released from clots 
Freeze-dried chitosan cakes were solubilized in PRP as described above and 250 µL of the 
solubilized mixture was dispensed into each well of a 48-well plate culture plate and allowed to 
clot for 1 hour in air atmosphere at 37oC with 5%CO2. Wells were washed with 500 µL -MEM 
cell culture medium (Invitrogen), the culture medium was immediately removed and replaced 
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with fresh -MEM cell culture medium. The cell culture medium were then removed and 
replenished at day 1, 3, 5 and 7. Culture medium was centrifuged at 400 g for 10 minutes and 
frozen at -80oC prior to ELISA quantification using platelet-derived growth factor (PDGF-AB) or 
epidermal growth factor (EGF) Quantikine kits (Product No DHD00C and DEG00 from RandD 
systems). Controls were PRP recalcified with 42.2 mM CaCl2. Duplicate clots were prepared for 
each donor, except for one donor, where one clot was prepared.  
 
5.2.10 Subcutaneous implantation 
The protocol for this study was approved by the University of Montreal ethics committee  and 
was consistent with the Canadian Council on Animal Care guidelines for the care and use of 
laboratory animals. Five New Zealand White (NZW) male rabbits (> 2.5 kg) were used for the 
study. Rabbits were anesthetized with ketamine/xylazine cocktail. From each animal, 18mL 
blood was collected from the ear artery and anticoagulated with sodium citrate (final citrate 
concentration 12.9 mM). Blood was centrifuged in an ACE EZ-PRPTM centrifuge for 10 min at 
160 g and then for 10 min at 400 g to extract PRP, as described above. The  back of the rabbit 
was shaved and the skin disinfected with 3 passages of Baxedin, then with 3 alternating passages 
of proviodine and isopropanol 70%. Freeze-dried chitosan formulations (300 µL) containing 1% 
(w/v) chitosan (80%-85% DDA and Mn 36-43 kDa), 1% (w/v) trehalose and 42.2 mM CaCl2 
were solubilised with 300 µL of PRP and shaken vigorously for 10 seconds. A 1-cc syringe 
equipped with a 26 gauge needle was used to deliver 150 µL of each implant under the skin of 
the back of the rabbits (n=4 CS-PRP implants injected in each rabbit). Controls consisted of 150 
µL PRP recalcified with 42.2 mM CaCl2 prior to injection (n=2 control PRP implants injected in 
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each rabbit). Animals were sacrificed at 2 weeks (n=2), 4 weeks (n=2) or 6 weeks (n=1) post-
implantation. At the time of sacrifice, rabbits were anesthetized with ketamine/xylazine cocktail 
and euthanized with an overdose of sodium pentobarbital. The skin with attached implants was 
carefully removed and fixed in 10% neutral buffered formalin (NBF) (Fisher) for 3 days. Each 
implant was excised using razor blades and a horizontal band was collected from the central area 
for paraffin embedding. Paraffin sections (5 µm) were collected and stained with Fast Green/Iron 
Hematoxylin (both from Sigma-Aldrich). The stained sections were then scanned for histological 
evaluation using a Nanozoomer RS system and images exported using NDPView software (both 
from Hamamatsu). 
 
5.2.11 Statistical analysis 
All statistical analyses were performed with SAS Enterprise Guide 7.1 and SAS 9.4. Data in 
the text are presented as mean  SD. Data in the Figures are presented as median (line); Box: 25th 
and 75th percentile; Whisker: Box to the most extreme point within 1.5 interquartile range. The 
Mixed model task in SAS Enterprise Guide was used to compare the different groups with post-
hoc analysis to look at pair-wise differences. Fixed effects were type of sample (CS-PRP vs PRP 
control) and time, while donor was a random effect, as some donors were sampled more than 
once. 
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5.3 Results 
5.3.1 Clot retraction and platelet aggregation are inhibited in chitosan-PRP 
hybrid clots 
Gravimetric measurements showed that PRP clots lost 78±4% of their initial mass after 
clotting for 1 hour at 37oC (Fig 5.1a). Although there was some variability between donors, % 
mass loss was significantly less for chitosan-PRP hybrid clots at average 21±18% (Fig 5.1a). 
Spinning disk microscopy and confocal microscopy images of clots fixed after clotting for 1 hour 
showed that platelet aggregates were smaller in chitosan-PRP hybrid clots (Fig 5.1b, d & f) 
compared to PRP clots (Fig 5.1c, e & g).  
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Figure 5-1 After clotting for 1 hour at 37oC, clot retraction and serum expression (expressed as % 
clot mass lost) was greater from PRP clots compared to CS-PRP hybrid clots (a). Data are 
presented as mean (diamond) and median (line) of n=7 clots from 3 different donors; Box: 25th 
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and 75th percentile; Whisker Box to the most extreme point within 1.5 interquartile range. The 
Mixed model task in SAS Enterprise Guide 7.1 and SAS 9.4 was used to compare the different 
groups using sample (CS-PRP vs PRP) as a fixed effect and donor as a random effect. * p < 0.05 
compared to PRP. Platelet aggregates were smaller in CS-PRP hybrid clots (b, d & f) compared 
to PRP clots (c, e & g), as shown by spinning disk microscopy images (b & c), confocal 
microscopy images (d & e) and 3-D stacks of confocal microscopy images (f & g). An Alexa-647 
fibrinogen tracer was added to allow imaging of fibrin-covered platelets and fibrin in white. A 
Rhodamine-chitosan tracer was added to allow imaging of chitosan in red in d) and orange in f).  
 
5.3.2 Chitosan coats clot components in chitosan-PRP hybrid clots 
Scanning electron microscopy (SEM) images demonstrated that blood components were 
coated with chitosan in chitosan-PRP hybrid clots (Fig 5.2a & b). Both cells and fibers were 
covered by a coating of what is presumed to be chitosan (Fig 5.2a & b). In contrast, the fibrin 
network was readily visible in PRP clots (Fig 5.2c & d). In transmission electron (TEM) images 
of chitosan-PRP hybrid clots, chitosan was observed in the space between cellular elements, and 
also at the surface of fibrin strands, erythrocytes and platelets (Fig 5.2e & f). Erythrocytes were 
closely packed and platelet aggregates were large in PRP clots (Fig 5.2g & h). 
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Figure 5-2 Chitosan (CS) appeared to be coating cellular and fibrous elements in scanning 
electron microscopy (SEM) images of CS-PRP clots (a & b) while the fibrin (F) network was 
readily visible in PRP clots (c & d). Chitosan (CS) was found in the space between cellular 
elements and also at the surface of erythrocytes (E), platelet aggregates (P) and fibrin (F) in 
transmission electron microscopy (TEM) images of CS-PRP clots (e & f). Erythrocytes (E) were 
tightly packed and platelet aggregates (P) were large in TEM images of PRP clots (g & h). 
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5.3.3 Chitosan induces platelet activation and granule secretion in cell 
suspension 
As expected, incubation with ADP (in green), a known platelet agonist, caused increased Pac-
1 and p-selectin expression in a cell suspension (unactivated cells in red) (Fig 5.3). Incubation 
with 1% (w/v) chitosan (in dark blue) also led to platelet activation (Fig 5.3a) and granule 
secretion (Fig 5.3b). In contrast, incubation with 1% (w/v) trehalose alone (in yellow) did not 
induce platelet activation and granule secretion (Fig 5.3). Finally, incubating the cell suspension 
with 1% (w/v) chitosan simultaneously with 1% (w/v) trehalose (in pale blue) induced platelet 
activation and granule secretion, albeit less than incubation with 1% (w/v) chitosan by itself (Fig 
5.3). 
 
Figure 5-3 a) Flow cytometric analysis of PAC-1 (a) and p-selectin (b) staining of cell suspension 
(unactivated in red). As expected, incubation with ADP (20 µm in green) and chitosan (in dark 
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blue), both known platelet agonists, led to platelet activation (a) and granule secretion (b).  In 
contrast, incubation with trehalose alone (in yellow) had no effect on platelet activation (a) or 
granule secretion (b). Interestingly, incubation with chitosan and trehalose simultaneously (in 
pale blue) decreased the intensity of both fluorescent signals compared to incubation with 
chitosan alone (in dark blue).  
 
5.3.4 Chitosan-PRP hybrids provide a greater and sustained release of PDGF-
AB and EGF over time 
PDGF-AB release into culture medium was ~100 times greater than that of EGF for both 
chitosan-PRP hybrid clots and PRP clots (Fig 5.4). For both growth factors, a phase of fast 
release was observed in the first 24 hours, followed by a more controlled release from day 1 to 
day 7 (Fig 5.4). In addition, for both growth factors, release was still ongoing at day 7 and no 
plateau had been reached (Fig 5.4). Both time (p<0.0001 and p<0.0001) and sample type 
(p<0.0001 and p=0.0003) had an effect on the release of PDGF-AB and EGF, respectively (Fig 
5.4). The cumulative release of PDGF-AB from chitosan-PRP hybrid clots was significantly 
greater than the cumulative release from PRP clots from day 1 to day 7 (Fig 5.4a). Similarly, the 
cumulative release of EGF was significantly greater from chitosan-PRP hybrid clots than from 
PRP clots from day 3 to day 7 (Fig 5.4b).  
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Figure 5-4 PDGF-AB (a) and EGF (b) cumulative release in culture medium was greater for CS-
PRP clots compared to PRP clots. Data are presented as mean (circle) and median (line) of n=13 
clots from 6 different donors; Box: 25th and 75th percentile; Whisker: Box to the most extreme 
point within 1.5 interquartile range. The Mixed model task in SAS Enterprise Guide 7.1 and SAS 
9.4 was used to compare the different groups with post-hoc analysis to look at pair-wise 
differences using sample and time as fixed effects and donor as a random effect. * p < 0.05 
compared to PRP. Insets show total amount of growth factors released. 
 
5.3.5 Chitosan-PRP hybrids reside for at least 6 weeks in vivo and induce cell 
recruitment 
No PRP implants could be recovered for histology at any time point tested. In contrast, 
chitosan-PRP implants were resident for up to 6 weeks post-implantation (Fig 5.5). Host-derived 
cells were recruited to the implants and were observed invading the implants from 2 weeks on, 
along with granulation tissue synthesis and new blood vessel formation (Fig 5.5). None of the 
chitosan implants induced deleterious effects in rabbits. No sign of infection or rejection were 
noted macroscopically or histologically. Blood work was normal and rabbits did not develop 
anorexia post-surgery 
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Figure 5-5 Formulations containing 1% (w/v) chitosan (CS Mn 38-43kDa and DDA 80-85%) 
with 1% (w/v) trehalose and 42.2 mM CaCl2 were solubilized in autologous PRP and injected 
subcutaneously in rabbits, where they were found to be resident and induce cell recruitment at 
two weeks (a-c), four weeks (d-f), and six weeks (g-i) post-implantation. Invasion of the CS-PRP 
implants by host cells was accompanied by granulation tissue (GT) synthesis and formation of 
new blood vessels (BV). In contrast, recalcified PRP implants were completely degraded within a 
few days (not shown since the implant was absent). Outlines in a, d & g show where higher 
magnification images b, c, e, f, h & i were acquired. 
 
5.4 Discussion 
One objective of this study was to investigate the mechanisms by which chitosan inhibits 
platelet-mediated clot retraction and liquid expression in CS-PRP hybrids, as shown in Figure 
5.1a. Under static or low shear stress a condition, which is the case here in our in vitro assay, 
platelet aggregation is mainly mediated by the interactions of GPIIb/IIIa on platelet surface with 
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fibrinogen (20). Stimulation of platelets with agonists induces cytoskeletal rearrangement, shape 
change, protein synthesis, granule secretion and increases the affinity of the GPIIb-IIIa platelet 
receptor for fibrinogen (21). Platelet aggregation results from binding of multiple platelets to the 
same fibrinogen molecule (1). Clot retraction, mediated by the platelet actin and myosin 
contractile system then follows, as long as platelet stimulation, comprising shape change and 
primary aggregation, are maintained (22, 23). In the absence or non-functioning GPIIb/IIIa, clot 
retraction does not occur. Confocal, SEM and TEM images (Figures 5.1&2) support our first 
hypothesis that chitosan physically coats platelets and other components of the blood clot to 
inhibit platelet aggregation, which is needed for clot retraction. In CS-PRP hybrids, chitosan 
physically interferes with the ability of the platelets to adhere to each other and the fibrin network 
and exert mechanical forces. 
Our second and third aims were to investigate whether platelets are activated in CS-PRP 
hybrid clots and, if so, how platelet-derived growth factors are released from CS-PRP hybrid 
clots. Chitosan (DDA > 90% and 50 kDa) was previously shown to be a platelet agonist and 
stimulate platelet activation and GPIIb/IIIa expression in vitro (24). In another study, stimulation 
of platelet suspensions with chitosan (DDA 84%) induced p-selectin and GPIIb/IIIa expression, 
in a process that was shown to be modulated by plasma and extracellular matrix proteins (25). 
Consistent with these previously published data and our third hypothesis, we found that chitosan 
induces platelet activation and granule secretion in cell suspensions (Figure 5.3), even more so 
than ADP (20 µm), a known platelet agonist. Interestingly, incubation of cell suspension with 
trehalose along with chitosan slightly decreased expression of Pac-1 and p-selectin compared to 
incubation with chitosan alone. This is consistent with published reports that lyoprotectants 
impede haemostatic mechanisms (26, 27).  
111 
 
Even though test conditions in the flow cytometry assay are different than in the hybrid clot 
system, we expected platelets within the CS-PRP hybrid clots to be activated and release their 
granule content, and this was ascertained by ELISA assays. In the case of physical adsorption of 
growth factors to chitosan, release is believed to be controlled by the electrostatic interactions 
that exist between the growth factors and the chitosan (28). Therefore, our third starting 
hypothesis was that the isoelectric point of platelet-derived growth factors would determine how 
growth factors would be released from our CS-PRP hybrids. The isoelectric point of PDGF is 9.8 
(29) and, under physiological conditions, we expected ionic repulsion between positively charged 
PDGF-AB and cationic chitosan to result in burst release. Meanwhile, EGF, which has an 
isoelectric point of 4.6 (30) would be expected to bind to chitosan under physiological conditions 
and be released in a more sustained manner. In contrast to this, we found that CS-PRP hybrid 
clots sustained and increased release of both PDGF-AB and EGF for 1 week in vitro, which 
suggests that additional factors are controlling their release in this system (Figure 5.4).  
We found that the cumulative levels of PDGF-AB and EGF released in the culture medium 
were higher in the case of CS-PRP clots compared to PRP clots (Figure 5.4). These results were 
not completely unexpected. Kutlu et al (31) previously prepared CS-PRP scaffolds by either 
adding PRP to a chitosan gel before freeze-drying or by delivering PRP to a lyophilized chitosan 
sponge. Sustained release of PDGF-BB was achieved in the first group, similarly to what we 
observed here, while a sharp burst release was observed in the second group. Interestingly, both 
of their CS-PRP scaffolds secreted higher cumulative levels of PDGF-BB when compared to 
unactivated PRP or PRP activated with type I collagen, similarly to what was found here for 
PDGF-AB. Hattori et al (32) showed that platelets in whole blood are activated when mixed with 
solutions of chitosan with different DDA and Mw. Of particular relevance to our study, the 
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amount of PDGF-AB released was the highest when chitosans of DDA 75-85% and Mw 50-190 
kDa were used in conjunction with calcium chloride than when calcium chloride was used by 
itself. Shen et al (33) showed that stimulation with chitosan of DDA > 90% and 450 kDa induced 
release of PDGF-AB and EGF from PRP for up to 60 minutes. Shimojo et al (34) prepared 
lyophilized scaffolds containing different concentrations of chitosan (DDA 83% and Mw 400 
kDa), loaded the scaffolds with PRP activated with autologous serum and calcium chloride and 
showed that PDGF-AB cumulative release was higher from the scaffolds compared to activated 
PRP alone, provided that the scaffolds be lyophilized at low temperatures. In a subsequent study, 
Shimojo et al (35) showed that stabilizing the chitosan scaffolds by treating them with NaOH 
prior to loading them with PRP was another way to increase cumulative PDGF-AB release from 
scaffolds lyophilized at -20oC. 
With regard to growth factor release, it is important to consider the contribution of each cell 
type present in the PRP preparation. Platelets are the main contributors to growth factor release 
from PRP and positive correlations were previously found between platelet doses and the amount 
of released growth factors including PDGF-AB, TGF-1, VEGF and EGF (36, 37). While it 
appears that the inclusion of leukocytes in PRP increases the content of some pro-inflammatory 
cytokines (38-41), the effect of leukocytes on growth factor content and release is still not fully 
understood. Previous studies found that leukocyte-rich PRP contained higher concentrations of 
growth factors compared to leukocyte-poor PRP, but that may be due to the fact that systems that 
include the buffy coat layer are usually more efficient at capturing platelets (39, 42-46). 
However, positive correlations and close associations were also found between PRP leukocyte 
counts and levels of PDGF-AB, VEGF and EGF (36, 37)_ENREF_11, which suggests that 
leukocytes contribute to the release of growth factors from PRP. Here, we found increased 
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cumulative PDGF-AB and EGF release from CS-PRP clots compared to PRP clots (Figure 5.4). 
One possible reason for this is that chitosan used in conjunction with calcium chloride stimulates 
platelet activation and granule secretion more than calcium chloride by itself. Another possibility 
would be that leukocytes, especially monocytes, present in CS-PRP hybrids are secreting higher 
amounts of growth factors than in PRP without chitosan. While it has been reported that M0 and 
polarized M2a macrophages secrete PDGF-BB (47, 48), and that biodegradable chitosan particles 
(DDA 81.5% and Mn 132 kDa) enhance release of PDGF-BB from M0 and M2a macrophages 
(49), we believe that the main contributors to growth factor release in the CS-PRP hybrid system 
are platelets and not monocytes, for the following reasons: 1) Monocytes typically require 
specific stimulatory signals to become macrophages, 2) There is a low number of monocytes 
present in each CS-PRP clot, compared to the number of platelets (on average ~ 2500X more 
platelets than monocytes); 3) In light of previous reports on the amount of growth factors 
released by M0 and M2a macrophages, it seems unlikely that such a limited number of 
monocytes could secrete the amount of PDGF-AB and EGF that was measured here in the culture 
medium. 
Our fourth aim was to investigate the implants in vivo, and, as previously shown (4), CS-PRP 
hybrids exhibited longer residency and higher bioactivity than PRP (Figure 5.5). In a 
subcutaneous implantation model in the mouse, porous chitosan scaffolds were found to elicit 
neutrophil migration into the implantation area along with angiogenic activity, as was shown here 
as well (50). It is of interest to mention that the site of implantation along with implant volume 
influences biodegradability. We have previously shown that CS-PRP implants are degraded 
within 3 weeks in meniscus tears in the sheep (13), and between 2-8 weeks in rotator cuff tears 
(11) and cartilage lesions in the rabbit (12) compared to more than 6 weeks in the current study. 
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One limitation of this study is the low number of animals used for the in vivo subcutaneous 
implants study. Another limitation is the limited number of growth factors studied for the release 
profiles. We chose both EGF and PDGF-AB, since they are frequently assessed in the literature, 
and they have widely different isoelectric points. Nevertheless, future studies should involve a 
greater number of platelet-derived growth factors. It is also important to mention that in vitro 
release profiles cannot be extrapolated to the in vivo situation; however, these data improve our 
understanding of the CS-PRP technology. 
 
5.5 Summary 
Chitosan physically coats platelets, blood cells and fibrin strands in CS-PRP hybrid clots, 
thus inhibiting platelet aggregation, which is required for clot retraction. Platelets are activated, 
granules secreted and higher levels of PDGF-AB and EGF are released from CS-PRP hydrid 
clots compared to PRP clots in vitro. Finally, CS-PRP implants reside for at least 6 weeks post-
implantation subcutaneously and induce cell recruitment and granulation tissue synthesis, 
confirming a longer residency and higher bioactivity compared to PRP in vivo.  
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Abstract 
Rotator cuff tears result in shoulder pain, stiffness, weakness and loss of motion. After 
surgical repair, failure rate ranges between 20 to 95% and it is recognized that current surgical 
treatments need improvement. The aim of the study was to assess whether implants composed of 
freeze-dried chitosan (CS) solubilized in autologous platelet-rich plasma (PRP) can improve 
rotator cuff repair in a rabbit model. Complete tears were created bilaterally in the supraspinatus 
(SSP) tendon of New Zealand White rabbits (n=4 in a pilot feasibility study followed by n=13 in 
a larger efficacy study), which were repaired using transosseous suturing. On the treated side, in 
addition to sutures, CS-PRP implants were injected into the transosseous tunnels and the tendon 
itself, and healing was assessed histologically at time points ranging from 1 day to 2 months post-
surgery. CS-PRP implants were resident within transosseous tunnels and adhered to tendon 
surfaces at one day post-surgery and induced recruitment of polymorphonuclear cells from 1 to 
14 days. CS-PRP implants improved attachment of the SSP tendon to the humeral head through 
increased bone remodeling at the greater tuberosity and also inhibited heterotopic ossification of 
the SSP tendon at 2 months. Using CS-PRP implants in conjunction with transosseous suturing 
improved attachment of the SSP tendon versus suturing alone, which would be expected to 
correlate with superior mechanical performance. This preliminary study provides evidence that 
CS-PRP implants are effective in improving rotator cuff tendon attachment in a small animal 
model, and could potentially be translated to a clinical setting. 
 
Keywords: Rotator cuff repair, chitosan, platelet-rich plasma, injectable implants, rabbit model 
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6.1 Introduction 
Rotator cuff tears are one of the most common shoulder pathologies 1 and are associated 
with structural and architectural alterations of the musculotendinous unit, such as tendon 
retraction, muscular atrophy and fatty infiltration. Rotator cuff tears may cause chronic pain and 
severe functional disability, as well as compromise joint mechanics leading to degenerative joint 
changes. Rotator cuff tears may require surgical repair, which attempts to reattach the tendon to 
bone through different suturing techniques. Repair success is affected by numerous factors, 
including patient age, number of tendons involved, and size of the tear 2. Failure rates range 
between 20 to 95% 3 and tendon degeneration, hypovascularization, muscle atrophy, and lack of 
tendon-to-bone integration are some of the reasons proposed for failures.  
The rotator cuff insertion site, also known as the enthesis, is never completely reformed 
after surgical reattachment 4; 5. Instead, healing occurs through synthesis of a fibrovascular 
disorganized scar tissue composed largely of type III collagen, which lacks strength and proper 
biomechanical properties leading to high re-tear rates. Patients with re-tears can experience pain 
relief but usually continue to have compromised function. There have been attempts to improve 
rotator cuff repair with biological or synthetic tendon grafts or with augmentation techniques 6; 
however, consistent healing of the rotator cuff following repair still remains an enormous clinical 
challenge.  
Platelet-rich plasma (PRP) is a plasma fraction with a high platelet concentration that is 
obtained through centrifugation of whole blood. Activation of platelets within PRP can be 
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achieved by treatment with calcium chloride, thrombin, or contact with collagen, and leads to the 
release of several growth platelet-derived factors. The use of PRP to improve rotator cuff repair 
has been evaluated in both animal models and clinical studies since it is believed that growth 
factor release at the injury site could lead to cell proliferation, cell differentiation, and 
angiogenesis. However, the ability of PRP to improve rotator cuff repair is not supported by 
current clinical evidence 7-10. Results have been inconsistent, possibly due to the lack of 
standardization of platelet separation techniques, variability in formulations of PRP used, as well 
as the short half-life, high diffusibility, and poor stability of PRP in vivo.  
Chitosan (CS) is a biodegradable and biocompatible natural polymer obtained through 
chitin deacetylation 11; 12. In the context of cartilage repair, implants of CS-glycerol phosphate 
(GP)/blood have previously been shown by our research group to increase cell recruitment, 
vascularization and bone remodeling 13; 14, activate a beneficial phenotype of pre-wound healing 
macrophages 15 and enhance tissue repair integration through osteoclast activity 16, all of which 
are expected to be beneficial for rotator cuff repair. More recently, we have developed freeze-
dried formulations of CS that can be solubilized in PRP to form injectable CS-PRP implants that 
coagulate in situ 17. We have shown that chitosan inhibits platelet-mediated clot retraction and 
increases platelet-derived growth factor release from PRP in vitro 18. The residency time and 
bioactivity of CS-PRP implants have also been shown in vivo to be superior to that of PRP alone 
17; 18. Finally, CS-PRP implants were successfully used to augment cartilage and meniscus repair 
in small and large animal models 19-21. 
The aim of the current study was to assess whether CS-PRP implants can improve rotator 
cuff repair in a rabbit model. Surgical tears were created bilaterally in the supraspinatus (SSP) 
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tendon of the rotator cuff of New Zealand White (NZW) rabbits, which were immediately 
repaired with transosseous suturing. On the treated side, CS-PRP implants were additionally 
injected into the transosseous tunnels and the tendon itself. Healing was assessed histologically at 
time points ranging from 1 day to 2 months post-surgery. Our starting hypotheses were that: 1) 
CS-PRP implants would induce recruitment of polymorphonuclear cells (PMN) at early time 
points post-surgery, 2) CS-PRP implants would be degraded by 2 months post-surgery, and 3) 
CS-PRP implants would improve tendon healing through an increase in cell recruitment, 
angiogenesis, and bone remodeling. 
 
6.2 Materials and methods 
6.2.1 Rotator cuff tear model, surgical repair and study design 
The protocol for this study was approved by the University of Montreal institutional 
committee (initial date of approval September 3rd 2015) and was consistent with the Canadian 
Council on Animal Care guidelines for the care and use of laboratory animals. The bilateral 
rotator cuff tear model was first validated in a pilot feasibility study in 4 retired breeder female 
NZW rabbits (Table 1). Then, a larger efficacy study was performed using 13 skeletally mature 
female NZW rabbits aged 9 months (Table 2). The SSP tendon was exposed and a complete tear 
was created with a scalpel blade, as close as possible to the insertion site (Figure 1a). The 
remaining stump was debrided, exposing the greater tuberosity. The tear was immediately 
repaired with a transosseous suturing technique described previously 22-28. Briefly, a ~ 5 mm 
bony trough was drilled in the cancellous bone of the greater tuberosity using a high-speed 
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microdrill (Ideal model, Geneq Scientific Instruments Inc) fitted with a 2.1 mm diameter drill bit 
(Fine Science Tools).Three 1.4 mm diameter drill holes were then drilled from the lateral aspect 
of the humerus to connect to the bony trough (Figure 1b). Cold irrigation with Ringer’s lactate 
was used throughout drilling. Two 3.0 prolene sutures were passed through the lateral holes, the 
bony trough and the tendon itself in a modified Mason-Allen pattern. In treated shoulders, in 
addition to sutures, CS-PRP implants were applied as described below (Figure 1c). Sutures were 
tightened over the lateral aspect of the humerus, thus pulling the tendon towards the greater 
tuberosity (Figure 1d). The animals were allowed ad libitum cage activity postoperatively. Pain 
control was achieved with transdermal fentanyl patches for 4 days and two rabbits had rymadyl 
injections for 3 consecutive days for additional pain relief.  
Table 6-1. Design of Study 1-Pilot feasibility study. 
Group Treatment shoulder 1 Treatment shoulder 2 # Animals / 
timepoints 
1 Intact Intact n = 1 at day 0 
2 Suturing + CS-PRP Suturing + CS-PRP n = 1 at day 1 
3 Suturing + CS-PRP Suturing n = 1 at day 14 
n = 1 at 2 months 
Table 6-2. Design of Study 2-Larger efficacy study. 
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Group Treatment shoulder 1 Treatment shoulder 2 # Animals / time 
points 
1 Intact Intact n = 2 at day 0 
2 Suturing + CS-PRP1 Suturing + CS-PRP1 n = 2 at day 1 
3 Suturing + CS-PRP Suturing only n = 1 at day 7 
4 Suturing + CS-PRP Suturing only n = 8 at 2 months 
1 A Rhodamine-chitosan tracer was used in these animals for imaging purposes. 
 
Figure 6-1. a-d) Surgical procedure. A complete surgical tear was created in the supraspinatus 
(SSP) tendon of the rotator cuff, as close as possible to the insertion site (a). Two 3.0 prolene 
sutures were pre-placed through the bony trough, the lateral tunnels (b) and the tendon itself in a 
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modified Mason-Allen pattern. In the case of treated shoulders, the CS-PRP mixture (150 µL) 
was injected into the bony trough prior to tightening the sutures (c), and it flowed out of all 
lateral tunnels. Sutures were tightened to attach the tendon to the humeral head (d). The CS-PRP 
mixture (150 µL) was then injected at the repaired insertion site and into the tendon itself. e) 
Schematic representation of the surgical model. f) Area in red is the region of interest (ROI) that 
was set over the greater tuberosity and used for micro-CT analysis.  
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6.2.2 Preparation of freeze-dried chitosan formulations 
Chitosan with 80.2% degree of deacetylation (DDA) and 36 kDa number average molar 
mass (Mn) was used to prepare formulations containing 1 % (w/v) chitosan, 28mM HCl, 1% 
(w/v) trehalose as a lyoprotecting agent and 42.2 mM CaCl2 as a PRP activator. This chitosan 
solution was filter-sterilized and 300 µL aliquots were distributed into sterile, de-pyrogenized 2cc 
glass vials and freeze-dried in 3 phases: 1) ramped freezing to -40oC in 1 hour, isothermal 2 hours 
at -40oC, 2) -40oC for 48 hours, 3) ramped heating to 30oC in 12 hours, isothermal 6 hours at 
30oC, at 100 millitorrs. Filter-sterile rhodamine-chitosan tracer 29 of corresponding Mn and DDA 
was added to 8 of the vials for imaging purposes.  
 
6.2.3 Preparation of platelet-rich plasma (PRP) 
Prior to surgery, 9 mL of blood was drawn from the rabbit ear artery and anti-coagulated 
with 1 mL 3.8% (w/v) sodium citrate (final citrate concentration 12.9 mM). Blood was 
centrifuged for 10 min at 1300 rpm and then for 10 min at 2000 rpm using the ACE EZ-PRPTM 
centrifuge to extract ~ 1.5 mL PRP per rabbit. On average, the leukocyte-rich PRP contained 838 
X 10E9/L platelets, 6.0 X 10E9/L leukocytes and 1.7 X 10E12/L erythrocytes.  
 
6.2.4 Solubilization of freeze-dried chitosan formulations in PRP and 
injection of CS-PRP implants 
Freeze-dried chitosan cakes (300 µL) were solubilized with autologous PRP (300 µL) and 
injected using a 1-cc syringe equipped with a 25-gauge needle in 2 phases: 1) 150 µL injected 
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prior to suturing the tendon, into the bony trough until it flowed out of the lateral tunnels and 2) 
150 µL injected following suturing, within the SSP tendon itself at the reattached insertion site. 
The rabbits were randomly divided into 3 groups (Tables 1 & 2): 1) Intact controls (n=3 rabbits; 
1 rabbit in Study 1 and 2 rabbits in Study 2); 2) Animals treated bilaterally with suturing + CS-
PRP and sacrificed at 1 day post-operative to assess implant distribution (n=3 rabbits; 1 rabbit in 
Study 1 and 2 rabbits in Study 2); 3) Animals treated with suturing + CS-PRP on one side and 
suturing only on the contralateral side and sacrificed at day 7 (n=1 rabbit in Study 2), day 14 (n=1 
rabbit in Study 1) and at 2 months (n=9 rabbits; 1 rabbit in Study 1 and 8 rabbits in Study 2). 
 
6.2.5 Specimen collection and histological processing 
Both shoulders were dissected carefully to remove the SSP muscle, its tendon, and the 
proximal part of the humerus in one piece and the glenoid articular surface. SSP tendon 
attachment was scored macroscopically as intact/native (0), completely attached with tissue 
different from native (1), partially attached with tissue different from native (2) or detached (3). 
The SSP muscle-tendon–humeral head complex and the glenoid surfaces were fixed with 10% 
neutral buffered formalin and trimmed for further processing. The calcified tissues were 
decalcified with 0.1N HCl with trace glutaraldehyde. All samples were dehydrated in graded 
alcohol solutions and cleared in xylene for paraffin processing. Sections (5µm thickness) were 
stained with Safranin O/Fast Green and scanned with a Nanozoomer RS (Hamamatsu) for 
histological evaluation by two blinded observers (GDT and AC). Histological scoring of the SSP 
tendon (Table 3) and SSP tendon enthesis (Table 4) was based on systems reported previously 30; 
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31. Briefly, the SSP tendon was scored for cellularity, presence of tenocytes or inflammatory 
cells, vascularity, tissue organization, and heterotopic bone formation, with ranges between 0 
(best score) to 3 (worst score). Inter-reader ICC for the tendon scoring system was excellent for 5 
out of 6 categories (ICC > 0.90), and good for the heterotopic bone formation category (ICC = 
0.68). The enthesis was scored for tendon attachment, attachment at anatomically correct 
location, presence of GAGs at the insertion site, and structural appearance of the enthesis, 
ranging between 0 (best score) to 2 (worst score) for the first three categories, and from 0 (best 
score) to 5 (worst score) for the last category. Inter-reader ICC was good for tendon attachment 
(ICC = 0.70) and excellent for attachment at anatomically correct location (ICC = 0.79), presence 
of GAGs at the insertion site (ICC = 0.80) and structural appearance of the enthesis (ICC = 0.95). 
Humeral head and glenoid articular surfaces were scored with the OARSI osteoarthritis cartilage 
histopathology assessment system 32. Fatty infiltration in SSP muscle was scored as minimal (0), 
mild (1), moderate (2) or marked (3). A synovial fluid smear was stained with May-Grünwald-
Giemsa staining for cell counting (% leukocyte differential). 
Table 6-3 Microscopic scoring of SSP tendon. 
Category to score Score 
 
 
I 
Cellularity 
     Minimal 0 
     Mild 1 
     Moderate 2 
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     Marked 3 
 
 
II 
Tenocytes 
     Minimal 0 
     Mild 1 
     Moderate 2 
     Marked 3 
 
 
III 
Inflammatory cells 
     None 0 
     Mild 1 
     Moderate 2 
     Marked 3 
 
 
IV 
Vascularity 
     Minimal 0 
     Mild 1 
     Moderate 2 
     Marked 3 
 Tissue organization 
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V 
     Native tendon 0 
     Repair tissue mostly tendon-like 1 
     Repair tissue a mixture of tendon-like tissue and 
     highly cellular and vascular tissue 
2 
     Repair tissue highly cellular and vascular tissue 3 
 
 
VI 
Heterotopic bone formation within tendon, far from insertion site 
     None 0 
     Slight 1 
     Moderate 2 
     Marked 3 
 
Table 6-4 Microscopic scoring of SSP enthesis.  
Category to score Score 
 
I 
 
Tendon attachment 
     Complete 0 
     Partial 1 
     Gap 2 
 Attachment at anatomically normal site 
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II 
   Yes 0 
   Partially 1 
   No 2 
 
 
 
 
III 
Structural appearance of the enthesis 
     Native insertion with tidemark throughout 0 
     Insertion has continuity with bone ingrowth and  
     fibrocartilage and tidemark partially present 
1 
     Insertion has continuity with bone ingrowth and  
     fibrocartilage cells but no tidemark 
2 
     Insertion has continuity with fibrous tissue 3 
     Insertion has continuity with fat 4 
     No continuity 5 
 
IV 
Glycosaminoglycans at insertion site 
     Normal 0 
     Slight 1 
     None 2 
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6.2.6 Micro CT analysis 
Prior to decalcification, the SSP tendon-humeral head complex was scanned using the 
Skyscan x-ray microtomography 1172 (Kontich, Belgium) with an aluminium filter at 14.1 µM 
pixel size resolutions and an X-ray source voltage of 56 kV, 1180 msec exposure, 0.45 rotation 
steps and 3 averaging frames. Images were reconstructed with NRecon software 1.6.1.5 (Kontich, 
Belgium), using the following parameters: Smoothing of 2, ring artifact reduction of 10, beam-
hardening correction of 40%. Datasets were repositioned with DataViewer software 1.4.3 
(Kontich, Belgium). The region of interest (4.5 mm in the x axis X 4.5 mm in the y axis X 3 mm 
in the z axis) was positioned on the edge of the greater tuberosity (Figure 1f) and 3D micro CT 
analysis was performed by using the global thresholding procedure in CTAn software 1.9.3.0 
(Kontich, Belgium).  
 
6.2.7 Statistical analysis 
Statistical analyses were performed using SAS Enterprise Guide 7.1 and SAS 9.4 
(Toronto, ON, Canada). Sections were systematically collected at three sites from each shoulder 
and scores from the 2 readers were averaged for each section. The mixed model task was used for 
statistical analysis, where the fixed effect was treatment (Intact vs Sutures + CS-PRP vs Sutures), 
the random effect was the rabbit number and the repeated effect was the section number. Data in 
figures are presented as mean (circle); median (line); Box: 25th and 75th percentile; Whiskers: 
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Box to the most extreme point within 1.5 interquartile range. p <0.05 was considered statistically 
significant. 
 
6.3 Results 
6.3.1 CS-PRP implants adhered to SSP tendon tissue and were resident within 
the bony trough and lateral tunnels at 1 day post-surgery 
At 1 day post-surgery, the attachment site of the SSP tendon was characterized by gap 
formation in all of the shoulders (Figure 2a&e). Despite our efforts, the stump of the SSP tendon 
was incompletely debrided in most cases (Figure 2a&e). The SSP tendons had areas that were 
structurally normal, and areas that had altered disorganized structure. Needle tracks containing 
CS-PRP implant were apparent in some cases (Figure 2f). In addition, CS-PRP implants were 
resident within the bony trough, the lateral tunnels and adhered to the tendon surface, as revealed 
by epifluorescent imaging (Figure 2g, i, j &k).  
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Figure 6-2. a to h) Safranin O/Fast Green-stained paraffin sections of shoulder treated with 
transosseous suturing + CS-PRP after 1 day. Polymorphonuclear cells (PMNs) were recruited to 
the bony trough (b), the lateral tunnels (c), to the endomyseal SSP muscle space (d) and to the 
SSP tendon (h). In some histological sections, needle tracks containing CS-PRP implant were 
visible within the SSP tendon (e & f). Note that stump of the tendon was not fully debrided in 
these samples (a and e). i to k) A rhodamine-chitosan tracer was used to image chitosan with 
epifluorescence in bright red. At one day post-surgery, chitosan-PRP hybrid implant was found 
adhering to the SSP tendon surface (i) and in the bony trough (j & k). 
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6.3.2 CS-PRP implants induced recruitment of polymorphonuclear (PMN) 
cells from day 1 to day 14 post-surgery 
In CS-PRP treated shoulders, PMN cells were recruited to the bony trough, the lateral 
tunnels, the SSP tendon and the endomysial space between SSP muscle fibers at day 1 (Figure 
2), day 7 (Figure 3) and day 14. Tears were still evident at the insertion site, for both groups, 
with CS-PRP and without CS-PRP, at day 7 post-surgery (Figure 3b&f), but not by day 14, 
where granulation tissue had filled the space. The structure of the SSP tendons was altered in all 
cases at days 7 and 14, where residual native-appearing tendon tissue was surrounded by highly 
cellular and vascularized granulation tissue (Figure 3). New bone was forming at the lateral 
aspect of the humerus by day 7 in both groups, without and with CS-PRP (See example in Figure 
3d). Chondrogenesis was visible within the SSP tendon body at 7 days, far from the insertion 
site, in the control sutured shoulder only (Figure 3h), but not in the case of CS-PRP treatment.  
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Figure 6-3. Safranin O/Fast Green-stained paraffin sections of shoulder treated with transosseous 
suturing + CS-PRP (a to d) or suturing only (e to h) after 7 days. Residual structurally normal 
SSP tendon tissue was apparent and gaps were present at the tear site in all samples (a, b, e & f). 
Polymorphonuclear (PMN) cells were abundant in the granulation tissue of the CS-PRP treated 
shoulder only (c vs g). New bone was forming at the lateral aspect of the cortical bone in both 
groups (example shown in d). Chondrogenesis was observed in the SSP tendon of the control 
sutured shoulder only (h). Outlines in a & e show where higher magnification images were 
acquired.  
 
6.3.3 CS-PRP implants inhibited heterotopic ossification of SSP tendon tissue 
at 2 months 
By 2 months post-surgery, significant remodeling of the SSP tendon structure had 
occurred in all shoulders, regardless of treatment (Figure 4e to l). SSP tendons were highly 
cellular and vascular compared to native intact tissues (Figure 4). Heterotopic bone formation 
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was observed in 5 out of 9 SSP tendons of control sutured shoulders and less frequently in the 
case of CS-PRP treatment (p=0.007 comparing suturing only to suturing+CS-PRP; Figure 4k, l 
& m). In 6 out of 9 shoulders treated with CS-PRP, PMNs were no longer visible at 2 months. 
However, in the remaining 3 shoulders, neutrophil-rich granulation tissue and areas of apoptotic 
or necrotic tissue was still apparent (p<0.0001 comparing suturing+CS-PRP to suturing only; 
Figure 4g, h & m). In contrast, there were no PMNs in any of the 9 control sutured shoulders. 
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Figure 6-4. Safranin O/Fast Green-stained paraffin sections of intact shoulders (a to d), and test 
shoulders treated with transosseous suturing + CS-PRP (e to h) or suturing only (i to l) after 2 
months, showing best and worst overall tendon scores for all groups. SSP tendon structure was 
altered in all surgically treated shoulders with several tendons displaying a highly cellular and 
vascular phenotype (e, f, i & j). Inflammatory PMN-rich tissue was present in 3 out 9 shoulders 
treated with transosseous suturing + CS-PRP at 2 months (g & h). Heterotopic ossification within 
the SSP tendon was observed in 5 out 9 shoulders treated with transosseous suturing (k & l). Data 
in m are presented as mean (circle), median (line); Box: 25th and 75th percentile; Whisker: Box to 
the most extreme point within 1.5 interquartile range. * p < 0.05 compared to intact. # p < 0.05 
compared to sutures group. & p < 0.05 compared to sutures + CS-PRP group. 
 
6.3.4 CS-PRP implants significantly improved attachment of SSP tendon at 2 
months  
The macroscopic attachment score (ranging from 0 for intact/native to 3 for detached) was 
better for shoulders treated with suturing + CS-PRP (average score of 1) compared to shoulders 
treated with suturing only (average score of 2). CS-PRP treated shoulders also showed better 
microscopic SSP tendon attachment at the greater tuberosity (p=0.0333 compared to suturing 
only) at 2 months (Figure 5m). In the best cases (Figure 5f&j), the enthesis had reformed with a 
partially calcified interface (in 14 out of 26 histological sections in the CS-PRP treated shoulders 
and in 7 out of 26 histological sections in the suturing only group). Polarized light microscopy 
(PLM) showed that collagen fibers were aligned parallel to the long axis of the SSP tendon in 
those cases, similar to the native intact enthesis (Figure 6a, c & e). In the worst cases (Figure 
5h&l), there were gaps between the humeral head and the repair tissue (in 1 out of 26 histological 
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sections in the CS-PRP treated shoulders and in 2 out of 26 histological sections in the suturing 
only group).   
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Figure 6-5. Safranin O/Fast Green-stained paraffin sections of intact shoulders (a to d), and test 
shoulders treated with transosseous suturing + CS-PRP (e to h) or suturing only (i to l) after 2 
months, showing best and worst overall enthesis scores for all groups. The original tendon stump 
was often observed in surgically treated shoulders (e, f, i & j). In the best repair cases, 
fibrocartilage formation and partial restoration of the tidemark were observed at the enthesis (f & 
j). In the worst repair cases, gaps were present at the tendon-bone interface (h & l), although 
treatment with transosseous suturing + CS-PRP decreased such instances (m). Data in m are 
presented as mean (circle), median (line); Box: 25th and 75th percentile; Whisker: Box to the most 
extreme point within 1.5 interquartile range. * p < 0.05 compared to intact. # p < 0.05 compared 
to sutures group.  
 
Figure 6-6. Polarized light microscopy images of SSP entheses. In the best cases, wave-like 
structures and alignment of the collagen fibres parallel to the long axis of the SSP tendon were 
visible (a, c & e). In the worst cases, very little collagen alignment was apparent in the fibrous 
tissue adjacent to the bone (b, d & f).  
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6.3.5 CS-PRP implants induced bone remodeling at the greater tuberosity at 2 
months 
Micro-CT images showed that incomplete cortical bone repair at the lateral aspect of the 
humerus (Figure 7c&d) and lateral outgrowths of bone (Figure 7e&f) were present in all 
shoulders, regardless of treatment. Incomplete repair of the bony troughs was observed bilaterally 
in 5 out of 8 rabbits (Figure 7g&h), demonstrating variability in inherent capacity for bone repair 
between animals. In half the treated shoulders (4 out of 8), bone remodeling was highly 
stimulated by CS-PRP treatment (Figure 7, compare panel c to d), which led to increases in 
bone surface (Figure 7j) and connectivity (Figure 7h). In addition, connectivity density and 
Euler number were also significantly increased by CS-PRP treatment, while there was no 
significant difference between the two groups for the other 3D bone morphometric parameters 
assessed (bone volume, trabecular thickness, trabecular separation, trabecular number, trabecular 
pattern factor, structural model index, fractal dimension and degree of anisotropy).  
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Figure 6-7. Micro-CT of intact (a) and surgically treated shoulder at 1 day (b), and test shoulders 
treated with transosseous suturing + CS-PRP (c to g) or suturing only (d to h) after 2 months. 
Incomplete repair of cortical bone at the lateral aspect of the humerus (c & d) and lateral bone 
formation (e & f) were present in all shoulders, regardless of treatment. Incomplete repair of the 
bone troughs was observed bilaterally in 5 rabbits (g & h). In half the treated shoulders, bone 
remodeling was highly stimulated by chitosan-PRP treatment (compare panel c to d), which led 
to increases in bone surface (j) and connectivity (k). Data in i, j & k are presented as mean 
(circle), median (line); Box: 25th and 75th percentile; Whisker: Box to the most extreme point 
within 1.5 interquartile range. * p < 0.05 compared to intact. # p < 0.05 compared to sutures 
group. & p < 0.1 compared to intact. 
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6.3.6 CS-PRP treatment was safe  
Clinical and macroscopic observations showed that the CS-PRP formulation did not 
induce any adverse event in any of the rabbits. No infection, contracture, mobility disability, or 
excessive inflammatory reaction was observed. Body weights were stable throughout the study, 
and the surgical sites healed well with no sign of significant effusion. Some humeral head and 
glenoid articular surfaces showed mild degenerative changes, such as GAG depletion (Figure 8f, 
j h & l), hypocellularity and fissures (Figure 8f & j), hypercellularity (Figure 8h) and thinning 
(Figure 8l), although average histological scores were not significantly different than those of 
intact tissues (Figure 8m). Surgical detachment and reattachment of the SSP tendon induced 
mild fatty infiltration of the SSP muscles compared to intact tissues (Figure 9). Finally, % 
leukocyte differential within the synovial fluid was similar for both groups, with and without CS-
PRP treatment at 2 months.  
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Figure 6-8. Safranin O/Fast Green-stained paraffin sections of intact shoulders (a to d), and test 
shoulders treated with transosseous suturing + CS-PRP (e to h) or suturing only (i to l) after 2 
months, showing best and worst OOCHAS scores for humeral head and glenoid articular surfaces 
(a to l). Some structural abnormalities such as GAG depletion, fissures, cell changes and thinning 
of the articular cartilage were occasionally observed in both humeral head (b, f & j) and glenoid 
(d, h & l) surfaces, although average histological scores were not significantly different from 
intact (m). Data in m are presented as mean (circle), median (line); Box: 25th and 75th percentile; 
Whisker: Box to the most extreme point within 1.5 interquartile range. 
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Figure 6-9. Safranin O/Fast Green-stained paraffin sections of SSP muscles from intact shoulders 
(a & b),  and test shoulders treated with transosseous suturing + CS-PRP (c & d) or suturing only 
(e & f) after 2 months, showing best and worst scores for fatty infiltration. Surgical treatment 
induced fatty infiltration of SSP muscle after 2 months (g). Data in g are presented as mean 
(circle), median (line); Box: 25th and 75th percentile; Whisker: Box to the most extreme point 
within 1.5 interquartile range. * p < 0.05 compared to intact.  
 
6.4 Discussion 
The aim of the current study was to histologically assess whether CS-PRP implants are 
capable of improving rotator cuff surgical repair. A transosseous repair model in the rabbit was 
chosen (Figure 1) since it has been well described in the literature 22-28. CS-PRP implants 
induced PMN recruitment at early time points post-surgery, supporting our first hypothesis. In 
contrast to the second hypothesis, implant degradation and associated inflammatory reactions 
were still ongoing in 3 out of 9 treated shoulders at 2 months. Results also supported our third 
hypothesis that CS-PRP would improve rotator cuff repair, since treatment improved SSP tendon 
attachment through increased bone remodeling.  
One of our objectives was to determine implant distribution and assess implant 
degradation over time. At 1 day post-surgery, CS-PRP implants were resident inside the bony 
trough and lateral tunnels and also adhered to tendon surfaces (Figure 2), the latter probably due 
to the mucoadhesive properties of chitosan 33. Similarly to CS-GP/blood implants 13, CS-PRP 
implants stimulated the innate immune response and induced recruitment of PMN cells (Figures 
2&3), which contributed to implant degradation. It is well known that chitosans with higher 
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degrees of deacetylation (DDA) and molar mass (Mn) will have lower degradation rates, but the 
site of implantation will also have a significant impact on implant degradation rate. We have 
previously shown that CS-PRP implants containing chitosan of similar DDA and Mn as that used 
in the current study were degraded after 3 weeks in sheep meniscus tears 19; 20, between 3 to 8 
weeks in rabbit cartilage lesions 21, but that they persisted for at least 6 weeks in a rabbit 
subcutaneous implantation model 17; 18. Unexpectedly, small areas of neutrophil-rich granulation 
tissue surrounding apoptotic/necrotic tissues were visible in 3 out of 9 CS-PRP treated shoulders 
at 2 months (Figure 4). This suggests that implant degradation was not complete in these 
animals, as residual apoptotic/necrotic granulation tissues were previously shown to correlate 
with resident chitosan oligomer particles in a rabbit cartilage repair model 34. Alternatively, it is 
also possible that PMNs could persist for some time after complete chitosan degradation. A 
leukocyte-rich PRP was used to prepare the implants in the current study, which would be 
expected to have an impact on the cytokine profile that is released upon activation. Previous in 
vitro studies have suggested that matrix metalloproteinases (MMP) and cytokines released from 
leukocyte-rich PRP could have deleterious effects on tendon healing 35; 36. However, MMPs are 
believed to be essential for tissue remodeling during rotator cuff tear repair in vivo 4; 37 and 
clinical data regarding using leukocyte-rich versus leukocyte-poor PRP for rotator cuff repair is 
still inconclusive.  
The suppression of SSP tendon heterotopic ossification (HO) by CS-PRP treatment was 
an unexpected finding in this study (Figure 4). HO is an abnormal formation of mature, lamellar 
bone in soft tissues where bone normally doesn’t exist 38. HO is a well known complication 
following surgical procedures or traumatic injuries 39; 40. Osteoinductive factors are released as a 
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consequence of soft tissue trauma thus inducing formation of heterotopic bone 41-43. The 
pathogenesis is unclear, but it may involve inappropriate differentiation of pluripotent 
mesenchymal stem cells (MSCs) into bone forming cells under growth factor influence 44. HO 
occurs through endochondral ossification 38, the first step of which is differentiation of MSCs 
into chondrocytes, an event we observed here in the control sutured shoulder at 7 days (Figure 
3), but not in the shoulder treated with CS-PRP. Interestingly, CS-GP/blood implants were also 
previously shown to modulate the timing and spatial development of chondrogenesis and 
endochondral ossification in a rabbit cartilage repair model 45. 
The bone surrounding the bony trough is a probable source of repair cells in this model, as 
are bursa or synovial-derived cells 22. The tendon stump appeared to contribute little to healing, 
and was integrated within the new repair tissue at 2 months in most cases (Figure 5). Improving 
tendon-bone healing is a common clinical challenge in rotator cuff repair. Development of bone-
tendon junction occurs through chondrogenesis and tenogenesis, followed by mineralization 46-50, 
while tendon-bone repair appears to depend upon bone ingrowth into fibrovascular interface 
tissue. Surgical reattachment of rotator cuff tendon with current repair techniques leads to a more 
abrupt interface and a disorganized scar tissue that is mechanically inferior to the native interface 
51; 52, and augmentation techniques still need to be developed to overcome this limitation. As 
reported previously 22, enthesis regeneration was not achieved in the transosseous repair model 
used here; however, partial restoration of the calcified interface was more common with CS-PRP 
treatment (Figures 5&6). Growth factors synthesized and secreted by cells involved in tissue 
repair, such as platelets, inflammatory cells, fibroblasts, epithelial cells, and vascular endothelial 
cells 53, all regulate tendon-bone repair, and it is likely that treatment with CS-PRP modulates 
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such signals. Gap formation is thought to be associated with impaired rotator cuff healing 54, 
preventing enthesis reformation 27. CS-PRP treatment promoted attachment of the SSP tendon, 
possibly through an increase in bone remodeling at the greater tuberosity (Figure 7). Previous 
cartilage repair studies in the rabbit also showed that both CS-GP/blood implants and CS-PRP 
implants promote bone remodeling and tissue integration 13; 14; 16; 21. The bony trough was 
incompletely healed in some rabbits, consistent with previously published data showing that 
complete recovery of the bony trough only occurs after 12 weeks post-surgery in this model 23. 
No treatment-specific adverse events occurred during the study, which suggests high 
safety. Surgical detachment and immediate reattachment of the SSP tendon was sufficient to 
cause fatty infiltration of the SSP muscle but did not induce degeneration of the humeral head 
and glenoid articular surfaces (Figures 8&9), while treatment with CS-PRP did not alter the cell 
distribution within the synovial fluid of the shoulder.  
This study had several limitations. No animal model fully reproduces human injury 
condition. The shoulder joints are weight-bearing in rabbits and acute tears do not represent 
human chronic tears. However, we chose this model since the rotator cuff in rabbits heals in a 
fashion that is similar to that of humans 55. Additionally, the rabbit model allowed us to collect 
enough blood to extract the required PRP volume to solubilize the freeze-dried chitosan. Another 
limitation is that the transosseous repair technique used here differs from suture anchors which 
are more commonly used in humans. However, use of suture anchors would be difficult due to 
the small size of the glenohumeral joint in rabbits. The inability to limit weight bearing and 
activity post-operatively may contribute to sutures pulling out of the rabbit tendon. We did not 
include a suturing+PRP group here as an additional control since it is well established in the 
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current literature that PRP alone does not improve rotator cuff repair. However, it will be 
imperative to conduct a comparative study with a control group receiving treatment with 
suturing+PRP alone in order to distinguish between the effects arising from chitosan and from 
PRP. Moreover, our small sample size at early time points does not allow us to elaborate on the 
mechanisms involved in the repair process. Finally, although a histological improvement in SSP 
tendon attachment would be expected to translate into superior attachment strength, no 
biomechanical testing was performed.  
 Rotator cuff repair remains a pressing clinical challenge. Despite our study’s limitations, 
our preliminary study showed that using CS-PRP implants in conjunction with transosseous 
suturing improves attachment of the SSP tendon to the humeral head compared to suturing alone. 
This study provides evidence that CS-PRP implants are safe and possibly effective in improving 
rotator cuff tear repair in a small animal model, and that this could potentially be translated to a 
clinical setting. Future work should involve a larger number of animals, a longer duration of 
follow-up, additional control groups, biomechanical testing, and assessment of efficacy in a 
larger animal model of rotator cuff repair.  
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ABSTRACT  
Abstract  
Rotator cuff tear is a very common shoulder pathology. Different suturing techniques 
have been used for surgical cuff repair, but failure of healing remains a significant clinical 
challenge. The objective of this study was to investigate the effect of using chitosan (CS)-
platelet-rich plasma (PRP) implants in conjunction with suture anchors in chronic and acute 
ovine rotator cuff tear models. In two subsequent pilot feasibility studies, unilateral full-thickness 
tears were created in the infraspinatus (ISP) tendon of mature female Texel-cross sheep. In the 
chronic model (n=4 sheep), the tendons were capped with silicon and allowed to retract for 6 
weeks, leading to degenerative changes, while the tendons were immediately repaired in the 
acute model (n=4 sheep). Transected ISP tendons were reattached with suture anchors and, in the 
case of treated shoulders, implants composed of freeze-dried CS solubilized in autologous PRP 
were additionally applied to the tendon-bone interface and on top of the repaired site. The chronic 
defect model induced significant tendon degeneration and retraction, which made repair more 
challenging than in the acute defect model. Half the tendons in the chronic repair model were 
found to be irrepairable at 6 weeks. In the other half, the tendons could not be reattached to the 
footprint due to significant retraction, which made this a model of tissue formation in a gap. In 
contrast, the acute tendon repair model was executed easily. Treatment with CS-PRP implants 
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induced recruitment of polymorphonuclear cells at 2 weeks post-operative and improved ISP 
tendon structural organization at 3 months. Treatment also increased bone remodeling and 
ingrowth at the tendon-bone interface at 3 months, suggesting that a more robust attachment 
could be achieved by combining CS-PRP implants with suture anchors. These very preliminary 
studies provide the first evidence that CS-PRP implants can improve rotator cuff repair in large 
animal models. 
7.1 INTRODUCTION 
Rotator cuff tears are a common cause of morbidity in adults and one of the most 
common shoulder pathologies 1-2. Cuff tears are associated with fatty infiltration, muscle atrophy, 
tendon retraction, and structural and architectural alterations of the musculotendinous unit 3-5. 
Ruptures of rotator cuff tendons may eventually lead to irreversible changes in the shoulder, 
causing chronic pain and severe functional disability. Persistent tendon defects with constant 
exposure of the intra-articular joint surface and fluid will occur if a rotator cuff tear is not 
repaired within a certain time-frame after injury 6. It is believed that there may be a “point of no 
return” in rotator cuff injury, with formation of scar tissue and infiltration of fat, after which the 
elasticity of the muscle-tendon unit can no longer return to normal 7.  
The goal of rotator cuff repair is to restore the footprint by suturing the tendon directly to 
the tuberosity using sutures anchors and varying suture configurations with the aim of increasing 
initial fixation strength, and mechanical stability under cyclic loading 8. These procedures are 
assumed to increase footprint contact area, and restore normal structure and function of the 
shoulder 9, while improving the rate of healing 10. However, patients often experience failed 
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healing or re-tears 11-12. Failure to heal occurs in 20 to 95% of cases at 2-years following surgical 
repair 11, 13, depending on surgical treatment used 14-15, time from injury 16, tendon quality 17, 
muscle quality 18, biological healing response 19, patient age, number of tendons involved, and 
tear size 20. One limitation of current surgical procedures is that regeneration of the structure and 
composition of the native enthesis is not achieved following surgical fixation, biological 
augmentation is one possible approach to overcome this limitation 21.  
Growth factors are known to be important in cell chemotaxis, proliferation, matrix 
synthesis and cell differentiation 22, and platelet-rich plasma (PRP) is a readily available source of 
autologous growth factors. PRP injections have been used clinically to treat rotator cuff tears, 
since it is believed that increased concentration of platelet-derived growth factors will stimulate 
revascularization of soft tissue and enhance tendon healing 20. However, current clinical evidence 
does not support the routine use of PRP injections to treat rotator cuff tears 23-27 and PRP 
injections are still very controversial in the orthopaedic field. Variability in the isolation protocols 
and resulting preparations and the poor stability of PRP in vivo are two possible reasons why 
results have been inconsistent to date.   
Chitosan (CS) is a biodegradable polymer that has been used for several tissue repair and 
regeneration applications. Our laboratory has implemented the use of PRP combined with freeze-
dried CS to form injectable implants that coagulates in situ 28. In vitro release of platelet-derived 
growth factors is increased and platelet-mediated clot retraction is inhibited by mixing PRP with 
chitosan 29. CS-PRP implants were shown to reside for at least 6 weeks subcutaneously in vivo 
and enhance cell recruitment to surrounding tissues compared to PRP alone 28-29. CS-PRP 
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implants were tested in ovine meniscus repair models where they increased cell recruitment, 
vascularization, remodeling and repair tissue integration compared to injection of PRP alone or 
wrapping the meniscus with a collagen membrane 30-31. Finally, CS-PRP implants improved 
marrow-stimulated cartilage repair and induced bone remodeling in a chronic rabbit defect model 
32. We hypothesized that all of the above would also be beneficial to rotator cuff repair, and we 
subsequently showed in a small rabbit model that CS-PRP implants improve transosseous rotator 
cuff repair, by favoring tendon attachment through increased bone remodeling 33. 
The two pilot feasibility studies presented here investigated whether CS-PRP implants 
can also improve rotator cuff repair in larger sheep models. The first study used a chronic repair 
model, where tendons were allowed to degenerate to a chronic stage prior to repair, while an 
acute model with immediate repair was used in the second study. In both repair models, the 
infraspinatus (ISP) tendons were surgically transected and repaired using suture anchors with or 
without additional application of CS-PRP implants and healing was assessed histologically. Our 
starting hypothesis was that CS-PRP implants would have positive effects on chronic and acute 
rotator cuff repair through increased cell recruitment, vascularization and bone remodeling 
 
7.2 MATERIALS AND METHODS 
7.2.1 Preparation of freeze-dried chitosan formulations 
Chitosan (degree of deacetylation 80.2%, number average molar mass Mn 36,000 g/mol, 
weight average molar mass Mw 65,000 g/mol, polydispersity index 1.8) was used to prepare 
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formulations containing 1% (w/v) chitosan, 28 mM HCl, 1% (w/v) trehalose as a lyoprotecting 
agent (Life Science) and 42.2 mM CaCl2 as a PRP activator (Sigma-Aldrich). Formulations were 
filter-sterilized and distributed in 1 mL aliquots into sterile, de-pyrogenized 3cc glass vials for 
lyophilization using the following steps: 1) ramped freezing to -40oC in 1 hour, isothermal 2 
hours at -40oC, 2) -40oC for 48 hours, 3) ramped heating to 30oC in 12 hours, isothermal 6 hours 
at 30oC, at 100 millitorrs. 
7.2.2 Preparation of platelet-rich plasma (PRP) 
Blood was drawn from the sheep jugular vein immediately prior to surgery. One small 
tube of blood was drawn for complete blood count and platelet analysis. Then, two 9ml tubes of 
blood were collected per sheep and anti-coagulated with 1 mL 3.8% (w/v) sodium citrate each 
(final citrate concentration 12.9 mM). Blood was centrifuged for 10 min at 1300 rpm and then for 
10 min at 2000 rpm using the ACE EZ-PRP centrifuge to extract ~ 3 mL PRP per sheep. The 
isolated leukocyte-rich PRP contained an average of 409 X 10E9/L platelets (2X that of whole 
blood), 6.2 X 10E9/L leukocytes (1X that of whole blood) and 2.4 X 10E12/L erythrocytes (0.2X 
that of whole blood). 
 
7.2.3 Experimental study design and surgical technique 
The protocol for this study was approved by the University of Montreal committee 
“Comité de déontologie de l’expérimentation sur les animaux” (initial date of approval March 
10th 2016) and was consistent with the Canadian Council on Animal Care guidelines for the care 
and use of laboratory animals. Eight adult Texel-cross female sheep (age ranging from 2-6 years; 
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weight ranging from 55-70kg) were divided into a chronic repair model group (Table 1) and an 
acute repair model group (Table 2). In both groups, the surgical method included unilateral 
exposure of the infraspinatus tendons (ISP) through a muscle separating approach to the lateral 
aspect of the shoulder using general anesthesia and aseptic technique. The ISP tendon was 
transected from its original footprint on the humerus, creating a full-thickness rotator cuff tear. 
The humeral head was debrided with a surgical scalpel removing any tendinous tissue still 
attached. In both the chronic and acute repair models, the surface of the tuberosity was roughened 
with use of a curette and the tendon surface slightly abraded prior to anchor insertion. 
In the chronic repair model (n = 4 sheep; Table 1 & Figure 1), the tendons were capped 
with a 5-cm silicon tube (3/4” wide Penrose drain) to prevent spontaneous re-attachment and to 
allow the tear to degenerate to a chronic stage for 6 weeks. The capped tendons were engulfed in 
scar tissue after 6 weeks, at the time of the second surgery. After freeing the tendons from scar 
tissue and removing the silicon tubes, we found that the muscle-tendon unit had significantly 
retracted, leaving a gap of several centimeters between the end of the tendon and the tuberosity. 
In two sheep, the ISP tendons were torn as soon as they were pulled to close the gap to the 
tuberosity, and were found to be irrepairable. Therefore, in those 2 sheep, a defect was created in 
the contralateral shoulders, but this time the ISP tendon was capped with a shorter 5-mm silicon 
tube and allowed to degenerate to a chronic stage for 2 weeks, without any further attempt to 
repair. In the third sheep, the 6-week chronic defect was repaired with suture anchors and sutured 
in a suture bridge configuration using four 4.65 mm PEEK Swivelock anchors and 2 mm 
FiberTape sutures (Arthrex, Product No AR2324-PSLC and AR-7237). In the fourth sheep, the 6-
week chronic defect was repaired with one suture anchor with the ISP tendon sutured using a 
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Masson-Allen configuration and the CS-PRP implant was additionally applied in a 2-part 
manner. Freeze-dried chitosan (1mL cake) was solubilized with 1 mL autologous PRP and 0.5 
mL CS-PRP injected at the footprint prior to anchor insertion and then 0.5 mL CS-PRP was 
injected on top and under the tendon after reattachment. In both of the above repairable cases, the 
tendons were too retracted to be reattached at the footprint, hence a gap remained between the 
tendon and tuberosity after repair, making this a model of tissue formation in a gap. In the 2 
sheep where the degenerated tendons were re-attached, the contralateral shoulders were left 
intact. The animals were allowed to walk ad libitum postoperatively and necropsy was 2 weeks 
after second surgery (n=4 sheep). 
Table 7-1. Design of the chronic repair study. 
Sheep # 
Treatment 
Right shoulder 
Treatment 
Left shoulder 
Necropsy 
1 
ISP tendon initially left intact. 
6 weeks later, tendon transected 
and capped with 5 mm silicon  
ISP tendon transected and 
capped with 5 cm silicon 
6 weeks later, tendon was found 
to be irrepairable  
6 week 
chronicity 
+ 2 weeks  
2 
ISP tendon initially left intact. 
6 weeks later, tendon transected 
and capped with 5 mm silicon  
ISP tendon transected and 
capped with 5 cm silicon 
6 weeks later, tendon was found 
to be irrepairable  
6 week 
chronicity 
+ 2 weeks  
3 
ISP tendon transected and capped 
with 5 cm silicon. 
6 weeks later, tendon repaired 
with 4 suture anchors 
Intact control  
6 week 
chronicity 
+ 2 weeks  
4 
ISP tendon transected and capped 
with 5 cm silicon. 
Intact control  
6 week 
chronicity 
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6 weeks later, tendon repaired 
with 1 suture anchor + CS-PRP 
+ 2 weeks  
 
In the acute repair model (n = 4 sheep; Table 2 & Figure 2), the tendons were transected 
and immediately repaired with suture anchors and sutured in a suture bridge configuration using 
four 4.65 mm PEEK Swivelock anchors and 2 mm FiberTape sutures (Arthrex, Product No 
AR2324-PSLC and AR-7237). In 2 out of 4 sheep, CS-PRP implants were additionally applied in 
a 2-part manner. The first proximal row of anchors was securely inserted and the sutures were 
passed through the ISP tendon. Freeze-dried chitosan (1mL cake) was solubilized with 1 mL 
autologous PRP and 0.5 mL CS-PRP was injected at the footprint. The sutures were tightened 
and the second (distal) row of anchors was inserted. Then, 0.5 mL CS-PRP was injected on top of 
the repaired site and under the tendon. The animals were allowed to walk ad libitum 
postoperatively and necropsy was 6 weeks (n=2 sheep) and 3 months (n=2 sheep) after repair.  
 
Table 7-2. Design of the acute repair study. 
Sheep # 
Treatment 
Right shoulder 
Treatment 
Left shoulder 
Necropsy 
1 Tendon transected and 
immediately repaired with 4 
suture anchors 
Intact control 6 weeks 
2 Intact control Tendon transected and 
immediately repaired with 4 
3 months 
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suture anchors 
3 Tendon transected and 
immediately repaired with 4 
suture anchors + CS-PRP 
Intact control 6 weeks 
4 Intact control Tendon transected and 
immediately repaired with 4 
suture anchors + CS-PRP 
3 months 
 
7.2.4 Specimen collection and histological processing 
Animals were euthanized by sedation followed by captive bolt pistol. The shoulders were 
dissected and the humeral head-ISP-tendon unit complex was harvested en bloc from just 
proximal to the musculotendinous junction. Glenoid surfaces, muscle biopsies and synovial 
membrane biopsies were collected. All samples were fixed for several days in 10% neutral 
buffered formalin and trimmed for further processing. The ISP insertion sites, humeral head and 
glenoid surfaces were decalcified with HCl with trace glutaraldehyde. All samples were 
dehydrated in graded ethanol series, cleared with xylene and embedded in paraffin. Sections 
(5µm thickness) were stained with Safranin O/Fast Green or Hematoxylin and Eosin, scanned 
with a Nanozoomer RS (Hamamatsu) and images exported using NDP View software 
(Hamamatsu) for qualitative histological assessment. In addition, polarized microscopy images of 
the ISP tendons were obtained with an Axiolab (Zeiss) microscope equipped with a CCD camera 
(Hitachi HV-F22 Progressive Scan Colour 3-CCD). 
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7.3 RESULTS 
7.3.1 The chronic repair model was more challenging than the acute repair 
model   
After 6 weeks of chronic degeneration, ISP tendons capped with 5-cm silicon tubes 
became macroscopically abnormal throughout and were red, spongy (Figure 1d), 
biomechanically weak, and easily torn. Two of the four tendons were irrepairable. Significant 
retraction had occurred to the extent that the tendons could not be reattached at the anatomic 
footprint. In the two cases where the tendons were found to be irrepairable, a decision was made 
to operate on the contralateral shoulders, cap the ISP tendons with smaller 5-mm silicon tubes 
and allow the tears to degenerate to a chronic stage for 2 weeks. Significant retraction and 
structural abnormalities of the ISP tendon under the capped end were apparent after 2 weeks 
(Figure 1f), although changes were less severe than in the 6-week chronic model. In both the 6-
week capped and the 2-week capped unrepaired defects, abundant scar tissue surrounded the 
capped ISP tendons and bridged the gap to the tuberosity, which suggests that a robust repair 
response occurs in this model, even in the presence of a silicon barrier. In contrast to the chronic 
model, the acute tear model was easily executed and the transected ISP tendons could be 
reattached at the footprint (Figure 2). 
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Figure 7-1. Chronic tear model and repair with CS-PRP. Full-thickness rotator cuff tears were 
created in the infraspinatus (ISP) tendon of the shoulder close to the enthesis (a, b) and capped 
with 5 cm length of silicone (c) in 4 sheep. At 6 weeks after surgery, the tendons were 
macroscopically abnormal (d) and 2 tendons were found to be irrepairable. One tendon was 
repaired with 4 suture anchors in the suture bridge configuration. One tendon was repaired with 
one suture anchor + CS-PRP. The sutures were pre-placed in a Mason-Allen pattern and a first 
injection of 0.5 mL CS-PRP was applied at the debrided bone interface (e). The anchor was 
inserted to tighten the sutures and an additional 0.5 mL CS-PRP implant was applied on top of 
tendon at the repaired site and also under the tendon. Macroscopic appearance of an ISP tendon 
capped for 2 weeks with 5 mm length of silicone (f). 
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Figure 7-2. Acute tear model and repair with CS-PRP. Full-thickness rotator cuff tears were 
created in the infraspinatus (ISP) tendon of the shoulder close to the enthesis in 4 sheep (a, b). All 
tendons were immediately repaired with 4 suture anchors in a suture bridge configuration. In 2 
out of 4 sheep, repair was augmented with CS-PRP. The first row of anchors were inserted and 
the sutures were passed (c) and a first injection of 0.5 mL CS-PRP was applied at the debrided 
bone interface (d). The second row of anchors were inserted to tighten the sutures (e) and an 
additional 0.5 mL CS-PRP was applied on top of tendon at the repaired site and also under the 
tendon (f). 
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7.3.2 CS-PRP implants induced recruitment of polymorphonuclear cells to 
the ISP tendon at 2 weeks and improved ISP tendon structural 
organization at 3 months 
As expected, intact ISP tendons consisted of fibrocartilaginous tissue organized in 
bundles with sparse cells and a small amount of glycosaminoglycans (GAG) (Figure 3a-c & 
Figure 4a-d). Histologically, none of the test tendons were structurally similar to intact (Figures 
3 & 4). Acellular areas were observed in ISP tendons of the chronic defect model, for both the 2-
week capped and the 6-week capped, (Figure 3), but not in tendons of the acute model (Figure 
4). The 6-week chronic defect repaired with anchors + CS-PRP at 2 weeks had a portion of 
tendon repair tissue that was rich in polymorphonuclear cells (Figure 3o). In the acute model of 
tendon repair without augmentation, there was evidence of chondrogenesis within the tendon 
body at 6 weeks (Figure 4f) and abundant GAG expression at 3 months (Figure 4m), while this 
was not observed in the case of repair augmented with CS-PRP (Figures 4 i & q). Repaired 
tendons consisted mainly of disorganized, hypercellular and vascularized tissues (Figures 3 & 4). 
The one exception was in the case of repair augmented with CS-PRP at 3 months in the acute 
model, which was mostly organized in bundles and had a portion of repair tissue that was 
structurally similar to normal tendon (Figure 4q-t). Polarized light microscopy images better 
highlight the tendon structural organization, confirming the beneficial effect of tendon repair 
augmented with CS-PRP in the acute model at 3 months (Figure 4t). 
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Figure 7-3. Safranin O/Fast Green stained paraffin sections of the ISP tendons in the chronic 
repair model. Intact control tendons were organized in bundles, as expected (a to c). Bundle 
organization was still apparent in areas of untreated tendons at chronic stage, while other areas 
were disorganized, hypercellular and vascularized  or hypocellular (d to i). The tendon of the 
shoulder treated for 2 weeks with suture anchors was mostly disorganized, hypercellular and 
vascularized , with a small hypocellular area (j to l). The tendon of the shoulder treated with 
suture anchors + CS-PRP was mostly disorganized, hypercellular and vascularized , with a small 
area organized in bundles and another area rich in polymorphonuclear cells (m to o) 
 
 Figure 7-4. Safranin O/Fast Green-stained paraffin sections and polarized light microscopy (d, h, 
l, p & t) images of the ISP tendons in the acute repair model. Intact control tendons were 
organized in bundles, as expected (a to d). At 6 weeks post-surgery, the tendons were mostly 
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composed of a disorganized and vascular fibrous repair tissue in both groups (e to l). 
Chondrogenesis and GAG expression were apparent in the anchors only group at 6 weeks (e&f). 
At 3 months post-surgery, the tendon in the anchors only group contained aligned tissue, 
expressed high levels of GAG, and had a small area organized in bundles (m to p). In contrast, 
the tendon in the anchors + CS-PRP group was mostly organized in bundles with a smaller area 
of tendon-like repair tissue (m to t). 
 
7.3.3 CS-PRP implants increased bone remodeling at the ISP tendon-bone 
junction  
Histologically, none of the repaired insertions had reformed the structure of the native 
enthesis. In the normal enthesis, the different zones were easily identified and no scar tissue was 
present above the bone front (Figure 5a-c & Figure 6a-c). The tidemark was still recognizable in 
the 2-week capped chronic defects (Figure 5d), but not in any other group (Figures 5 & 6). In all 
cases, even in untreated chronic defects (Figure 5 d & g), scar tissue was growing superior to the 
enthesis and integration of the scar tissue with the underlying bone was achieved through bone 
remodeling and ingrowth at the junction of the scar tissue with the original bone front (Figures 5 
& 6). Augmentation with CS-PRP increased bone remodeling at the tendon-bone junction in both 
the chronic repair model (Figure 5m-o) and the acute repair model (Figure 6m-o). 
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Figure 7-5. Safranin O/Fast Green stained paraffin sections of the ISP tendon entheses in the 
chronic repair model. Intact controls had normal entheses consisting of 1) unmineralized 
fibrocartilage, 2) tidemark, 3) mineralized fibrocartilage and 4) bone, as expected (a to c). The 
tidemark was still recognizable 2 weeks after defect creation (d), but not at longer time points or 
after repair (g, j & m). Scar tissue was growing above the entheses in the untreated chronic 
defects (d&g), suggesting that some spontaneous repair can occur even without any treatment in 
this model. Integration of the scar tissue with the underlying bone was achieved through bone 
remodeling and ingrowth into the scar tissue (f, i, l & o). Treatment with anchors + CS-PRP 
increased the area of remodeling bone (compare o to l). 
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Figure 7-6. Safranin O/Fast Green stained paraffin sections of the ISP tendon entheses in the 
acute repair model. Intact controls had normal entheses consisting of 1) unmineralized 
fibrocartilage, 2) tidemark, 3) mineralized fibrocartilage and 4) bone, as expected (a to c). Scar 
tissue was growing superior to the entheses from 6 weeks (d to i) to 3 months (j to o) post-
surgery. Integration of the scar tissue with the underlying bone was achieved through bone 
remodeling and ingrowth into the scar tissue (d to o). This was more apparent in the anchors + 
CS-PRP group (compare g&m to d&j). The site of anchor insertion was apparent in some 
sections (* in panel j). 
 
7.3.4 CS-PRP implants did not induce any treatment-specific deleterious 
effects in the shoulder joint 
In both the chronic and acute repair models, the humeral head was macroscopically free 
of defects, while small synovial fossae, defined as nonarticulating depressions, were apparent at 
the center of almost all of the glenoid surfaces. Almost all humeral heads, including intact 
controls, showed signs of GAG depletion (Figure 7a, c, e, g & i). Several glenoids, including 
intact controls, exhibited GAG depletion as well as other structural abnormalities including, 
hypercellularity, cell cloning and fissures (Figure 7k-m). Muscle histology showed increased 
fatty infiltration in chronic defects as early as 2 weeks after defect creation, which was not 
reversed by repair (Figure 8 b & c). Similarly, fatty infiltration was also induced by surgical 
detachment and immediate reattachment in the acute repair model (Figure 8 d & e). Histology of 
the synovial membranes showed that different forms of normal synovium can be found in sheep 
shoulders including the adipose form of synovium and the fibrous form of synovium (Figure 9). 
There was mild synovitis and increased cell infiltration in the chronic model treated with anchors 
+ CS-PRP for 2 weeks (Figure 9c), but not in any other sample 
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Figure 7-7. Safranin O/Fast Green stained sections of humeral head and glenoid articular surfaces 
from intact controls (a&b), from the chronic defect model (c to f) and from the acute defect 
model (g to j). The humeral articular surfaces were all structurally normal but showed signs of 
GAG depletion (a, c, e, g & i). Mild structural abnormalities were observed at the center of some 
glenoid articular surfaces, including GAG depletion, hypercellularity, cell cloning and fissures (k 
to m).  These were apparent in all treatment groups as well as the intact controls. 
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Figure 7-8. Hematoxylin and Eosin (a, d & e) and Safranin O/Fast Green (b & c) stained paraffin 
sections of muscle biopsies from intact control (a), from the chronic defect model (b & c) and 
from the acute defect model (d & f). Fatty infiltration was not prevented by any treatment 
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Figure 7-9. Hematoxylin and Eosin (a, d & e) and Safranin O/Fast Green (b & c) stained paraffin 
sections of synovial biopsies from intact control (a), from the chronic defect model (b & c) and 
from the acute defect model (d & f). There was mild synovitis and increased cell infiltration in 
the chronic model treated with anchors + CS-PRP for 2 weeks (c). 
 
7.4 DISCUSSION 
The purpose of the current study was to determine whether CS-PRP implants can improve 
rotator cuff repair in chronic and acute repair models in the sheep. Large animal models, like 
sheep, have infraspinatus tendons that are similar in size to the human supraspinatus 34, making 
them amenable to using repair techniques commonly employed in humans 6, 35. Although these 
are very preliminary pilot studies, our starting hypothesis was supported in that treatment 
augmented with CS-PRP implants led to improved tendon structural appearance, increased bone 
remodeling and ingrowth at the tendon-bone junction. 
One important finding reported here, were the difficulties we faced during 
implementation of the chronic repair model. We found that capping the ISP tendons for 6 weeks 
with 5-cm e tubes likely prevented proper nutrient diffusion and led to cell death and severe 
tendon degeneration, which rendered some tendons irrepairable. Although degeneration was not 
as marked when the tendons were capped for 2 weeks with 5-mm silicone length, reattachment at 
the footprint would have been difficult to achieve since the tendon-muscle unit had significantly 
retracted. Therefore, this chronic model would constitute a model of tissue formation in a gap, 
and not a “true” tendon repair model. Capping with silicone has been used by other research 
groups studying chronic rotator cuff repair in sheep, but the surgery usually involves osteotomy, 
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leaving a small bone chip attached to the ISP tendon, with the silicone covering the bone chip and 
not the tendon itself 15, 36. Other groups have used a Preclude™ sheet to wrap the ISP tendon and 
allow the tears to develop to chronic stage 37-38. Preclude is a dura substitute composed of Gore-
Tex, with pores of <1μm in size, which would still allow nutrient diffusion to the tendons, and 
most likely would have been a better choice than silicone in the current study. We found that 
abundant scar tissues bridged the gap between the capped tendon and the tuberosity after 2 weeks 
and 6 weeks, which supports the notion that the healing response is robust and spontaneous in 
sheep even in these well-established chronic models 15, 36. As of now, we consider the acute repair 
model to be more consistent and easily reproducible. 
Even though this study presented some challenges, some interesting findings are worth 
further discussion. Polymorphonuclear (PMN) cells were observed in the tendon repair tissue of 
the shoulder treated with CS-PRP augmentation for 2 weeks, which is not unexpected at this time 
point, since CS-PRP implants were previously shown to induce PMN recruitment for at least 2 
weeks in a rabbit transosseous rotator cuff repair model 33. PMN were no longer visible at 6 
weeks, which suggests that CS-PRP implants were fully degraded by then, which is consistent 
with previous sheep studies using similar doses of the CS-PRP implants, albeit in the knee joint 
for meniscus repair 30-31. Similarly to what was previously seen in the transosseous rotator cuff 
repair model in the rabbit, the tendon treated with repair alone (non-augmented) showed 
chondrogenesis and GAG expression within the tendon body at 6 weeks, while the tendon repair 
augmented with CS-PRP did not. The significance of chondrogenesis occurring within the tendon 
repair tissue is still unclear, but we hypothesize that this may be the first step in heterotopic 
ossification, a well known complication of tendon injury, which we previously found was 
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inhibited by treatment with CS-PRP implants in the transosseous rabbit model 33. GAG 
deposition is also frequently observed in cases of tendonosis 39-40. The anchors + CS-PRP repair 
technique resulted in better tendon structural outcome than anchors only at 3 months only, with 
no apparent improvement at 6 weeks, possibly through a modulation of timing of the healing 
sequence or through increased repair tissue remodeling. 
During development, tendon-bone integration occurs through establishment of an 
embryonic tendon-bone attachment unit, which matures into the fibrocartilaginous insertion, 
known as the enthesis 41-42. Maturation of the enthesis appears to follow pathways similar to the 
growth plate development 41. The insertion site matures through mineralization of fibrocartilage 
matrix under the influence of chondrocyte-like cells, with associated remodeling through 
osteoclasts and osteoblasts, creating the interface between tendon and the tuberosity 41. Following 
repair however, the tendon-bone insertion site usually heals through a fibrovascular scar tissue 
formation, lacking any sort of reestablishment of the four zones of the native enthesis 43. Rotator 
cuff healing occurs in overlapping phases similar to those observed in the case of wound healing, 
namely the inflammatory phase, the matrix production phase and the remodeling phase 44. In the 
chronic and acute models used here, the integration of the tendon repair tissue occurred through 
bone remodeling and ingrowth at the junction between the tendon and the underlying bone, and 
the native structure of the enthesis was not re-established. Bone remodeling appears to be a 
mechanism that enables the repair to become mechanically stronger. It has previously been 
suggested that strong healing between tendon and the tuberosity, with reformation of a new 
enthesis, requires bone ingrowth into scar tissue and outer tendon 45. Other authors have 
suggested that the formation of a callus appears to be essential for remodeling the tendon-bone 
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boundary after injury 46. In that respect, it is significant that bone remodeling was greater in the 
case of the insertion sites treated with anchors + CS-PRP compared to suture anchors only, 
although it is impossible to draw solid conclusions on the basis of such a small number of 
samples. Of note, CS-PRP implants have previously been shown to increase bone remodeling 
over standard treatment in the context of rotator cuff and cartilage repair in small rabbit models, 
leading to better integration of repair tissues 32-33.  
There were no treatment-specific deleterious effects in the shoulder joint, suggesting that 
CS-PRP implants have high safety. Structural abnormalities were visible in most glenoids, 
suggesting that greater stresses are applied on that surface compared to the humeral head in the 
sheep model. Fatty infiltration of the ISP muscle was induced in both chronic and acute models, 
and no treatment could reverse that effect. A longer follow-up time may be required to see 
treatment-specific protective effects. Mild transient synovitis was present in the shoulder treated 
with CS-PRP at 2 weeks, and this was resolved at the later 6 weeks and 3-month time points, 
once the biomaterial was degraded. 
There were several limitations to this study. The main limitation is the small number of 
animals used, although we feel that these numbers were reasonable for pilot feasibility studies. 
Obviously, a larger number of animals would be required to draw firm conclusions, and the 
results reported here should be viewed with caution. Moreover, different repair techniques were 
used for the chronic group, making it harder to compare treatments. Furthermore, although the 
sheep is a commonly used model of rotator cuff repair, it is not identical to human. In contrast to 
humans, the sheep infraspinatus tendon is not intraarticular, although a bursa exists underneath 
the tendon. The sheep forelimb is also weight-bearing, has no clavicle, a less-developed 
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acromion, and no coracoacromial arch 47. Most importantly, robust scar tissue formation occurs 
between tendon stump and the bone in the sheep, not analogous to humans, where gaping is a 
common recurrent problem. Inability to control post-operative weight-bearing is another 
limitation. Finally, assessment was purely qualitative and, although improved histological 
appearance would be expected to translate into superior performance, no other type of 
measurement was performed 
 
 
7.5 CONCLUSIONS 
In summary, developing techniques to augment of rotator cuff repair remains clinically 
relevant. The technical challenges associated with the chronic repair model in the sheep make the 
acute model preferable for future studies. Despite their limitations, these two very preliminary 
pilot studies provide the first evidence that CS-PRP implants improve the healing response in 
large animal models of rotator cuff repair, partly through increased bone remodeling at the tendon 
repair tissue and underlying bone interface. Future work will involve a larger number of animals 
and a longer duration of follow-up, with the long-term objective of translating this technology to 
the clinic. 
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CHAPTER 8 GENERAL DISCUSSION  
Rotator cuff injuries are extremely common and often require surgical repair to restore the 
tendon to its original footprint. Chronic rotator cuff tears are associated with structural changes 
such as fatty accumulation, loss of muscle volume, retraction, which all result in muscle 
remodeling, subtraction of sarcomeres and profound muscle weakness (Williams and Rockwood 
1996). Finding the right animal model is challenging but critically important to improve our 
understanding of the cellular and molecular pathways involved in rotator cuff pathology. 
However, it is important to mention that none of the animals have anatomy comparable to 
humans. Open versus mini-open or arthroscopy does not seem to have a significant impact on 
clinical outcomes. The latest generation techniques involve the use of different configuration of 
sutures, which seem to increase the rate of tendon healing but this has not been translated into 
improved clinical and functional outcomes. ECM patches have shown some promising findings 
in some animal studies, but not in randomized clinical trials. Scaffolds and cells are becoming 
more popular in tissue engineering as structural supports and as cellular delivery aid but further 
clinical studies are still needed. Growth factors have been shown to improve healing but there is 
still no study on rotator cuff repair using growth factors in humans. One strategy would require 
using the ideal combination of growth factors and scaffold together to complement each other. 
PRP use in orthopedics is still controversial and under investigation for now, with limited data on 
its effectiveness. Present research on the use of growth factors, BMPs, gene therapy, stem-cell 
augmentation for tendon healing, and rotator cuff tear repair, is underway (Isaac, Gharaibeh et al. 
2012, Jo, Shin et al. 2013). None of these strategies are perfectly suited for rotator cuff tear 
repair. In summary, several repair strategies are available but further clinical trials are needed to 
find the optimal treatment for rotator cuff repair. PRP growth factors are important in tissue 
repair, regeneneration and signalling molecules in biological environment (Lee, Silva et al. 
2011), by increasing  endothelial, epithelial, epidermal regeneration, collagen, soft tissue healing, 
hemostatic reponse to injury, and decreases dermal scarring (Mohammadi, Mehrtash et al. 2016). 
Unfortunately, these released platelets diffuse very quickly and don’t last long, hence decreasing 
their efficacy (Busilacchi, Gigante et al. 2013). On the other hand, chitosan can stimulate platelet 
activation in PRP (Zucker and Nachmias 1985, Kroll, Hellums et al. 1996, Li, Delaney et al. 
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2010, Brown, Narayanan et al. 2013) (Hattori and Ishihara 2016) and therefore increase PRP 
treatment efficacy (Oktay, Demiralp et al. 2010, Busilacchi, Gigante et al. 2013, Kutlu, Aydin et 
al. 2013). This was expected to have positive effects on rotator cuff tear repair. 
Based on our data, CS-PRP implants coat various clot components and inhibited clot 
retraction and platelet aggregation in vitro. In cell suspension, CS was shown to induce platelet 
activation and granule secretion. This platelet activation was then translated to a greater sustained 
release of PDGF-AB and EGF in CS-PRP hybrids. Moreover, our in vivo data showed that CS-
PRP reside for at least 6 weeks subcutaneously in rabbits and induce cell recruitment compared to 
PRP treatement alone. Under static or low shear stress conditions, platelet aggregation is mainly 
mediated by the interactions of GPIIb/IIIa on platelet surface with fibrinogen (Jackson 2007). 
Stimulation of platelets with agonists induces cytoskeletal rearrangement, shape change, protein 
synthesis, granule secretion and increases the affinity of the GPIIb-IIIa platelet receptor for 
fibrinogen. Platelet aggregation results from binding of multiple platelets to the same fibrinogen 
molecule (Jurk and Kehrel 2005). Clot retraction, mediated by the platelet actin and myosin 
contractile system then follows, as long as platelet stimulation, comprising shape change and 
primary aggregation, are maintained (Cohen, Gerrard et al. 1982, Cohen 1985). In the absence or 
non-functioning GPIIb/IIIa, clot retraction does not occur. Our Confocal, SEM and TEM images 
data provided support that chitosan physically coats platelets and other components of the blood 
clot to inhibit platelet aggregation, which is needed for clot retraction. In CS-PRP hybrids, 
chitosan physically interferes with the ability of platelets to adhere to each other as well as the 
fibrin network and exert mechanical forces. 
In addition, chitosan (DDA > 90% and 50 kDa) was previously shown to be a platelet agonist 
and stimulate platelet activation and GPIIb/IIIa expression in vitro (Chahla, Dean et al. 2016). In 
another study, stimulation of platelet suspensions with chitosan (DDA 84%) induced p-selectin 
and GPIIb/IIIa expression, in a process that was shown to be modulated by plasma and 
extracellular matrix proteins (Lord, Cheng et al. 2011). Consistent with these previously 
published data, we found that chitosan induces platelet activation and granule secretion in cell 
suspensions, even more so than ADP, a known platelet agonist. Interestingly, incubation of cell 
suspension with trehalose along with chitosan slightly decreased expression of Pac-1 and p 
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selectin compared to incubation with chitosan alone. This is consistent with published reports that 
lyoprotectants impede haemostatic mechanisms (Bakaltcheva and Reid 2003, Luostarinen, Niiya 
et al. 2011).  
In the case of physical adsorption of growth factors to chitosan, release is believed to be 
controlled by electrostatic interactions that exist between growth factors and chitosan (Yao, Li et 
al. 2012). The isoelectric point of PDGF is 9.8 (Antoniades, Scher et al. 1979) and, under 
physiological conditions, we expected ionic repulsion between positively charged PDGF-AB and 
cationic chitosan to result in burst release. Meanwhile, EGF, which has an isoelectric point of 4.6 
(Taylor, Mitchell et al. 1972) would be expected to bind to chitosan under physiological 
conditions and be released in a more sustained manner. In contrast to this, we found that CS-PRP 
hybrid clots sustained and increased release of both PDGF-AB and EGF for 1 week in vitro, 
which suggests that additional factors are controlling their release in this system. 
One important observation was that cumulative levels of PDGF-AB and EGF released in the 
culture medium were higher in the case of CS-PRP clots compared to PRP clots. These results 
were not completely unexpected. Kutlu et al (Kutlu, Aydin et al. 2013) previously prepared CS-
PRP scaffolds by either adding PRP to a chitosan gel before freeze-drying or by delivering PRP 
to a lyophilized chitosan sponge. Sustained release of PDGF-BB was achieved in the first group, 
similarly to what we observed here, while a sharp burst release was observed in the second group. 
Interestingly, both of their CS-PRP scaffolds secreted higher cumulative levels of PDGF-BB 
when compared to unactivated PRP or PRP activated with collagen type-I, similarly to what was 
found here for PDGF-AB. Hattori et al (Hattori and Ishihara 2016) showed that platelets in whole 
blood are activated when mixed with solutions of chitosan with different DDA and Mw. Of 
particular relevance to our study, the amount of PDGF-AB released was the highest when 
chitosans of DDA 75-85% and Mw 50-190 kDa were used in conjunction with calcium chloride 
than when calcium chloride was used by itself. Shen et al (Shen, Chou et al. 2006) showed that 
stimulation with chitosan of DDA > 90% and 450 kDa induced release of PDGF-AB and EGF 
from PRP for up to 60 minutes. Shimojo et al (Shimojo, Perez et al. 2015) prepared lyophilized 
scaffolds containing different concentrations of chitosan (DDA 83% and Mw 400 kDa), loaded 
the scaffolds with PRP activated with autologous serum and calcium chloride and showed that 
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PDGF-AB cumulative release was higher from the scaffolds compared to activated PRP alone, 
provided that the scaffolds be lyophilized at low temperatures. In a subsequent study, Shimojo et 
al (Shimojo, Perez et al. 2016) showed that stabilizing the chitosan scaffolds by treating them 
with NaOH prior to loading them with PRP was another way to increase cumulative PDGF-AB 
release from scaffolds lyophilized at -20oC. 
With regard to growth factor release, it is important to consider the contribution of each cell 
type present in the PRP preparation. Platelets are the main contributors to growth factor release 
from PRP and positive correlations were previously found between platelet doses and the amount 
of released growth factors including PDGF-AB, TGF-1, VEGF and EGF (Weibrich, Kleis et al. 
2012, Magalon, Bausset et al. 2014). While it appears that the inclusion of leukocytes in PRP 
increases the content of some pro-inflammatory cytokines (Sundman, Cole et al. 2011, Anitua, 
Zalduendo et al. 2014, Cavallo, Filardo et al. 2014, Pochini, Antonioli et al. 2016), the effect of 
leukocytes on growth factor content and release is still not fully understood. Previous studies 
found that leukocyte-rich PRP contained higher concentrations of growth factors compared to 
leukocyte-poor PRP, but that may be due to the fact that systems that include the buffy coat layer 
are usually more efficient at capturing platelets (Leitner, Gruber et al. 2006, Castillo, Pouliot et 
al. 2011, Cavallo, Filardo et al. 2014, Masuki, Okudera et al. 2016, Parrish, Roides et al. 2016, 
Fitzpatrick, Bulsara et al. 2017). However, positive correlations and close associations were also 
found between PRP leukocyte counts and levels of PDGF-AB, VEGF and EGF (Weibrich, Kleis 
et al. 2012, Magalon, Bausset et al. 2014), which suggests that leukocytes contribute to the 
release of growth factors from PRP. Here, we found increased cumulative PDGF-AB and EGF 
release from CS-PRP clots compared to PRP clots. One possible reason for this is that chitosan 
used in conjunction with calcium chloride stimulates platelet activation and granule secretion 
more than calcium chloride by itself. Another possibility would be that leukocytes, especially 
monocytes, present in CS-PRP hybrids are secreting higher amounts of growth factors than in 
PRP without chitosan. While it has been reported that M0 and polarized M2a macrophages 
secrete PDGF-BB (Spiller, Anfang et al. 2014, Spiller, Nassiri et al. 2015), and that 
biodegradable chitosan particles (DDA 81.5% and Mn 132 kDa) enhance release of PDGF-BB 
from M0 and M2a macrophages (Fong, Ariganello et al. 2015), we believe that the main 
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contributors to growth factor release in the CS-PRP hybrid system are platelets and not 
monocytes, for the following reasons: 1) Monocytes typically require specific stimulatory signals 
to become macrophages, 2) There is a low number of monocytes present in each CS-PRP clot, 
compared to the number of platelets (on average ~ 2500X more platelets than monocytes); 3) In 
light of previous reports on the amount of growth factors released by M0 and M2a macrophages, 
it seems unlikely that such a limited number of monocytes could secrete the amount of PDGF-
AB and EGF that was measured here in the culture medium. 
In a subcutaneous implantation model in the mouse, porous chitosan scaffolds were found to 
elicit neutrophil migration into the implantation area along with angiogenic activity, as was 
shown here as well (VandeVord, Matthew et al. 2002). It is of interest to mention that the site of 
implantation along with implant volume influences biodegradability. We have previously shown 
that CS-PRP implants are degraded within 3 weeks in meniscus tears in the sheep (Ghazi zadeh, 
Chevrier et al. 2017), and between 2-8 weeks in rotator cuff tears (Deprés-Tremblay, Chevrier et 
al. 2017) and cartilage lesions in the rabbit (Dwivedi, Chevrier et al. 2017) compared to more 
than 6 weeks in the current study.  
In conclusion, Chitosan physically coats platelets, blood cells and fibrin strands in CS-PRP 
hybrid clots, thus inhibiting platelet aggregation, which is required for clot retraction. Platelets 
are activated, granules secreted and higher levels of PDGF-AB and EGF are released from CS-
PRP hydrid clots compared to PRP clots in vitro. Finally, CS-PRP implants reside for at least 6 
weeks post-implantation subcutaneously and induce cell recruitment and granulation tissue 
synthesis, confirming a longer residency and higher bioactivity compared to PRP in vivo.  
CS-PRP hybrids were then tested in a rabbit transosseous surgical repair model, which 
demonstrated an adherence to SSP tendon and a residence within the bony trough and lateral 
tunnels for at least a day. In addition, CS-PRP implants induced bone remodeling at the greater 
tuberosity and a better SSP attachment. One important finding in our rabbit model was the 
inhibition that CS-PRP had on heterotopic bone formation within soft tissue, which seemed to act 
like a protective or inhibiting agent. CS-PRP implants in a transosseous repair model in rabbit 
induced PMN recruitment at early time points post-surgery. Implant degradation and associated 
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inflammatory reactions were still ongoing in 3 out of 9 treated shoulders at 2 months. Results 
showed that CS-PRP would improve rotator cuff repair, since treatment improved SSP tendon 
attachment through increased bone remodeling. At 1 day post-surgery, CS-PRP implants were 
resident inside the bony trough and lateral tunnels and also adhered to tendon surfaces, probably 
due to the mucoadhesive properties of chitosan (Benjamin, Kumai et al. 2002). Similarly to CS-
GP/blood implants (Chevrier, Hoemann et al. 2007), CS-PRP implants stimulated the innate 
immune response and induced recruitment of PMN cells, which contributed to implant 
degradation. It is well known that chitosans with higher degrees of deacetylation (DDA) and 
molar mass (Mn) will have lower degradation rates, but the site of implantation will also have a 
significant impact on the implants’ degradation rate. Unexpectedly, small areas of neutrophil-rich 
granulation tissue surrounding apoptotic/necrotic tissues were visible in 3 CS-PRP treated 
shoulders at 2 months, which suggests that implant degradation was not complete in these 
animals, as residual apoptotic/necrotic granulation tissues were previously shown to correlate 
with resident chitosan oligomer particles in a rabbit cartilage repair model (Lafantaisie-Favreau, 
Guzman-Morales et al. 2013). A leukocyte-rich PRP was used to prepare the implants in the 
current study, which would be expected to have an impact on the cytokine cocktail that is 
released upon activation. Previous in vitro studies have suggested that matrix metalloproteinases 
(MMP) and cytokines released from leukocyte-rich PRP could have deleterious effects on tendon 
healing (McCarrel and Fortier 2009, Pandey and Jaap Willems 2015). However, MMPs are 
believed to be essential for tissue remodeling during rotator cuff tear repair in vivo (Fabis, 
Kordek et al. 1998, Gulotta and Rodeo 2009) and clinical data regarding using leukocyte-rich 
versus leukocyte-poor PRP for rotator cuff repair is still inconclusive.  
The suppression of SSP tendon heterotopic ossification (HO) by CS-PRP treatment was 
an unexpected finding in this study. HO is an abnormal formation of mature, lamellar bone in soft 
tissues where bone normally doesn’t exist (Barile, Bruno et al. 2017). HO is a well-known 
complication following surgical procedures or traumatic injuries (Stein, Patel et al. 2003, 
Apostolakos, Durant et al. 2014). Osteoinductive factors are released as a consequence of soft 
tissue trauma thus inducing formation of heterotopic bone (VandeVord, Matthew et al. 2002, 
Fotiadou, Vlychou et al. 2008, Deprés-Tremblay, Chevrier et al. 2017). The pathogenesis is 
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unclear, but it may involve inappropriate differentiation of pluripotent mesenchymal stem cells 
(MSCs) into bone forming cells under growth factor influence (Naqvi, Jadaan et al. 2009). HO 
occurs through endochondral ossification (Barile, Bruno et al. 2017), the first step of which is 
differentiation of MSCs into chondrocytes, an event we observed here in the shoulder treated 
with suturing only at 7 days, but not in the shoulder treated with CS-PRP. Interestingly, CS-
GP/blood implants were also previously shown to modulate the timing and spatial development 
of endochondral ossification in a rabbit cartilage repair model (Chevrier, Hoemann et al. 2011), 
although the mechanisms by which this occurs still remain unclear. 
The bone surrounding the bony trough is a probable source of repair cells in this model, as 
are bursa or synovial-derived cells (Uhthoff, Sano et al. 2000). The tendon stump appeared to 
contribute little to healing, and was integrated within the new repair tissue at 2 months. 
Improving tendon-bone healing is a common clinical challenge in rotator cuff repair (Lee, Lee et 
al. 2016). Development of bone-tendon junction occurs through endochondral ossification (Lin, 
Cardenas et al. 2004, Hamada, Katoh et al. 2006, Rees, Wilson et al. 2006), while tendon-bone 
repair appears to depend upon bone ingrowth into fibrovascular interface tissue. Surgical 
reattachment of rotator cuff tear with current repair techniques leads to a more abrupt interface 
and a disorganized scar tissue that is mechanically a lot weaker than a native interface 
(Thomopoulos, Hattersley et al. 2002, Tutwiler, Litvinov et al. 2016), and augmentation 
techniques still need to be developed to overcome this limitation. As reported previously 
(Uhthoff, Sano et al. 2000), enthesis regeneration was not achieved in the transosseous repair 
model used here, however, partial restoration of the calcified interface was more common with 
CS-PRP treatment. Growth factors synthesized and secreted by cells involved in tissue repair, 
such as platelets, inflammatory cells, fibroblasts, epithelial cells, and vascular endothelial cells 
(Kobayashi, Itoi et al. 2006), all regulate tendon-bone repair, and it is likely that treatment with 
CS-PRP modulates such signals. Gap formation is thought to be associated with impaired rotator 
cuff healing (Gwinner, Gerhardt et al. 2016), preventing enthesis reformation (Trudel, 
Ramachandran et al. 2012a). CS-PRP treatment promoted attachment of the SSP tendon, possibly 
through an increase in bone remodeling at the greater tuberosity. Previous cartilage repair studies 
in the rabbit also showed that both CS-GP/blood implants and CS-PRP implants promote bone 
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remodeling and tissue integration (Chevrier, Hoemann et al. 2007, Hoemann, Sun et al. 2007, 
Chen, Sun et al. 2011, Dwivedi, Chevrier et al. 2016). The bony trough was incompletely healed 
in some rabbits, consistent with previously published data showing that complete recovery of the 
bony trough only occurs after 12 weeks post-surgery in this model (Uhthoff, Seki et al. 2002). 
No treatment-specific adverse events occurred during the study, which suggests high 
safety. Surgical detachment and immediate reattachment of the SSP tendon was sufficient to 
cause fatty infiltration of the SSP muscle but did not induce degeneration of the humeral head 
and glenoid articular surfaces. CS-PRP implants in conjunction with transosseous suturing 
improved the attachment of the SSP tendon to the humeral head over suturing alone. These 
results provide evidence that CS-PRP implants are safe and effective in improving rotator cuff 
tear repair in a small animal model, and that this could potentially be translated to a clinical 
setting.  
Subsequently, CS-PRP hybrids were tested in a sheep rotator cuff tear model. Our datad 
showed that CS-PRP induced PMNs recruitment at 3 weeks and a better ISP tendon structural 
organization at 3 months. We also found that bone remodeling was significantly increased in CS-
PRP treated shoulders. Moreover, no treatment-specific deleterious effects were seen. Large 
animal models, like sheep, have infraspinatus tendons that are similar in size to the human 
supraspinatus (Edelstein, Thomas et al. 2011), making them suitable for using repair techniques 
commonly employed in humans (Derwin, Baker et al. 2007, Schlegel, Hawkins et al. 2007), as 
was done here in this study with suture anchors. One important finding reported here, are the 
difficulties we faced during implementation of the chronic repair model. We found that capping 
the ISP tendons for 6 weeks with 5-cm e tubes likely prevented proper nutrient diffusion and led 
to cell death and severe tendon degeneration, which rendered some tendons unrepairable. 
Although degeneration was not as marked when the tendons were capped for 2 weeks with 5-mm 
silicone length, reattachment at the footprint would have been difficult to achieve since the 
tendon-muscle unit had significantly retracted. Capping with silicone has been used by other 
research groups studying chronic rotator cuff repair in sheep, but the surgery usually involves 
osteotomy, leaving a small bone chip attached to the ISP tendon, with the silicone covering the 
bone chip and not the tendon itself (Gerber, Meyer et al. 2004, Meyer, Hoppeler et al. 2004). 
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Other groups have used a Preclude sheet to wrap the ISP tendon and allow the tears to develop to 
a chronic stage (Coleman, Fealy et al. 2003, Uggen, Dines et al. 2010). Preclude is a dura 
substitute composed of Gore-Tex, with pores of <1μm in size, which would still allow nutrient 
diffusion to the tendons, and most likely would have been a better choice than silicone in the 
current study. We found that abundant scar tissues were bridging the gap between the capped 
tendon and the tuberosity after 2 and 6 weeks, which supports the notion that the healing 
response is robust and spontaneous in sheep even in these chronic models (Gerber, Meyer et al. 
2004, Meyer, Hoppeler et al. 2004). As of now, we consider the acute repair model to be more 
consistent and easily reproducible. 
Polymorphonuclear (PMN) cells were observed in the tendon repair tissue of the shoulder 
treated with anchors + CS-PRP for 2 weeks, which is not unexpected at this time point, since CS-
PRP implants were previously shown to induce PMN recruitment for at least 2 weeks in a rabbit 
transosseous rotator cuff repair model (Wrana, Attisano et al. 1994). PMN recruitment was 
abrogated by 6 weeks, which suggests that CS-PRP implants were fully degraded by then, which 
is consistent with previous sheep studies using similar doses of the CS-PRP implants, albeit in the 
knee joint for meniscus repair (Laiho, Weis et al. 1990, Chevrier, Deprés-Tremblay et al. 2016). 
Similarly to what was previously seen in the transosseous rotator cuff repair model in the rabbit, 
the tendon treated with anchors only showed chondrogenesis and GAG expression within the 
tendon body at 6 weeks, while the tendon treated with anchors + CS-PRP did not. The 
significance of chondrogenesis occurring within the tendon repair tissue is still unclear, but we 
hypothesized that this may be the first step in heterotopic ossification, a well known complication 
of tendon injury, which we previously found was inhibited by treatment with CS-PRP implants in 
the transosseous rabbit model. Unexpectedly, the anchors + CS-PRP repair technique resulted in 
better tendon structural outcome than anchors only at 3 months, possibly through a modulation of 
timing of the healing sequence or through increased repair tissue remodeling. 
During development, tendon-bone integration occurs through establishment of an 
embryonic tendon-bone attachment unit, which matures into the fibrocartilaginous insertion, 
known as the enthesis (Thomopoulos, Genin et al. 2010, Zelzer, Blitz et al. 2014). Maturation of 
the enthesis appears to follow pathways similar to the growth plate development (Thomopoulos, 
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Genin et al. 2010). The insertion site matures through mineralization of chondrocyte-like cells, 
with associated remodeling through osteoclasts and osteoblasts, creating the interface between 
tendon and tuberosity (Thomopoulos, Genin et al. 2010). Following repair however, tendon-bone 
insertion usually heals through a fibrovascular scar tissue formation, lacking any sort of 
reestablishment of the four zones of the native enthesis (Apostolakos, Durant et al. 2014). Rotator 
cuff healing occurs in overlapping phases similar to those observed in the case of wound healing, 
namely the inflammatory phase, the matrix production phase and the remodeling phase (Galatz 
2013). In the chronic and acute models used here, the integration of the tendon repair tissue 
occurred through bone remodeling and ingrowth at the junction between the tendon and the 
underlying bone, and the native structure of the enthesis was not re-established. Bone remodeling 
appears to be a mechanism that enables the repair to become mechanically stronger. It has 
previously been suggested that strong healing between tendon and the tuberosity, with 
reformation of a new enthesis, necessitates bone ingrowth into scar tissue and outer tendon 
(Sanchez Marquez, Martínez Díez et al. 2011). Other authors have suggested that the formation 
of a callus appears to be essential for remodeling the tendon-bone boundary after injury 
(Newsham-West, Nicholson et al. 2007). In that respect, it is significant that bone remodeling and 
GAG expression were greater in the case of the insertion sites treated with anchors + CS-PRP 
compared to suture anchors only, although it is impossible to draw solid conclusions on the basis 
of such a small number of samples. Of note, CS-PRP implants have previously been shown to 
increase bone remodeling over standard treatment in the context of rotator cuff and cartilage 
repair in small rabbit models, leading to better integration of repair tissues (Wrana, Attisano et al. 
1994, Angeline and Rodeo 2012).  
There were no treatment-specific deleterious effects in the shoulder joint, suggesting that 
CS-PRP implants have high safety. Structural abnormalities were visible in most glenoids, 
suggesting that greater stresses are applied on that surface compared to the humeral head in the 
sheep model. Fatty infiltration of the ISP muscle was induced in both chronic and acute models, 
and no treatment could reverse that effect. Mild transient synovitis was present in the shoulder 
treated with CS-PRP at 2 weeks, and this was resolved at the later 6 weeks and 3 months time 
points, once the biomaterial was degraded. 
210 
 
 
 
In summary, developing techniques to augment of rotator cuff repair remains clinically 
relevant. The technical challenges associated with the chronic repair model in sheep make the 
acute model more preferable for future studies. These studies provide the first evidence that CS-
PRP implants improve the healing response in animal models of rotator cuff repair, partly 
through increased bone remodeling at the tendon repair tissue and underlying bone interface. 
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CHAPTER 9 CONCLUSION AND RECOMMENDATIONS 
Surgical reattachment of rotator cuff tears with current repair techniques leads to a more 
disorganized scar tissue that is mechanically a lot weaker than a native interface, increasing the 
risk for failure. Over a third of the surgeries result in unsuccessful outcomes such as persistent 
pain and disabilities, regardless of repair technique used. Several new repair strategies are 
available but further clinical trials are needed to find the optimal treatment for rotator cuff repair. 
The best rotator cuff tear surgical treatment is currently a topic of debate, since current repair 
strategies do not regenerate the native enthesis. A biological strategy improving patient’s 
intrinsic healing potential is hence needed. The thesis presented here was carried out with an 
objective to improve current surgical procedures in rotator cuff tear repair by injection of 
chitosan-PRP implants. These implants were tested in rabbit and sheep models of rotator cuff 
repair. Furthermore, cellular and molecular mechanisms of action of chitosan-PRP implants were 
elucidated, focusing on clot retraction mechanisms, platelet activation and growth factor 
secretion, the induction of cellular recruitment, vascularization, and biodegradability of the 
implants.  
Our data provided support that chitosan physically coats platelets and other components of 
the blood clot to inhibit platelet aggregation, needed for clot retraction. Chitosan physically 
interferes with the ability of platelets to adhere to each other as well as the fibrin network and 
exert mechanical forces. Chitosan also induced platelet activation and granule secretion in cell 
suspensions, even more so than ADP, a known platelet agonist. Interestingly, incubation of cell 
suspension with trehalose along with chitosan slightly decreased expression of Pac-1 and p 
selectin compared to incubation with chitosan alone. One important observation was that 
cumulative levels of PDGF-AB and EGF released in the culture medium were higher in the case 
of CS-PRP clots compared to PRP clots. Platelets are activated, granules secreted and higher 
levels of PDGF-AB and EGF are released from CS-PRP hydrid clots compared to PRP clots in 
vitro. Finally, CS-PRP implant was still visible after 6 weeks post-implantation subcutaneously 
and induced cell recruitment and granulation tissue synthesis, confirming a longer residency and 
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higher bioactivity compared to PRP in vivo. It is of interest to mention that the site of 
implantation along with implant volume influences biodegradability.
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CS-PRP implants induced PMN recruitment at early time points post-surgery in a 
transosseous repair model of the SSP tendon in the rabbit. At 1 day post-surgery, CS-PRP 
implants were resident inside the bony trough, the lateral tunnels and also adhered  to the tendon 
surfaces, probably due to the mucoadhesive properties of chitosan. Small areas of neutrophil-rich 
granulation tissue surrounding apoptotic/necrotic tissues were visible in few shoulders at 2 
months, suggesting that implant degradation was not complete in these animals. CS-PRP 
treatment suppressed SSP tendon heterotopic ossification; an event we observed in the shoulder 
treated with suturing only, but not in the shoulder treated with CS-PRP. Although the bony 
trough was incompletely healed in some rabbits, CS-PRP treatment promoted attachment of the 
SSP tendon, possibly through an increase in bone remodeling at the greater tuberosity. Surgical 
detachment and immediate reattachment of the SSP tendon was sufficient to cause fatty 
infiltration of the SSP muscle. CS-PRP implants in conjunction with transosseous suturing 
improved attachment of the SSP tendon to the humeral head compared to suturing alone. These 
results provide evidence that CS-PRP implants are safe and effective in improving rotator cuff 
tear repair in a small animal model, and that this could potentially be translated to a clinical 
setting.  
One important finding reported here, are the difficulties we faced during implementation 
of the chronic sheep repair model. We found that capping the ISP tendons for 6 weeks with 5-cm 
silicone tubes likely prevented proper nutrient diffusion and led to cell death and severe tendon 
degeneration, which rendered some tendons unrepairable. Although degeneration was not as 
marked when the tendons were capped for 2 weeks with 5-mm silicone length, reattachment at 
the original footprint would have been difficult to achieve since the tendon-muscle unit had 
significantly retracted. Abundant scar tissues were bridging the gap between the capped tendon 
and the tuberosity after 2 and 6 weeks, supporting the notion that the healing response is robust 
and spontaneous in sheep even in chronic models. As of now, we consider the acute repair model 
to be more consistent and easily reproducible. 
Polymorphonuclear (PMN) cells were observed in the tendon repair tissue of the shoulder 
treated with anchors + CS-PRP for 2 weeks, but abrogated by 6 weeks, which suggests that CS-
PRP implants were fully degraded by then. The tendon treated with anchors only showed 
chondrogenesis and GAG expression within the tendon body at 6 weeks, while the tendon treated 
with anchors + CS-PRP did not. The anchors + CS-PRP repair technique resulted in better tendon 
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structural outcome than anchors only at 3 months, possibly through a modulation of timing of the 
healing sequence or through increased repair tissue remodeling. Bone remodeling was greater in 
the case of the insertion sites treated with anchors + CS-PRP compared to suture anchors only, 
although it is impossible to draw solid conclusions on the basis of such a small number of 
samples. Structural abnormalities were visible in most glenoids, suggesting that greater stresses 
are applied on that surface compared to the humeral head in the sheep model. Fatty infiltration of 
the ISP muscle was induced in both chronic and acute models, and no treatment could reverse 
that effect. Mild transient synovitis was present in the shoulder treated with CS-PRP at 2 weeks, 
and this was resolved at the later 6 weeks and 3 months time points, once the biomaterial was 
degraded. 
In summary, there were no treatment-specific deleterious effects in the shoulder joint, 
suggesting that CS-PRP implants have high safety and developing techniques to augment of 
rotator cuff repair remains clinically relevant. The technical challenges associated with the 
chronic repair model in sheep make the acute model more preferable for future studies. These 
studies provide the first evidence that CS-PRP implants improve the healing response in large 
animal models of rotator cuff repair, partly through increased bone remodeling at the tendon 
repair tissue and underlying bone interface.  
 
Although beyond the scope of this research, following recommendations are worth considering 
for the future: 
1. Mechanical testing of the SSP repair tendon. Mechanical strength, such as load-to-failure 
and tensile strength are important parameters in determining the quality of repair tissue 
and should be used in future studies.  
 
2. Additional time points for the repair model. We chose different time points according to 
our understanding from the current existing literature. Although our time points were 
relevant, additional time points must be studied in order to evaluate the long-term repair 
outcome, as well as the mechanisms of action of the implants. A long term study will 
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likely improve the quality and volume of the repair tissue, as well as a better enthesis 
reformation, since enthesis reformation takes a long time. 
 
3. PRP alone group. The study presented in this research compared the effect of treatments 
augmented with CS-PRP compared to sutures or suture anchors alone. A group 
augmented with PRP was unfortunately absent. We did not use PRP augmentation as a 
treatment since it is well established in the current literature that PRP does not improve 
rotator cuff tear repair. However, it will be imperative to conduct a study with a control 
group receiving treatment with PRP augmentation, in order to distinguish between the 
effects arising from chitosan and from PRP.  
 
4. A different chronic model in a large animal. CS-PRP augmentation must be retested in a 
large chronic animal model in order to evaluate the role of CS-PRP on chronic tears with 
fatty infiltration and tendon and muscle retraction. However, the use of a different chronic 
model is required; transecting the tendons then capping the tendon ends with Gore-Tex or 
Preclude sheets in order to avoid spontaneous reattachment while still diffusing nutrients 
apprears to be more appropriate than capping with a silicone tube.  
 
5. Additional animals for larger animal models. More animals must be tested with CS-PRP 
in a larger animal model, to evaluate fully its effect on rotator cuff tears. Stastistical 
analysis requires a larger number of animals to obtain robust results.  
 
To summarize our studies, augmentation of rotator cuff repair by CS-PRP implants induced 
superior healing in small and large rotator cuff tear repair models. Histological assessment 
showed improvements in CS-PRP treated shoulders, as indicated by better structural outcome, 
which seemed to be a result of a modulation of timing of the healing sequence, as well as better 
macroscopic and microscopic attachment scores. CS-PRP implants increased bone remodeling at 
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the enthesis, compared to sutures or suture anchors only, which contributed to improving tendon 
attachment. CS-PRP implants were also able to protect against heterotopic bone formation in soft 
tissue far from the enthesis zone. Finally, our results also provided evidence that CS-PRP 
implants are safe. Hence, due to their increased bioactivity, CS-PRP hybrid implants show a 
significant potential to be used to augment rotator cuff tear repair. We believe that we have made 
a significant contribution to the orthopaedic field of rotator cuff tear repair, by improving current 
standard-of-care surgical repair techniques, and that this technology could potentially be 
translated to a clinical setting in the future.  
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APPENDIX A – CLINICAL STUDIES COMPARING ARTHROSCOPIC VERSUS OPEN ROTATOR 
CUFF REPAIR 
Table 9-1 Clinical studies comparing arthroscopic versus open rotator cuff repair.  
Study Design Inclusion 
criteria 
Surgical 
approach 1  
Surgical 
approach 2 
Sample size 
(% males) 
Mean 
age 
(years) 
FU rate (%) Mean FU 
times 
(months) 
Outcome 
measures 
Definition of 
retear 
Results 
Severud et 
al 2002 
Level III 
Retrospective 
 
Surgically 
proven full-
thickness 
rotator cuff 
tears 
Bone anchors 
were the primary 
method of fixation 
in the all-
arthroscopic 
group, averaging 
1.5 a case 
 
The majority 
of fixations 
were through 
bone tunnels 
in the mini-
open group 
64 (60.9) 35 
shoulders in 
the all-
arthroscopic 
group 29 in 
the mini-
open group 
60.8 100 44.6 
 
UCLA score 
ASES score 
RofM 
NA Clinical 
scores 
improved in 
both groups 
No effect of 
surgical 
approach on 
clinical 
scores 
Significantly 
better range 
of motion for 
all-
arthroscopic 
group at 6 
weeks and 
12 weeks but 
not at final 
FU 
Kim et al 
2003 
Level III 
Retrospective 
 
Patients with 
medium and 
large rotator 
cuff tears 
All-arthroscopic 
repair 
Mini-open 
salvage of 
technically 
unsuccessful 
arthroscopic 
repair 
76 (62.8) 42 
patients in 
the all-
arthroscopic 
group 34 in 
the mini-
open group 
56.5 100 39 UCLA score 
ASES score 
VAS scale for 
shoulder 
function 
VAS scale for 
NA Clinical 
scores 
improved in 
both groups 
No effect of 
surgical 
approach on 
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 pain clinical 
scores 
Lower 
shoulder 
scores and 
less 
predictable 
recovery of 
strength and 
function for 
patients with 
large tears 
Sauerbrey 
et al 2005 
Level III 
Retrospective 
 
Patients who 
had undergone 
mini-open and 
all arthroscopic 
rotator cuff 
repairs 
The edge of the 
rotator cuff was 
secured to the 
tuberosity using 
anchors with 
nonabsorbable 
simple Sutures in 
the all 
arthroscopic 
group 
The rotator 
cuff was 
secured to the 
tuberosity 
using sutures 
through bone 
in all cases in 
the mini-open 
group 
54 (59.3) 28 
patients in 
the all-
arthroscopic 
group 26 in 
the mini-
open group 
56.5 100 Mini-open, 
33 
Arthroscopy, 
19 
Modified 
ASES score 
VAS scale for 
pain 
 
NA Clinical 
scores 
improved in 
both groups 
No effect 
surgical 
approach on 
clinical 
scores 
 
 
Warner et 
al 2005 
Level III 
Retrospective 
 
Patients with 
full-thickness 
rotator cuff 
tears  
Absorbable suture 
anchor loaded 
with absorbable 
suture in the all 
arthroscopic 
group 
Transosseous 
tendon repair 
in the mini-
open group 
21 (61.9) 
9 patients in 
the all-
arthroscopic 
group 12 in 
the mini-
open group 
54 100 50 SST score 
Pain score 
Flexion 
External 
rotation 
Strength 
 
NA Clinical 
scores 
improved in 
both groups 
No effect of 
surgical 
approach on 
clinical 
scores 
All 
arthroscopic 
group 
showed a 
significant 
improvement 
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in strength 
Youm et al 
2005 
Level III 
Retrospective 
 
Surgically 
confirmed and 
repaired rotator 
cuff tear by 
either an all-
arthroscopic 
repair or mini-
open repair 
with at least 2 
years of 
follow-up 
The tendon was 
secured to the 
tuberosity with 
suture anchors in 
the all 
arthroscopic 
group 
Margin 
convergence 
sutures were 
used in 
combination 
with suture 
anchors in the 
mini-open 
group If the 
hold of the 
anchor was 
determined to 
be inadequate, 
bone tunnels 
were used 
instead 
84 (NR) 42 
patients in 
the all 
arthroscopic 
group 42 in 
the mini-
open group 
59 100 36.3 UCLA score 
ASES score 
 
NA Good or 
excellent 
clinical 
scores for 
both groups 
post-surgery 
No effect of 
surgical 
approach on 
clinical 
scores 
 
Ide et al 
2005 
Level III 
Retrospective 
 
Patients who 
had undergone 
mini-open and 
all arthroscopic 
rotator cuff 
repairs 
Repair with suture 
anchors and 
nonabsorbable 
sutures in the all 
arthroscopic 
group 
The majority 
of fixations 
were 
performed 
using the 
suture anchor 
technique in 
the mini-open 
group The 
conventional 
bone tunnel 
technique was 
used in 3 
patients  
100 (80) 50 
patients in 
the all-
arthroscopic 
group 50 in 
the mini-
open group 
57 100 49 UCLA score 
JOA score 
NA Clinical 
scores 
improved in 
both groups 
No effect of 
surgical 
approach on 
clinical 
scores 
Scores in 
patients with 
a large-to-
massive tear 
were 
significantly 
lower than 
those with a 
small-to-
medium tear 
Bishop et 
al 2006 
Level III 
Prospective 
Patients treated 
with open, 
mini-open and 
all arthroscopic 
The tendon was 
repaired to the 
prepared greater 
tuberosity with 
The rotator 
cuff was 
repaired to the 
prepared 
72 (43.1) 40 
patients in 
the all-
arthroscopic 
64 100  12 ASES score 
Constant score 
Forward 
Any tendon 
filled with 
fluid on MRI 
images was 
Clinical 
scores 
improved in 
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 rotator cuff 
repairs 
suture anchors in 
the all 
arthroscopic 
group 
greater 
tuberosity 
with sutures 
placed in a 
modified 
Mason-Allen 
fashion and 
passed 
through bone 
tunnels, 
reinforced 
with CuffLink 
Bone Tunnel 
Devices in the 
mini-open or 
open group 
group 32 in 
the mini-
open (n=8) 
or open 
(n=24) 
group 
elevation 
External 
rotation 
Short Form 36 
VAS scale for 
pain 
considered a 
retear 
both groups 
Significantly 
greater 
strength of 
elevation 
and external 
rotation in 
all 
arthroscopic 
group More 
retears for 
tears greater 
than 3 cm in 
all 
arthroscopic 
group 
Verma et 
al 2006 
Level III 
Retrospective 
 
Patients that 
had undergone 
arthroscopic or 
mini-open 
rotator cuff 
repair, with a 
minimum of 2 
years’ follow 
up 
No consistent data 
on anchor 
configuration 
(single or double 
row) or on suture 
configuration 
(simple, mattress, 
etc.) could be 
obtained for the 
all arthroscopic 
group 
Tendon repair 
was then 
carried out 
with the use of 
anchors, bone 
tunnels, or a 
combination 
of both in the 
mini-open 
group 
71 (63.3 ) 
38 patients 
in the all-
arthroscopic 
group 33 in 
the mini-
open group 
60 100 38.9 ASES score 
SST score 
L’Insalata 
Scoring 
Survey 
VAS scale for 
pain 
Strength 
Ultrasound 
Failure of 
repair was 
defined as any 
full-thickness 
rotator cuff 
defect on 
ultrasound 
images 
Clinical 
scores 
improved in 
both groups 
No effect 
surgical 
approach on 
clinical 
scores or 
failure rate 
 
Liem et al 
2007 
Level III 
Retrospective 
 
An isolated 
supraspinatus 
tear confirmed 
by clinical 
examination 
and magnetic 
resonance 
imaging (MRI) 
that resulted in 
persistent pain 
and reduced 
function of the 
patient’s 
A single row of 1 
to 3 bioabsorbable 
suture anchors 
armed with 2 pairs 
of nonabsorbable 
No. 2 sutures that 
were placed along 
the lateral part of 
the footprint. 
According to the 
shape of the 
tendon, additional 
side-to-side 
The 
supraspinatus 
was repaired 
by use of 1 to 
3 
bioabsorbable 
suture anchors 
armed with 2 
pairs of 
nonabsorbable 
No. 2 sutures  
Side-to-side 
FiberWire 
38 (88.9) 19 
patients in 
the all-
arthroscopic 
group 19 in 
the mini-
open group 
62 100 Mini-open, 
17.6 
Arthroscopy, 
25 
Constant score 
Early RofM at 
6 weeks and 3 
months 
MRI 
 
Cuff integrity 
was evaluated 
with 
established 
criteria 
(Owens et al 
1993) 
Clinical 
scores 
improved in 
both groups 
No effect 
surgical 
approach on 
clinical 
scores or 
failure rate 
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arm sutures were used 
The tendon was 
then repaired via a 
Mason-Allen 
technique 
modified for the 
arthroscopic 
technique 
sutures were 
used if 
necessary 
The tendon 
was sutured to 
the bone via 
the modified 
Mason-Allen 
technique with 
the 
combination 
of a U-shaped 
mattress 
suture and 
single suture 
on top of the 
mattress 
suture 
Kose et al 
2008 
Level III 
Retrospective 
 
Patient had 
required rotator 
cuff repair and 
that the tear 
was also 
confirmed 
intraoperatively 
Suture anchors 
were used for 
fixation and repair 
of the rotator cuff 
in the all 
arthroscopic 
group 
Tendon 
repairs were 
performed 
using sutures 
passed 
through bone 
tunnels in the 
mini-open 
group 
50 (22) 25 
patients in 
the all-
arthroscopic 
group  
25 in the 
mini-open 
group 
59 100 Mini-open, 
31.2 
Arthroscopy, 
21.6 
Constant-
Murley  score 
UCLA score 
RofM 
External 
rotation 
Forward 
flexion 
 
NA Clinical 
scores 
improved in 
both groups 
No effect 
surgical 
approach on 
clinical 
scores 
Colegate-
Stone et al 
2009 
Level III 
Prospective 
 
Patients who 
had undergone 
mini-open and 
all arthroscopic 
rotator cuff 
repairs 
Bioabsorbable 
Bio-corkscrew 
anchors with a 
single row repair 
technique in the 
all arthroscopic 
group 
Bioabsorbable 
Bio-corkscrew 
anchors with a 
single row 
repair 
technique in 
the mini-open 
group 
123 (48.8) 
92 patients 
in the all-
arthroscopic 
group  
31 in the 
mini-open 
group 
60 100 Longest  24 DASH 
OSS 
Constant-
Murley  score 
 
NA Clinical 
scores 
improved in 
both groups 
No effect 
surgical 
approach on 
clinical 
scores 
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Shinoda et 
al 2009 
Level II 
Randomized 
controlled 
trial 
Patients who 
had undergone 
mini-open and 
all arthroscopic 
rotator cuff 
repairs 
The rotator cuff 
was secured to the 
footprint using 2 
or 4 Fastin RC 
suture anchors in 
the all 
arthroscopic 
group 
The rotator 
cuff was 
secured to the 
footprint using 
2 or 4 Fastin 
RC suture 
anchors in the 
mini-open 
group 
32 (71.9) 17 
patients in 
the all-
arthroscopic 
group  
15 in the 
mini-open 
group 
64 100 Median 34 Serum levels 
C-reactive 
protein 
Hemoglobin 
IL-6 
UCLA score 
JOA score 
 
NA Clinical 
scores 
improved in 
both groups 
No effect 
surgical 
approach on 
clinical 
scores 
Increased 
IL-6 at 24h 
in the mini-
open group 
Kasten et 
al 2011 
Level III 
Prospective 
randomized  
 Rupture of the 
supraspinatus 
tendon with 
retraction with 
a maximum to 
the apex of the 
humeral head 
and minor fatty 
degeneration 
and atrophy of 
the muscle 
Double row repair 
with resorbable 
anchors in the all 
arthroscopic 
group 
Transosseous 
repair with 
Mason-Allen 
stitches in the 
mini-open 
group 
34 (61.8) 
17 patients 
in the all-
arthroscopic 
group 17 in 
the mini-
open group 
60 For pain 
Mini-open, 
94 
Arthroscopy, 
82 
For scores 
Mini-open, 
94 
Arthroscopy, 
100 
 
Longest 6 VAS scale for 
pain 
Constant-
Murley  score 
ASES score 
Abduction 
Forward 
flexion 
External 
rotation 
MRI 
 
 
Post-operative 
integrity 
evaluated on 
MRI images 
according to a 
modified 
Sugaya 
Clinical 
scores 
improved in 
both groups 
No effect 
surgical 
approach on 
clinical 
scores or 
failure rate 
Decreased 
pain in mini-
open group 
from 4-8 
weeks 
Cho et al 
2012 
Level II 
Randomized 
controlled 
trial 
Intraoperative 
confirmation of 
the presence of 
a supraspinatus 
tear smaller 
than 3 cm 
The tear was 
adequately 
mobilized and 
repaired by 
attaching the 
supraspinatus to 
the prepared 
greater tuberosity 
using either the 
The torn 
tendon was 
repaired using 
either the 
single-row 
(n=7) or 
double-row 
(n=23) repair 
technique with 
60 ( 56.7) 
30 patients 
in the all-
arthroscopic 
group  
30 in the 
mini-open 
group 
56 100 Longest 6 VAS scale for 
pain 
Forward 
flexion 
External 
rotation 
 
NA No effect of 
surgical 
approach on 
functional 
scores 
Decreased 
pain in all 
arthroscopic 
group at1 
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single-row (n=5) 
or double-row 
(n=25) repair 
technique with a 
suture anchor in 
the all 
arthroscopic 
group 
a suture 
anchor in the 
mini-open 
group 
 and 2 days 
van der 
Zwaal et al 
2013 
Level II 
Randomized 
controlled 
trial 
Eligible 
patients were 
(1) younger 
than 70 years 
of age and (2) 
had a small to 
medium-sized 
full-thickness 
supraspinatus 
and/or 
infraspinatus 
tendon tear 
with stage <3 
fatty muscle 
infiltration 
based on 
magnetic 
resonance 
imaging (MRI) 
findings 
A Suture Bridge 
repair construct 
was applied, using 
2 to 4 anchors 
depending on the 
size of the tear, to 
secure the tendons 
in both groups 
with a 5.5-mm 
CorkScrew in the 
medial row and a 
knotless 3.5-mm 
Bio-Push-Lock 
anchor in the 
lateral row in the 
all arthroscopic 
group 
A Suture 
Bridge repair 
construct was 
applied, using 
2 to 4 anchors 
depending on 
the size of the 
tear, to secure 
the tendons in 
both groups 
with a 5.5-mm 
CorkScrew in 
the medial 
row and a 
knotless 3.5-
mm Bio-Push- 
Lock anchor 
in the lateral 
row in the 
mini-open 
group 
100 (60) 
50 patients 
in the all-
arthroscopic 
group  
50 in the 
mini-open 
group 
58 95 Longest 13 DASH 
Constant-
Murley  score 
VAS scale for 
pain 
VAS scale for 
impairment 
Forward 
flexion 
External 
rotation 
Ultrasonogram 
Scored as 
intact or 
retear on 
ultrasonogram 
Clinical 
scores 
improved in 
both groups 
No effect 
surgical 
approach on 
clinical 
scores or 
failure rate 
DASH score, 
VAS pain 
and 
impairment 
scores and 
active 
forward 
flexion were 
significantly 
more 
improved in 
the all 
arthroscopic 
group at 6 
weeks 
Zhang et al 
2014 
Level I 
Randomized 
controlled 
trial 
Inclusion 
criteria 
included (1) a 
full- or partial-
thickness tear 
measuring 
more than 1 cm 
in diameter; (2) 
A single row of 1–
3 bioabsorbable 
suture anchors 
armed with 2 pairs 
of nonabsorbable 
No. 2 sutures were 
placed along the 
lateral part of the 
The 
supraspinatus 
was repaired 
by use of 1–3 
bioabsorbable 
suture anchors 
armed with 2 
pairs of 
125 (50.9) 
62 patients 
in the all-
arthroscopic 
group  63 in 
the mini-
open group 
54 86.4 29.1 UCLA score 
ASES score 
MRI 
 
Retear visible 
on MRI 
images 
Clinical 
scores 
improved in 
both groups 
No effect 
surgical 
approach on 
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patient’s 
willingness to 
be randomized 
to a 
arthroscopic or 
mini-open 
repair; and (3) 
adequate 
circumstances 
for MRI 
examination 
footprint in the all 
arthroscopic 
group According 
to the shape of the 
tendon, additional 
side-to-side 
sutures were used  
The tendon was 
then repaired via a 
Mason-Allen 
techniquemodified 
for the 
arthroscopic 
technique 
nonabsorbable 
No. 2 sutures 
in the mini-
open group  
Side-to-side 
FiberWire 
 sautures were 
used if 
necessary 
The tendon 
was sutured to 
the bone via 
the modified 
Mason-Allen 
technique with 
the 
combination 
of a U-shaped 
mattress 
suture and 
single suture 
on top of the 
mattress 
suture. 
 clinical 
scores 
Retearing 
rate was 
significantly 
higher in all 
arthroscopy 
group 
APPENDIX B – CLINICAL STUDIES COMPARING DIFFERENT SUTURING TECHNIQUES. 
Table 9-2 Clinical studies comparing different suturing techniques.  
Study Design Inclusion 
criteria 
Surgical 
approach 1  
Surgical 
approach 2 
Concomitant 
procedures 
Sample size 
(% males) 
Mean 
age 
(yrs) 
FU 
rate 
(%) 
Mean 
FU 
time 
(mo) 
Outcome 
measures 
Definition 
of retear 
Results 
Sugaya et 
al 2005 
Level III 
Retrospective 
cohort study 
Full thickness 
rotator cuff 
tear 
confirmed 
during 
surgery and 
SR repair  
One to three 
anchors 
depending on 
tear length   
DR repair  
Two to five 
anchors 
depending on 
tear length 
Bursectomy, 
subacromial 
decompression, 
debridement of 
greater 
tuberosity in all 
80 (69) 39 
repairs 
arthroscopic 
with SR 
41 repairs 
58 75.5 35 UCLA 
score 
ASES score 
MRI 
Cuff 
integrity 
was 
determined 
through 
MRI 
Clinical 
scores 
improved in 
both groups 
No effect of 
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no major 
associated 
pathology 
 
patients 
As required: 
Osteophyte 
removal 
Tendon 
mobilization 
procedure 
arthroscopic 
with DR  and 
classified 
into 5 
categories 
surgical 
approach on 
clinical scores 
Improved 
structural 
outcome in 
DR group 
Charousset 
et al 2007 
Level II 
Non-
randomized  
Prospective 
comparative 
study 
No previous 
surgery on 
shoulder 
concerned, no 
sign of 
adhesive 
capsulitis or 
shoulder 
instability, 
complete SSP 
tears 
SR repair 
First suture 
into cortical 
bone 
2-4 anchors 
DR repair 
2-4 anchors 
panalock 
Place a cuff 
tack between 
2 suture 
anchors close  
to 
cartilaginous 
rim to ensure 
cuff spread 
over burred 
surface 
Bursectomy and 
coracoacromial 
ligament 
resection and 
acromioplasty 
before cuff 
reinsertion 
66 (50) 
35 repairs 
arthroscopic 
with SR 
31 repairs 
arthroscopic 
with DR 
59 76 28.7 Constant 
score 
CT 
arthrogram 
 Clinical 
outcomes 
improved for 
both groups 
Tendon rate 
healing was 
better with 
DR repair 
Franceschi 
et al 2007 
Level I 
Randomized 
controlled 
trial  
RCT 
diagnosed on 
clinical 
grounds, no 
episodes of 
shoulder 
instability, no 
radiographic 
signs of 
fracture of the 
glenoid or 
greater or 
lesser 
tuberosity, 
MRI evidence 
of cuff tear, 
duration of 
symptoms of 
at least 3cm, 
inadequate 
response to 
SR repair 
1 row of 
suture 
anchors 
double-loaded 
just inside 
lateral aspect 
of footprint 
1-2 anchors 
DR repair 
1 row of 
anchors in 
medial aspect 
of footprint & 
lateral row 
placed on 
lateral aspect 
2-4 anchors 
NA 60 (47) 
30 repairs 
arthroscopic 
SR 
30 repairs 
arthroscopic 
DR 
62 86.7 24 UCLA 
score 
RoM 
Shoulder 
pain, 
strength 
MRI 
arthrograph
y 
NA Clinical 
outcomes 
improved for 
both groups 
No difference 
in MRI 
DR repair 
superior 
construct in 
restoring 
anatomical 
footprint of 
RC but does 
not translate 
to superior 
clinical 
performance. 
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nonoperated 
management 
& an 
unretracted & 
sufficiently 
mobile full-
thickness RC 
lesion to 
allow a DR 
repair found 
at the time of 
surgery. 
Park et al 
2008 
Level II 
Cohort study 
Patients 
undergoing 
SR or DR 
surgical 
repair for full-
thickness 
RCT 
SR repair 
small to 
medium tears 
1-2 anchors  
Large to 
massive tears 
3 anchors 
 
DR repair 
small to 
medium tears 
1-2 anchors 
were used at 
both the 
medial row & 
the lateral 
row 
For large to 
massive tears 
2-3 anchors 
were used at 
the medial 
row & 3-4 
anchors were 
used at the 
lateral row 
Complete 
bursectomy 
performed to 
create a flat 
acromial 
undersurface in 
all patients. 
Osteophytes in 
inferior part of 
acromioclavicul
ar joints were 
removed if 
mobility of the 
tendon was 
insufficient for 
repair, release 
of the 
coracohumeral 
ligament & 
debridement of 
RC from the 
bursal & 
articular sides 
were performed. 
78 (54) 
40 repair 
arthroscopic 
with SR 
38 repairs 
arthroscopic 
with DR 
56 10 25.1 ASES score 
Constant 
score 
Shoulder 
strength 
index 
NA Functional 
outcomes 
improved for 
both groups 
Patients with 
large to 
massive tears 
ASES score & 
Constant 
score & 
Shoulder 
strength were 
all 
significantly 
higher in DR 
repais 
Grasso et 
al 2009 
Level I 
Prospective 
randomized 
Repairable 
full thickness 
tear of the 
SSP or 
posterior-
superior 
rotator cuff 
SR repair One 
to four 
anchors 
depending on 
tear length  
DR repair 
Medial row: 
One to two 
anchors at the 
articular 
margin of the 
humeral head 
Debridement of 
greater 
tuberosity and 
cuff edges in all 
patients 
80 (47) 
40 repairs 
arthroscopic 
with SR 
40 repairs 
arthroscopic 
with DR 
57 90 24 DASH 
score 
Work-
DASH 
score 
Constant-
Murley 
NA Clinical 
scores 
improved in 
both groups 
No effect of 
surgical 
approach on 
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Lateral row: 
One to three 
anchors 
depending on 
tear length  
score 
Strength 
assessment 
 
clinical scores 
and strength 
Burks et al 
2009 
Level I 
Randomized 
Prospective 
controlled 
trial 
Full thickness 
tear as seen 
on MRI, 
ability of the 
patient to 
complete 
serial MRI 
examination, 
willingness to 
comply with 
standardized 
rotator cuff 
physical 
therapy 
program, 
willingness to 
be 
randomized 
to a SR or 
DR repair, 
tear pattern 
that was 
amenable to 
repair with 
either SR or 
DR fixation 
SR repair  
Anchors were 
placed along 
the lateral 
edge of the 
greater 
tuberosity 
within the 
footprint of 
the rotator 
cuff and 
spaced at 5- 
to 10-mm 
increments 
Average 2.25 
anchors  
DR repair 
Medial row: 
Established 
with a 
diamond 
pattern of 
double-loaded 
anchors 
Lateral row: 
Established in 
a fashion 
similar to 
what had 
been done for 
the SR 
Average 3.2 
anchors 
 
 
Acromioplasty 
in 38 of 40 
cases Buffing of 
outer cortex to 
induce bleeding 
As required: 
Distal clavicle 
resections 
Tenodesis 
Biceps 
tenotomy SLAP 
repair 
40 (NR) 
20 repairs 
arthroscopic 
with SR 
20 repairs 
arthroscopic 
with DR  
57 100 12 UCLA 
score 
Constant 
score, 
WORC 
index 
SANE 
ASES score 
RofM 
Internal 
rotation  
External 
rotation  
MRI 
Presence of 
a full-
thickness 
tear on 
MRI, 
defined as 
fluid signal 
and/or 
absence of 
visible 
tendon 
fibers 
extending 
across the 
entire 
tendon 
from 
inferior to 
superior 
Clinical 
scores 
improved in 
both groups 
No 
differences in 
MRI 
No effect of 
surgical 
approach on 
clinical scores 
and rate of 
retear 
Aydin et al 
2010 
Level II 
Randomized 
clinical trial 
Full thickness 
tear as seen 
on MRI, 
willingness to 
comply with 
physical 
therapy 
program and 
tear pattern 
amenable to 
repair by SR 
or DR 
SR repair  
One to three 
anchors 
depending on 
tear length  
DR repair 
Medial row: 
One to two 
anchors at the 
articular 
margin of the 
humeral head 
Lateral row: 
One to three 
anchors 
Complete 
bursectomy and 
subacromial 
decompression 
in all patients 
As required: 
Osteophyte 
removal 
68 (NR) 
34 repairs 
arthroscopic 
with SR 
34 repairs 
arthroscopic 
with DR 
58 100 36 Constant 
score 
 
NA Clinical 
scores 
improved in 
both groups 
No effect of 
surgical 
approach on 
clinical scores 
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depending on 
tear length  
Koh et al 
2011 
Level I 
Randomized 
Prospective 
controlled 
trial 
Full thickness 
tear as seen 
on MRI or 
arthrography, 
symptoms 
lasting more 
than 6 
months, 2-cm 
to 4-cm tear 
SR repair  
Two anchors 
with simple 
stitches 
DR repair 
Medial row: 
One anchor 
with mattress 
sutures 
Lateral row: 
Two anchors 
with simple 
stitches  
Debridement of 
tear and 
decortications 
in all patients 
As required: 
Bursectomy 
Acromioplasty 
Osteophyte 
removal 
71 (28) 
37 repairs 
arthroscopic 
with SR  
34 repairs 
arthroscopic 
with DR  
61 Clinica
l 87 
MRI 
66 
32 ASES score 
Constant 
score 
UCLA 
score 
VAS scale 
for pain 
MRI 
MRI scans 
classified 
as in 
Sugaya 
Clinical 
scores 
improved in 
both groups 
No effect of 
surgical 
approach on 
clinical scores 
and rate of 
retear 
Mihata et 
al 2011 
Level III 
Cohort study 
Patients who 
retrospectivel
y underwent 
arthroscopic 
RC repair 
with SR, DR 
or 
combination 
of DR & 
suture bridge 
techniques 
SR repair 
Average of 
1.7 anchors 
DR repair 
Average of 
3.5 anchors 
DR 
compression 
Repair 
Average of 
3.8 anchors 
Arthroscopic 
subacromial 
decompression 
performed to 
create a flat 
acromion 
surface 
Spurs in the 
inferior of the 
acromioclavicul
ar joint & at the 
distal end of the 
clavicle were 
removed 
206 (49) 
65 repairs 
arthroscopic 
with SR 
23 repairs 
arthroscopic 
with DR 
107 repairs 
arthroscopic 
with 
compression 
DR 
61 95 38.5 MRI 
ASES score 
JOA score 
UCLA 
score 
RoM 
Sugaya’s 
classificatio
n 
Large to 
massive tears 
retear rate in 
compression 
DR was 
significantly 
less 
Clinical 
outcomes 
improved in 3 
groups 
Denard et 
al 2012 
Level III 
Retrospective 
comparative 
study 
Arthroscopic 
complete or 
partial repair 
of a massive 
rotator cuff 
tear and a 
minimum of 5 
years of 
follow-up 
SR repair A 
mean of 3.3 
anchors were 
used for the 
superior 
rotator cuff 
(SSP and ISP) 
A mean of 1.6 
anchors was 
used to repair 
a 
subscapularis 
tendon tear  
DR repair A 
mean of 5 
anchors were 
used for the 
superior 
rotator cuff 
(SSP and ISP 
only) 
As required: 
Modified 
acromioplasty 
Distal clavicle 
excisions 
Biceps 
tenodeses or 
tenotomise 
Coracoplasty 
SLAP repair 
115 (64) 
62 repairs 
arthroscopic 
with SR 
45 repairs 
arthroscopic 
with DR 
62 100 99 UCLA 
score 
ASES score 
VAS score 
Forward 
flexion 
 
NA Clinical 
scores 
improved in 
both groups 
Better UCLA, 
subjective 
shoulder 
value, 
satisfaction 
and return to 
activity scores 
in DR repair 
group 
Lapner et Level I RC of any SR repair DR repair NA 90 (71) 57 81 24 WORC MRI Clinical and 
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al 2012 
Randomized 
controlled 
trial 
size was 
considered 
for inclusion. 
Full-thickness 
tear classified 
as repairable 
if the tendon 
could be 
restorded to 
its anatomical 
insertion 
when traction 
was applied 
without 
undue tension 
Anchors were 
placed along 
the lateral 
edge of the 
footprint 
Anchors were 
placed along 
the lateral 
edge of the 
footprint 
Medial 
anchors 
placed along 
the bone-
cartilage 
junction at the 
medial aspect 
of the 
footprint 
48 repairs 
arthroscopic 
with SR 
42 repairs 
arthroscopic 
with DR 
score 
Constant 
score 
ASES score 
MRI 
Shoulder 
strength 
functional 
outcomes 
improved for 
both groups 
Kim et al 
2012 
Level II 
Cohort study 
Full thickness 
SSP and/or 
ISP tears with 
1 to 4 cm of 
anterior to 
posterior 
dimension 
SB repair 
Medial row: 
Two or three 
anchors 
lateral to the 
articular 
surface of the 
humeral head 
Lateral row: 
Two anchors 
inserted 
perpendicular 
to the cortical 
surface of the 
humerus 
distal to the 
footprint 
DR repair 
Medial row:  
One or two 
anchors 
lateral to the 
articular 
surface of the 
humeral head 
Lateral row:  
Two or three 
anchors at the 
lateral margin 
of the greater 
tuberosity 
NR 52 (58) 
26 repairs 
arthroscopic 
with DR 
26 repairs 
arthroscopic 
with SB 
58 Clinica
l 100 
MRI or 
ultraso
nograp
hy 96 
Clinica
l 37 
MRI or 
ultraso
nograp
hy 34 
UCLA 
score 
ASES score 
Constant 
score 
VAS score 
MRI or 
ultrasonogr
aphy 
 
A full-
thickness 
retear was 
diagnosed 
if there was 
a focal 
defect in 
the rotator 
cuff into 
which the 
deltoid 
muscle 
could be 
compressed 
with a 
probe to 
separate the 
torn tendon 
ends or if 
the cuff 
retracted to 
such an 
extent that 
the torn 
ends could 
be 
distinctly 
visualize 
Clinical 
scores 
improved in 
both groups 
No effect of 
surgical 
approach on 
clinical scores 
and rate of 
retear 
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MRI scans 
classified 
as in 
Sugaya 
Ma et al 
2012 
Level II 
Randomized 
Prospective 
control trial 
Full thickness 
tear 
measuring 
more than 1 
cm in 
diameter 
(Medium to 
massive tear), 
a tear pattern 
that was 
amenable to 
repair with 
either SR or 
DR fixation, 
patient’s 
willingness to 
be 
randomized 
to a SR or DR 
repair, 
adequate 
circumstances 
for MRI 
examination 
SR repair  
Two to four 
anchors 
placed on the 
lateral edge of 
the greater 
tuberosity 
DR repair 
Medial row: 
One to two 
anchors at the 
articular 
margin of the 
humeral head 
Lateral row: 
Placed in a 
fashion 
similar to the 
SR repair 
technique 
 
Bursectomy, 
acromioplasty, 
coracoacromial 
ligament 
release, 
debridement of 
greater 
tuberosity in all 
patients 
As required: 
Release of the 
coracohumeral 
ligament and 
detachment of 
the tendon from 
the bursal and 
articular sides 
53 (55) 
 27 repairs 
arthroscopic 
with SR 
26 repairs 
arthroscopic 
with DR 
61 100 33 UCLA 
score 
ASES score 
Abduction 
External 
rotation 
Contrast 
MRI 
Partial tear 
was 
diagnosed 
in the 
presence of 
contrast 
material 
filling a 
partial 
tendon 
defect 
without 
tendon gap  
A full 
thickness 
tear was 
diagnosed 
in the 
presence of 
tendon gap 
and 
presence of 
extravasatio
n of 
contrast 
material to 
the 
subacromia
l space  
Clinical 
scores 
improved in 
both groups 
No effect of 
surgical 
approach on 
clinical scores 
and rate of 
retear 
Strength 
better in DR 
group for tears 
larger than 
3cm 
Carbonel et 
al 2012 
Level I 
Randomized 
Prospective 
clinical study 
Rotator cuff 
tear, clinically 
confirmed, in 
a sane patient 
with complete 
passive range 
of motion 
(ROM) with 
inability to 
perform 
SR repair  
Anchors 
placed along 
the lateral 
edge of the 
greater 
tuberosity 
within the 
footprint of 
DR repair 
Medial row: 
Anchors 
placed in the 
medial aspect 
of the 
footprint, just 
lateral to the 
articular 
Complete 
bursectomy, 
subacromial 
decompression, 
debridement of 
tendon and 
greater 
tuberosity in all 
patients As 
required: 
160 (43) 
 80 repairs 
arthroscopic 
with SR 
80 repairs 
arthroscopic 
with DR 
55 100 24 UCLA 
score 
ASES score 
Constant-
Murley 
score 
SSI 
MRI 
images 
graded as 
full 
thickness 
tear, partial 
thickness 
tear 
and cuff 
Clinical 
scores 
improved in 
both groups 
Better UCLA 
score for DR 
repair group 
Better UCLA, 
268 
 
 
 
activities of 
daily living, 
full thickness 
tears bigger 
than 10 mm 
with MRI 
evidence, 
older than 18, 
informed 
consent 
the rotator 
cuff 
surface of the 
humeral head 
Lateral row: 
Anchors 
placed in the 
lateral aspect 
of the 
footprint, 
slightly 
proximal to 
the greater 
tuberosity 
Osteophyte 
removal, release 
of the 
coracohumeral 
ligament, 
detachment of 
the rotator cuff 
from the bursal 
and articular 
sides 
RofM 
MRI 
integrity ASES scores, 
RofM for DR 
repair group 
for tears > 30 
mm 
No effect of 
surgical 
approach on 
MRI results 
Gartsman 
et al 2013 
Level I 
Randomized 
controlled 
trial 
Full thickness 
SSP tears 
repairable 
less than 25 
mm in their 
anterior to 
posterior 
dimension 
SR repair  
Two double-
loaded suture 
anchors were 
placed 
laterally 8mm 
distal to 
greater 
tuberosity 
 
SB repair 
Medial row: 
Two single-
loaded suture 
anchors 
positioned 
just lateral to 
the humeral 
articular 
margin 
Lateral row: 
Two anchors 
Abrasion of the 
footprint in all 
patients 
As required: 
Tenodesis, 
tenotomy, 
subacromial 
decompression 
90 (NR) 
 43 repairs 
arthroscopic 
with SR 
47 repairs 
arthroscopic 
with SB 
NR 92 10 Ultrasound Rotator 
cuff could 
not be 
visualized 
because of 
complete 
avulsion 
and 
retraction 
under the 
acromion, 
when there 
was a focal 
defect in 
the rotator 
cuff or 
when the 
torn cuff 
was 
retracted a 
variable 
degree 
from the 
surgical 
repair site 
Higher tendon 
healing rate in 
SB repair 
group 
 
Ide et al 
2015 
Level III 
Retrospective 
cohort design 
Patients 
undergoing 
arthroscopic 
SR or SB 
repair for a 
Full thickness 
SR repair One 
to three 
anchors 
SB repair 
Knotless 
double-row 
suture bridge 
repair 
Acromioplasty 
in all patients 
As required: 
Tenodesis, 
coracoplasty 
61 (77) 
25 repairs 
arthroscopic 
with SR 
36 repairs 
63 100 SR 
repair 
81 
SB 
repair 
34 
UCLA 
score  
JOA score 
MRI 
Full 
thickness 
RCT was 
diagnosed 
when a 
fluid-
Clinical 
scores 
improved in 
both groups 
No effect of 
surgical 
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RCT in the 
subscapularis 
combined 
with a tear in 
the SSP or 
tears in the 
SSP and ISP, 
availability of 
preoperative 
and 
postoperative 
MRI of the 
affected 
shoulder 
joint, a 
follow-up of 
more than 2 
years 
arthroscopic 
with SB 
equivalent 
signal 
appeared or 
when the 
tendon 
could not 
be 
visualized 
in at least 1 
section of a 
fluid-
sensitive 
sequence 
approach on 
clinical scores 
Abduction 
strength score 
better in SB 
repair group 
APPENDIX C – ROTATOR CUFF RABBIT REPAIR MODELS 
Table 9-3 Rotator cuff rabbit repair models 
Study Acute/Chronic? 
Age/Weight? 
Tear model Repair procedure Associated 
procedures/Post-operative 
immobilization 
Time points/ 
Outcome 
measures 
Results 
Chang  
et al   
2009 
Acute model 36 
skeletally 
mature New 
Zealand white 
rabbits  (average 
weight between 
2.5 and 3 kg) 
Infraspinatus tendon shoulder 
joint was approached and the 
infraspinatus tendon was 
detached from its insertion 
on the greater tuberosity by 
performing a sharp 
dissection. 
Two tunnels (1-mm in diameter) were created 
from the footprint to the proximal humeral 
metaphysis. A section of periosteum (2 9 5 
mm) was obtained from anterior cortex of 
proximal tibia. The sutured tendon end was 
pulled and attached to the footprint by the 
suture through the tunnel. The harvested 
periosteum was fixed between tendon end and 
footprint.  
 
The limbs were not 
immobilized postoperatively 
and the rabbits were 
Allowed to exercise as 
desired in their respective 
cages. 
Radiography and 
Histological 
examination at 4, 
8, and 12 weeks  
 
Histological analysis of the 
tendon–bone interface 
revealed that the periosteum 
formed a fibrous layer over 
the interface between t-b.  
 
12 weeks, a statistically 
significant increase in failure 
load was noted in the 
attachment strength of the 
limb treated with the 
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periosteum. 
 
 
Fabis 
Et al 
2016 
Chronic model 
Twelve adult 
male rabbits of 
mixed breed 
(weight, 3.8-4.6 
kg) 
 
The deltoid muscle was split 
and retracted, and 
3 mm of the SSP tendon was 
resected and detached from 
the greater tubercle. 
 
Twelve weeks after the procedure, the edges of 
SSP tendon were resected, and the tendon was 
reattached to the abraded groove between the 
humeral head and the greater tubercle using a 
modified Mason-Allen suture.  
The suture was passed through the groove with 
the help of the needle and tied over the external 
cortex.  
 
The shoulder was not 
immobilized postoperatively. 
After 6 weeks, the animals 
were moved every second 
week from the standard cage 
to an open cage 4 times as 
large to allow more space for 
activity. 
Histologic 
morphometry  
8 weeks (n=2) 
9 weeks (n=2)  
24 weeks (n=10) 
 
No statistically significant 
differences were found 
between controls and 
operated-on shoulders for 
type I and  II muscle fibers. 
Fei 
Et al 
2015 
64 NZW rabbits 
were randomly 
divided into 2 
groups, the SB 
group and DR 
group. 
Aged 
12 to 13 months, 
with a mean 
body-weight of 
2.8 kg 
(Range: 2.5 to 3 
kg) 
The SSP tendon was 
identified and sharply 
divided over a 10 mm width, 
near its insertion at the 
greater tuberosity. The 
surface of the greater 
tuberosity was decorticated 
using a scalpel to promote 
healing. 
DR:   
The medial suture was sutured through the 
greater tuberosity cancellous bone and the 
supraspinatus tendon at the medial part of the 
footprint. The second and third sutures were 
placed equidistant from the lateral part of the 
footprint in the coronal plane of the humerus 
head. 
These sutures were then tied down using a 
simple suture Configuration 
Suture bridge: Two sutures each were placed 
through the center of the anterior 1/3 zone and 
posterior 1/3 zone of the tendon and then 
through the greater tuberosity of the humeral 
head in the coronal direction. The other two 
sutures were oblique and crossed each other. 
 
No restrictions were placed 
on animal movement.  
 
Histology 2nd, 
4th, or 8th week 
Biomechanical 
comparison 8th 
week. 
The load to failure of the SB 
group significantly higher 
than in the DR group. 
Histological evaluation 
showed that the collagen 
fibers of the SB group were 
more compact than those of 
the DR group at all times 
tested. At the 4th and 8th 
weeks, the collagen fibers and 
cartilage cells in the SB group 
were arranged in a column 
modality, but those in the DR 
group were distributed 
horizontally. 
Friel  
Et al 
2015 
44 skeletally 
mature, male 
NZW rabbits  
4 months old 
with a mean 
body mass of 
4.1_0.1 kg 
The left supraspinatus tendon 
was transected approximately 
1mm medial to its insertion 
and repaired through two 
transosseous tunnels within 
the lateral aspect of the 
proximal humerus. 
In accordance with the specific treatment 
group, using a syringe, 1ml of highly purified 
capsaicin aqueous solution was instilled into 
the joint, and the rotator cuff was subjected to 
gentle passive motion to facilitate distribution 
of the aqueous solution into both the rotator 
cuff tendon–bone insertion site, transosseous 
tunnels, as well as into the joint space.  In the 
Rabbits were housed in 
individual cages with no 
limitations on their motion. 
Biomechanical 
and histological 
analysis 
18-week 
 
Biomechanical testing 
revealed no difference. 
Histologic features of both 
cartilage and repaired tendons 
showed minimal differences 
across groups. 
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(Range, 3.6–4.4 
kg) 
right (sham treated) shoulder, the surgical 
approach to the rotator cuff was identical to 
that of the left shoulder. 
 
Funakos
hi 
Et al 
2006 
Twenty-one 
mature Japanese 
white rabbits, 
weighing 3 kg 
Both infraspinatus tendons 
were removed to create a 
defect of 10 mm in length 
and 10 mm in width. A 
trough was created in the 
cortical bone over the 
insertion of the infraspinatus 
tendon until cancellous bone 
was exposed. 
In the right shoulder, the defect was covered 
with a 10X10–mm patch of nonwoven chitin 
fabric. 
The distal end of the fabric was fixed into the 
bony trough, and the proximal stump of the 
fabric was sutured to the infraspinatus tendon 
via the same technique.  
The defect of the contralateral (left) shoulder 
was left free as a control. 
 
The animals were not 
immobilized and were 
allowed to move freely in 
their cages. 
Histological and 
immunohistochem
ical at 2, 4, 8, and 
12 weeks and 
biomechanically 
at 12 weeks. 
The matrix increased cell 
numbers and improved 
collagen fiber alignment. The 
regenerated tissues were 
composed of type III 
collagen. The structural 
properties 
of the grafted shoulder were 
significantly greater than 
those of the control. 
Gilotra 
Et al 
2015 
Chronic model 
14 skeletally 
mature NZW 
rabbits average 
weight of 7 to 9 
lbs. 
 
The SSP tendon was 
detached from its insertion 
with a scalpel and then 
sutured using a 5-0 Prolene 
suture to a Penrose drain to 
prevent healing. 
The second procedure was performed 12 
weeks after. Penrose drain removed. A bony 
trough approximately 2 X2X5 mm was made 
at the medial aspect of the greater tuberosity. 
Three 1-mm drill holes were created from the 
lateral aspect of the greater tuberosity. The 
SSP tendon was repaired to its original 
insertion site with two horizontal mattress 
sutures with 2-0 nonabsorbable-braided 
sutures. The suture was then passed through 
the drill holes; Botox was injected into the SSP 
muscle 2 cm from the myotendinous junction.  
Rabbit shoulders were not 
immobilized postoperatively. 
Biomechanics, 
histology, and 
MRI  
6 weeks 
Botox-treated repairs were 
significantly weaker than 
control repairs. 80% of 
Botox-treated repairs and 
40% of control repairs healed 
with some partial defect. 
Fatty infiltration of the SSP 
was present in all shoulders 
but was increased in the 
setting of Botox. 
Inui 
Et al  
2012 
42 skeletally 
mature female 
Japanese white 
rabbits.  
Mean age was 
16.3 weeks 
(range, 15 
to 18 weeks), 
and their mean 
weight was 3.1 
kg 
(Range, 2.7 to 
A 3-cm incision was made in 
the right shoulder and the 
infraspinatus tendon was 
exposed. Rotator cuff defects 
were created by resecting the 
infraspinatus tendon (5-mm 
width and 
5-mm length) from the 
greater tuberosity 
Scaffolds were implanted into this defect. The 
proximal edge of the scaffold was sutured to 
the mid-substance of the tendon by No. 4-0 
nylon mattress suture. Decortication was 
performed at the greater tuberosity and the 
distal edge of the scaffold was fixed to the 
bone by No. 4-0 nylon transosseous mattress 
suture. 
In the contralateral shoulder, the ISP tendon 
was resected. Decortication was performed at 
the footprint of the humeral head, and the 
tendon was reattached to the humeral head 
without creating a defect by No. 4-0 nylon 
The rabbits were allowed free 
cage movement. 
 
Histologic 
analyses (4, 8, and 
16 weeks)  
Mechanical 
evaluations  
(0, 4, 8, and 16 
weeks) 
At 8 weeks, the PLG scaffold 
had dissolved and bone 
formation was observed at the 
scaffold-bone interface. At 16 
weeks, the scaffold-bone 
interface matured and 
expression of type II collagen 
was observed.  
No difference in ultimate 
failure load and stiffness at 8 
weeks. 
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3.6 kg). transosseous mattress suture as a control. 
Itoigawa 
Et al 
2015 
29 adult male 
Japanese white 
rabbits weighing 
3.0 to 3.5 kg. 
Both omovertebral and 
deltoid muscles were 
retracted to expose the ISP 
tendon. The ISP tendon was 
detached from the greater 
tuberosity. The medial 
tendinous stump retracted 
after creation of the defect. 
 
With a dental burr, a trough, 10 mm long X2 
mm wideX2mm deep,was prepared to mount 
the OCP/Gel composite on the greater 
tuberosity. Two small drill holes were made 
from the lateral aspect of the humerus into the 
bony trough. Either theOCP/Gel composite 
(OCPþgroup) or Gel alone was mounted onto 
the trough of the greater tuberosity. Then, the 
stump of the ISP tendon was inserted into the 
bony trough. Each suture end was passed 
through a drill hole and tied to the lateral 
aspect of the cortex.  
 
The animals were not 
immobilized postoperatively.  
 
All shoulders 
were harvested at 
2 (n = 6), 4 (n = 
6), and 8 (n = 7 or 
8) weeks 
postoperatively 
for Histologic 
Macroscopic 
Immunohistochem
istry observations 
On immunohistochemical 
evaluation, both the bone and 
the fibers in the OCP group 
demonstrated that type I 
collagen was picked up, 
whereas the newly formed 
tendon fibers and Sharpey 
fibers revealed type III 
collagen. 
Kang  
Et al 
2013 
12 adult male 
NZW rabbits, 
with an average 
age of 15 weeks 
and an average 
weight of 4.1kg. 
The rabbits were randomly 
divided into 2 groups: group 
A, the nonpore bioabsorbable 
anchor group and control 
group, and group pA, the 
micropore bioabsorbable 
anchor group and 
experimental group.  
A 5-cm incision was made 
parallel to the scapular spine 
and the SSP tendon. The 
release of the SSP tendon 
was performed with a sharp 
blade at the base of the 
tendon insertion area. 
An anchor was inserted into the junction area 
of the articular cartilage, and the greater 
tuberosity of the humeral head and detached 
cuff were repaired using the single-row method 
Antibiotics were used for 3 
days after surgery, and the 
dressing of the surgical site 
was performed at 3-day 
intervals. 
CT 4 and 8 weeks 
(BVF), 
Biomechanical 
test of pullout 
strength4 weeks 
 
The mean BVF was higher 
in-group pA than in-group A. 
The micropore anchor had 
higher pullout strength than 
the nonpore anchor. 
Biomechanical no 
Significant difference 
Kim 
Et al 
2016 
Acute Model  
36 mature NZW 
male rabbits 
(average age, 24 
weeks old; 
weight, 3.5-4.0 
kg) 
The SSP tendon, posterior to 
the bicipital groove and 
anterior to the scapular spine, 
was identified. Insertion of 
the SSP at the greater 
tuberosity was sharply 
released using a scalpel. 
Decortication of the greater 
tuberosity was performed 
using a small burr. 
The repair technique of PTR or SBCR was 
randomly chosen. Two bone tunnels were 
created parallel to the tendon for PTR, and 
crisscross transosseous tunnels were added for 
SBCR. Two transosseous simple stitches were 
made with two 3-0-nylon sutures for PTR, and 
2 crisscross sutures were added for SBCR. The 
other repair type was then performed on the 
contralateral shoulder. 
 
The limbs were not 
immobilized postoperatively. 
 
Biomechanical 
evaluation 
Histologic 
evaluation 
1, 2, and 5 weeks 
postoperatively 
Failure loads at 1 week and 5 
weeks were not statistically 
different between groups, 
respectively, but were 
significantly lower in the 
SBCR group than in the PTR 
group 
Markedly greater fibrinoid 
deposition was observed in 
the SBCR group than in the 
PTR group at 2 weeks.  
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Koike  
Et al  
2005 
89 mature NZW 
rabbits (male, 
average weight 
3.2 kg) 
The SSP tendon was 
transected 3 mm proximal to 
its insertion into the greater 
tuberosity at the level of the 
tendon proper.  
 
Attached SSP: A 7 mm long, 2 mm wide and 2 
mm deep trough was prepared in the 
cancellous bone of the greater tuberosity. 
Three small holes were made from the lateral 
aspect of the humerus into the bony trough. 
Two sutures were placed in the SSP tendon, 
each being passed through one hole, then going 
through the tendon, exiting through another 
hole and tied to the lateral aspect of the 
humeral cortex. Not attached SSP: To prevent 
spontaneous adhesion to surrounding tissues 
[7], the SSP tendon was not attached but rather 
wrapped with a polyvinylidine fluoride 
membrane in 14 animals. 
After surgery, the animals 
were not immobilized but 
kept in cages 
Histology  
2, 6, 8, 12 or 24 
weeks. 
 
In the attached group, 
chondrocytes appeared at 2 
weeks and their number 
reached control levels by 6 
weeks  
The percentage of 
chondrocytes aligned in rows 
increased at 2 weeks to reach 
near normal values at 24 
weeks. Area of 
metachromasia increased 
from at 24 weeks. 
Neither chondrocytes nor 
metachromasia were observed 
in the non-attached tendons. 
Koike  
Et al  
2006 
Acute versus 
chronic models 
35 animals 
The SSP tendon was 
transected at the tendon 
proper and the 
fibrocartilaginous enthesis 
resected. In 35 animals, the 
SSP tendon was inserted 
The SSP tendon was wrapped with a 
polyvinylidine fluoride membrane after 
transection. The polyvinylidine fluoride 
membrane has pores of 5 mm in size that 
allowed some nutrition to diffuse to the end of 
the tendon but inhibited adhesion of the tendon 
to the surrounding soft tissue. The SSP tendon 
was inserted immediately, after 6 or 12 weeks 
into the bony trough of the greater tuberosity. 
N/A Histology  
2, 8, or 
12 weeks  
 
Formation of a 
fibrocartilaginous enthesis 
depended on the elapsed time 
after repair and not on the 
duration between detachment 
and repair. 
 
Lee  
Et al 
2016 
Chronic model 
42 adult (5-
month-old) male 
NZW rabbits 
(_3.0 kg)\ 
 
The SSP tendon was cut off 
from the right proximal 
humerus bone. The detached 
end of the tendon was placed 
in a silicone tube and fixed 
by suturing. The silicone 
tube-inserted tendon was 
relocated and sutured with a 
polygluconate DexonVR 
5-0 suture from the outside to 
the inside. 
Dermal patch implantation, the SSP repair by 
SR repair technique. After 4 weeks, the 
silicone tube was removed and two holes were 
made on the proximal humerus bone for patch 
insertion. The rabbits were assigned to groups: 
Normal; no patch, the cut SSP tendon was 
inserted into the hole without patch and fixed 
by suturing; dermal patch insertion, a dermal 
patch was inserted and fixed by suturing 
between tendon and bone; rhBMP-2-coated 
dermal-patch insertion, a dermal patch coated 
with rhBMP-2 was inserted and fixed by 
suturing. 
 
Postoperatively, the animals 
were allowed free movement 
without use of any type of 
immobilization. 
 
Bone mineral 
density, 
biomechanical 
strength, 
histological and 
histomorphometri
c analyses 
4 and 8 weeks 
Insertion of an rhBMP- 
2-coated acellular dermal 
patch not only significantly 
ameliorated new bone 
formation, it also improved 
biomechanical properties 
such as ultimate tensile 
strength.  
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Matsum
oto 
Et al 
2002 
Chronic model 
28 mature NZW 
rabbits (average 
body weight 
3.3 kg, age 
between 24 and 
27 months 
 
The SSP tendon was 
transected close to its 
insertion and any 
fibrocartilaginous tissue still 
attached to the greater 
tuberosity was removed. The 
proximal stump of the 
supraspinatus tendon was 
wrapped with a 
polyvinylidine fluoride 
membrane to prevent 
Spontaneous reattachment.  
 
After 12 weeks the supraspinatus tendon was 
reattached to the greater tuberosity.  
The polyvinylidine fluoride membrane was 
removed and a bony trough (2 r 2 x 5 mm3) 
made between articular cartilage of the 
humeral head and medial wall of the 
tuberosity. Three drill holes were then made 
with a 1 mm diameter drill bit from the lateral 
aspect of the greater tuberosity into the bony 
trough. Two horizontal mattress sutures with 
non-resorbable, monofilament 3-0 prolene 
were placed, each suture passing through one 
drill hole then through the tendon and exiting 
through the second drill hole. The sutures were 
tied over the lateral aspect of the cortex. 
 
The shoulders were not 
immobilized postoperatively. 
 
Volume of the 
supraspinatous 
and extramuscular 
fat Biochemical 
quantijication of 
intramuscular fat 
Ooerall fat content 
Histomorphometri
c quantiJication of 
intrumuscuiar fat 
24 weeks 
 
Accumulation of fat was 
increased in both groups 
when compared to controls. 
The muscle atrophy was 
significant. Neither atrophy 
nor fat accumulation was 
reversed by surgical 
reattachment of the 
supraspinatus tendon. On the 
contrary, the fat accumulation 
was higher in the reattached 
group  
 
Oh 
Et al 
2014 
Chronic model 
40 mature NZW 
male rabbits 
(average age, 24 
weeks; weight, 
3.5-4.0 kg) into 
5 groups 
ADSCþrepair 
group, 
salineþrepair 
group, ADSC-
only group, 
saline-only 
group, and 
control group. 
 
The chronic tear model was 
created in both rabbit 
shoulders by completely 
severing the SSC tendon and 
the torn tendon was wrapped 
with a 10-mm-long silicone 
Penrose drain with an 8-mm 
outer diameter. 
 
After 6 weeks, removed the Penrose drain 
wrapped around the SSC tendon and reattached 
it to the lesser tuberosity by using 2 
singleloaded 1.9-mm Mini Quick Anchor Plus. 
This was performed in the ADSCþ repair and 
saline repair groups. Both sutures were tied in 
a mattress fashion over the lateral aspect of the 
SSC tendon. In the ADSCþ repair and ADSC-
only groups, injected ADSCs into SSC muscle. 
In the salineþrepair group, injected the same 
volume of 
Saline.  
 
The rabbits were permitted 
usual cage activity without 
immobilization. 
Electromyographi
c, Biomechanical, 
and Histologic 
evaluation 
12 weeks 
On electromyographic 
evaluation, the ADSCþrepair 
group exhibited a larger 
compound muscle action 
potential area than the 
salineþrepair group  
Biomechanically, no 
significant difference.  
 
Quigley  
et al 
2013 
Chronic model 
21 NZW 
Rabbits 
weighing 3–4 kg 
 
The tendon of the left 
shoulder was used as a sham 
control by exposing it and 
observing it to be free of any 
tendon pathology. The SSC 
tendon of the right shoulder 
was resected at its insertion, 
followed by wrapping in 
Six weeks after tendon resection SR: two holes 
were punched and tapped in the middle of the 
footprint, one dorsally and the other ventrally. 
Two 1.3 mm Micro Quickanchor suture 
anchors were sunk into the holes orthogonally 
to the footprint surface.  For DR: The first row 
of anchors was placed at the medial part of the 
footprint, one dorsally and one ventrally, 
Rabbits were allowed ad-lib 
activity immediately after 
surgery 
Cyclic loading 
and load to 
failure, 
biomechanical 
testing  
12 weeks. 
The TOE repair showed 
greater biomechanical 
characteristics than DR, 
which in turn were greater 
than SR.  
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sterile penrose drain. 
 
orthogonally to the footprint surface. A 
horizontal mattress suture configuration was 
used to tie these sutures down. The second row 
was placed at the lateral part of the footprint. 
For TOE repair the medial row of sutures was 
placed in the exact same manner as with the 
DR repair, except that after tying the horizontal 
mattress sutures the limbs were not cut. Two 
lateral suture anchors were then placed 5 mm 
to 1 cm distal to the lateral edge of the 
footprint in line with the anchors from the 
medial row. One suture limb from each of the 
medial row anchors was then tied to a suture 
limb from the lateral row. 
Sano  
et al 
202 
21 mature 
Japanese white 
rabbits. 
Their mean age 
was 6.1 months 
(SD, 1.2 
months), and 
their mean body 
weight was 3.3 
kg 
5-cm-long skin incision was 
made at the lateral aspect of 
the thigh to harvest a 2x2-cm 
strip of fascia.  A tendinous 
defect was made close to the 
SSP insertion. The medial 
tendinous stump retracted 
after creation of the defect.  
 
With a dental burr, a 10-mm-longX2-mm-wide 
trough was prepared in the cancellous bone of 
the greater tuberosity. Two small drill holes 
were made from the lateral aspect of the 
humerus into the bony trough. The fascia was 
sutured to the lateral stump of the SSP tendon. 
The other end of the fascia was inserted into 
the bony trough. Each suture end was passed 
through a drill hole and tied to the lateral 
aspect of the cortex. 
The animals were not 
immobilized postoperatively. 
Histological and 
immunohistochem
ical evaluation  
1, 2, 3, 4, 
6, and 8 weeks. 
The distribution of collagen 
types II and III represented a 
pattern similar to that of a 
normal SSP tendon insertion. 
In the grafted fascia, the 
cellular density showed a 
marked increase over time. 
 
Yokoya 
Et al  
2008 
30 adolescent 
Japanese white 
rabbits, 
weighing 
3.0 to 3.4 kg, 
A full-thickness defect of the 
rotator cuff was created by 
completely resecting a 
segment 10 mm in length and 
5 mm in width at the 
insertion of the infraspinatus 
into bone. 
A trough was created in the cortical bone over 
the insertion of the infraspinatus tendon, 
exposing the cancellous bone. In the left 
shoulders, the defects were covered using a 
PGA sheet. The distal end of the scaffold was 
fixed into the bony trough. The proximal end 
of the scaffold was sutured to the ISP tendon. 
In the right shoulders, the defects were covered 
with PLC sheet. 
 
After surgery, the animals 
were not immobilized and 
were allowed to move freely 
in their cages. 
 
Histology 
4, 8, and 16 
weeks, and 
mechanical 
evaluations  
4 and 16 weeks  
 
In mechanical examinations, 
the PGA group had higher 
values in the maximum 
failure load, tensile strength, 
and Young’s modulus for the 
4-week and 16-week periods.  
 
Trudel  
Et al  
2010a 
40adult female 
NZW rabbits 
(3.1–3.3 kg) 
The tendon was transected 
close to its insertion, and any 
tendinous/fibrocartilaginous 
tissue still attached to the 
greater tuberosity was 
removed. 
 
A 2X2X5mmbony trough was made using a 
burr. Three 1-mm holes were drilled from the 
lateral aspect of the greater tuberosity. The first 
thread was passed first through the most 
proximal drill hole, then through the tendon in 
a modified MA fashion, and finally through the 
middle drill hole. The second thread was 
The shoulders were not 
immobilized postoperatively. 
 
CT and 
 Biomechanical 
Testing 
1, 2, and 6 weeks 
Suture pullout was the most 
common mode of failure, 
whereas at 6 weeks, mid-
substance tears predominated. 
Hypoattenuation on CT was 
associated with increased 
strength of the tendon–bone 
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passed first through the middle drill hole, then 
through the tendon in a modified MA fashion, 
and then through the distal drill hole.  
 
construct. 
 
Trudel  
Et al  
2012a 
Chronic model 
 54 adult male 
NZW rabbits 
weighing 
3.1 kg 
  
The SSP tendon was 
transected close to its 
insertion. Sutured a 
polyvinylidene membrane 
over the proximal stump of 
the SSP to prevent 
spontaneous reattachment. 
 
The tendons were repaired 1, 2, or 3 months 
after transaction we produced a bony trough 
(2X2X5 mm) at the medial wall of the greater 
tuberosity. Three 1-mm holes were drilled 
from the lateral aspect of the greater tuberosity 
into the bony trough.  The first thread was 
passed through the most proximal drill hole 
and then through the tendon in a modified MA 
fashion, exiting through the middle drill hole; 
the second thread was passed through the 
middle drill hole and the tendon in a modified 
MA fashion, exiting through the distal drill 
hole.  
 
We did not immobilize the 
shoulders postoperatively; 
the rabbits were housed in 
large cages with free access 
to water and food 
CT and 
Biomechanical 
testing 3 months 
The mean peak loads to 
failure 3 months after repair 
delayed by 1 month and 
delayed by 2 months were 
significantly greater than 
control values, there was no 
difference after a delay of 3 
months.  
 
Trudel  
Et al  
2012b 
Chronic model 
36 NZW rabbits  
The SSP was transected close 
to its insertion. The proximal 
stump of the tendon was 
wrapped with a 
polyvinylidene fluoride 
membrane to prevent 
spontaneous postoperative 
reattachment. 
Repaired at 4, 8, or 12 weeks. The 
polyvinylidene membrane removed. A bony 
trough (2 mmX2 mmX5 mm) at the medial 
wall of the greater tuberosity was created. 
Three 1-mm holes were drilled from the lateral 
aspect of the greater tuberosity into the bony 
trough. The first thread was passed first 
through the most proximal drill hole, then 
through the tendon in a modified MA fashion, 
and finally through the middle drill hole. The 
second thread was passed first through the 
middle drill hole, then through the tendon in a 
modified MA fashion, and then through the 
distal drill hole.  
 
The rabbits were housed in 
large cages and bore weight; 
they had free access to water 
and food. 
SSP muscle, e-fat 
weights and 
volumes, muscle 
tissue and i-fat 
areas on 
histology, e-fat 
and attenuation 
values on CT 
between the 
experimental and 
control 
shoulders.12 
weeks 
SSP muscle tissue atrophy, e-
fat and i-fat accumulation was 
present after tendon repair 
delayed by 4, 8, or 12 weeks 
(all p < 0.05).  SSP muscles 
showed tissue atrophy, e-fat 
and i-fat accumulation after 
successful SSP tendon repairs 
delayed by 4, 8, or 12 weeks.  
 
Uhthoff 
Et al 
2000 
14 mature NZW 
rabbits: body-
weight of 3.9 kg 
(3.6 to 4.2). 
SSP tendon was then 
transected close to its 
insertion into the greater 
tuberosity. 
 
 
Using a dental burr, a trough 7 mm long, 2 mm 
wide and 2 mm deep was made in the 
cancellous bone of the greater tuberosity. 
Three small drill holes were made from the 
lateral aspect of the humerus into the bony 
trough. Two horizontal mattress sutures with 
non-absorbable 3-0 prolene were placed, each 
suture passing through a drill hole then through 
The animals were not 
immobilised after the 
operation 
Histology 
2 weeks 
Cellularity of the underlying 
bone and the thickness of the 
subacromial bursa were 
significantly increased. 
The cellularity of the stump 
of the tendon, however, was 
significantly decreased in the 
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the tendon and exiting through the second hole.  operated shoulders. 
Uhthoff 
Et al 
2002 
21 adult NZW 
rabbits (age, 24-
27 months; 
mean body 
weight, 
4.1 kg, range, 
3.7-4.3 kg) 
SSP tendon was transected 
medial to its insertion on the 
greater tuberosity at the level 
of the tendon proper.  
 
A 7-mm–long, 2-mm–wide, 2-mm–deep 
trough was prepared in the cancellous bone of 
the greater tuberosity. Three drill holes on the 
lateral aspect of the humerus into the bony 
trough were used to tie the SSP tendon in the 
trough. Each suture passed through a drill hole, 
then through the tendon, and exited through the 
second hole.  
 
Neither postoperative 
immobilization nor any 
restrictions in activity were 
used.  
 
Tensile strength, 
Microscopically, 
8 and 12 weeks 
The mean peak loads of the 
operated tendons were 
significantly ower than their 
controls. Histologically, at 8 
weeks, the fibrocartilaginous 
enthesis had partially 
reformed; Twelve weeks after 
reimplantation, 4 of 7 
entheses had a normal 
histologic appearance. 
Uhthoff 
Et al 
2003a 
Chronic model 
17 mature NZW 
rabbits (average 
weight 3.0 kg)  
The SSP tendon was 
transected close to its 
insertion. The proximal 
stump of the SSP tendon was 
wrapped with a 
polyvinylidine fluoride 
membrane to prevent 
spontaneous reattachment. 
 
Reattachment after 6 weeks The polyvinylidine 
fluoride membrane was removed and a bony 
trough (2 x 2 x 5 mm) made between articular 
cartilage of the humeral head and medial wall 
of the tuberosity. Three drill holes were then 
made with a 1 mm in diameter drill bit from 
the lateral aspect of the greater tuberosity into 
the bony trough. Two horizontal mattress 
sutures were placed, each suture passing 
through one drill hole then twice through the 
tendon and exiting through the second drill 
hole. The sutures were tied over the lateral 
aspect of the cortex. 
 
The shoulders were not 
immobilized postoperatively. 
Muscle, extra- and 
intramuscular Fat 
in volume and 
cross-sectional 
area 6 and 12 
weeks 
Extra- and intramuscular fat 
in the reattachment group was 
greater than in both, the 
detachment group and control 
group.  
Uhthoff 
Et al 
2014a 
30 adult female 
NZW rabbits 
(3.4 kg to 4.3 
kg) 
The SSP tendon was 
transected close to its 
insertion. 
 
A 2 x 2 x 5 mm bony trough was made 
between the rim of the wall of the tuberosity 
and the articular cartilage using a burr. Three 1 
mm holes were drilled from the lateral aspect 
of the greater tuberosity into the bony trough. 
The first thread was passed first through the 
most proximal drill hole, then through the 
tendon in a modified MA fashion and finally 
exited through the middle drill hole. The 
second thread was passed first through the 
middle drill hole, then passed through the 
tendon in a similar fashion to the first suture 
and brought through the distal drill hole. Both 
sutures were tied over the lateral aspect of the 
cortex. 
 
The shoulder was not 
immobilised post-
operatively. 
 
Weight and 
volume of SSP 
muscles and 
quantified the 
cross-sectional 
area of 
intramuscular fat 
(i-fat) 
histologically 1, 
two and six weeks  
There was significant loss of 
muscle weight and volume 
after one week and two weeks 
in the experimental group. I-
fat continued to accumulate 
up to six weeks at all sites of 
the SSP muscle. More fat 
accumulated closer to the 
musculotendinous junction 
than at the mid-part after two 
and six weeks. 
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Uhthoff 
Et al 
2014b 
30 female NZW 
rabbits,  
After complete detachment 
of SSP tendon at the greater 
tuberosity, the tendon stump 
was enveloped with a 
polyvinylidene fluoride 
membrane to avoid 
spontaneous reattachment. 
SSP tendon was repaired after 4 weeks or 8 
weeks of detachment or after 12 weeks.  In the 
second cohort, the polyvinylidene membrane 
was removed, a trough burred into the greater 
tuberosity and the tendon inserted into it. 
All animals were allowed to 
roam freely in their cages. 
SSP fossa volume, 
percentage of 
intramuscular at 
(i-fat), and muscle 
tissue volume 
(muscle belly 
volume minus i-
fat), CT 
determination of 
e-fat and i-fat  
12 weeks 
 
Muscle belly and muscle 
tissue volumes did not 
increase after repair, but early 
repair prevented further 
volume losses, a fact not seen 
after 8 and 12 weeks delay of 
repair. No reversal of e-fat or 
of i-fat occurred. CT studies 
confirmed the fat results.  
 
Trudel 
Et al 
2017 
112 adult female 
NZW rabbits 
(3.0 kg) 
SSP tendon was transected at 
the humerus insertion Site 
and the tendon stump was 
wrapped in a polyvinylidene 
membrane stitched to the 
tendon to allow nutrition to 
diffuse but to prevent 
adhesion to surrounding 
tissue. At the first surgery 
(the channeling group) was 
performed at the footprint 
while the remaining were 
only subjected to tendon 
detachment (the no-
channeling group). 
Channeling consisted of 
exposing the SSP insertion 
footprint, dividing it into four 
quadrants, and drilling a 1-
mmdiameter hole at the 
center of each quadrant. The 
four holes were drilled to a 
depth of 10mm to ensure 
communication with the 
medullary canal. In the no-
channeling group, the 
footprint of the SSP was left 
untouched. 
The repair surgery was performed 1 week after 
tendon detachment and was identical for the no 
channeling and channeling groups. Used a 
curette to clear and microfracture the footprint 
for SSP tendon reattachment. The retracted 
SSP tendon was mobilized and Millipore was 
removed. A single 3 anchor was inserted 
lateral and distal to the footprint, and apposing 
the SSP tendon to the footprint using an 
inverted horizontal mattress suture completed 
the repair. 
Nothing Quantitative T2 
mapping 0, 1, 2, 4 
or 16 weeks 
Tendon repair and 
postoperative duration both 
affected significantly the T2 
values while channeling had 
no significant effect. For the 
time effect, the only pair with 
a statistical difference was the 
0-week and 4-week for the 
channeling groups. 
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APPENDIX D – ROTATOR CUFF SHEEP REPAIR MODELS 
Table 9-4 Rotator cuff sheep repair models 
Study Acute/Chronic? 
Age/Weight? 
Tear model Repair procedure Associated 
procedures/Post-operative 
immobilization 
Time points/ 
Outcome 
measures 
Results 
Baums 
et al 
2012 
Acute model in 
18 skeletally 
mature ewes (2-
3 years; average 
weight 57 kg) 
Unilateral, the infraspinatus 
tendon was detached sharply 
from its insertion on the 
proximal part of the humerus 
to create a full-thickness 
standardized tear. 
 Bioabsorbable suture anchors (Duet Suture 
Anchors; ConMed Linvatec, Largo, FL) 
coupled with braided, nonabsorbable polyester 
suture material (No. 2 Ethibond; Ethicon, 
Somerville, NJ) were used. In SR repair (n = 
9), 1 row of 2 suture anchors, with arthroscopic 
Mason-Allen stitch technique. In DR repair (n 
= 9), 2 rows of suture 2 anchors running 
parallel to each other with arthroscopic Mason-
Allen stitches in the lateral aspect of the tendon 
and mattress stitches medially.  
Surface of the tuberosity was 
roughened with a curette to 
create a bleeding surface and 
remove any fibrocartilage. A 
soft protector, 10 cm in 
diameter, was affixed to the 
hoof of the operatively 
treated limb to try to reduce 
weight bearing and to 
simulate relief of the strains 
on the operated shoulder. 
The animals were placed in a 
small pen for the first 6 
weeks to limit their activities. 
6 weeks (n = 3 per 
group), 12 weeks 
(n = 3 per group), 
and 26 weeks (n = 
3 per group).  
1.5T MRI of 
isolated shoulders 
and scoring 
according to 
Sugaya. 
Macroscopic 
evidence of 
foreign-body 
reaction to the 
anchors. 
Biomechanical 
tensile testing. 
No difference in MRI 
integrity. Mean load to failure 
was significantly higher in 
the DR compared with SR 
group at 6 and 12 weeks, but 
not at 26 weeks. DR group 
achieved a mean load to 
failure similar to that of a 
healthy infraspinatus tendon, 
whereas SR reached only 
70% of the load of a healthy 
infraspinatus tendon. 
Baums 
et al 
2015 
Acute model in 
24 skeletally 
mature ewes (2-
3 years; average 
weight 57 kg) 
Unilateral, the infraspinatus 
tendon was identified and 
sharply removed from its 
insertion site on the proximal 
humerus, antero-inferior to 
the acromial aspect of the 
deltoid muscle, to mimic an 
acute tendon tear. 
In the SR group, an arthroscopic Mason-Allen 
stitch configuration with two double-loaded 
bio-absorbable anchors was applied in a single 
row.  In the DR group, the repair consisted of 
two rows of suture anchors running parallel to 
each other. Each row consisted of two 6.0 mm 
suture anchor systems (Duet_ Suture Anchor, 
Conmed Livatec, Largo, FL, USA). A 
combination of laterally applied arthroscopic 
Mason-Allen stitches was combined with 
mattress stitches medially. Tendons were fixed 
using braided, non-absorbable No. 2 polyester 
sutures (Ethibond, Ethicon, Sommerville, NJ, 
The surface of the tuberosity 
was roughened with a curette 
to generate bleeding and to 
remove fibrocartilage. Soft 
protectors 10 cm in diameter 
were affixed to the hooves of 
the treated limbs to reduce 
weight-bearing, as previously 
described. Animals were 
housed in small pens for the 
first 6 weeks to limit 
excessive movement.  
1, 2, 3, 6, 12, and 
26 weeks (n=2 per 
group). Histology. 
Immunohistochem
istry for Col 1, 
Col 2, Col 3. 
Collagen expression differed 
between SR and DR repair. 
Col 3 collagen was no longer 
visible 6 weeks 
postoperatively in the DR 
group, but remained 
detectable until 12 weeks in 
the SR group. Clusters of 
chondrocytes were detectable 
only in the DR group between 
weeks three and twelve, and 
the content of proteoglycans 
was higher in the DR group. 
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USA).  Faster healing in DR group. 
Colema
n et al 
2003 
Acute and 
chronic models 
in 36 skeletally 
mature ewes (> 
3.5 years; 
average weight 
67 kg) 
Unilateral, the infraspinatus 
tendon was detached sharply 
from its insertion on the 
proximal part of the humerus. 
For the chronic groups, the 
tendons were wrapped in a 5 
cm X 3 cm sheet of Preclude 
(WL Gore and associates, 
Flagstaff, AZ), a porous 
membrane composed of 
Gore-Tex. 
Twelve sheep underwent immediate repair of 
the tendon to bone with use of 2 sheep allograft 
bone-suture anchors with 2 No 2 Ethibond 
suture per anchor. The tendons were grasped in 
a modified Mason-Allen technique. The other 
sheep underwent delayed repair at 6 weeks 
(n=8) and at 18 weeks (n=16). For the 6-week 
delayed group, repair technique was the same 
as acute group. For the 18-week delayed group, 
repair was with a PLA patch (Smith and 
Nephew). 
The surface of the tuberosity 
was roughened with use of a 
curet to create bleeding 
surface prior to anchor 
insertion. No post-operative 
immobilization for the acute 
group. Softballs were affixed 
to the hooves for 5 weeks in 
the chronic groups. 
 
For acute group: 6 
weeks (n=4), 12 
weeks (n=4) and 
20 weeks (n=4).  
For chronic 6-
week delayed 
group: 12 weeks 
(n=4) and 20 
weeks (n=4). For 
chronic 18-week 
delayed group: 12 
weeks (n=8), 20 
weeks (n=4), 36 
weeks (n=4). In 
vivo muscle 
testing. Muscle 
lipid content.      
EM.   
Biomechanics. 
Histology. 
 
There was retraction of the 
tendon in the delayed repair 
groups. Muscle force 
decreased initially in the 
delayed repair groups but 
increased following repair. 
Muscle lipid content 
increased initially in the 
delayed repair groups but 
decreased following repair. 
Module of elasticity increased 
initially in the delayed repair 
groups and decreased 
following repair only in the 6-
week delayed group. There is 
probably a point-of-no-return 
after which tears become 
irreparable. 
Farshad 
et al 
2011 
Chronic model 
in 12 ewes 
(Mean age 16 
months; average 
weight 45 kg) 
Unilateral, the infraspinatus 
tendon was released through 
an osteotomy of the greater 
tuberosity. During the 16 
week period of retraction, the 
bone chip and distal part of 
the tendon of the 
musculotendinous unit were 
shielded against spontaneous 
healing (scar formation) by 
encasement within a silicone 
tube as previously described 
Continuous traction of the tendon to the 
original tendon reinsertion site, and then 12 
weeks of rehabilitation 
Not described 34 weeks after 
tendon release 
MRI 
Histology 
Retracted musculotendinous 
units have deteriorated 
tendons, characterized by 
increased collagen fiber 
crimp, and ultrastructural 
collagen fibril atrophy and 
disorganization. Continuous 
traction may arrest and 
partially restore degenerative 
changes in retracted tendon. 
Gerber 
et al 
1999 
Acute and 
chronic models 
in 47 skeletally 
mature ewes 
(Mean age 5 
years; average 
Unilateral, the infraspinatus 
tendon was released at its 
insertion.  
For chronic group, the sheep were kept in a 
hanging device, which kept them immobilized 
for 4-6 weeks prior to repair. For acute group, 
the infraspinatus tendon was shortened by 5-10 
mm to simulate tendon retraction. Two 
modified Mason-Allen stiches or three simple 
stiches with Ethibond No 3 were placed into 
The bone of the greater 
tuberosity was decorticated 
until cancellous bone was 
exposed. In early studies, no 
post-op immobilization. In 
later studies fixation of a ball 
6 weeks, 3 
months, 6 months.  
Histology. 
Biomechanics. 
Transient localized tissue 
damage induced by the two 
suturing techniques. Modified 
Mason-Allen stitch is a more 
secure way of suturing the 
tendon. Rate of failure 
exceedingly high when no 
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weight 60 kg) the tendon end and passed through a bony 
trough created at the site of the original 
insertion and tied over the greater tuberosity. 
In the Mason-Allen group, the sutures were 
tied over absorbable poly lactide plates. 
under the hoof of the sheep. post-operative immobilization 
was used. The Mason-Allen 
technique with poly lactide 
plates gave superior repair. 
Gerber 
et al 
2004 
Chronic model 
in 6 skeletally 
mature ewes 
(Mean age 3.6 
years; average 
weight 51 kg) 
Unilateral, the insertion of 
the infraspinatus tendon was 
released by osteotomy of the 
greater tuberosity leaving a 2 
cm X 1.5 cm fragment of the 
greater tuberosity attached to 
the tendon. The end of the 
tendon was covered with a 5-
cm long silicone rubber tube 
(Silicone Penrose drain tube 
12-mm diameter), which was 
closed with a running suture 
at distal end. 
At 40 weeks after tendon release, repair was 
carried out with a sensor device interposed 
between the tendon and the greater tuberosity 
(to allow measurement of tension in the 
muscle). Sensors were removed after ~2 
weeks, sensor screw reinserted and tendon 
attached to these screws using Ethibond No 6 
sutures.   
None 75 weeks. CT 
Biopsies. 
Histology. 
EM. 
Tendon release induced 
muscle atrophy, fatty 
infiltration, and histological 
changes in the muscle tissue. 
Structural changes worsened 
after the repair and then 
recovered but only partially. 
Repair should be performed 
before significant muscle 
retraction occurs.  
Gerber 
et al 
2009 
Chronic model 
in 6 males and 6 
females (Mean 
age 16 months; 
average weight 
45 kg) 
Unilateral, the infraspinatus 
tendons were released using 
a greater tuberosity 
osteotomy. A fragment of the 
greater tuberosity of 20 x 10 
x 10 mm attached to the 
tendon. The distal part of the 
musculotendinous unit was 
encased in a silicone tube 
(Silicone Penrose drain tube, 
12 mm diameter; Fortune 
Medical Instrument, Taipei, 
Taiwan) and allowed to 
retract for 4 months. 
A device was mounted on the scapular spine 
and used to extend the infraspinatus 
muscuculotendinous unit transcutaneously by 1 
mm per day for 4 weeks. Rotator cuff repair 
was performed as near as possible to the 
original insertion area of the greater tuberosity, 
using a 3.5-mm cortical bone screw and the 
previously placed 2 Fiberwire #5 sutures 
(Arthrex Medical, Naples, FL). As in a 
previous study,15 the threads were augmented 
by 2 Fiberwire 2.5 threads (Arthrex, Naples, 
FL). 
None. A ball was attached to 
the sheep’s’ claw for 6 weeks 
postoperatively, followed by 
a full weight bearing 
rehabilitation protocol for 
another 12 weeks. 
34 weeks (18 
weeks after 
tensioner 
implantation and 
12 weeks after 
tendon repair).  
CT. Biopsies. 
MRI. Histology. 
EM. 
Elongation protocol 
technically difficult. Tendon 
release induced muscle 
atrophy and fatty infiltration. 
In the sheep where elongation 
worked, muscle atrophy 
decreased and fatty 
infiltration remained stable. 
There was no improvement in 
the group where elongation 
failed. 
Gerber 
et al 
2015 
Chronic model 
in 18 ewes 
(Mean age 25 
months; average 
weight 53 kg) 
Unilateral, ISP tendon was 
released by an osteotomy of 
the greater tuberosity (20 x 
10 x 10 mm). Piece wrapped 
in a silicone tube (Silicone 
Penrose drain tube, 12-mm 
diameter; Fortune Medical 
Instruments) and allowed to 
retract for 16 weeks. 
The tendon–bone chip complex was released 
from adhesions to the surrounding structures, 
the silicone tube was removed. Reattaching the 
bone chip to its original site then performed 
rotator cuff repair, or as near as possible, with 
Fiberwire No. 2 sutures and a 3.5-mm self-
tapping cortical bone screw. 
Weekly injections of 150 mg 
(3 mL) of nandrolone 
decanoate into the gluteus 
maximus muscle for test test 
group. During the first 3 
weeks of the rehabilitation 
period, animals were 
prevented from full 
weightbearing and stress to 
6 weeks after cuff 
repair 
CT. MRI. 
Biopsies. 
Histology. 
In a sheep model of rotator 
cuff tendon tear, further 
muscle atrophy can be 
prevented with the 
application of anabolic 
steroids starting immediately 
after tendon repair. In 
addition, fatty muscle 
infiltration can largely be 
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the repaired tendon by 
attachment of a ball to the 
sheep’s claws, and they were 
prevented from lying down 
by use of a loose suspension 
belt. 
prevented if the steroids 
are applied immediately after 
tendon release. 
Klinger 
et al 
2008 
Acute model in 
18 skeletally 
mature ewes (2-
3 years; average 
weight 57 kg) + 
16 matched 
cadaveric 
controls 
Unilateral, the infraspinatus 
tendon was sharply detached 
from its insertion on the 
proximal part of the humerus. 
Sutures were braided, non-absorbable polyester 
Ethibond (Ethicon, Sommerville, NJ, USA) 
suture size No. 2. In group 1, two transosseous 
sutures were passed through three bone tunnels 
and placed in the rotator cuff tendon 5 mm 
apart from the free margin of the tendon using 
a modified Mason-Allen technique. In-group 2, 
two bioabsorbable anchors (Duet Suture 
Anchor, Conmed Linvatec, Largo, FL, USA), 
double loaded, were used with the so-called 
arthroscopic Mason-Allen stitch configuration. 
The surface of the tuberosity 
was roughened with use of a 
curet to create bleeding of the 
surface prior to tendon 
Refixation. 10 cm diameter 
softball was affixed to the 
hoof of the operatively 
treated limb to inhibit weight 
bearing. The animals were 
placed in a small pen for the 
first six weeks to limit 
activities. After six weeks, 
the ball was removed and the 
sheep were turned into a 
large pen. 
6, 12, or 26 weeks 
(n=3 per treatment 
per time point).  
MRI. 
Biomechanics. 
Imaging showed good cuff 
integrity in both groups and 
no evidence of foreign body 
reaction to the anchors. At 
time 0, there was a higher 
load-to-failure in the anchor 
group, but not at longer time 
points. 
Kovacev
ic et al 
2008 
Group 1: Acute 
model in 72 
skeletally 
mature ewes 
Group 2: Acute 
model in 56 
skeletally 
mature ewes 
 
Unilateral, infraspinatus 
detachment. 
 
Group 1: Repair of the infraspinatus tendon to 
the greater tuberosity using sutures through 
bone tunnels. The experimental animals (n = 
24) received an osteoinductive bone protein 
extract (containing BMP-2–7, TGF-b1-3, FGF) 
at the tendon-bone interface using a type I 
collagen sponge carrier. The two control 
groups (n = 24 each) consisted of repairs 
treated with the collagen sponge carrier alone 
or no implant.  Group 2: Double-row suture 
reattachment of the infraspinatus tendon to the 
proximal humerus. RhBMP-12 was tested 
using various delivery vehicles -hyaluranon 
paste, hyaluranon sponge, absorbable type I 
collagen sponge, and type I/III collagen sponge 
(n=8 per group), type I/III collagen sponge 
alone (n=10), the tendon repair with no implant 
(n=14). 
None. No post-operative 
immobilization. 
Group 1: 6 and 12 
weeks.  Group 2: 
4 and 8 weeks.  
MRI. Plain 
radiographs. 
Histology. 
Mechanical 
testing. 
Ultrasound. 
Group 1: A gap consistently 
formed between the end of 
the repairedtendon and bone, 
with reparative scar tissue 
and new bone spanning the 
gap. MRI showed the volume 
of newly formed bone and 
soft tissue   in the tendon-
bone gap was greater in the 
growth-factor-treated 
animals. The repairs treated 
with the osteoinductive 
growth factors had greater 
failure loads at 6 weeks and 
12 weeks.  Group 2: 
Ultrasound evaluation 
demonstrated a gap (10–18 
mm) between the tendon and 
the bone in all repair groups 
at both time points, with no 
differences between groups. 
RhBMP-12- treated repairs 
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had increased load-to-failure 
and stiffness compared to the 
sponge carrier alone or 
untreated repairs. 
Reestablishment of collagen 
fiber continuity between the 
bone and the fibrovascular 
interface scar tissue, with 
increased glycosaminoglycan 
content in the rhBMP-12-
treated repairs. 
Lewis et 
al 1999 
Acute model in 
38 skeletally 
mature ewes 
Unilateral, using sharp 
dissection the infraspinatus 
tendon was detached from 
the greater tuberosity. The 
tendon was then split 
longitudinally for 2 cm into 2 
strips. 
The proximal strip was reattached with suture 
anchors, and the distal half was reattached 
using bone tunnel sutures. Bone tunnel 
method: A bony trough was created in the 
proximal humerus, three holes were created 
into the greater tuberosity to pass the sutures, 
the tendon was sutured into the trough using 
two Ethibon No 2 sutures in a modified 
Mason-Allen pattern. Anchor method: Two 
SDsorb suture anchors were used and sutures 
placed in the tendon using a horizontal 
mattress pattern. 
None. No post-operative 
immobilization. 
0, 3, 6, 9, 12 
weeks (n=6 for 
day 0 and n=8 for 
other days).  
Biomechanics on 
proximal and 
distal attachments 
done separately. 
Most failures were at the 
tendon-bone interface. No 
difference in tensile force and 
stifnness between two repair 
techniques, except at time 0, 
where the bone tunnel 
technique had higher tensile 
force. 
Liem et 
al 2015 
Acute model in 
18 ewes (40-50 
kg) 
Unilateral, the tendon was 
sharply detached from the 
greater tuberosity. 
SR repair: The modified Mason-Allen sutures 
were performed with a single row of two 
Corkscrew suture anchors positioned at the 
lateral edge of the footprint, each armed with 
two strands of No. 2 FiberWire (Arthrex Inc., 
Naples, FL, USA), the first one passed through 
the tendon in a horizontal mattress pattern, the 
second one as a simple stitch on top of the 
horizontal mattress. SB repair: A medial row 
of two Corkscrew suture anchors at the medial 
edge of the footprint, armed with No. 2 
FiberWire and a lateral row of two PushLock 
anchors (Arthrex Inc., Naples, FL, USA). The 
medial row sutures were tied before the suture 
limbs were affixed with the lateral row of 
PushLock anchors. 
Light decortication of the 
humeral insertion The 
animals were kept in a small 
pen of approximately 3 m2 
for one week to limit 
ambulation and protect the 
repair. 
12 weeks. 
Doppler 
flowmetry. 
Macroscopic. 
Tendon blood flow decreased 
after repair. No difference in 
restoration of blood flow and 
in failure rates at 12 weeks. 
Lovric 
et al 
Acute model in 
8 skeletally 
Unilateral, the infraspinatus 
tendon was sharply detached 
The infraspinatus tendon was repaired with a 
transosseous-equivalent suture bridge construct 
Cartilage at the footprint of 
the muscle insertion was 
28 days.  Improved histological 
appearance, increased BMD 
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2013 mature wethers 
(18 months) 
from its insertion into the 
greater tuberosity. 
using medial row and lateral push-in suture 
anchors (Arthrex, Inc, Naples, Florida, USA). 
Low-intensity Pulsed Ultrasound treatment 
was done on 4 of the sheep. 
burred to create a bleeding 
bone bed. No post-operative 
immobilization. 
MicroCT. 
Histology. 
Immunohistochem
istry for BMP-2, 
Smad4, VEGF 
and RUNX2. 
at the tendon-bone interface, 
increased immuno of VEGF, 
Smad4 and Runx2 with 
Ultrasound.  
Luan et 
al 2015 
Acute model in 
12 skeletally 
mature ewes.  
Unilateral, the insertion of 
the infraspinatus tendon to 
the greater tuberosity of the 
humerus was sharply 
transected, and any 
remaining fibrocartilage at 
the insertion was removed. 
Two 5.5 mm suture anchors were deployed 
into the dense bone of the medial footprint of 
the proximal humerus (one anchor cranially 
and one anchor caudally). The suture anchors 
were placed approximately 1 cm apart and 2 
mm to 4 mm deep to the cortex. Sutures were 
passed from inferior to superior through the 
infraspinatus tendon and tied in simple 
mattress fashion on the superior surface of the 
tendon. 
A hall air drill and burr were 
used to create a bed of 
bleeding bone at the footprint 
of the infraspinatous tendon. 
After suturing the tendon 
back to the footprint, the 
surgical site was lavaged 
with sterile saline. No post-
operative immobilization. 
6 months.  
Histology. 
Western blot. 
qRT-PCR. 
Increased adipocytes, muscle 
fatty infiltration, and collagen 
deposition in rotator cuff 
muscles compared to 
contralateral. Also, increased 
expression of genes related to 
muscle atrophy, fatty 
infiltration and fibrosis. 
Meyer et 
al 2004 
Chronic model 
in 8 sheep 
(Mean age 3.75 
years; average 
weight 48 kg) 
Unilateral, the infraspinatus 
tendon was released by 
osteotomy of the greater 
tuberosity. The tendon end 
was encased using a closed 
silicone rubber tube of 5 cm 
length to prevent 
spontaneous healing. 
 
Forty weeks after tendon release, the silicone 
sheath was removed and the retracted tendon 
was reconnected to the humeral head using 
three USP#3 sutures bridging the gap between 
tendon end and bone. 
None. No post-operative 
immobilization. 
35 weeks.  
Biopsies.  
MRI. 
Macroscopic. 
Histology. 
EM. 
At necropsy, muscles had 
retracted, pennetion andle had 
increased and fiber length had 
decreased compared to 
contralateral. Fat and fibrous 
tissue in the muscle was also 
increased.   
Meyer et 
al 2006 
 
Chronic model 
in 6 sheep 
(Mean age 3.75 
years; average 
weight 48 kg) 
Unilateral, the infraspinatus 
tendon was released 
by osteotomy of the greater 
tuberosity, leaving a bone 
chip approximately 1 cm 
long and 0.5 cm thick on the 
tendon. The tendon end was 
encased using a closed 
silicone rubber tube of 5 cm 
length to prevent 
spontaneous healing. 
 40 weeks after release, the retracted tendon 
was surgically repaired using two sutures 
under moderate tension. 
None. No post-operative 
immobilization. 
75 weeks.  CT 
was performed 
under general 
anaesthesia at 
intervals of 0, 16, 
40, 46, 52 and 75 
weeks.  MRI. 
Histology. 
Tendon retracted after release 
and stayed partly retracted 
after repair. Muscle retracted 
less. 
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Peterson 
et al 
2015 
Acute model in 
80 skeletally 
mature ewes (2-
4 years; 50-80 
kg) 
Unilateral, the infraspinatus 
tendon was released 
completely from the humerus 
with a scalpel, beginning 
with the most distal portion 
of the tendon attachment. 
The tendon was repaired to the footprint using 
2 double-loaded 5- mm Poly Insite anchors 
(Tornier) placed in the humerus about 5 mm 
beyond the distal edge of the tendon footprint. 
The 4 sutures from these 2 anchors were used 
to secure the tendon to the humerus using 4 
modified Mason-Allen stitches 1 cm from the 
distal edge of the infraspinatus tendon. The 
repairs in the treatment groups were reinforced 
with scaffolds containing 0, 1, 8, or 32 mg of 
F2A (a synthetic mimetic of bFGF). Two No. 2 
ForceFiber sutures (Tornier) were embedded 
into the tendon 2 cm from the distal edge of the 
tendon using Mason-Allen stitches before 
reattachment of the tendon to the footprint in 
the same manner as the controls. These sutures 
were used to attach the proximal edge of the 
scaffold to the tendon. Two more No. 2 
ForceFiber sutures were placed at the distal 
edge of the scaffold in a mattress stitch pattern 
and then tensioned to the humerus using two 
3.5-mm Piton anchors (Tornier) so that the 
scaffold fit tightly against the infraspinatus 
with the limb in neutral abduction. 
None. No post-operative 
immobilization. 
8 and 26 weeks.  
Macroscopic. 
Histology (they 
refer to the Movin 
score, a validated 
scoring system for 
tendinopathy). 
MRI. 
Immunohistochem
itry for F2A. 
Biomechanics. 
Scaffold-repaired tendons 
were thicker than surgically 
repaired controls (at 8 weeks. 
There was more new bone 
formed at the tendon footprint 
in sheep treated with F2A.  
The extent of delamination 
decreased to with increasing 
doses of F2A. More of the 
repair tissue at the footprint 
was tendon-like in the 
peptide-treated sheep.  
Schlegel 
et al 
2006 
Acute model in 
26 sheep  
Unilateral, the tendon was 
sharply detached from the 
greater tuberosity of the 
humerus, and 5 mm of the 
distal tendon was resected 
before reattachment to 
simulate a rotator cuff repair 
being performed under 
tension. 
A bone trough, 2.0 cm in length and 0.5 cm in 
depth, was prepared in the proximal humerus 
using an osteotome and burr. Four separate 
tunnels were created in the greater tuberosity 
using the Linvatec shoulder set (Linvatec Corp, 
Largo, Fla). The infraspinatus tendon was 
sutured into the trough using three No. 2 
nonabsorbable sutures (Ethibond, Ethicon Inc, 
Somerville, NJ) in a modified Mason-Allen 
stitch. Each limb of the suture was passed 
through a separate osseous tunnel, with the 2 
center tunnels being used twice. The sutures 
were tied over a cortical bridge. In the 
treatment group, a 10 to 20-mm patch of SIS 
was placed on the superficial aspect of the 
repaired tissue. The initial fixation of the patch 
was achieved by using a free No. 5 Mayo 
needle to pass the free ends of the 2 central 
limbs of the nonabsorbable suture used in the 
Once the repair was 
completed, the surgical site 
was lavaged with sterile 
saline solution. The animals 
were placed in a small pen 
for the first 6 weeks to limit 
activities. 
12 weeks. 
Histology. 
Biomechanics. 
No difference in load-to-
failure between groups. 
Increased stiffness in the 
augmented group. Insertion 
of the tendon to bone was 
through a fibrocartilaginous 
zone. 
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transosseous repair of the infraspinatus tendon, 
eventually tying these ends over the patch. The 
implant was sutured to the surrounding tissues 
using simple 2-0 polydioxanone sutures. 
Rodeo et 
al 2007 
Acute model in 
72 skeletally 
mature ewes 
Unilateral, the tendon was 
sharply detached from the 
greater tuberosity. 
Four 2.0-mm drillholes were placed into the 
greater tuberosity for repair of the rotator cuff 
tendon to bone. These holes exited laterally 
over the proximal humeral cortex. Two 
number-5 Ethibond sutures (Ethicon, 
Somerville, New Jersey) were passed in a 
Mason-Allen configuration through the tendon, 
and each suture was brought through one of the 
four holes. The sutures were then tied over the 
lateral humeral cortex over a stainless-steel 
cortical bone augmentation plate (Synthes, 
Paoli, Pennsylvania).  The experimental group 
consisted of twenty-four animals that received 
1.0 mg of an osteoinductive bone protein 
extract (Growth Factor Mixture [GFM; Sulzer 
Biologics, Wheat Ridge, Colorado] described 
in detail below) on a Type-I collagen sponge 
carrier applied to the tendon-bone interface. 
Twenty-four animals received only the 
collagen sponge carrier with no growth factors 
and twenty-four animals underwent the tendon 
repair with no implant. 
The greater tuberosity was 
then prepared for repair of 
the tendon by removing any 
remaining soft tissue and 
fibrocartilage. The greater 
tuberosity was lightly 
decorticated with use of a 
high-speed burr until 
punctate bleeding from the 
bone was noted. 
Decortication was done to a 
depth of only 1 mm; cortical 
bone still remained. 
 
6 and 12 weeks 
Radiographs. 
MRI. 
Histology. 
Biomechanical 
testing. 
A gap consistently formed 
between the end of the 
repaired tendon and bone in 
this model, with reparative 
scar tissue and new bone 
spanning the gap. This model 
tests the effects of growth 
factors on scar tissue 
formation in a gap between 
tendon and bone. The 
administration of 
osteoinductive growth factors 
resulted in greater formation 
of new bone, fibrocartilage, 
and soft tissue, with a 
concomitant increase in 
tendon attachment strength 
but less stiffness than repairs 
treated with the collagen 
sponge carrier alone. 
Uggen 
et al 
2010 
Chronic model 
in 18 sheep 
Unilateral, the infraspinatus 
tendon was detached sharply 
from its insertion on the 
proximal humerus. The 
tendon was wrapped in a 5 to 
3–cm sheet of Preclude 
(Gore Medical, Flagstaff, 
AZ). 
Two weeks after release, the tendon was 
repaired. For the single-row repair, 1 double-
loaded, 5.5-mm metal corkscrew anchor 
(Arthrex) was placed proximally in the tendon 
footprint and 1 single-loaded 3.5-mm metal 
corkscrew anchor (Arthrex) was placed distally 
in the footprint. The tendon was unwrapped 
and mobilized by blunt dissection. The tendon 
was then repaired with uncoated No. 2 
FiberWire (n = 9) or No. 2 FiberWire coated 
with rhPDGF-BB (n = 9). Repairs were 
performed with a “rip-stop” horizontal mattress 
stitch and medially placed simple stitch from 
the double-loaded anchor and a horizontal 
mattress stitch from the single-loaded anchor. 
The surface of the tuberosity 
was roughened with a bur to 
create a bleeding bone 
surface before anchor 
insertion. 
6 weeks. 
Histology (they 
used the 
Soslowsky 
scoring system). 
Biomechanics. 
Improved tendon-to-bone 
healing in the rhPDGF-BB–
augmented repairs. There was 
no significant difference in 
the ultimate load to failure 
between both groups. 
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Wieser 
et al 
2015 
Chronic model 
in 20 skeletally 
mature ewes 
(Average age 23 
months; average 
weight 55 kg) 
Unilateral, the right 
infraspinatus (ISP) tendon 
was released using an 
osteotomy of the greater 
tuberosity, immediately after 
initial biopsy of the ISP 
tendon. The biopsy site was 
marked with non-resorbable 
USP no. 4–0 monofilament 
suture, and the tendon–bone 
chip complex was wrapped 
in a silicone tube to prevent 
scarring and was allowed to 
retract for a total of 4 
months. 
A second biopsy of the tendon was performed 
next to the first biopsy site, which was again 
marked with a second suture. A device, 
allowing continuous lengthening (1 mm/day) 
of the musculotendinous unit by external 
manipulation of the lever arm, was then 
implanted on the scapular spine of all sheep. 
The tendon–bone chip complex was grasped 
with 2 USP No. 2 FiberWire sutures (Arthrex, 
Naples, Florida), which were connected to the 
traction device. After the relengthening period 
of 6 weeks (+ or – anabolic steroids/IGF), 
during which the sheep could ambulate freely, 
the traction device was removed and the rotator 
cuff was repaired by re-attaching the bone chip 
to its original site or as near to this site as 
possible with attachment of the remaining 
sutures to a 3.5-mm cortical bone screw with a 
washer. 
None. For the first 6 weeks 
after this repair, a suspension 
belt and a ball, attached to 
the sheep’s hooves, were 
used to prevent the sheep 
from stressing the repaired 
tendon. Subsequently, a full 
weight-bearing period of 8 
weeks was allowed before 
killing. 
14 weeks. 
Histology (they 
developed a new 
degeneration 
score for 
tendinous tissues 
(DSTT), based on 
established 
knowledge on 
histological 
changes 
associated with 
tendon 
degeneration).  
Histological score improved 
after re-lengthening. Adding 
steroids or IGF had no further 
benefit on the histological 
score. 
Zumstea
in et al 
2012 
Chronic model 
in 12 sheep 
(Mean age 16 
months; average 
weight 45 kg) 
Unilateral, the infraspinatus 
was released using an 
osteotomy of the greater 
tuberosity. Two Fibre wire 
No. 5 sutures (Arthrex, 
Naples, FL) were passed in a 
figure-of-eight configuration 
through tendon and bone. 
The sutures and the greater 
tuberosity were wrapped into 
a 5 cm long silicone rubber 
tube (Silicone Penrose drain 
tube, 12 mm, Fortune 
medical instrument corp. 
Taipei, Taiwan). The tube 
was closed with non-
resorbable suture at its end to 
prevent spontaneous healing. 
After a retraction and degeneration time of 
40 weeks, the tensioner was implanted using 
the same approach. The tensioner pulled the 
tendon axially by a distance of 1 mm/day 
towards its original insertion. Subsequent to 
the elongation protocol, the tensioner was 
removed and the greater tuberosity was 
reattached as near as possible to its original 
insertion using 3.5 mm cortical bone screws 
and the previously prepared sutures. Tthe 
fixation was augmented by two Fiber Wire No. 
2 sutures (Arthrex, Naples, FL). 
None.  Rehabilitation 
included prevention from 
lying down by using a loose 
suspension net. To avoid full 
weight bearing, a ball was 
attached to the sheep’s’ claw 
for six weeks 
postoperatively. 
Radiographic 
assessment. 
The tensioner proved to be 
capable of actively stretching 
the retracted and degenerated 
muscle back to the original 
length and to withstand the 
external forces acting on it. 
APPENDIX E- CLINICAL STUDIES COMPARING PRP STUDY IN ROTATOR CUFF REPAIR. 
Table 9-5 Clinical studies comparing PRP study in Rotator cuff repair. 
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Study Design Inclusion 
criteria 
Details of 
surgery 
PRP 
fomulation 
Sample 
size (% 
males) 
Mean 
age 
(years) 
FU 
rate 
(%) 
Mean 
FU times 
(months) 
Outcome 
measures 
Definition 
of retear 
Results 
Sanchez 
Marquez 
et al 2011 
Level II 
Prospective 
randomized 
Evidence of a 
massive rotator cuff 
tear of at least 5 cm 
and including 2 
tendons (SSP and 
ISP) 
SR repair 
Average three 
suture anchors   
Removal of 
osteophytes in 
3 patients 
Vivostat PRF 
(Visostat A/S, 
Alleroed, 
Denmark) 
L-PRF 
28  
(28.6) 
14 in 
PRP+ 
group 
14 in PRP- 
group 
65 100 12 Constant score 
VAS score for 
pain 
Retear rate-
MRI 
Frank re-tearing 
of the tendon 
with retraction 
of the cable on 
MRI 
No effect on 
clinical scores 
No effect on 
re-tear rate 
Barber et 
al 2011 
Level III 
case-control 
study 
1- or 2-tendon Full-
thickness rotator 
cuff tear measuring 
10-50 mm in width; 
stage 2 fatty 
infiltration or 
lower 
SR repair 1 or 
2 double-
loaded suture 
anchors 
Abrasion of 
the bone at the 
attachment site 
Cascade PRP 
fibrin matrix 
construct 
(Musculoskeletal 
Transplant 
Foundation) P-
PRF Recalcified 
with CaCl2 
40 (67.5) 
20 in 
PRP+ 
group 
20 in PRP- 
group 
57 100 Clinical, 31 
MRI, 4 
ASES score 
Constant score 
Rowe score 
SANE score 
SST score 
Retear rate-
MRI 
(Primary 
outcome) 
Full-thickness 
rotator cuff 
defect 
Less retears in 
PRP+ group 
No effect on 
clinical scores 
except higher 
Rowe score in 
PRP+ group 
Randelli et 
al 2011 
Level I 
Prospective 
randomized 
Complete rotator 
cuff tear confirmed 
intraoperatively, 
agreed to wear a 
dedicated brace for 
4 weeks, 
preoperative 
platelet count 
>150,00, minimum 
preop hemoglobin 
11,0g/dl or +, no 
infectious disease, 
BMI >33 
SR repair 
Acromioplasty 
Autologous PRP 
(GPSII-Plasmax 
Biomet, 
Warsaw, IN, 
USA) 
L-PRP 
Mixed with 
autologous 
thrombin and 
recalcified with  
CaCl2 
53 (40) 
26 in 
PRP+ 
group 
27 in 
PRP- 
group 
60 85 Clinical 
3,6,12,24 
months. 
VAS 
3,7,14,30 
days 
MRI 12 
months 
SER score, 
VAS score, 
SST score, 
UCLA score, 
MRI 
Lack of 
continuity of the 
tendon in 1 slice 
of the coronal 
plane. 
VAS < in 
PRP+ group in 
1st month. No 
change 3,6,12 
months. 
Clinical 
outcome better 
in PRP+ group 
at 3 months, 
no change 
between two 
groups at 
6,12,24 
months . 
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Re-tear 9 in 
PRP+(40%), 
12 in PRP- 
(52%). SER 
score high in 
PRP+ at 
3,6,12,24 
months. 
Castricini 
et al 2011 
Level I 
Randomized 
controlled 
clinical trial 
Rotator cuff tear 
MRI evidence, 
isolated SSP 
tendon, failure of 6 
months of 
nonoperative 
treatment, no 
shoulder instability, 
no sign of fracture 
of glenoid or 
greater or lesser 
tuberosity, 
reparable full-
thickness, 
associated injury of 
long head of biceps 
DR repair Cascade PRP 
fibrin matrix 
construct 
(Musculoskeletal 
Transplant 
Foundation) 
P-PRF 
Recalcified with 
CaCl2 
88 (45) 
43 in 
PRFM+ 
group 
45 in 
PRFM- 
group 
55 Clinical 
100% 
MRI 
92% 
Clinical 
constant 
score and 
MRI 16 
months 
Constant-
Murley 
scoring 
system, MRI: 
thickness and 
size of 
footprint 
Absence of 
visible tendon 
fiber extending 
across entire 
tendon from 
inferior to 
superior 
No change in 
Cst score, no 
change of 
signal 
intensity, MRI 
reruptures 4 in 
PRFM-group 
(10.5%) 
1 in PRFM+ 
group (2.5%) 
Jo et al 
2011 
Level II 
cohort study 
Full-thickness 
rotator cuff tear 
treated by 
arthroscopy  
Open 
technique 
SB repair 
2 or 3 suture 
anchors with 
small or 
medium tears, 
3 or 5 suture 
anchors with 
large or 
massive tears 
Plateletpheresis 
system with 
leukoreduction 
set (COBE 
spectra LRS 
turbo, Colorado) 
Mixed with 10% 
calcium 
gluconate  
42  (36) 
19 in 
PRP+ 
group 
23 in 
PRP- 
group 
 
60 100 Clinical 3, 
6,12,16 
months  
MRI 13 
months 
Clinical 
outcome: pain, 
ROM, 
strength, 
satisfaction, 
VAS 
Functional 
scores: ASES 
score, UCLA 
score, DASH 
score, SST 
score, SPADI 
score 
Sugaya’s 
method: grade 
IV (minor 
discontinuity) & 
V (major 
discontinuity) 
No difference 
between two 
groups in pain, 
ROM, 
strength, 
functional 
scores, 
satisfaction 
Retears 26.7% 
PRP+ 
41.2% in PRP- 
group 
Rodeo et 
al 2012 
Level II 
Randomized 
controlled 
clinical trial 
Patients of 40 years 
old or >, who had 
had failed 
nonoperative 
treatment for full-
Suture anchors 
SR or DR or 
SB repair 
technique 
Cascade PRP 
fibrin matrix 
construct 
(Musculoskeletal 
79 (56) 
40 in 
PRFM+ 
group 39 
58 85 6 and 12 
weeks 
Primary 
outcome: 
ultrasound and 
power 
Doppler at 6 
Not assessed No difference 
between the 
two groups 
Higher failure 
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thickness rotator 
cuff tear Transplant 
Foundation) 
P-PRF 
Recalcified with 
CaCl2 
in PRFM- 
group 
amd 12 weeks 
Secondary 
outcome: 
strength 
measurements, 
ASES and 
l’insalata 
shoulder score 
rate in PRFM+ 
group with DR 
or TOE 
technique at 
12 weeks 
Bergeson 
et al 2011 
Level III 
prospective 
cohort with 
historical 
control 
High-risk tears 
included per 
algorithm score 3; 
minimum age, 50 
yr; minimum tear 
size, 2 cm 
Full-thickness tear 
SR repair in 
majority Mean 
no. Of suture 
anchors 2.9  
 
Cascade PRP 
fibrin matrix 
construct 
(Musculoskeletal 
Transplant 
Foundation) 
P-PRF 
Recalcified with 
CaCl2 
37 (NR) 
16 in 
PRP+ 
group 
21 in PRP- 
group 
65 Clinical 
and 
MRI, 
97.3 
Clinical, 12 
for 
PRP+ group 
and 
27 for PRP- 
group MRI, 
12 
ASES score 
Constant score 
SANE score 
UCLA score 
WORC score 
Retear rate-
MRI 
Full-thickness 
defect in 
repaired tendon 
in which no 
fibers were 
visualized 
spanning defect 
in any MRI 
plane 
More retears 
in PRP+  group  
No effect on 
clinical scores 
 
Ruiz-
Moneo et 
al 2013 
Level I 
Randomized 
double-blind 
controlled 
clinical trial 
Diagnosis of rotator 
cuff tears based on 
physical 
examination and 
imaging and 
agreement to 
cooperate with 
study procedures 
(follow-up for at 
least 1 year 
including arthro-
MRI). Cases with 
tendon retraction 
and fatty atrophy 
were allowed. 
DR repair 
1 or 2 simple 
stitches 
depending on 
tear size 
2-6 total suture 
anchors  
PRGF System 
(B.T.I. 
Biotechnology 
Institute, 
Vitoria-Gasteiz, 
Spain) 
P-PRP 
Recalcified with 
CaCl2 
63 (39.7) 
32 in 
PRP+ 
group 
31 in PRP- 
group 
55 Clinical, 
100 
MRI, 
95.2 
Clinical and 
MRI, 12 
UCLA score 
as modified by 
Burkhart 
Healing rate 
assessed as in 
Charousset- 
MRI 
Not assessed No effect on 
healing rate 
No effect on 
clinical scores 
Weber et 
al 2013 
Level I 
Randomized 
controlled 
clinical trial 
Patients who 
required 
arthroscopic rotator 
cuff repair with or 
without additional 
arthroscopic 
procedures 
SR repair 
All patients 
had 
acromioplasty 
Cascade PRP 
fibrin matrix 
construct 
(Musculoskeletal 
Transplant 
Foundation) 
60 (60) 
30 in 
PRP+ 
group 
30 in PRP- 
group 
62 Clinical, 
100 
MRI, 89 
Clinical, 12 
MRI, 3-5 
ASES score 
SST score 
UCLA score 
FF 
ER 
MRI images No effect on 
clinical scores 
No effect on 
re-tear rate 
No effect on 
FF and ER 
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P-PRF 
Recalcified with 
CaCl2 
 
 
Antuna et 
al 2013 
Level II 
Prospective 
randomized  
Patients with a 
diagnosis of a 
massive rotaor cuff 
tear of the postero-
superior rotator cuff 
(two tendons, larger 
than 5 cms) made 
by clinical 
examination and 
magnetic resonance 
imaging (MRI). 
Only patients with 
tears affecting the 
supraspinatus and 
infraspinatus 
tendons were 
included 
Bioabsorbable 
suture anchors 
were used in 
every case 
(Biocorkscrew, 
Arthrex, 
Naples, Fl, 
USA) and in 
all cases the 
repair was 
considered 
complete 
Vivostat PRF 
(Visostat A/S, 
Alleroed, 
Denmark) 
L-PRF 
28 (21.4) 
14 in 
PRP+ 
group 
14 in PRP- 
group 
65 100 Clinical, 
12,24 
MRI, 12 
Constant score 
FF 
RofM 
DASH score 
VAS score for 
pain 
Suguya-MRI 
MRI images No effect on 
clinical scores 
No effect on 
re-tear rate 
No effect on 
FF and RofM 
Jo et al 
2013 
Level I 
Randomized 
controlled 
clinical trial 
Patients between 45 
and 85 years of age, 
large to massive 
rotator cuff tear 
>30mm MRI 
evidence 
Suture anchors 
3-5 anchors 
 
Plateletpheresis 
system with 
leukoreduction 
set (COBE 
spectra LRS 
turbo, Colorado) 
Mixed with 10% 
calcium 
gluconate 
48 
24 in 
PRP+ 
group 
24 in 
PRP- 
group 
63 Clinical 
100 
MRI 79 
MRI, CTA 
9 months 
Functional 
scores 
(clinical) 
12m 
months 
Primary 
outcome: 
MRI, CTA 
Secondary 
outcomes: 
CSA, clinical 
(pain, ROM, 
strength, 
satisfaction, 
functional 
scores), VAS 
score, ASES 
score, ULCA 
score, DASH 
score, SST 
score, SPADI 
score 
Sugaya’s 
method: grade 
IV (minor 
discontinuity) & 
V (major 
discontinuity) 
Retear rate 
lower in PRP+ 
group 4/20 
(20%), versus 
PRP- group 
10/18 (55.6%) 
No difference 
in pain, ROM, 
strength, 
satisfaction, 
functional 
scores, CSA. 
Malavolta 
et al 2014 
Level I 
Randomized 
controlled 
Complete SSP tears 
with MRI evidence 
without history of 
trauma and 
SR + 
acromioplasty  
99-CFE-
apheresis set 
(Haemonics 
corp.) PRP 
54 (31) 
In PRP+ 
group 28 
55 98 Clinical 3, 
6,12,24 
months 
UCLA score, 
CST score, 
VAS score, 
MRI 
Sugaya’s 
method: grade 
IV (minor 
discontinuity) & 
No change in 
clinical results, 
partial retear 
4fold higher in 
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clinical trial retraction of less 
than 3cm. 
mixed with 
autologous 
thrombin and 
recalcified with 
CaCl2 
and in 
PRP- 
group 27  
MRI 12 
months 
V (major 
discontinuity) 
control group 
at 3 months 
and 2fold 
higher at 6 and 
12 months 
compared to 
PRP+ group. 
1 retear in 
control group 
only. 
Zumstein 
et al 2014 
Level I 
Randomized 
controlled 
clinical trial 
Presence of a 
posterosuperior 
chronic full-
thickness 
detachment that 
was limited to the 
supraspinatus and 
infraspinatus 
tendons with an 
intact insertion of 
the subscapularis, a 
double-row cuff 
repair performed 
solely with use of 
arthroscopic 
techniques, and age 
older than 55 years. 
Patients with 
rotator interval 
involvement or 
biceps disease were 
also included. 
Suture bridge 
 
Choukroun’s 
PRF (PRF 
Process, Nice, 
France) 
L-PRF 
20 (59) 
10 in L-
PRP+ 
group 
10 in L-
PRP- 
group 
64 100 Clinical and 
MRI, 3 
Ultrasound, 
1.5 and 3 
SST score 
Constant-
Murley score 
Retear rate 
and Suguya-
MRI 
Vascularity-
ultrasound 
When a 
fluid-equivalent 
signal or 
nonvisualization 
of the 
supraspinatus or 
infraspinatus 
tendon was 
found 
 
No effect on 
clinical scores 
No effect on 
re-tear rate 
Increased 
vascularization 
in in PRP+ 
group 
 
Jo et al 
2015 
Level I 
Randomized 
controlled 
clinical trial 
Patients between 45 
and 85 years of age 
with medium to 
large rotator cuff 
tear 
(anteroposterior 
size >10mm 
<50mm) MRI 
evidence 
Suture bridge 
3-5 anchors 
1 or 2 anchors 
for medial 
row, 2 or 3 
anchors for 
lateral row 
Plateletpheresis 
system with 
leukoreduction 
set (COBE 
spectra LRS 
turbo; caridian 
BCT) 
73 (23) 
36 in 
PRP+ 
group and 
37 in 
PRP- 
group 
60 MRI 86 
Clinical 
100 
Clinical and 
functional 
scores 3,6 
and 12 
months  
MRI 9 
months 
Clinical 
outcome: pain, 
ROM, 
strength, 
satisfaction 
Functional 
scores: ASES 
score, UCLA 
score, SST 
score, SPADI 
score, CSA  
Sugaya’s 
method: grade 
IV (minor 
discontinuity) & 
V (major 
discontinuity) 
No change in 
functional 
scores 
Retear rate 
PRP+ 1/33 3% 
PRP- 6/30 
20% 
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MRI 
 
